Index Sample Index Original Filename Sample Name Sample ID Sample Comment Sample Type Acquisition Date & Time Rack Number Plate Number Vial Number Dilution Factor Injection Volume Operator Name Acq. Method Name IS Component Name Component Index Component Comment IS Comment Mass Info IS Mass Info IS Name Component Group Name Conc. Units Failed Query IS Failed Query Peak Comment IS Peak Comment Actual Concentration IS Actual Concentration Concentration Ratio Expected RT IS Expected RT Integration Type IS Integration Type Area IS Area Corrected Area IS Corrected Area Area Ratio Height IS Height Corrected Height IS Corrected Height Height Ratio Area / Height IS Area / Height Corrected Area/Height IS Corrected Area/Height Region Height IS Region Height Quality IS Quality Retention Time IS Retention Time Start Time IS Start Time End Time IS End Time Total Width IS Total Width Width at 50% IS Width at 50% Signal / Noise IS Signal / Noise Baseline Delta / Height IS Baseline Delta / Height Modified Relative RT Used Calculated Concentration Accuracy SF Peak Width Confidence SF Model Source SF Candidate Model Quality SF Asymmetry SF Saturated SF Integration Quality SF Group Confidence SF Num Peaks Score_IMPAQT MSSimScore_IMPAQT HeightScore_IMPAQT RTminScore_IMPAQT RankScore_IMPAQT MSSim_IMPAQT MSSimSita_IMPAQT RTminDiff_IMPAQT RankSum_IMPAQT CosSimilarity_IMPAQT CosSimilaritySita_IMPAQT Height_IMPAQT InterfereTrans_IMPAQT InterfereTransAll_IMPAQT LScore_IMPAQT LRTminScore_IMPAQT LSNScore_IMPAQT LSNAllScore_IMPAQT HLSimScore_IMPAQT HLSim_IMPAQT HLSimSita_IMPAQT BaseLine_IMPAQT BaseLineUnitNum_IMPAQT BaseLineMaxCount_IMPAQT Symbol Description 1 1 C20140716_OR021_03 C20140716_OR021_03 TB420305.[MT7]-VLIPSYAAGSIIGK[MT7].3y7_1.heavy 559.678 / 789.495 8249.0 41.4193000793457 48 18 10 10 10 27.326353284402302 3.6594710958772287 0.0 3 0.9842600742492857 9.824031180454673 8249.0 92.68048560124402 0.0 - - - - - - - 207.86666666666667 16 15 NOVA1;NOVA2 neuro-oncological ventral antigen 1;neuro-oncological ventral antigen 2 3 1 C20140716_OR021_03 C20140716_OR021_03 TB420305.[MT7]-VLIPSYAAGSIIGK[MT7].3b6_1.heavy 559.678 / 817.494 6438.0 41.4193000793457 48 18 10 10 10 27.326353284402302 3.6594710958772287 0.0 3 0.9842600742492857 9.824031180454673 6438.0 90.9901462982119 0.0 - - - - - - - 156.66666666666666 12 9 NOVA1;NOVA2 neuro-oncological ventral antigen 1;neuro-oncological ventral antigen 2 5 1 C20140716_OR021_03 C20140716_OR021_03 TB420305.[MT7]-VLIPSYAAGSIIGK[MT7].3y6_1.heavy 559.678 / 718.458 12272.0 41.4193000793457 48 18 10 10 10 27.326353284402302 3.6594710958772287 0.0 3 0.9842600742492857 9.824031180454673 12272.0 60.88289774872487 1.0 - - - - - - - 210.54545454545453 28 11 NOVA1;NOVA2 neuro-oncological ventral antigen 1;neuro-oncological ventral antigen 2 7 1 C20140716_OR021_03 C20140716_OR021_03 TB420305.[MT7]-VLIPSYAAGSIIGK[MT7].3b5_1.heavy 559.678 / 654.431 20119.0 41.4193000793457 48 18 10 10 10 27.326353284402302 3.6594710958772287 0.0 3 0.9842600742492857 9.824031180454673 20119.0 84.14208643660425 0.0 - - - - - - - 221.4 40 10 NOVA1;NOVA2 neuro-oncological ventral antigen 1;neuro-oncological ventral antigen 2 9 2 C20140716_OR021_03 C20140716_OR021_03 TB420054.[MT7]-FVDDLFETVFSTAHR.3y6_1.heavy 643.327 / 718.363 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLXNA3 plexin A3 11 2 C20140716_OR021_03 C20140716_OR021_03 TB420054.[MT7]-FVDDLFETVFSTAHR.3b4_1.heavy 643.327 / 621.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLXNA3 plexin A3 13 2 C20140716_OR021_03 C20140716_OR021_03 TB420054.[MT7]-FVDDLFETVFSTAHR.3b5_1.heavy 643.327 / 734.384 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLXNA3 plexin A3 15 2 C20140716_OR021_03 C20140716_OR021_03 TB420054.[MT7]-FVDDLFETVFSTAHR.3y5_1.heavy 643.327 / 571.295 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLXNA3 plexin A3 17 3 C20140716_OR021_03 C20140716_OR021_03 TB420306.[MT7]-VLIPSYAAGSIIGK[MT7].2b3_1.heavy 839.013 / 470.346 25535.0 41.39794921875 34 9 10 5 10 1.0648550935306982 60.55036218087665 0.04270172119140625 3 0.8116233909324766 2.7975819918755245 25535.0 269.94471197119714 0.0 - - - - - - - 234.77777777777777 51 9 NOVA1;NOVA2 neuro-oncological ventral antigen 1;neuro-oncological ventral antigen 2 19 3 C20140716_OR021_03 C20140716_OR021_03 TB420306.[MT7]-VLIPSYAAGSIIGK[MT7].2y8_1.heavy 839.013 / 860.532 2212.0 41.39794921875 34 9 10 5 10 1.0648550935306982 60.55036218087665 0.04270172119140625 3 0.8116233909324766 2.7975819918755245 2212.0 14.856716417910448 0.0 - - - - - - - 192.83333333333334 4 12 NOVA1;NOVA2 neuro-oncological ventral antigen 1;neuro-oncological ventral antigen 2 21 3 C20140716_OR021_03 C20140716_OR021_03 TB420306.[MT7]-VLIPSYAAGSIIGK[MT7].2y6_1.heavy 839.013 / 718.458 1508.0 41.39794921875 34 9 10 5 10 1.0648550935306982 60.55036218087665 0.04270172119140625 3 0.8116233909324766 2.7975819918755245 1508.0 5.366441351888668 0.0 - - - - - - - 191.2 3 10 NOVA1;NOVA2 neuro-oncological ventral antigen 1;neuro-oncological ventral antigen 2 23 3 C20140716_OR021_03 C20140716_OR021_03 TB420306.[MT7]-VLIPSYAAGSIIGK[MT7].2y11_1.heavy 839.013 / 1207.68 15984.0 41.39794921875 34 9 10 5 10 1.0648550935306982 60.55036218087665 0.04270172119140625 3 0.8116233909324766 2.7975819918755245 15984.0 67.24381536028467 0.0 - - - - - - - 276.625 31 8 NOVA1;NOVA2 neuro-oncological ventral antigen 1;neuro-oncological ventral antigen 2 25 4 C20140716_OR021_03 C20140716_OR021_03 TB420052.[MT7]-C[CAM]LEVEMSK[MT7].2y4_1.heavy 642.333 / 638.33 29857.0 29.52400016784668 50 20 10 10 10 6.902061132265725 14.488425715692438 0.0 3 0.9950331749002815 17.50423022977351 29857.0 39.911113948405855 0.0 - - - - - - - 780.2 59 10 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 27 4 C20140716_OR021_03 C20140716_OR021_03 TB420052.[MT7]-C[CAM]LEVEMSK[MT7].2b3_1.heavy 642.333 / 547.267 37299.0 29.52400016784668 50 20 10 10 10 6.902061132265725 14.488425715692438 0.0 3 0.9950331749002815 17.50423022977351 37299.0 87.58931185329007 0.0 - - - - - - - 224.21428571428572 74 14 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 29 4 C20140716_OR021_03 C20140716_OR021_03 TB420052.[MT7]-C[CAM]LEVEMSK[MT7].2y5_1.heavy 642.333 / 737.398 27615.0 29.52400016784668 50 20 10 10 10 6.902061132265725 14.488425715692438 0.0 3 0.9950331749002815 17.50423022977351 27615.0 41.47387764333371 0.0 - - - - - - - 157.0 55 4 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 31 4 C20140716_OR021_03 C20140716_OR021_03 TB420052.[MT7]-C[CAM]LEVEMSK[MT7].2y3_1.heavy 642.333 / 509.287 27795.0 29.52400016784668 50 20 10 10 10 6.902061132265725 14.488425715692438 0.0 3 0.9950331749002815 17.50423022977351 27795.0 98.78342980812045 0.0 - - - - - - - 707.4444444444445 55 9 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 33 5 C20140716_OR021_03 C20140716_OR021_03 TB420057.[MT7]-QHSVVFIGTR.3y6_1.heavy 429.915 / 692.409 1456.0 28.034900665283203 40 16 10 6 8 2.258807826623197 44.271141095475535 0.03639984130859375 4 0.9629847054914775 6.394740894844921 1456.0 24.016494845360825 0.0 - - - - - - - 138.57142857142858 2 7 PLXNA3 plexin A3 35 5 C20140716_OR021_03 C20140716_OR021_03 TB420057.[MT7]-QHSVVFIGTR.3b5_1.heavy 429.915 / 695.396 1068.0 28.034900665283203 40 16 10 6 8 2.258807826623197 44.271141095475535 0.03639984130859375 4 0.9629847054914775 6.394740894844921 1068.0 7.442969072164949 0.0 - - - - - - - 277.14285714285717 2 7 PLXNA3 plexin A3 37 5 C20140716_OR021_03 C20140716_OR021_03 TB420057.[MT7]-QHSVVFIGTR.3y4_1.heavy 429.915 / 446.272 4077.0 28.034900665283203 40 16 10 6 8 2.258807826623197 44.271141095475535 0.03639984130859375 4 0.9629847054914775 6.394740894844921 4077.0 20.49444845360825 2.0 - - - - - - - 213.4 10 10 PLXNA3 plexin A3 39 5 C20140716_OR021_03 C20140716_OR021_03 TB420057.[MT7]-QHSVVFIGTR.3y5_1.heavy 429.915 / 593.341 5144.0 28.034900665283203 40 16 10 6 8 2.258807826623197 44.271141095475535 0.03639984130859375 4 0.9629847054914775 6.394740894844921 5144.0 53.03092783505155 0.0 - - - - - - - 229.27272727272728 10 11 PLXNA3 plexin A3 41 6 C20140716_OR021_03 C20140716_OR021_03 TB420205.[MT7]-HLLLVDPEGVVR.2b3_1.heavy 745.944 / 508.336 12053.0 37.55550003051758 43 17 10 6 10 4.131129412630456 24.206455429418753 0.03800201416015625 3 0.9781680994470939 8.337258997364314 12053.0 38.98008687964882 0.0 - - - - - - - 249.69230769230768 24 13 LOC100291393;SHC2;SHC1 SHC-transforming protein 2-like;SHC (Src homology 2 domain containing) transforming protein 2;SHC (Src homology 2 domain containing) transforming protein 1 43 6 C20140716_OR021_03 C20140716_OR021_03 TB420205.[MT7]-HLLLVDPEGVVR.2y6_1.heavy 745.944 / 656.373 38476.0 37.55550003051758 43 17 10 6 10 4.131129412630456 24.206455429418753 0.03800201416015625 3 0.9781680994470939 8.337258997364314 38476.0 94.56573661578761 0.0 - - - - - - - 278.27272727272725 76 11 LOC100291393;SHC2;SHC1 SHC-transforming protein 2-like;SHC (Src homology 2 domain containing) transforming protein 2;SHC (Src homology 2 domain containing) transforming protein 1 45 6 C20140716_OR021_03 C20140716_OR021_03 TB420205.[MT7]-HLLLVDPEGVVR.2y10_1.heavy 745.944 / 1096.64 11125.0 37.55550003051758 43 17 10 6 10 4.131129412630456 24.206455429418753 0.03800201416015625 3 0.9781680994470939 8.337258997364314 11125.0 78.70315412395153 0.0 - - - - - - - 200.83333333333334 22 12 LOC100291393;SHC2;SHC1 SHC-transforming protein 2-like;SHC (Src homology 2 domain containing) transforming protein 2;SHC (Src homology 2 domain containing) transforming protein 1 47 6 C20140716_OR021_03 C20140716_OR021_03 TB420205.[MT7]-HLLLVDPEGVVR.2y11_1.heavy 745.944 / 1209.72 3708.0 37.55550003051758 43 17 10 6 10 4.131129412630456 24.206455429418753 0.03800201416015625 3 0.9781680994470939 8.337258997364314 3708.0 32.96118561151079 0.0 - - - - - - - 173.875 7 16 LOC100291393;SHC2;SHC1 SHC-transforming protein 2-like;SHC (Src homology 2 domain containing) transforming protein 2;SHC (Src homology 2 domain containing) transforming protein 1 49 7 C20140716_OR021_03 C20140716_OR021_03 TB436032.[MT7]-LGSLGAAC[CAM]EQTQTEGAK[MT7].3b6_1.heavy 670.345 / 643.39 36696.0 28.44770050048828 39 13 10 6 10 1.5319984685491133 38.73633122665771 0.038799285888671875 3 0.9154392431071675 4.213752291894239 36696.0 100.10321503131524 0.0 - - - - - - - 343.0833333333333 73 12 C8A complement component 8, alpha polypeptide 51 7 C20140716_OR021_03 C20140716_OR021_03 TB436032.[MT7]-LGSLGAAC[CAM]EQTQTEGAK[MT7].3b5_1.heavy 670.345 / 572.352 21558.0 28.44770050048828 39 13 10 6 10 1.5319984685491133 38.73633122665771 0.038799285888671875 3 0.9154392431071675 4.213752291894239 21558.0 51.70723280928661 0.0 - - - - - - - 314.7142857142857 43 14 C8A complement component 8, alpha polypeptide 53 7 C20140716_OR021_03 C20140716_OR021_03 TB436032.[MT7]-LGSLGAAC[CAM]EQTQTEGAK[MT7].3y5_1.heavy 670.345 / 649.364 36792.0 28.44770050048828 39 13 10 6 10 1.5319984685491133 38.73633122665771 0.038799285888671875 3 0.9154392431071675 4.213752291894239 36792.0 72.0358532285716 0.0 - - - - - - - 780.1428571428571 73 7 C8A complement component 8, alpha polypeptide 55 7 C20140716_OR021_03 C20140716_OR021_03 TB436032.[MT7]-LGSLGAAC[CAM]EQTQTEGAK[MT7].3b7_1.heavy 670.345 / 714.427 26444.0 28.44770050048828 39 13 10 6 10 1.5319984685491133 38.73633122665771 0.038799285888671875 3 0.9154392431071675 4.213752291894239 26444.0 254.7989583333333 0.0 - - - - - - - 191.8181818181818 52 11 C8A complement component 8, alpha polypeptide 57 8 C20140716_OR021_03 C20140716_OR021_03 TB435896.[MT7]-EEQIFLLHR.2b3_1.heavy 664.876 / 531.253 3282.0 35.3872013092041 32 11 10 5 6 0.8096626396231481 74.55667255077165 0.043399810791015625 5 0.864595334844616 3.315268420115863 3282.0 4.898698492767716 0.0 - - - - - - - 296.0 6 8 PTH1R parathyroid hormone 1 receptor 59 8 C20140716_OR021_03 C20140716_OR021_03 TB435896.[MT7]-EEQIFLLHR.2y5_1.heavy 664.876 / 685.414 4011.0 35.3872013092041 32 11 10 5 6 0.8096626396231481 74.55667255077165 0.043399810791015625 5 0.864595334844616 3.315268420115863 4011.0 10.409895121716541 1.0 - - - - - - - 318.9 8 10 PTH1R parathyroid hormone 1 receptor 61 8 C20140716_OR021_03 C20140716_OR021_03 TB435896.[MT7]-EEQIFLLHR.2b4_1.heavy 664.876 / 644.337 2917.0 35.3872013092041 32 11 10 5 6 0.8096626396231481 74.55667255077165 0.043399810791015625 5 0.864595334844616 3.315268420115863 2917.0 3.032936371081053 4.0 - - - - - - - 242.88888888888889 6 9 PTH1R parathyroid hormone 1 receptor 63 8 C20140716_OR021_03 C20140716_OR021_03 TB435896.[MT7]-EEQIFLLHR.2b5_1.heavy 664.876 / 791.406 1276.0 35.3872013092041 32 11 10 5 6 0.8096626396231481 74.55667255077165 0.043399810791015625 5 0.864595334844616 3.315268420115863 1276.0 3.6162191780821917 8.0 - - - - - - - 294.53846153846155 4 13 PTH1R parathyroid hormone 1 receptor 65 9 C20140716_OR021_03 C20140716_OR021_03 TB435894.[MT7]-EC[CAM]VC[CAM]PNC[CAM]SR.2b3_1.heavy 663.279 / 533.251 5932.0 17.948699951171875 50 20 10 10 10 3.802048240482011 20.704458514379688 0.0 3 0.9926392459163336 14.375880719994646 5932.0 20.189833542355487 0.0 - - - - - - - 657.625 11 8 ATXN7L3 ataxin 7-like 3 67 9 C20140716_OR021_03 C20140716_OR021_03 TB435894.[MT7]-EC[CAM]VC[CAM]PNC[CAM]SR.2y8_1.heavy 663.279 / 1052.41 18859.0 17.948699951171875 50 20 10 10 10 3.802048240482011 20.704458514379688 0.0 3 0.9926392459163336 14.375880719994646 18859.0 148.81931972789116 0.0 - - - - - - - 264.0 37 14 ATXN7L3 ataxin 7-like 3 69 9 C20140716_OR021_03 C20140716_OR021_03 TB435894.[MT7]-EC[CAM]VC[CAM]PNC[CAM]SR.2y5_1.heavy 663.279 / 633.277 9346.0 17.948699951171875 50 20 10 10 10 3.802048240482011 20.704458514379688 0.0 3 0.9926392459163336 14.375880719994646 9346.0 69.510875 0.0 - - - - - - - 220.0 18 14 ATXN7L3 ataxin 7-like 3 71 9 C20140716_OR021_03 C20140716_OR021_03 TB435894.[MT7]-EC[CAM]VC[CAM]PNC[CAM]SR.2y6_1.heavy 663.279 / 793.308 10409.0 17.948699951171875 50 20 10 10 10 3.802048240482011 20.704458514379688 0.0 3 0.9926392459163336 14.375880719994646 10409.0 185.8564125 0.0 - - - - - - - 162.4 20 10 ATXN7L3 ataxin 7-like 3 73 10 C20140716_OR021_03 C20140716_OR021_03 TB420472.[MT7]-C[CAM]GQLDLLQDWLADFRK[MT7].4y5_1.heavy 567.303 / 780.448 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 75 10 C20140716_OR021_03 C20140716_OR021_03 TB420472.[MT7]-C[CAM]GQLDLLQDWLADFRK[MT7].4b4_1.heavy 567.303 / 603.304 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 77 10 C20140716_OR021_03 C20140716_OR021_03 TB420472.[MT7]-C[CAM]GQLDLLQDWLADFRK[MT7].4y7_2.heavy 567.303 / 540.31 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 79 10 C20140716_OR021_03 C20140716_OR021_03 TB420472.[MT7]-C[CAM]GQLDLLQDWLADFRK[MT7].4b6_1.heavy 567.303 / 831.415 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 81 11 C20140716_OR021_03 C20140716_OR021_03 TB420059.[MT7]-LYYGDDEK[MT7].2y5_1.heavy 645.826 / 707.333 10769.0 27.09969997406006 38 13 10 5 10 1.743237963139407 45.45357777683804 0.04419898986816406 3 0.9024901205117197 3.9196223100002334 10769.0 16.823161512027493 1.0 - - - - - - - 360.2857142857143 21 7 C8A complement component 8, alpha polypeptide 83 11 C20140716_OR021_03 C20140716_OR021_03 TB420059.[MT7]-LYYGDDEK[MT7].2y3_1.heavy 645.826 / 535.284 12418.0 27.09969997406006 38 13 10 5 10 1.743237963139407 45.45357777683804 0.04419898986816406 3 0.9024901205117197 3.9196223100002334 12418.0 13.394749904543719 0.0 - - - - - - - 400.125 24 8 C8A complement component 8, alpha polypeptide 85 11 C20140716_OR021_03 C20140716_OR021_03 TB420059.[MT7]-LYYGDDEK[MT7].2y6_1.heavy 645.826 / 870.396 15426.0 27.09969997406006 38 13 10 5 10 1.743237963139407 45.45357777683804 0.04419898986816406 3 0.9024901205117197 3.9196223100002334 15426.0 40.21210603829161 0.0 - - - - - - - 226.33333333333334 30 12 C8A complement component 8, alpha polypeptide 87 11 C20140716_OR021_03 C20140716_OR021_03 TB420059.[MT7]-LYYGDDEK[MT7].2y7_1.heavy 645.826 / 1033.46 35702.0 27.09969997406006 38 13 10 5 10 1.743237963139407 45.45357777683804 0.04419898986816406 3 0.9024901205117197 3.9196223100002334 35702.0 64.226793814433 0.0 - - - - - - - 303.125 71 8 C8A complement component 8, alpha polypeptide 89 12 C20140716_OR021_03 C20140716_OR021_03 TB420473.[MT7]-C[CAM]GQLDLLQDWLADFRK[MT7].3b6_1.heavy 756.068 / 831.415 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 91 12 C20140716_OR021_03 C20140716_OR021_03 TB420473.[MT7]-C[CAM]GQLDLLQDWLADFRK[MT7].3y4_1.heavy 756.068 / 709.411 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 93 12 C20140716_OR021_03 C20140716_OR021_03 TB420473.[MT7]-C[CAM]GQLDLLQDWLADFRK[MT7].3y5_1.heavy 756.068 / 780.448 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 95 12 C20140716_OR021_03 C20140716_OR021_03 TB420473.[MT7]-C[CAM]GQLDLLQDWLADFRK[MT7].3b7_1.heavy 756.068 / 944.499 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 97 13 C20140716_OR021_03 C20140716_OR021_03 TB420475.[MT7]-AYILLSQDYTGK[MT7]EEQAR.4y8_2.heavy 569.056 / 531.787 4702.0 35.10710144042969 47 17 10 10 10 3.2309230174114782 30.950907669758436 0.0 3 0.9718332894753833 7.336173807551873 4702.0 19.83156462585034 0.0 - - - - - - - 356.64285714285717 9 14 SKI v-ski sarcoma viral oncogene homolog (avian) 99 13 C20140716_OR021_03 C20140716_OR021_03 TB420475.[MT7]-AYILLSQDYTGK[MT7]EEQAR.4y9_2.heavy 569.056 / 613.318 5805.0 35.10710144042969 47 17 10 10 10 3.2309230174114782 30.950907669758436 0.0 3 0.9718332894753833 7.336173807551873 5805.0 22.766351554245674 0.0 - - - - - - - 670.375 11 8 SKI v-ski sarcoma viral oncogene homolog (avian) 101 13 C20140716_OR021_03 C20140716_OR021_03 TB420475.[MT7]-AYILLSQDYTGK[MT7]EEQAR.4y10_2.heavy 569.056 / 670.832 5437.0 35.10710144042969 47 17 10 10 10 3.2309230174114782 30.950907669758436 0.0 3 0.9718332894753833 7.336173807551873 5437.0 15.842270514745408 0.0 - - - - - - - 250.75 10 12 SKI v-ski sarcoma viral oncogene homolog (avian) 103 13 C20140716_OR021_03 C20140716_OR021_03 TB420475.[MT7]-AYILLSQDYTGK[MT7]EEQAR.4b4_1.heavy 569.056 / 605.378 9331.0 35.10710144042969 47 17 10 10 10 3.2309230174114782 30.950907669758436 0.0 3 0.9718332894753833 7.336173807551873 9331.0 15.141504513134317 0.0 - - - - - - - 211.0 18 8 SKI v-ski sarcoma viral oncogene homolog (avian) 105 14 C20140716_OR021_03 C20140716_OR021_03 TB442356.[MT7]-LIVPNSTAGLIIGK[MT7].3b9_1.heavy 562.025 / 997.58 N/A N/A - - - - - - - - - 0.0 - - - - - - - NOVA2 neuro-oncological ventral antigen 2 107 14 C20140716_OR021_03 C20140716_OR021_03 TB442356.[MT7]-LIVPNSTAGLIIGK[MT7].3y6_1.heavy 562.025 / 744.51 N/A N/A - - - - - - - - - 0.0 - - - - - - - NOVA2 neuro-oncological ventral antigen 2 109 14 C20140716_OR021_03 C20140716_OR021_03 TB442356.[MT7]-LIVPNSTAGLIIGK[MT7].3b5_1.heavy 562.025 / 681.442 N/A N/A - - - - - - - - - 0.0 - - - - - - - NOVA2 neuro-oncological ventral antigen 2 111 14 C20140716_OR021_03 C20140716_OR021_03 TB442356.[MT7]-LIVPNSTAGLIIGK[MT7].3y4_1.heavy 562.025 / 574.404 N/A N/A - - - - - - - - - 0.0 - - - - - - - NOVA2 neuro-oncological ventral antigen 2 113 15 C20140716_OR021_03 C20140716_OR021_03 TB420063.[MT7]-LFVGTAVDGK[MT7].2y4_1.heavy 647.884 / 562.332 N/A 34.58980051676432 36 20 0 6 10 5.545893324468552 18.031360170380257 0.039897918701171875 3 0.9918091831158099 13.627050947952853 7806.0 2.80200558177048 2.0 - - - - - - - 746.8571428571429 421 7 PLXNA3 plexin A3 115 15 C20140716_OR021_03 C20140716_OR021_03 TB420063.[MT7]-LFVGTAVDGK[MT7].2y8_1.heavy 647.884 / 890.506 9246.0 34.58980051676432 36 20 0 6 10 5.545893324468552 18.031360170380257 0.039897918701171875 3 0.9918091831158099 13.627050947952853 9246.0 13.157855013068271 1.0 - - - - - - - 712.3 18 10 PLXNA3 plexin A3 117 15 C20140716_OR021_03 C20140716_OR021_03 TB420063.[MT7]-LFVGTAVDGK[MT7].2y9_1.heavy 647.884 / 1037.57 13869.0 34.58980051676432 36 20 0 6 10 5.545893324468552 18.031360170380257 0.039897918701171875 3 0.9918091831158099 13.627050947952853 13869.0 41.65122349592853 0.0 - - - - - - - 616.8571428571429 27 7 PLXNA3 plexin A3 119 15 C20140716_OR021_03 C20140716_OR021_03 TB420063.[MT7]-LFVGTAVDGK[MT7].2y7_1.heavy 647.884 / 791.438 18037.0 34.58980051676432 36 20 0 6 10 5.545893324468552 18.031360170380257 0.039897918701171875 3 0.9918091831158099 13.627050947952853 18037.0 78.93676757603818 0.0 - - - - - - - 274.0 36 13 PLXNA3 plexin A3 121 16 C20140716_OR021_03 C20140716_OR021_03 TB420069.[MT7]-SGQHC[CAM]SDSQR.3y6_1.heavy 435.862 / 752.299 483.0 11.292900085449219 41 15 10 6 10 2.6794659795136884 29.530025243231584 0.03280067443847656 3 0.9592321557157403 6.091397003977665 483.0 106.743 0.0 - - - - - - - 0.0 0 0 PTGER4 prostaglandin E receptor 4 (subtype EP4) 123 16 C20140716_OR021_03 C20140716_OR021_03 TB420069.[MT7]-SGQHC[CAM]SDSQR.3y5_1.heavy 435.862 / 592.268 813.0 11.292900085449219 41 15 10 6 10 2.6794659795136884 29.530025243231584 0.03280067443847656 3 0.9592321557157403 6.091397003977665 813.0 67.89263157894737 0.0 - - - - - - - 0.0 1 0 PTGER4 prostaglandin E receptor 4 (subtype EP4) 125 16 C20140716_OR021_03 C20140716_OR021_03 TB420069.[MT7]-SGQHC[CAM]SDSQR.3b4_1.heavy 435.862 / 554.28 340.0 11.292900085449219 41 15 10 6 10 2.6794659795136884 29.530025243231584 0.03280067443847656 3 0.9592321557157403 6.091397003977665 340.0 12.349056603773585 0.0 - - - - - - - 0.0 0 0 PTGER4 prostaglandin E receptor 4 (subtype EP4) 127 16 C20140716_OR021_03 C20140716_OR021_03 TB420069.[MT7]-SGQHC[CAM]SDSQR.3y4_1.heavy 435.862 / 505.237 364.0 11.292900085449219 41 15 10 6 10 2.6794659795136884 29.530025243231584 0.03280067443847656 3 0.9592321557157403 6.091397003977665 364.0 5.49433962264151 0.0 - - - - - - - 0.0 0 0 PTGER4 prostaglandin E receptor 4 (subtype EP4) 129 17 C20140716_OR021_03 C20140716_OR021_03 TB419948.[MT7]-FDYGNK[MT7].2b3_1.heavy 516.274 / 570.268 2410.0 24.62849998474121 46 18 10 10 8 4.0093062567303 24.94197090385227 0.0 4 0.9878482669873486 11.184137334497498 2410.0 6.234825870646766 1.0 - - - - - - - 270.2857142857143 5 7 SKI v-ski sarcoma viral oncogene homolog (avian) 131 17 C20140716_OR021_03 C20140716_OR021_03 TB419948.[MT7]-FDYGNK[MT7].2y4_1.heavy 516.274 / 625.343 10245.0 24.62849998474121 46 18 10 10 8 4.0093062567303 24.94197090385227 0.0 4 0.9878482669873486 11.184137334497498 10245.0 159.6313953488372 0.0 - - - - - - - 198.46153846153845 20 13 SKI v-ski sarcoma viral oncogene homolog (avian) 133 17 C20140716_OR021_03 C20140716_OR021_03 TB419948.[MT7]-FDYGNK[MT7].2y5_1.heavy 516.274 / 740.37 6112.0 24.62849998474121 46 18 10 10 8 4.0093062567303 24.94197090385227 0.0 4 0.9878482669873486 11.184137334497498 6112.0 90.3770542635659 1.0 - - - - - - - 186.33333333333334 12 6 SKI v-ski sarcoma viral oncogene homolog (avian) 135 17 C20140716_OR021_03 C20140716_OR021_03 TB419948.[MT7]-FDYGNK[MT7].2b4_1.heavy 516.274 / 627.289 775.0 24.62849998474121 46 18 10 10 8 4.0093062567303 24.94197090385227 0.0 4 0.9878482669873486 11.184137334497498 775.0 0.848169142672237 6.0 - - - - - - - 161.25 6 8 SKI v-ski sarcoma viral oncogene homolog (avian) 137 18 C20140716_OR021_03 C20140716_OR021_03 TB436043.[MT7]-C[CAM]GYFFLDDTDPDSMK[MT7].2b8_1.heavy 1049.97 / 1162.5 2791.0 42.47879981994629 45 20 10 5 10 7.704391646930143 12.979610147395032 0.041202545166015625 3 0.9950115253904324 17.466174005147998 2791.0 25.819153773880366 0.0 - - - - - - - 154.75 5 8 ATXN7L3 ataxin 7-like 3 139 18 C20140716_OR021_03 C20140716_OR021_03 TB436043.[MT7]-C[CAM]GYFFLDDTDPDSMK[MT7].2b3_1.heavy 1049.97 / 525.225 7339.0 42.47879981994629 45 20 10 5 10 7.704391646930143 12.979610147395032 0.041202545166015625 3 0.9950115253904324 17.466174005147998 7339.0 39.40807404514567 0.0 - - - - - - - 206.58333333333334 14 12 ATXN7L3 ataxin 7-like 3 141 18 C20140716_OR021_03 C20140716_OR021_03 TB436043.[MT7]-C[CAM]GYFFLDDTDPDSMK[MT7].2y5_1.heavy 1049.97 / 721.367 15505.0 42.47879981994629 45 20 10 5 10 7.704391646930143 12.979610147395032 0.041202545166015625 3 0.9950115253904324 17.466174005147998 15505.0 71.33050847457626 0.0 - - - - - - - 247.8 31 10 ATXN7L3 ataxin 7-like 3 143 18 C20140716_OR021_03 C20140716_OR021_03 TB436043.[MT7]-C[CAM]GYFFLDDTDPDSMK[MT7].2y3_1.heavy 1049.97 / 509.287 9717.0 42.47879981994629 45 20 10 5 10 7.704391646930143 12.979610147395032 0.041202545166015625 3 0.9950115253904324 17.466174005147998 9717.0 99.28994902272204 0.0 - - - - - - - 241.11111111111111 19 9 ATXN7L3 ataxin 7-like 3 145 19 C20140716_OR021_03 C20140716_OR021_03 TB442092.[MT7]-LVVTFK[MT7].2y4_1.heavy 497.831 / 638.399 10828.0 36.07379913330078 49 20 9 10 10 9.80469980947746 10.199190382487547 0.0 3 0.9975122723935171 24.73835867828569 10828.0 64.65921588048369 1.0 - - - - - - - 268.3636363636364 21 11 USP29 ubiquitin specific peptidase 29 147 19 C20140716_OR021_03 C20140716_OR021_03 TB442092.[MT7]-LVVTFK[MT7].2y5_1.heavy 497.831 / 737.468 8367.0 36.07379913330078 49 20 9 10 10 9.80469980947746 10.199190382487547 0.0 3 0.9975122723935171 24.73835867828569 8367.0 97.26106598984772 0.0 - - - - - - - 196.66666666666666 16 9 USP29 ubiquitin specific peptidase 29 149 19 C20140716_OR021_03 C20140716_OR021_03 TB442092.[MT7]-LVVTFK[MT7].2b4_1.heavy 497.831 / 557.378 689.0 36.07379913330078 49 20 9 10 10 9.80469980947746 10.199190382487547 0.0 3 0.9975122723935171 24.73835867828569 689.0 6.715126903553299 18.0 - - - - - - - 286.45454545454544 42 11 USP29 ubiquitin specific peptidase 29 151 19 C20140716_OR021_03 C20140716_OR021_03 TB442092.[MT7]-LVVTFK[MT7].2y3_1.heavy 497.831 / 539.331 18900.0 36.07379913330078 49 20 9 10 10 9.80469980947746 10.199190382487547 0.0 3 0.9975122723935171 24.73835867828569 18900.0 108.4751269035533 0.0 - - - - - - - 157.4 37 5 USP29 ubiquitin specific peptidase 29 153 20 C20140716_OR021_03 C20140716_OR021_03 TB419949.[MT7]-LDDLFK[MT7].2y4_1.heavy 519.807 / 666.394 2598.0 38.90904903411865 37 16 9 6 6 3.292712484842141 23.867951903796538 0.034198760986328125 5 0.9672438202148332 6.800221779973382 2598.0 6.481496881496881 0.0 - - - - - - - 256.46666666666664 5 15 PLXNA1;PLXNA3 plexin A1;plexin A3 155 20 C20140716_OR021_03 C20140716_OR021_03 TB419949.[MT7]-LDDLFK[MT7].2y5_1.heavy 519.807 / 781.421 2406.0 38.90904903411865 37 16 9 6 6 3.292712484842141 23.867951903796538 0.034198760986328125 5 0.9672438202148332 6.800221779973382 2406.0 4.99515570934256 2.0 - - - - - - - 180.25 8 8 PLXNA1;PLXNA3 plexin A1;plexin A3 157 20 C20140716_OR021_03 C20140716_OR021_03 TB419949.[MT7]-LDDLFK[MT7].2b4_1.heavy 519.807 / 601.331 2887.0 38.90904903411865 37 16 9 6 6 3.292712484842141 23.867951903796538 0.034198760986328125 5 0.9672438202148332 6.800221779973382 2887.0 20.710724595842954 1.0 - - - - - - - 325.6923076923077 6 13 PLXNA1;PLXNA3 plexin A1;plexin A3 159 20 C20140716_OR021_03 C20140716_OR021_03 TB419949.[MT7]-LDDLFK[MT7].2y3_1.heavy 519.807 / 551.367 4715.0 38.90904903411865 37 16 9 6 6 3.292712484842141 23.867951903796538 0.034198760986328125 5 0.9672438202148332 6.800221779973382 4715.0 12.692321192321192 1.0 - - - - - - - 243.6 11 15 PLXNA1;PLXNA3 plexin A1;plexin A3 161 21 C20140716_OR021_03 C20140716_OR021_03 TB442090.[MT7]-LQLLSK[MT7].2b3_1.heavy 495.333 / 499.336 6345.0 34.2484016418457 39 11 10 10 8 0.9672205114942801 62.72289907728596 0.0 4 0.8709621434697772 3.3979671984646798 6345.0 58.40159173596673 0.0 - - - - - - - 252.25 12 8 PLXNA3 plexin A3 163 21 C20140716_OR021_03 C20140716_OR021_03 TB442090.[MT7]-LQLLSK[MT7].2y4_1.heavy 495.333 / 604.415 5960.0 34.2484016418457 39 11 10 10 8 0.9672205114942801 62.72289907728596 0.0 4 0.8709621434697772 3.3979671984646798 5960.0 38.698611111111106 0.0 - - - - - - - 206.84615384615384 11 13 PLXNA3 plexin A3 165 21 C20140716_OR021_03 C20140716_OR021_03 TB442090.[MT7]-LQLLSK[MT7].2y5_1.heavy 495.333 / 732.474 3461.0 34.2484016418457 39 11 10 10 8 0.9672205114942801 62.72289907728596 0.0 4 0.8709621434697772 3.3979671984646798 3461.0 10.506569286257328 2.0 - - - - - - - 224.33333333333334 7 9 PLXNA3 plexin A3 167 21 C20140716_OR021_03 C20140716_OR021_03 TB442090.[MT7]-LQLLSK[MT7].2b4_1.heavy 495.333 / 612.42 1730.0 34.2484016418457 39 11 10 10 8 0.9672205114942801 62.72289907728596 0.0 4 0.8709621434697772 3.3979671984646798 1730.0 10.16375 0.0 - - - - - - - 297.09090909090907 3 11 PLXNA3 plexin A3 169 22 C20140716_OR021_03 C20140716_OR021_03 TB442251.[MT7]-QLAPFHEVGK[MT7].3b5_1.heavy 471.941 / 701.41 30322.0 28.91360092163086 48 18 10 10 10 3.070811777588446 25.584056064340526 0.0 3 0.9876679158861503 11.10188706488205 30322.0 180.26726274509804 0.0 - - - - - - - 204.0 60 10 WNT9A wingless-type MMTV integration site family, member 9A 171 22 C20140716_OR021_03 C20140716_OR021_03 TB442251.[MT7]-QLAPFHEVGK[MT7].3b3_1.heavy 471.941 / 457.289 74827.0 28.91360092163086 48 18 10 10 10 3.070811777588446 25.584056064340526 0.0 3 0.9876679158861503 11.10188706488205 74827.0 259.73516511219873 0.0 - - - - - - - 245.55555555555554 149 9 WNT9A wingless-type MMTV integration site family, member 9A 173 22 C20140716_OR021_03 C20140716_OR021_03 TB442251.[MT7]-QLAPFHEVGK[MT7].3y4_1.heavy 471.941 / 576.347 47563.0 28.91360092163086 48 18 10 10 10 3.070811777588446 25.584056064340526 0.0 3 0.9876679158861503 11.10188706488205 47563.0 231.10022352941178 0.0 - - - - - - - 240.83333333333334 95 12 WNT9A wingless-type MMTV integration site family, member 9A 175 22 C20140716_OR021_03 C20140716_OR021_03 TB442251.[MT7]-QLAPFHEVGK[MT7].3y5_1.heavy 471.941 / 713.406 6455.0 28.91360092163086 48 18 10 10 10 3.070811777588446 25.584056064340526 0.0 3 0.9876679158861503 11.10188706488205 6455.0 68.52321866758399 1.0 - - - - - - - 170.0 51 7 WNT9A wingless-type MMTV integration site family, member 9A 177 23 C20140716_OR021_03 C20140716_OR021_03 TB420481.[MT7]-GAILSEEELAAMSPTAAAVAK[MT7].4y4_1.heavy 580.318 / 532.357 2097.0 41.103275299072266 27 18 0 5 4 5.197399777104773 19.24039025062361 0.0417022705078125 9 0.9878040712169979 11.163813028254237 2097.0 4.120513141426783 8.0 - - - - - - - 756.0 6 7 TPR translocated promoter region (to activated MET oncogene) 179 23 C20140716_OR021_03 C20140716_OR021_03 TB420481.[MT7]-GAILSEEELAAMSPTAAAVAK[MT7].4b8_1.heavy 580.318 / 973.496 3095.0 41.103275299072266 27 18 0 5 4 5.197399777104773 19.24039025062361 0.0417022705078125 9 0.9878040712169979 11.163813028254237 3095.0 15.696847117794487 0.0 - - - - - - - 191.5 6 12 TPR translocated promoter region (to activated MET oncogene) 181 23 C20140716_OR021_03 C20140716_OR021_03 TB420481.[MT7]-GAILSEEELAAMSPTAAAVAK[MT7].4b7_1.heavy 580.318 / 844.453 1298.0 41.103275299072266 27 18 0 5 4 5.197399777104773 19.24039025062361 0.0417022705078125 9 0.9878040712169979 11.163813028254237 1298.0 4.500773814295258 4.0 - - - - - - - 181.8181818181818 3 11 TPR translocated promoter region (to activated MET oncogene) 183 23 C20140716_OR021_03 C20140716_OR021_03 TB420481.[MT7]-GAILSEEELAAMSPTAAAVAK[MT7].4b6_1.heavy 580.318 / 715.411 899.0 41.103275299072266 27 18 0 5 4 5.197399777104773 19.24039025062361 0.0417022705078125 9 0.9878040712169979 11.163813028254237 899.0 0.07997329773030706 11.0 - - - - - - - 241.41666666666666 40 12 TPR translocated promoter region (to activated MET oncogene) 185 24 C20140716_OR021_03 C20140716_OR021_03 TPX_ECO57.AQTFTLVAK.2y7.peptide 489.78 / 779.47 284453.0 31.021900177001953 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 284453.0 2526.5012149892277 0.0 - - - - - - - 192.33333333333334 568 15 187 24 C20140716_OR021_03 C20140716_OR021_03 TPX_ECO57.AQTFTLVAK.2y6.peptide 489.78 / 678.42 112900.0 31.021900177001953 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 112900.0 625.2250476856866 0.0 - - - - - - - 169.76470588235293 225 17 189 24 C20140716_OR021_03 C20140716_OR021_03 TPX_ECO57.AQTFTLVAK.2y5.peptide 489.78 / 531.35 139987.0 31.021900177001953 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 139987.0 435.1224132554672 0.0 - - - - - - - 650.4285714285714 279 7 191 25 C20140716_OR021_03 C20140716_OR021_03 TB442350.[MT7]-AYILLSQDYTGK[MT7].3b4_1.heavy 553.978 / 605.378 18700.0 38.10217571258545 46 20 10 6 10 22.8527076198522 4.375849096897812 0.038501739501953125 3 0.9916344100819554 13.483755153934506 18700.0 71.1297599070608 0.0 - - - - - - - 282.6666666666667 37 9 SKI v-ski sarcoma viral oncogene homolog (avian) 193 25 C20140716_OR021_03 C20140716_OR021_03 TB442350.[MT7]-AYILLSQDYTGK[MT7].3b5_1.heavy 553.978 / 718.462 5691.0 38.10217571258545 46 20 10 6 10 22.8527076198522 4.375849096897812 0.038501739501953125 3 0.9916344100819554 13.483755153934506 5691.0 18.26049212598425 0.0 - - - - - - - 231.0 11 11 SKI v-ski sarcoma viral oncogene homolog (avian) 195 25 C20140716_OR021_03 C20140716_OR021_03 TB442350.[MT7]-AYILLSQDYTGK[MT7].3y4_1.heavy 553.978 / 612.347 8639.0 38.10217571258545 46 20 10 6 10 22.8527076198522 4.375849096897812 0.038501739501953125 3 0.9916344100819554 13.483755153934506 8639.0 10.201750695823948 0.0 - - - - - - - 213.5 17 10 SKI v-ski sarcoma viral oncogene homolog (avian) 197 25 C20140716_OR021_03 C20140716_OR021_03 TB442350.[MT7]-AYILLSQDYTGK[MT7].3y5_1.heavy 553.978 / 727.374 6098.0 38.10217571258545 46 20 10 6 10 22.8527076198522 4.375849096897812 0.038501739501953125 3 0.9916344100819554 13.483755153934506 6098.0 28.01783783783784 0.0 - - - - - - - 279.5 12 8 SKI v-ski sarcoma viral oncogene homolog (avian) 199 26 C20140716_OR021_03 C20140716_OR021_03 TB420484.[MT7]-YNPVVIDFEMQPIHEVLR.4y5_1.heavy 586.563 / 653.373 N/A N/A - - - - - - - - - 0.0 - - - - - - - C8A complement component 8, alpha polypeptide 201 26 C20140716_OR021_03 C20140716_OR021_03 TB420484.[MT7]-YNPVVIDFEMQPIHEVLR.4y9_1.heavy 586.563 / 1122.61 N/A N/A - - - - - - - - - 0.0 - - - - - - - C8A complement component 8, alpha polypeptide 203 26 C20140716_OR021_03 C20140716_OR021_03 TB420484.[MT7]-YNPVVIDFEMQPIHEVLR.4b4_1.heavy 586.563 / 618.337 N/A N/A - - - - - - - - - 0.0 - - - - - - - C8A complement component 8, alpha polypeptide 205 26 C20140716_OR021_03 C20140716_OR021_03 TB420484.[MT7]-YNPVVIDFEMQPIHEVLR.4b3_1.heavy 586.563 / 519.268 N/A N/A - - - - - - - - - 0.0 - - - - - - - C8A complement component 8, alpha polypeptide 207 27 C20140716_OR021_03 C20140716_OR021_03 TB420325.[MT7]-QIASLTGLVQSALLR.3y7_1.heavy 572.016 / 786.483 2956.0 51.439300537109375 48 18 10 10 10 8.846837284878672 11.303474538965869 0.0 3 0.9899085412690221 12.27494333207103 2956.0 -1.997297297297301 0.0 - - - - - - - 123.33333333333333 5 3 SRCIN1 SRC kinase signaling inhibitor 1 209 27 C20140716_OR021_03 C20140716_OR021_03 TB420325.[MT7]-QIASLTGLVQSALLR.3y6_1.heavy 572.016 / 687.415 7909.0 51.439300537109375 48 18 10 10 10 8.846837284878672 11.303474538965869 0.0 3 0.9899085412690221 12.27494333207103 7909.0 -0.02671959459459572 1.0 - - - - - - - 222.0 15 2 SRCIN1 SRC kinase signaling inhibitor 1 211 27 C20140716_OR021_03 C20140716_OR021_03 TB420325.[MT7]-QIASLTGLVQSALLR.3b4_1.heavy 572.016 / 544.321 5396.0 51.439300537109375 48 18 10 10 10 8.846837284878672 11.303474538965869 0.0 3 0.9899085412690221 12.27494333207103 5396.0 -1.9445045045045042 1.0 - - - - - - - 166.5 10 12 SRCIN1 SRC kinase signaling inhibitor 1 213 27 C20140716_OR021_03 C20140716_OR021_03 TB420325.[MT7]-QIASLTGLVQSALLR.3y5_1.heavy 572.016 / 559.356 6209.0 51.439300537109375 48 18 10 10 10 8.846837284878672 11.303474538965869 0.0 3 0.9899085412690221 12.27494333207103 6209.0 -2.80316027088036 2.0 - - - - - - - 221.875 12 8 SRCIN1 SRC kinase signaling inhibitor 1 215 28 C20140716_OR021_03 C20140716_OR021_03 TB420077.[MT7]-K[MT7]PPC[CAM]C[CAM]VLSNPDQK[MT7].3b6_2.heavy 659.02 / 515.774 22011.0 24.584800720214844 41 11 10 10 10 1.1794459818082823 56.06103845871484 0.0 3 0.860701811348244 3.2674905430980035 22011.0 20.652203196096103 0.0 - - - - - - - 303.3333333333333 44 6 NFIA;NFIX nuclear factor I/A;nuclear factor I/X (CCAAT-binding transcription factor) 217 28 C20140716_OR021_03 C20140716_OR021_03 TB420077.[MT7]-K[MT7]PPC[CAM]C[CAM]VLSNPDQK[MT7].3y6_1.heavy 659.02 / 832.428 8440.0 24.584800720214844 41 11 10 10 10 1.1794459818082823 56.06103845871484 0.0 3 0.860701811348244 3.2674905430980035 8440.0 33.77679507396561 0.0 - - - - - - - 266.77777777777777 16 9 NFIA;NFIX nuclear factor I/A;nuclear factor I/X (CCAAT-binding transcription factor) 219 28 C20140716_OR021_03 C20140716_OR021_03 TB420077.[MT7]-K[MT7]PPC[CAM]C[CAM]VLSNPDQK[MT7].3y4_1.heavy 659.02 / 631.353 N/A 24.584800720214844 41 11 10 10 10 1.1794459818082823 56.06103845871484 0.0 3 0.860701811348244 3.2674905430980035 30038.0 29.988074568180398 0.0 - - - - - - - 83.0 60 1 NFIA;NFIX nuclear factor I/A;nuclear factor I/X (CCAAT-binding transcription factor) 221 28 C20140716_OR021_03 C20140716_OR021_03 TB420077.[MT7]-K[MT7]PPC[CAM]C[CAM]VLSNPDQK[MT7].3y5_1.heavy 659.02 / 745.396 3310.0 24.584800720214844 41 11 10 10 10 1.1794459818082823 56.06103845871484 0.0 3 0.860701811348244 3.2674905430980035 3310.0 19.782537187123655 1.0 - - - - - - - 206.7 7 10 NFIA;NFIX nuclear factor I/A;nuclear factor I/X (CCAAT-binding transcription factor) 223 29 C20140716_OR021_03 C20140716_OR021_03 TB420326.[MT7]-QIASLTGLVQSALLR.2b4_1.heavy 857.521 / 544.321 1625.0 51.43927574157715 39 18 10 3 8 11.444035007344972 8.738176695179483 0.0718994140625 4 0.9889282767359902 11.717993258941611 1625.0 3.4724737413980438 2.0 - - - - - - - 237.88888888888889 6 18 SRCIN1 SRC kinase signaling inhibitor 1 225 29 C20140716_OR021_03 C20140716_OR021_03 TB420326.[MT7]-QIASLTGLVQSALLR.2y9_1.heavy 857.521 / 956.589 2585.0 51.43927574157715 39 18 10 3 8 11.444035007344972 8.738176695179483 0.0718994140625 4 0.9889282767359902 11.717993258941611 2585.0 -0.25467980295566495 0.0 - - - - - - - 186.94117647058823 5 17 SRCIN1 SRC kinase signaling inhibitor 1 227 29 C20140716_OR021_03 C20140716_OR021_03 TB420326.[MT7]-QIASLTGLVQSALLR.2y10_1.heavy 857.521 / 1057.64 4357.0 51.43927574157715 39 18 10 3 8 11.444035007344972 8.738176695179483 0.0718994140625 4 0.9889282767359902 11.717993258941611 4357.0 -1.7711382113821141 0.0 - - - - - - - 607.3333333333334 8 9 SRCIN1 SRC kinase signaling inhibitor 1 229 29 C20140716_OR021_03 C20140716_OR021_03 TB420326.[MT7]-QIASLTGLVQSALLR.2y11_1.heavy 857.521 / 1170.72 1108.0 51.43927574157715 39 18 10 3 8 11.444035007344972 8.738176695179483 0.0718994140625 4 0.9889282767359902 11.717993258941611 1108.0 -0.7503386004514674 8.0 - - - - - - - 247.7058823529412 6 17 SRCIN1 SRC kinase signaling inhibitor 1 231 30 C20140716_OR021_03 C20140716_OR021_03 TB436057.[MT7]-ETAFLYAISSAGLTHALAK[MT7].4y5_1.heavy 563.819 / 683.432 13957.0 47.5281982421875 47 17 10 10 10 4.045145539051916 24.720989401888758 0.0 3 0.9798016614957183 8.669036315974303 13957.0 136.14952152489627 0.0 - - - - - - - 160.30769230769232 27 13 WNT9A wingless-type MMTV integration site family, member 9A 233 30 C20140716_OR021_03 C20140716_OR021_03 TB436057.[MT7]-ETAFLYAISSAGLTHALAK[MT7].4y4_1.heavy 563.819 / 546.373 36175.0 47.5281982421875 47 17 10 10 10 4.045145539051916 24.720989401888758 0.0 3 0.9798016614957183 8.669036315974303 36175.0 155.79475946308864 0.0 - - - - - - - 254.7058823529412 72 17 WNT9A wingless-type MMTV integration site family, member 9A 235 30 C20140716_OR021_03 C20140716_OR021_03 TB436057.[MT7]-ETAFLYAISSAGLTHALAK[MT7].4b4_1.heavy 563.819 / 593.305 58875.0 47.5281982421875 47 17 10 10 10 4.045145539051916 24.720989401888758 0.0 3 0.9798016614957183 8.669036315974303 58875.0 236.1855690814544 0.0 - - - - - - - 280.6666666666667 117 12 WNT9A wingless-type MMTV integration site family, member 9A 237 30 C20140716_OR021_03 C20140716_OR021_03 TB436057.[MT7]-ETAFLYAISSAGLTHALAK[MT7].4b5_1.heavy 563.819 / 706.389 55988.0 47.5281982421875 47 17 10 10 10 4.045145539051916 24.720989401888758 0.0 3 0.9798016614957183 8.669036315974303 55988.0 790.3290498442368 0.0 - - - - - - - 207.08333333333334 111 12 WNT9A wingless-type MMTV integration site family, member 9A 239 31 C20140716_OR021_03 C20140716_OR021_03 TB420073.[MT7]-LAPATSYDGK[MT7].3y3_1.heavy 437.578 / 463.263 72409.0 25.80459976196289 47 17 10 10 10 4.98403010886339 20.064084248240032 0.0 3 0.9784050154756588 8.383034623299606 72409.0 185.67790758171816 0.0 - - - - - - - 273.45454545454544 144 11 FAM160B2 family with sequence similarity 160, member B2 241 31 C20140716_OR021_03 C20140716_OR021_03 TB420073.[MT7]-LAPATSYDGK[MT7].3b4_1.heavy 437.578 / 497.32 22728.0 25.80459976196289 47 17 10 10 10 4.98403010886339 20.064084248240032 0.0 3 0.9784050154756588 8.383034623299606 22728.0 235.47819122797847 0.0 - - - - - - - 174.57142857142858 45 7 FAM160B2 family with sequence similarity 160, member B2 243 31 C20140716_OR021_03 C20140716_OR021_03 TB420073.[MT7]-LAPATSYDGK[MT7].3y4_1.heavy 437.578 / 626.327 11833.0 25.80459976196289 47 17 10 10 10 4.98403010886339 20.064084248240032 0.0 3 0.9784050154756588 8.383034623299606 11833.0 56.247844953773225 0.0 - - - - - - - 329.0 23 4 FAM160B2 family with sequence similarity 160, member B2 245 31 C20140716_OR021_03 C20140716_OR021_03 TB420073.[MT7]-LAPATSYDGK[MT7].3y5_1.heavy 437.578 / 713.359 4790.0 25.80459976196289 47 17 10 10 10 4.98403010886339 20.064084248240032 0.0 3 0.9784050154756588 8.383034623299606 4790.0 24.867234042553193 0.0 - - - - - - - 274.1666666666667 9 12 FAM160B2 family with sequence similarity 160, member B2 247 32 C20140716_OR021_03 C20140716_OR021_03 ODP2_ECOLI.AEAPAAAPAAK.2y7.peptide 484.26 / 599.35 109018.0 16.324899673461914 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 109018.0 40.56059361880452 0.0 - - - - - - - 166.22222222222223 218 9 249 32 C20140716_OR021_03 C20140716_OR021_03 ODP2_ECOLI.AEAPAAAPAAK.2y8.peptide 484.26 / 696.4 134123.0 16.324899673461914 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 134123.0 927.7950840336134 0.0 - - - - - - - 157.0909090909091 268 11 251 32 C20140716_OR021_03 C20140716_OR021_03 ODP2_ECOLI.AEAPAAAPAAK.2y6.peptide 484.26 / 528.31 88870.0 16.324899673461914 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 88870.0 379.00400210018176 0.0 - - - - - - - 194.0 177 13 253 33 C20140716_OR021_03 C20140716_OR021_03 TB419978.[MT7]-ELSEDEIR.2b6_1.heavy 567.792 / 847.38 11625.0 26.13990020751953 46 18 10 10 8 5.303673604780393 18.85485560609657 0.0 4 0.9814448846256199 9.046002679176796 11625.0 69.12495808182427 1.0 - - - - - - - 256.7142857142857 32 7 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 255 33 C20140716_OR021_03 C20140716_OR021_03 TB419978.[MT7]-ELSEDEIR.2y6_1.heavy 567.792 / 748.347 9167.0 26.13990020751953 46 18 10 10 8 5.303673604780393 18.85485560609657 0.0 4 0.9814448846256199 9.046002679176796 9167.0 32.612708909154094 1.0 - - - - - - - 283.75 18 8 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 257 33 C20140716_OR021_03 C20140716_OR021_03 TB419978.[MT7]-ELSEDEIR.2b5_1.heavy 567.792 / 718.338 14838.0 26.13990020751953 46 18 10 10 8 5.303673604780393 18.85485560609657 0.0 4 0.9814448846256199 9.046002679176796 14838.0 62.77979261049028 1.0 - - - - - - - 300.90909090909093 29 11 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 259 33 C20140716_OR021_03 C20140716_OR021_03 TB419978.[MT7]-ELSEDEIR.2y7_1.heavy 567.792 / 861.431 18051.0 26.13990020751953 46 18 10 10 8 5.303673604780393 18.85485560609657 0.0 4 0.9814448846256199 9.046002679176796 18051.0 123.20523809523809 0.0 - - - - - - - 241.77777777777777 36 9 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 261 34 C20140716_OR021_03 C20140716_OR021_03 TB435878.[MT7]-LAPVDNINK[MT7].2y4_1.heavy 636.382 / 632.385 10864.0 28.64669942855835 44 18 10 6 10 16.187310800014423 6.177678382496424 0.03679847717285156 3 0.9882927606412234 11.39489976886899 10864.0 12.276140623545304 0.0 - - - - - - - 722.5714285714286 21 7 PLXNA3 plexin A3 263 34 C20140716_OR021_03 C20140716_OR021_03 TB435878.[MT7]-LAPVDNINK[MT7].2y8_1.heavy 636.382 / 1014.57 10489.0 28.64669942855835 44 18 10 6 10 16.187310800014423 6.177678382496424 0.03679847717285156 3 0.9882927606412234 11.39489976886899 10489.0 41.92188943089431 0.0 - - - - - - - 262.2 20 10 PLXNA3 plexin A3 265 34 C20140716_OR021_03 C20140716_OR021_03 TB435878.[MT7]-LAPVDNINK[MT7].2y5_1.heavy 636.382 / 747.412 3091.0 28.64669942855835 44 18 10 6 10 16.187310800014423 6.177678382496424 0.03679847717285156 3 0.9882927606412234 11.39489976886899 3091.0 8.983333333333333 0.0 - - - - - - - 221.45454545454547 6 11 PLXNA3 plexin A3 267 34 C20140716_OR021_03 C20140716_OR021_03 TB435878.[MT7]-LAPVDNINK[MT7].2y7_1.heavy 636.382 / 943.533 18637.0 28.64669942855835 44 18 10 6 10 16.187310800014423 6.177678382496424 0.03679847717285156 3 0.9882927606412234 11.39489976886899 18637.0 108.56417281138789 0.0 - - - - - - - 227.5 37 14 PLXNA3 plexin A3 269 35 C20140716_OR021_03 C20140716_OR021_03 TB419979.[MT7]-RADLEDK[MT7].2y4_1.heavy 567.821 / 648.369 1811.0 18.14579963684082 47 17 10 10 10 3.8092586722498543 26.25182708869104 0.0 3 0.973059099008838 7.501989228310624 1811.0 2.7766609880749575 0.0 - - - - - - - 235.2 3 15 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 271 35 C20140716_OR021_03 C20140716_OR021_03 TB419979.[MT7]-RADLEDK[MT7].2b6_1.heavy 567.821 / 844.428 2791.0 18.14579963684082 47 17 10 10 10 3.8092586722498543 26.25182708869104 0.0 3 0.973059099008838 7.501989228310624 2791.0 31.327551020408166 0.0 - - - - - - - 147.0 5 20 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 273 35 C20140716_OR021_03 C20140716_OR021_03 TB419979.[MT7]-RADLEDK[MT7].2y6_1.heavy 567.821 / 834.432 490.0 18.14579963684082 47 17 10 10 10 3.8092586722498543 26.25182708869104 0.0 3 0.973059099008838 7.501989228310624 490.0 4.0 1.0 - - - - - - - 0.0 0 0 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 275 35 C20140716_OR021_03 C20140716_OR021_03 TB419979.[MT7]-RADLEDK[MT7].2b5_1.heavy 567.821 / 729.401 979.0 18.14579963684082 47 17 10 10 10 3.8092586722498543 26.25182708869104 0.0 3 0.973059099008838 7.501989228310624 979.0 7.4590476190476185 0.0 - - - - - - - 0.0 1 0 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 277 36 C20140716_OR021_03 C20140716_OR021_03 TB435879.[MT7]-GGASHPGRHPR.3y10_2.heavy 424.898 / 536.281 1196.0 11.739800453186035 39 9 10 10 10 0.5143985624805656 91.77832425418772 0.0 3 0.8141733569797827 2.817354337304198 1196.0 20.271186440677965 0.0 - - - - - - - 78.1 2 20 ZNFX1 zinc finger, NFX1-type containing 1 279 36 C20140716_OR021_03 C20140716_OR021_03 TB435879.[MT7]-GGASHPGRHPR.3y6_1.heavy 424.898 / 719.406 168.0 11.739800453186035 39 9 10 10 10 0.5143985624805656 91.77832425418772 0.0 3 0.8141733569797827 2.817354337304198 168.0 5.353220338983051 0.0 - - - - - - - 0.0 0 0 ZNFX1 zinc finger, NFX1-type containing 1 281 36 C20140716_OR021_03 C20140716_OR021_03 TB435879.[MT7]-GGASHPGRHPR.3b5_1.heavy 424.898 / 554.28 613.0 11.739800453186035 39 9 10 10 10 0.5143985624805656 91.77832425418772 0.0 3 0.8141733569797827 2.817354337304198 613.0 14.08757763975155 0.0 - - - - - - - 0.0 1 0 ZNFX1 zinc finger, NFX1-type containing 1 283 36 C20140716_OR021_03 C20140716_OR021_03 TB435879.[MT7]-GGASHPGRHPR.3b3_1.heavy 424.898 / 330.189 N/A 11.739800453186035 39 9 10 10 10 0.5143985624805656 91.77832425418772 0.0 3 0.8141733569797827 2.817354337304198 1551.0 12.63844537815126 0.0 - - - - - - - 147.25925925925927 3 27 ZNFX1 zinc finger, NFX1-type containing 1 285 37 C20140716_OR021_03 C20140716_OR021_03 TB419974.[MT7]-ILHSQVAGR.2y8_1.heavy 562.836 / 867.479 15018.0 21.785099983215332 36 20 0 6 10 9.611678230187245 10.404010372083784 0.03579902648925781 3 0.9938463710600631 15.724388246289037 15018.0 192.37003451623343 0.0 - - - - - - - 174.5 30 10 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 287 37 C20140716_OR021_03 C20140716_OR021_03 TB419974.[MT7]-ILHSQVAGR.2y5_1.heavy 562.836 / 530.305 5732.0 21.785099983215332 36 20 0 6 10 9.611678230187245 10.404010372083784 0.03579902648925781 3 0.9938463710600631 15.724388246289037 5732.0 6.557024711787832 3.0 - - - - - - - 1233.142857142857 138 7 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 289 37 C20140716_OR021_03 C20140716_OR021_03 TB419974.[MT7]-ILHSQVAGR.2y6_1.heavy 562.836 / 617.337 15381.0 21.785099983215332 36 20 0 6 10 9.611678230187245 10.404010372083784 0.03579902648925781 3 0.9938463710600631 15.724388246289037 15381.0 377.1505479452055 0.0 - - - - - - - 186.78571428571428 30 14 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 291 37 C20140716_OR021_03 C20140716_OR021_03 TB419974.[MT7]-ILHSQVAGR.2y7_1.heavy 562.836 / 754.396 14220.0 21.785099983215332 36 20 0 6 10 9.611678230187245 10.404010372083784 0.03579902648925781 3 0.9938463710600631 15.724388246289037 14220.0 154.15721607086365 0.0 - - - - - - - 125.54545454545455 28 11 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 293 38 C20140716_OR021_03 C20140716_OR021_03 TB435875.[MT7]-FLESLLQK[MT7].2b4_1.heavy 633.389 / 621.336 4384.0 44.04180018107096 41 15 10 6 10 2.8823706560352966 34.693664324750685 0.038402557373046875 3 0.9592597054771055 6.093470447104125 4384.0 10.003005367545235 0.0 - - - - - - - 286.125 8 8 ZNFX1 zinc finger, NFX1-type containing 1 295 38 C20140716_OR021_03 C20140716_OR021_03 TB435875.[MT7]-FLESLLQK[MT7].2y3_1.heavy 633.389 / 532.357 12391.0 44.04180018107096 41 15 10 6 10 2.8823706560352966 34.693664324750685 0.038402557373046875 3 0.9592597054771055 6.093470447104125 12391.0 10.553368424141805 0.0 - - - - - - - 702.75 24 8 ZNFX1 zinc finger, NFX1-type containing 1 297 38 C20140716_OR021_03 C20140716_OR021_03 TB435875.[MT7]-FLESLLQK[MT7].2y6_1.heavy 633.389 / 861.516 5623.0 44.04180018107096 41 15 10 6 10 2.8823706560352966 34.693664324750685 0.038402557373046875 3 0.9592597054771055 6.093470447104125 5623.0 53.58041884816754 0.0 - - - - - - - 262.25 11 8 ZNFX1 zinc finger, NFX1-type containing 1 299 38 C20140716_OR021_03 C20140716_OR021_03 TB435875.[MT7]-FLESLLQK[MT7].2y7_1.heavy 633.389 / 974.6 N/A 44.04180018107096 41 15 10 6 10 2.8823706560352966 34.693664324750685 0.038402557373046875 3 0.9592597054771055 6.093470447104125 15536.0 39.42435260749778 0.0 - - - - - - - 200.1 31 10 ZNFX1 zinc finger, NFX1-type containing 1 301 39 C20140716_OR021_03 C20140716_OR021_03 TB442086.[MT7]-LAAESAK[MT7].2y4_1.heavy 489.297 / 578.327 5296.0 24.140999794006348 39 13 10 6 10 1.769000714327654 46.478819993460505 0.038799285888671875 3 0.9270619027398858 4.54160554995947 5296.0 23.68875133542685 0.0 - - - - - - - 153.69230769230768 10 13 NOVA2 neuro-oncological ventral antigen 2 303 39 C20140716_OR021_03 C20140716_OR021_03 TB442086.[MT7]-LAAESAK[MT7].2y5_1.heavy 489.297 / 649.364 18191.0 24.140999794006348 39 13 10 6 10 1.769000714327654 46.478819993460505 0.038799285888671875 3 0.9270619027398858 4.54160554995947 18191.0 115.7996120941714 0.0 - - - - - - - 153.72727272727272 36 11 NOVA2 neuro-oncological ventral antigen 2 305 39 C20140716_OR021_03 C20140716_OR021_03 TB442086.[MT7]-LAAESAK[MT7].2b4_1.heavy 489.297 / 529.31 1842.0 24.140999794006348 39 13 10 6 10 1.769000714327654 46.478819993460505 0.038799285888671875 3 0.9270619027398858 4.54160554995947 1842.0 0.0 4.0 - - - - - - - 258.45454545454544 4 11 NOVA2 neuro-oncological ventral antigen 2 307 39 C20140716_OR021_03 C20140716_OR021_03 TB442086.[MT7]-LAAESAK[MT7].2y6_1.heavy 489.297 / 720.401 15351.0 24.140999794006348 39 13 10 6 10 1.769000714327654 46.478819993460505 0.038799285888671875 3 0.9270619027398858 4.54160554995947 15351.0 98.19452304024828 1.0 - - - - - - - 139.72727272727272 30 11 NOVA2 neuro-oncological ventral antigen 2 309 40 C20140716_OR021_03 C20140716_OR021_03 TB442388.[MT7]-AGPHC[CAM]PTAQLIATLK[MT7].3y3_1.heavy 622.688 / 505.347 35987.0 36.48699951171875 40 14 10 10 6 1.3647143814327436 56.790068693639455 0.0 6 0.9355682369363804 4.835623217064955 35987.0 -0.19679545019549938 1.0 - - - - - - - 341.5 73 4 PF4;PF4V1 platelet factor 4;platelet factor 4 variant 1 311 40 C20140716_OR021_03 C20140716_OR021_03 TB442388.[MT7]-AGPHC[CAM]PTAQLIATLK[MT7].3b4_1.heavy 622.688 / 507.28 16580.0 36.48699951171875 40 14 10 10 6 1.3647143814327436 56.790068693639455 0.0 6 0.9355682369363804 4.835623217064955 16580.0 7.793754308523168 3.0 - - - - - - - 488.0 67 1 PF4;PF4V1 platelet factor 4;platelet factor 4 variant 1 313 40 C20140716_OR021_03 C20140716_OR021_03 TB442388.[MT7]-AGPHC[CAM]PTAQLIATLK[MT7].3b5_1.heavy 622.688 / 667.31 15117.0 36.48699951171875 40 14 10 10 6 1.3647143814327436 56.790068693639455 0.0 6 0.9355682369363804 4.835623217064955 15117.0 5.020473544078777 2.0 - - - - - - - 341.5 41 2 PF4;PF4V1 platelet factor 4;platelet factor 4 variant 1 315 40 C20140716_OR021_03 C20140716_OR021_03 TB442388.[MT7]-AGPHC[CAM]PTAQLIATLK[MT7].3y4_1.heavy 622.688 / 576.384 74510.0 36.48699951171875 40 14 10 10 6 1.3647143814327436 56.790068693639455 0.0 6 0.9355682369363804 4.835623217064955 74510.0 24.758058644889488 1.0 - - - - - - - 488.0 149 1 PF4;PF4V1 platelet factor 4;platelet factor 4 variant 1 317 41 C20140716_OR021_03 C20140716_OR021_03 TB420453.[MT7]-GQNLLLTNLQTIQGILER.3b4_1.heavy 723.422 / 557.316 N/A N/A - - - - - - - - - 0.0 - - - - - - - TPR translocated promoter region (to activated MET oncogene) 319 41 C20140716_OR021_03 C20140716_OR021_03 TB420453.[MT7]-GQNLLLTNLQTIQGILER.3b5_1.heavy 723.422 / 670.4 N/A N/A - - - - - - - - - 0.0 - - - - - - - TPR translocated promoter region (to activated MET oncogene) 321 41 C20140716_OR021_03 C20140716_OR021_03 TB420453.[MT7]-GQNLLLTNLQTIQGILER.3y8_1.heavy 723.422 / 929.542 N/A N/A - - - - - - - - - 0.0 - - - - - - - TPR translocated promoter region (to activated MET oncogene) 323 41 C20140716_OR021_03 C20140716_OR021_03 TB420453.[MT7]-GQNLLLTNLQTIQGILER.3y9_2.heavy 723.422 / 529.304 N/A N/A - - - - - - - - - 0.0 - - - - - - - TPR translocated promoter region (to activated MET oncogene) 325 42 C20140716_OR021_03 C20140716_OR021_03 TB442378.[MT7]-EHVIHIIDFGLAK[MT7].4b8_2.heavy 445.764 / 551.312 29492.0 38.18960189819336 39 9 10 10 10 0.7216013345897931 82.57266066375328 0.0 3 0.8129111296436347 2.8075171571559694 29492.0 219.17387775761392 0.0 - - - - - - - 241.6 58 5 CSNK1G1 casein kinase 1, gamma 1 327 42 C20140716_OR021_03 C20140716_OR021_03 TB442378.[MT7]-EHVIHIIDFGLAK[MT7].4b4_1.heavy 445.764 / 623.363 14796.0 38.18960189819336 39 9 10 10 10 0.7216013345897931 82.57266066375328 0.0 3 0.8129111296436347 2.8075171571559694 14796.0 207.6294015073149 0.0 - - - - - - - 145.44444444444446 29 9 CSNK1G1 casein kinase 1, gamma 1 329 42 C20140716_OR021_03 C20140716_OR021_03 TB442378.[MT7]-EHVIHIIDFGLAK[MT7].4b5_1.heavy 445.764 / 760.422 4731.0 38.18960189819336 39 9 10 10 10 0.7216013345897931 82.57266066375328 0.0 3 0.8129111296436347 2.8075171571559694 4731.0 70.37889759125166 0.0 - - - - - - - 167.66666666666666 9 3 CSNK1G1 casein kinase 1, gamma 1 331 42 C20140716_OR021_03 C20140716_OR021_03 TB442378.[MT7]-EHVIHIIDFGLAK[MT7].4b3_1.heavy 445.764 / 510.279 17514.0 38.18960189819336 39 9 10 10 10 0.7216013345897931 82.57266066375328 0.0 3 0.8129111296436347 2.8075171571559694 17514.0 164.62592020244207 0.0 - - - - - - - 191.3 35 10 CSNK1G1 casein kinase 1, gamma 1 333 43 C20140716_OR021_03 C20140716_OR021_03 TB420319.[MT7]-VVTVSGEPEQVHK[MT7].3y6_1.heavy 566.321 / 881.496 9728.0 24.927900314331055 47 17 10 10 10 4.137909881806906 24.1667902048009 0.0 3 0.9753435766540249 7.843337869022733 9728.0 54.6613953488372 1.0 - - - - - - - 129.0 19 6 NOVA2 neuro-oncological ventral antigen 2 335 43 C20140716_OR021_03 C20140716_OR021_03 TB420319.[MT7]-VVTVSGEPEQVHK[MT7].3y3_1.heavy 566.321 / 527.342 16787.0 24.927900314331055 47 17 10 10 10 4.137909881806906 24.1667902048009 0.0 3 0.9753435766540249 7.843337869022733 16787.0 117.90506237809453 0.0 - - - - - - - 221.14285714285714 33 7 NOVA2 neuro-oncological ventral antigen 2 337 43 C20140716_OR021_03 C20140716_OR021_03 TB420319.[MT7]-VVTVSGEPEQVHK[MT7].3b4_1.heavy 566.321 / 543.362 12999.0 24.927900314331055 47 17 10 10 10 4.137909881806906 24.1667902048009 0.0 3 0.9753435766540249 7.843337869022733 12999.0 80.05973255813953 0.0 - - - - - - - 258.0 25 9 NOVA2 neuro-oncological ventral antigen 2 339 43 C20140716_OR021_03 C20140716_OR021_03 TB420319.[MT7]-VVTVSGEPEQVHK[MT7].3b7_1.heavy 566.321 / 816.458 17820.0 24.927900314331055 47 17 10 10 10 4.137909881806906 24.1667902048009 0.0 3 0.9753435766540249 7.843337869022733 17820.0 239.94837209302327 0.0 - - - - - - - 182.75 35 8 NOVA2 neuro-oncological ventral antigen 2 341 44 C20140716_OR021_03 C20140716_OR021_03 TB442379.[MT7]-EHVIHIIDFGLAK[MT7].3b4_1.heavy 594.017 / 623.363 64680.0 38.18960189819336 48 18 10 10 10 3.538677904696864 28.25914160406367 0.0 3 0.9806783758745354 8.864184601869777 64680.0 107.51402114283425 0.0 - - - - - - - 652.75 129 8 CSNK1G1 casein kinase 1, gamma 1 343 44 C20140716_OR021_03 C20140716_OR021_03 TB442379.[MT7]-EHVIHIIDFGLAK[MT7].3y4_1.heavy 594.017 / 532.357 58453.0 38.18960189819336 48 18 10 10 10 3.538677904696864 28.25914160406367 0.0 3 0.9806783758745354 8.864184601869777 58453.0 72.23737656071046 0.0 - - - - - - - 753.3 116 10 CSNK1G1 casein kinase 1, gamma 1 345 44 C20140716_OR021_03 C20140716_OR021_03 TB442379.[MT7]-EHVIHIIDFGLAK[MT7].3b3_1.heavy 594.017 / 510.279 69400.0 38.18960189819336 48 18 10 10 10 3.538677904696864 28.25914160406367 0.0 3 0.9806783758745354 8.864184601869777 69400.0 151.1975280750284 0.0 - - - - - - - 691.8888888888889 138 9 CSNK1G1 casein kinase 1, gamma 1 347 44 C20140716_OR021_03 C20140716_OR021_03 TB442379.[MT7]-EHVIHIIDFGLAK[MT7].3y5_1.heavy 594.017 / 679.426 41078.0 38.18960189819336 48 18 10 10 10 3.538677904696864 28.25914160406367 0.0 3 0.9806783758745354 8.864184601869777 41078.0 216.35698265429608 0.0 - - - - - - - 170.6 82 10 CSNK1G1 casein kinase 1, gamma 1 349 45 C20140716_OR021_03 C20140716_OR021_03 TB420086.[MT7]-EEQIFLLHR.3b4_1.heavy 443.586 / 644.337 9715.0 35.3872013092041 41 16 10 5 10 3.2220340674139734 31.036295057010584 0.043399810791015625 3 0.9625187802871775 6.354620257339962 9715.0 70.7467247817011 1.0 - - - - - - - 188.33333333333334 19 6 PTH1R parathyroid hormone 1 receptor 351 45 C20140716_OR021_03 C20140716_OR021_03 TB420086.[MT7]-EEQIFLLHR.3y4_1.heavy 443.586 / 538.346 22517.0 35.3872013092041 41 16 10 5 10 3.2220340674139734 31.036295057010584 0.043399810791015625 3 0.9625187802871775 6.354620257339962 22517.0 564.4261333333334 0.0 - - - - - - - 160.0 45 8 PTH1R parathyroid hormone 1 receptor 353 45 C20140716_OR021_03 C20140716_OR021_03 TB420086.[MT7]-EEQIFLLHR.3b3_1.heavy 443.586 / 531.253 26132.0 35.3872013092041 41 16 10 5 10 3.2220340674139734 31.036295057010584 0.043399810791015625 3 0.9625187802871775 6.354620257339962 26132.0 202.34509669879486 0.0 - - - - - - - 125.44444444444444 52 9 PTH1R parathyroid hormone 1 receptor 355 45 C20140716_OR021_03 C20140716_OR021_03 TB420086.[MT7]-EEQIFLLHR.3y5_1.heavy 443.586 / 685.414 7832.0 35.3872013092041 41 16 10 5 10 3.2220340674139734 31.036295057010584 0.043399810791015625 3 0.9625187802871775 6.354620257339962 7832.0 137.2064745722714 0.0 - - - - - - - 160.0 15 8 PTH1R parathyroid hormone 1 receptor 357 46 C20140716_OR021_03 C20140716_OR021_03 TB435868.[MT7]-GHPAASPALPR.2y8_1.heavy 609.347 / 782.452 N/A N/A - - - - - - - - - 0.0 - - - - - - - PTGER4 prostaglandin E receptor 4 (subtype EP4) 359 46 C20140716_OR021_03 C20140716_OR021_03 TB435868.[MT7]-GHPAASPALPR.2y5_1.heavy 609.347 / 553.346 N/A N/A - - - - - - - - - 0.0 - - - - - - - PTGER4 prostaglandin E receptor 4 (subtype EP4) 361 46 C20140716_OR021_03 C20140716_OR021_03 TB435868.[MT7]-GHPAASPALPR.2y9_1.heavy 609.347 / 879.505 N/A N/A - - - - - - - - - 0.0 - - - - - - - PTGER4 prostaglandin E receptor 4 (subtype EP4) 363 46 C20140716_OR021_03 C20140716_OR021_03 TB435868.[MT7]-GHPAASPALPR.2y7_1.heavy 609.347 / 711.415 N/A N/A - - - - - - - - - 0.0 - - - - - - - PTGER4 prostaglandin E receptor 4 (subtype EP4) 365 47 C20140716_OR021_03 C20140716_OR021_03 TB436066.[MT7]-TAVTEIVNSFLC[CAM]LVPEEAK[MT7].3b6_1.heavy 803.438 / 759.437 N/A N/A - - - - - - - - - 0.0 - - - - - - - FAM160B2 family with sequence similarity 160, member B2 367 47 C20140716_OR021_03 C20140716_OR021_03 TB436066.[MT7]-TAVTEIVNSFLC[CAM]LVPEEAK[MT7].3b5_1.heavy 803.438 / 646.353 N/A N/A - - - - - - - - - 0.0 - - - - - - - FAM160B2 family with sequence similarity 160, member B2 369 47 C20140716_OR021_03 C20140716_OR021_03 TB436066.[MT7]-TAVTEIVNSFLC[CAM]LVPEEAK[MT7].3b7_1.heavy 803.438 / 858.505 N/A N/A - - - - - - - - - 0.0 - - - - - - - FAM160B2 family with sequence similarity 160, member B2 371 47 C20140716_OR021_03 C20140716_OR021_03 TB436066.[MT7]-TAVTEIVNSFLC[CAM]LVPEEAK[MT7].3y5_1.heavy 803.438 / 717.39 N/A N/A - - - - - - - - - 0.0 - - - - - - - FAM160B2 family with sequence similarity 160, member B2 373 48 C20140716_OR021_03 C20140716_OR021_03 TB420081.[MT7]-NIAIQSQFTR.2y8_1.heavy 661.371 / 950.505 19383.0 30.96619987487793 45 15 10 10 10 1.6263978681345832 48.87451129350586 0.0 3 0.9539080349502778 5.7262111223639565 19383.0 54.41486219817743 0.0 - - - - - - - 199.63636363636363 38 22 TPR translocated promoter region (to activated MET oncogene) 375 48 C20140716_OR021_03 C20140716_OR021_03 TB420081.[MT7]-NIAIQSQFTR.2y9_1.heavy 661.371 / 1063.59 16809.0 30.96619987487793 45 15 10 10 10 1.6263978681345832 48.87451129350586 0.0 3 0.9539080349502778 5.7262111223639565 16809.0 28.272658956656116 0.0 - - - - - - - 244.0 33 18 TPR translocated promoter region (to activated MET oncogene) 377 48 C20140716_OR021_03 C20140716_OR021_03 TB420081.[MT7]-NIAIQSQFTR.2y6_1.heavy 661.371 / 766.384 6057.0 30.96619987487793 45 15 10 10 10 1.6263978681345832 48.87451129350586 0.0 3 0.9539080349502778 5.7262111223639565 6057.0 28.399590221136652 0.0 - - - - - - - 215.21052631578948 12 19 TPR translocated promoter region (to activated MET oncogene) 379 48 C20140716_OR021_03 C20140716_OR021_03 TB420081.[MT7]-NIAIQSQFTR.2y7_1.heavy 661.371 / 879.468 9010.0 30.96619987487793 45 15 10 10 10 1.6263978681345832 48.87451129350586 0.0 3 0.9539080349502778 5.7262111223639565 9010.0 33.98877887788779 0.0 - - - - - - - 227.15 18 20 TPR translocated promoter region (to activated MET oncogene) 381 49 C20140716_OR021_03 C20140716_OR021_03 TB436064.[MT7]-TAVTEIVNSFLC[CAM]LVPEEAK[MT7].4y4_1.heavy 602.83 / 620.337 N/A N/A - - - - - - - - - 0.0 - - - - - - - FAM160B2 family with sequence similarity 160, member B2 383 49 C20140716_OR021_03 C20140716_OR021_03 TB436064.[MT7]-TAVTEIVNSFLC[CAM]LVPEEAK[MT7].4y5_1.heavy 602.83 / 717.39 N/A N/A - - - - - - - - - 0.0 - - - - - - - FAM160B2 family with sequence similarity 160, member B2 385 49 C20140716_OR021_03 C20140716_OR021_03 TB436064.[MT7]-TAVTEIVNSFLC[CAM]LVPEEAK[MT7].4b5_1.heavy 602.83 / 646.353 N/A N/A - - - - - - - - - 0.0 - - - - - - - FAM160B2 family with sequence similarity 160, member B2 387 49 C20140716_OR021_03 C20140716_OR021_03 TB436064.[MT7]-TAVTEIVNSFLC[CAM]LVPEEAK[MT7].4b6_1.heavy 602.83 / 759.437 N/A N/A - - - - - - - - - 0.0 - - - - - - - FAM160B2 family with sequence similarity 160, member B2 389 50 C20140716_OR021_03 C20140716_OR021_03 TB419965.[MT7]-SPMQHWR.2y4_1.heavy 543.275 / 626.316 850.0 23.436949729919434 38 18 10 6 4 5.809358485346173 17.21360460922582 0.03569984436035156 7 0.9818903768493489 9.156933646344159 850.0 1.4926062846580406 6.0 - - - - - - - 221.6 4 15 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 391 50 C20140716_OR021_03 C20140716_OR021_03 TB419965.[MT7]-SPMQHWR.2y5_1.heavy 543.275 / 757.356 541.0 23.436949729919434 38 18 10 6 4 5.809358485346173 17.21360460922582 0.03569984436035156 7 0.9818903768493489 9.156933646344159 541.0 9.709896103896103 6.0 - - - - - - - 182.54545454545453 3 11 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 393 50 C20140716_OR021_03 C20140716_OR021_03 TB419965.[MT7]-SPMQHWR.2b4_1.heavy 543.275 / 588.293 1159.0 23.436949729919434 38 18 10 6 4 5.809358485346173 17.21360460922582 0.03569984436035156 7 0.9818903768493489 9.156933646344159 1159.0 5.946941441843845 2.0 - - - - - - - 209.0 3 17 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 395 50 C20140716_OR021_03 C20140716_OR021_03 TB419965.[MT7]-SPMQHWR.2y6_1.heavy 543.275 / 854.409 3786.0 23.436949729919434 38 18 10 6 4 5.809358485346173 17.21360460922582 0.03569984436035156 7 0.9818903768493489 9.156933646344159 3786.0 20.371112529293605 0.0 - - - - - - - 255.69230769230768 7 13 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 397 51 C20140716_OR021_03 C20140716_OR021_03 ODP2_ECOLI.EAAPAAAPAAAAAK.2y7.peptide 590.82 / 599.35 366291.0 19.353700637817383 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 366291.0 1684.4038686131385 0.0 - - - - - - - 252.6153846153846 732 13 399 51 C20140716_OR021_03 C20140716_OR021_03 ODP2_ECOLI.EAAPAAAPAAAAAK.2y9.peptide 590.82 / 741.43 172433.0 19.353700637817383 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 172433.0 1521.5031973545858 0.0 - - - - - - - 194.6153846153846 344 13 401 51 C20140716_OR021_03 C20140716_OR021_03 ODP2_ECOLI.EAAPAAAPAAAAAK.2y11.peptide 590.82 / 909.52 161959.0 19.353700637817383 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 161959.0 1028.7165295812524 0.0 - - - - - - - 231.69230769230768 323 13 403 52 C20140716_OR021_03 C20140716_OR021_03 TB442509.[MT7]-AEVEEFSFITQLSGLTDHLPVAMR.3y7_1.heavy 945.489 / 823.461 2669.0 54.12980079650879 41 18 10 5 8 4.1299042903096455 24.213636193613183 0.04560089111328125 4 0.9886325657252903 11.564287565722541 2669.0 43.293662790697674 0.0 - - - - - - - 150.57142857142858 5 14 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 405 52 C20140716_OR021_03 C20140716_OR021_03 TB442509.[MT7]-AEVEEFSFITQLSGLTDHLPVAMR.3b6_1.heavy 945.489 / 849.411 1593.0 54.12980079650879 41 18 10 5 8 4.1299042903096455 24.213636193613183 0.04560089111328125 4 0.9886325657252903 11.564287565722541 1593.0 12.558767441860464 0.0 - - - - - - - 151.93333333333334 3 15 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 407 52 C20140716_OR021_03 C20140716_OR021_03 TB442509.[MT7]-AEVEEFSFITQLSGLTDHLPVAMR.3y11_1.heavy 945.489 / 1209.64 1636.0 54.12980079650879 41 18 10 5 8 4.1299042903096455 24.213636193613183 0.04560089111328125 4 0.9886325657252903 11.564287565722541 1636.0 4.086234639554897 2.0 - - - - - - - 203.11111111111111 5 18 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 409 52 C20140716_OR021_03 C20140716_OR021_03 TB442509.[MT7]-AEVEEFSFITQLSGLTDHLPVAMR.3b5_1.heavy 945.489 / 702.343 3100.0 54.12980079650879 41 18 10 5 8 4.1299042903096455 24.213636193613183 0.04560089111328125 4 0.9886325657252903 11.564287565722541 3100.0 26.803156146179397 1.0 - - - - - - - 190.1578947368421 6 19 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 411 53 C20140716_OR021_03 C20140716_OR021_03 TB435860.[MT7]-LLLIDYAAR.2y8_1.heavy 596.365 / 934.536 20451.0 43.56037521362305 41 15 10 6 10 2.742276279553093 36.46605586228421 0.0399017333984375 3 0.9519339689817241 5.606452349287462 20451.0 45.882295336787564 0.0 - - - - - - - 184.66666666666666 40 12 PLXNA3 plexin A3 413 53 C20140716_OR021_03 C20140716_OR021_03 TB435860.[MT7]-LLLIDYAAR.2y5_1.heavy 596.365 / 595.284 7332.0 43.56037521362305 41 15 10 6 10 2.742276279553093 36.46605586228421 0.0399017333984375 3 0.9519339689817241 5.606452349287462 7332.0 13.094004016163819 0.0 - - - - - - - 289.22222222222223 14 9 PLXNA3 plexin A3 415 53 C20140716_OR021_03 C20140716_OR021_03 TB435860.[MT7]-LLLIDYAAR.2b7_1.heavy 596.365 / 946.573 482.0 43.56037521362305 41 15 10 6 10 2.742276279553093 36.46605586228421 0.0399017333984375 3 0.9519339689817241 5.606452349287462 482.0 2.5473575129533677 23.0 - - - - - - - 304.0769230769231 6 13 PLXNA3 plexin A3 417 53 C20140716_OR021_03 C20140716_OR021_03 TB435860.[MT7]-LLLIDYAAR.2y7_1.heavy 596.365 / 821.452 10033.0 43.56037521362305 41 15 10 6 10 2.742276279553093 36.46605586228421 0.0399017333984375 3 0.9519339689817241 5.606452349287462 10033.0 66.02025906735753 0.0 - - - - - - - 214.92307692307693 20 13 PLXNA3 plexin A3 419 54 C20140716_OR021_03 C20140716_OR021_03 TB435863.[MT7]-LREATEAK[MT7].2y5_1.heavy 603.358 / 663.379 834.0 19.020700454711914 47 17 10 10 10 6.277151653070982 15.930792424152575 0.0 3 0.978792251996527 8.459497312525947 834.0 4.316031128404669 0.0 - - - - - - - 0.0 1 0 SKI v-ski sarcoma viral oncogene homolog (avian) 421 54 C20140716_OR021_03 C20140716_OR021_03 TB435863.[MT7]-LREATEAK[MT7].2b6_1.heavy 603.358 / 844.464 2438.0 19.020700454711914 47 17 10 10 10 6.277151653070982 15.930792424152575 0.0 3 0.978792251996527 8.459497312525947 2438.0 11.931295839144102 0.0 - - - - - - - 167.69230769230768 4 13 SKI v-ski sarcoma viral oncogene homolog (avian) 423 54 C20140716_OR021_03 C20140716_OR021_03 TB435863.[MT7]-LREATEAK[MT7].2y6_1.heavy 603.358 / 792.422 577.0 19.020700454711914 47 17 10 10 10 6.277151653070982 15.930792424152575 0.0 3 0.978792251996527 8.459497312525947 577.0 10.458124999999999 0.0 - - - - - - - 0.0 1 0 SKI v-ski sarcoma viral oncogene homolog (avian) 425 54 C20140716_OR021_03 C20140716_OR021_03 TB435863.[MT7]-LREATEAK[MT7].2b7_1.heavy 603.358 / 915.502 834.0 19.020700454711914 47 17 10 10 10 6.277151653070982 15.930792424152575 0.0 3 0.978792251996527 8.459497312525947 834.0 6.379629088785046 0.0 - - - - - - - 0.0 1 0 SKI v-ski sarcoma viral oncogene homolog (avian) 427 55 C20140716_OR021_03 C20140716_OR021_03 TB442374.[MT7]-ARVDFHNNLVGVK[MT7].4y4_1.heavy 440.007 / 546.373 40928.0 29.093799591064453 44 14 10 10 10 6.126055134029584 16.32371857780232 0.0 3 0.9444364699193233 5.211175983971785 40928.0 118.2570525091349 0.0 - - - - - - - 291.7 81 10 WNT9A wingless-type MMTV integration site family, member 9A 429 55 C20140716_OR021_03 C20140716_OR021_03 TB442374.[MT7]-ARVDFHNNLVGVK[MT7].4b8_2.heavy 440.007 / 549.782 67519.0 29.093799591064453 44 14 10 10 10 6.126055134029584 16.32371857780232 0.0 3 0.9444364699193233 5.211175983971785 67519.0 203.2044424657534 0.0 - - - - - - - 250.125 135 8 WNT9A wingless-type MMTV integration site family, member 9A 431 55 C20140716_OR021_03 C20140716_OR021_03 TB442374.[MT7]-ARVDFHNNLVGVK[MT7].4b5_1.heavy 440.007 / 733.411 7252.0 29.093799591064453 44 14 10 10 10 6.126055134029584 16.32371857780232 0.0 3 0.9444364699193233 5.211175983971785 7252.0 96.93215421686747 1.0 - - - - - - - 178.42857142857142 17 7 WNT9A wingless-type MMTV integration site family, member 9A 433 55 C20140716_OR021_03 C20140716_OR021_03 TB442374.[MT7]-ARVDFHNNLVGVK[MT7].4y3_1.heavy 440.007 / 447.305 138873.0 29.093799591064453 44 14 10 10 10 6.126055134029584 16.32371857780232 0.0 3 0.9444364699193233 5.211175983971785 138873.0 164.94099580083983 0.0 - - - - - - - 677.5 277 8 WNT9A wingless-type MMTV integration site family, member 9A 435 56 C20140716_OR021_03 C20140716_OR021_03 TB420463.[MT7]-AIDEDC[CAM]SQYEPIPGSQK[MT7].3y7_1.heavy 742.359 / 870.516 12849.0 29.22010040283203 44 18 10 6 10 2.741970637989798 28.45051908760611 0.035800933837890625 3 0.9828688327308872 9.415576967967418 12849.0 105.22405406921308 0.0 - - - - - - - 239.0 25 15 C8A complement component 8, alpha polypeptide 437 56 C20140716_OR021_03 C20140716_OR021_03 TB420463.[MT7]-AIDEDC[CAM]SQYEPIPGSQK[MT7].3b4_1.heavy 742.359 / 573.3 9826.0 29.22010040283203 44 18 10 6 10 2.741970637989798 28.45051908760611 0.035800933837890625 3 0.9828688327308872 9.415576967967418 9826.0 80.81690728588255 0.0 - - - - - - - 226.53333333333333 19 15 C8A complement component 8, alpha polypeptide 439 56 C20140716_OR021_03 C20140716_OR021_03 TB420463.[MT7]-AIDEDC[CAM]SQYEPIPGSQK[MT7].3b5_1.heavy 742.359 / 688.327 11621.0 29.22010040283203 44 18 10 6 10 2.741970637989798 28.45051908760611 0.035800933837890625 3 0.9828688327308872 9.415576967967418 11621.0 25.67072751322751 0.0 - - - - - - - 264.3 23 10 C8A complement component 8, alpha polypeptide 441 56 C20140716_OR021_03 C20140716_OR021_03 TB420463.[MT7]-AIDEDC[CAM]SQYEPIPGSQK[MT7].3y5_1.heavy 742.359 / 660.38 56688.0 29.22010040283203 44 18 10 6 10 2.741970637989798 28.45051908760611 0.035800933837890625 3 0.9828688327308872 9.415576967967418 56688.0 193.51090335649633 0.0 - - - - - - - 647.8571428571429 113 7 C8A complement component 8, alpha polypeptide 443 57 C20140716_OR021_03 C20140716_OR021_03 TB442506.[MT7]-ALPSAVPDAAAPADAPSGLEAELEHLR.4y8_1.heavy 703.87 / 996.511 N/A N/A - - - - - - - - - 0.0 - - - - - - - SKI v-ski sarcoma viral oncogene homolog (avian) 445 57 C20140716_OR021_03 C20140716_OR021_03 TB442506.[MT7]-ALPSAVPDAAAPADAPSGLEAELEHLR.4b5_1.heavy 703.87 / 584.352 N/A N/A - - - - - - - - - 0.0 - - - - - - - SKI v-ski sarcoma viral oncogene homolog (avian) 447 57 C20140716_OR021_03 C20140716_OR021_03 TB442506.[MT7]-ALPSAVPDAAAPADAPSGLEAELEHLR.4y7_1.heavy 703.87 / 867.468 N/A N/A - - - - - - - - - 0.0 - - - - - - - SKI v-ski sarcoma viral oncogene homolog (avian) 449 57 C20140716_OR021_03 C20140716_OR021_03 TB442506.[MT7]-ALPSAVPDAAAPADAPSGLEAELEHLR.4b6_1.heavy 703.87 / 683.421 N/A N/A - - - - - - - - - 0.0 - - - - - - - SKI v-ski sarcoma viral oncogene homolog (avian) 451 58 C20140716_OR021_03 C20140716_OR021_03 TB442505.[MT7]-DFEIVDQPGLDIFGQVFNQWK[MT7].3b6_1.heavy 928.481 / 863.427 1075.0 54.57400131225586 45 15 10 10 10 2.6793175251271957 37.322937301077324 0.0 3 0.9500390020354833 5.498216983002304 1075.0 15.949728260869566 0.0 - - - - - - - 106.3076923076923 2 13 ATXN7L3 ataxin 7-like 3 453 58 C20140716_OR021_03 C20140716_OR021_03 TB442505.[MT7]-DFEIVDQPGLDIFGQVFNQWK[MT7].3b3_1.heavy 928.481 / 536.247 2212.0 54.57400131225586 45 15 10 10 10 2.6793175251271957 37.322937301077324 0.0 3 0.9500390020354833 5.498216983002304 2212.0 26.498831537152576 0.0 - - - - - - - 116.66666666666667 4 15 ATXN7L3 ataxin 7-like 3 455 58 C20140716_OR021_03 C20140716_OR021_03 TB442505.[MT7]-DFEIVDQPGLDIFGQVFNQWK[MT7].3y5_1.heavy 928.481 / 866.464 1444.0 54.57400131225586 45 15 10 10 10 2.6793175251271957 37.322937301077324 0.0 3 0.9500390020354833 5.498216983002304 1444.0 18.27503896103896 0.0 - - - - - - - 114.66666666666667 2 15 ATXN7L3 ataxin 7-like 3 457 58 C20140716_OR021_03 C20140716_OR021_03 TB442505.[MT7]-DFEIVDQPGLDIFGQVFNQWK[MT7].3b7_1.heavy 928.481 / 991.485 1382.0 54.57400131225586 45 15 10 10 10 2.6793175251271957 37.322937301077324 0.0 3 0.9500390020354833 5.498216983002304 1382.0 13.815110769531058 1.0 - - - - - - - 98.71428571428571 3 14 ATXN7L3 ataxin 7-like 3 459 59 C20140716_OR021_03 C20140716_OR021_03 TB420460.[MT7]-YNNSTGISYETLGPEELR.3b6_1.heavy 729.694 / 781.36 7472.0 37.10649871826172 45 15 10 10 10 1.6716098764152545 46.37651185604232 0.0 3 0.9521060978053038 5.616600009825545 7472.0 40.75636363636363 1.0 - - - - - - - 224.0 14 11 ATXN7L3 ataxin 7-like 3 461 59 C20140716_OR021_03 C20140716_OR021_03 TB420460.[MT7]-YNNSTGISYETLGPEELR.3y6_1.heavy 729.694 / 700.362 28395.0 37.10649871826172 45 15 10 10 10 1.6716098764152545 46.37651185604232 0.0 3 0.9521060978053038 5.616600009825545 28395.0 114.0192885042506 0.0 - - - - - - - 213.71428571428572 56 7 ATXN7L3 ataxin 7-like 3 463 59 C20140716_OR021_03 C20140716_OR021_03 TB420460.[MT7]-YNNSTGISYETLGPEELR.3b3_1.heavy 729.694 / 536.258 3868.0 37.10649871826172 45 15 10 10 10 1.6716098764152545 46.37651185604232 0.0 3 0.9521060978053038 5.616600009825545 3868.0 0.10646999478605873 2.0 - - - - - - - 758.0 11 8 ATXN7L3 ataxin 7-like 3 465 59 C20140716_OR021_03 C20140716_OR021_03 TB420460.[MT7]-YNNSTGISYETLGPEELR.3y5_1.heavy 729.694 / 643.341 14154.0 37.10649871826172 45 15 10 10 10 1.6716098764152545 46.37651185604232 0.0 3 0.9521060978053038 5.616600009825545 14154.0 13.872377770561013 0.0 - - - - - - - 352.0 28 4 ATXN7L3 ataxin 7-like 3 467 60 C20140716_OR021_03 C20140716_OR021_03 TB420310.[MT7]-LIVPNSTAGLIIGK[MT7].2y4_1.heavy 842.534 / 574.404 2525.0 41.718299865722656 47 17 10 10 10 3.895108432856126 25.673226233312853 0.0 3 0.9704623654404599 7.163077897683592 2525.0 4.458333333333334 2.0 - - - - - - - 232.3 5 10 NOVA2 neuro-oncological ventral antigen 2 469 60 C20140716_OR021_03 C20140716_OR021_03 TB420310.[MT7]-LIVPNSTAGLIIGK[MT7].2y8_1.heavy 842.534 / 916.595 606.0 41.718299865722656 47 17 10 10 10 3.895108432856126 25.673226233312853 0.0 3 0.9704623654404599 7.163077897683592 606.0 1.4285714285714288 22.0 - - - - - - - 209.76923076923077 2 13 NOVA2 neuro-oncological ventral antigen 2 471 60 C20140716_OR021_03 C20140716_OR021_03 TB420310.[MT7]-LIVPNSTAGLIIGK[MT7].2y3_1.heavy 842.534 / 461.32 3939.0 41.718299865722656 47 17 10 10 10 3.895108432856126 25.673226233312853 0.0 3 0.9704623654404599 7.163077897683592 3939.0 15.145 0.0 - - - - - - - 223.64285714285714 7 14 NOVA2 neuro-oncological ventral antigen 2 473 60 C20140716_OR021_03 C20140716_OR021_03 TB420310.[MT7]-LIVPNSTAGLIIGK[MT7].2y11_1.heavy 842.534 / 1214.72 9594.0 41.718299865722656 47 17 10 10 10 3.895108432856126 25.673226233312853 0.0 3 0.9704623654404599 7.163077897683592 9594.0 36.476198019801984 0.0 - - - - - - - 266.27272727272725 19 11 NOVA2 neuro-oncological ventral antigen 2 475 61 C20140716_OR021_03 C20140716_OR021_03 TB435926.[MT7]-SLDQIPGYLNR.2y8_1.heavy 710.389 / 960.526 37121.0 35.53340148925781 45 15 10 10 10 2.1468800750601797 46.579220312153154 0.0 3 0.9582417383095975 6.0182216291371144 37121.0 215.49070051572875 0.0 - - - - - - - 280.92857142857144 74 14 THPO thrombopoietin 477 61 C20140716_OR021_03 C20140716_OR021_03 TB435926.[MT7]-SLDQIPGYLNR.2b4_1.heavy 710.389 / 588.311 55354.0 35.53340148925781 45 15 10 10 10 2.1468800750601797 46.579220312153154 0.0 3 0.9582417383095975 6.0182216291371144 55354.0 222.67167526214627 0.0 - - - - - - - 292.5 110 8 THPO thrombopoietin 479 61 C20140716_OR021_03 C20140716_OR021_03 TB435926.[MT7]-SLDQIPGYLNR.2y6_1.heavy 710.389 / 719.383 88922.0 35.53340148925781 45 15 10 10 10 2.1468800750601797 46.579220312153154 0.0 3 0.9582417383095975 6.0182216291371144 88922.0 214.95848999339995 0.0 - - - - - - - 291.3333333333333 177 9 THPO thrombopoietin 481 61 C20140716_OR021_03 C20140716_OR021_03 TB435926.[MT7]-SLDQIPGYLNR.2b5_1.heavy 710.389 / 701.395 47967.0 35.53340148925781 45 15 10 10 10 2.1468800750601797 46.579220312153154 0.0 3 0.9582417383095975 6.0182216291371144 47967.0 48.73652406417112 0.0 - - - - - - - 421.0 95 2 THPO thrombopoietin 483 62 C20140716_OR021_03 C20140716_OR021_03 OPPA_ECOLI.LAIAASSLWK.2y7.peptide 530.31 / 762.41 367480.0 39.493499755859375 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 367480.0 313.50536499560246 0.0 - - - - - - - 155.0 734 2 485 62 C20140716_OR021_03 C20140716_OR021_03 OPPA_ECOLI.LAIAASSLWK.2y8.peptide 530.31 / 875.5 166012.0 39.493499755859375 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 166012.0 186.68822249093108 0.0 - - - - - - - 335.75 332 4 487 62 C20140716_OR021_03 C20140716_OR021_03 OPPA_ECOLI.LAIAASSLWK.2y6.peptide 530.31 / 691.38 273310.0 39.493499755859375 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 273310.0 256.3933268858801 0.0 - - - - - - - 258.0 546 2 489 63 C20140716_OR021_03 C20140716_OR021_03 TB435923.[MT7]-QLAPFHEVGK[MT7].2y4_1.heavy 707.408 / 576.347 N/A 28.876800537109375 39 13 10 10 6 1.170655660008927 67.06725237993469 0.0 5 0.9125337263023366 4.142137649749578 4371.0 1.3487135079451025 3.0 - - - - - - - 380.0 13 4 WNT9A wingless-type MMTV integration site family, member 9A 491 63 C20140716_OR021_03 C20140716_OR021_03 TB435923.[MT7]-QLAPFHEVGK[MT7].2y5_1.heavy 707.408 / 713.406 2376.0 28.876800537109375 39 13 10 10 6 1.170655660008927 67.06725237993469 0.0 5 0.9125337263023366 4.142137649749578 2376.0 8.269418464193269 1.0 - - - - - - - 285.0 9 9 WNT9A wingless-type MMTV integration site family, member 9A 493 63 C20140716_OR021_03 C20140716_OR021_03 TB435923.[MT7]-QLAPFHEVGK[MT7].2y6_1.heavy 707.408 / 860.475 1045.0 28.876800537109375 39 13 10 10 6 1.170655660008927 67.06725237993469 0.0 5 0.9125337263023366 4.142137649749578 1045.0 0.2604541678205483 2.0 - - - - - - - 215.9090909090909 7 11 WNT9A wingless-type MMTV integration site family, member 9A 495 63 C20140716_OR021_03 C20140716_OR021_03 TB435923.[MT7]-QLAPFHEVGK[MT7].2y7_1.heavy 707.408 / 957.527 10547.0 28.876800537109375 39 13 10 10 6 1.170655660008927 67.06725237993469 0.0 5 0.9125337263023366 4.142137649749578 10547.0 11.100663056706457 0.0 - - - - - - - 295.55555555555554 21 9 WNT9A wingless-type MMTV integration site family, member 9A 497 64 C20140716_OR021_03 C20140716_OR021_03 TB419914.[MT7]-DIFSEQHLK[MT7].3y3_1.heavy 468.929 / 541.358 3772.0 30.385849952697754 30 18 0 6 6 6.483816689013798 15.423014683533598 0.03149986267089844 6 0.9824309493448217 9.297160300735055 3772.0 18.639844357976653 0.0 - - - - - - - 181.0 7 18 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 499 64 C20140716_OR021_03 C20140716_OR021_03 TB419914.[MT7]-DIFSEQHLK[MT7].3b5_1.heavy 468.929 / 736.363 1200.0 30.385849952697754 30 18 0 6 6 6.483816689013798 15.423014683533598 0.03149986267089844 6 0.9824309493448217 9.297160300735055 1200.0 13.117580094324282 0.0 - - - - - - - 234.46666666666667 2 15 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 501 64 C20140716_OR021_03 C20140716_OR021_03 TB419914.[MT7]-DIFSEQHLK[MT7].3b3_1.heavy 468.929 / 520.289 3858.0 30.385849952697754 30 18 0 6 6 6.483816689013798 15.423014683533598 0.03149986267089844 6 0.9824309493448217 9.297160300735055 3858.0 11.697988338192419 2.0 - - - - - - - 186.58823529411765 31 17 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 503 64 C20140716_OR021_03 C20140716_OR021_03 TB419914.[MT7]-DIFSEQHLK[MT7].3b7_2.heavy 468.929 / 501.244 2829.0 30.385849952697754 30 18 0 6 6 6.483816689013798 15.423014683533598 0.03149986267089844 6 0.9824309493448217 9.297160300735055 2829.0 2.5123906705539354 1.0 - - - - - - - 744.3684210526316 22 19 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 505 65 C20140716_OR021_03 C20140716_OR021_03 TB435851.[MT7]-FLHEVVK[MT7].2y4_1.heavy 580.357 / 618.394 6373.0 29.52400016784668 38 20 2 10 6 13.454267216045613 7.4325861374850355 0.0 5 0.9981427759052988 28.632744439405965 6373.0 7.928959298557265 2.0 - - - - - - - 704.375 39 8 SKI v-ski sarcoma viral oncogene homolog (avian) 507 65 C20140716_OR021_03 C20140716_OR021_03 TB435851.[MT7]-FLHEVVK[MT7].2y5_1.heavy 580.357 / 755.453 6465.0 29.52400016784668 38 20 2 10 6 13.454267216045613 7.4325861374850355 0.0 5 0.9981427759052988 28.632744439405965 6465.0 14.165530803322474 0.0 - - - - - - - 225.0 12 16 SKI v-ski sarcoma viral oncogene homolog (avian) 509 65 C20140716_OR021_03 C20140716_OR021_03 TB435851.[MT7]-FLHEVVK[MT7].2b4_1.heavy 580.357 / 671.363 3879.0 29.52400016784668 38 20 2 10 6 13.454267216045613 7.4325861374850355 0.0 5 0.9981427759052988 28.632744439405965 3879.0 13.965659945408119 0.0 - - - - - - - 258.4 7 15 SKI v-ski sarcoma viral oncogene homolog (avian) 511 65 C20140716_OR021_03 C20140716_OR021_03 TB435851.[MT7]-FLHEVVK[MT7].2y6_1.heavy 580.357 / 868.537 4803.0 29.52400016784668 38 20 2 10 6 13.454267216045613 7.4325861374850355 0.0 5 0.9981427759052988 28.632744439405965 4803.0 19.067925275779913 0.0 - - - - - - - 208.89473684210526 9 19 SKI v-ski sarcoma viral oncogene homolog (avian) 513 66 C20140716_OR021_03 C20140716_OR021_03 TB420198.[MT7]-FTEEIEWLK[MT7].2b3_1.heavy 741.908 / 522.268 3055.0 43.30007457733154 38 14 10 6 8 1.598597302434149 42.69813898282236 0.038898468017578125 4 0.9470921261918297 5.341565604280689 3055.0 16.487757142168906 0.0 - - - - - - - 283.7857142857143 6 14 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 515 66 C20140716_OR021_03 C20140716_OR021_03 TB420198.[MT7]-FTEEIEWLK[MT7].2b4_1.heavy 741.908 / 651.311 3259.0 43.30007457733154 38 14 10 6 8 1.598597302434149 42.69813898282236 0.038898468017578125 4 0.9470921261918297 5.341565604280689 3259.0 3.0507324739681 2.0 - - - - - - - 669.2857142857143 8 7 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 517 66 C20140716_OR021_03 C20140716_OR021_03 TB420198.[MT7]-FTEEIEWLK[MT7].2y3_1.heavy 741.908 / 590.378 3972.0 43.30007457733154 38 14 10 6 8 1.598597302434149 42.69813898282236 0.038898468017578125 4 0.9470921261918297 5.341565604280689 3972.0 4.456661991584853 1.0 - - - - - - - 319.1333333333333 9 15 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 519 66 C20140716_OR021_03 C20140716_OR021_03 TB420198.[MT7]-FTEEIEWLK[MT7].2b6_1.heavy 741.908 / 893.437 3768.0 43.30007457733154 38 14 10 6 8 1.598597302434149 42.69813898282236 0.038898468017578125 4 0.9470921261918297 5.341565604280689 3768.0 25.325127908657322 0.0 - - - - - - - 216.625 7 16 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 521 67 C20140716_OR021_03 C20140716_OR021_03 TB420197.[MT7]-FTEEIEWLK[MT7].3y3_1.heavy 494.941 / 590.378 5906.0 43.30979919433594 46 16 10 10 10 2.2761364205540646 35.835439030159634 0.0 3 0.9651555514539274 6.592139287737464 5906.0 36.6422908496732 0.0 - - - - - - - 254.75 11 4 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 523 67 C20140716_OR021_03 C20140716_OR021_03 TB420197.[MT7]-FTEEIEWLK[MT7].3b4_1.heavy 494.941 / 651.311 8045.0 43.30979919433594 46 16 10 10 10 2.2761364205540646 35.835439030159634 0.0 3 0.9651555514539274 6.592139287737464 8045.0 -1.840359477124185 0.0 - - - - - - - 224.2 16 5 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 525 67 C20140716_OR021_03 C20140716_OR021_03 TB420197.[MT7]-FTEEIEWLK[MT7].3b5_1.heavy 494.941 / 764.395 1426.0 43.30979919433594 46 16 10 10 10 2.2761364205540646 35.835439030159634 0.0 3 0.9651555514539274 6.592139287737464 1426.0 15.830464052287581 0.0 - - - - - - - 153.0 2 4 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 527 67 C20140716_OR021_03 C20140716_OR021_03 TB420197.[MT7]-FTEEIEWLK[MT7].3b3_1.heavy 494.941 / 522.268 4379.0 43.30979919433594 46 16 10 10 10 2.2761364205540646 35.835439030159634 0.0 3 0.9651555514539274 6.592139287737464 4379.0 28.477810457516338 0.0 - - - - - - - 215.22222222222223 8 9 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 529 68 C20140716_OR021_03 C20140716_OR021_03 TB420194.[MT7]-GGSSGWSGGLAQNR.3y7_1.heavy 493.247 / 715.385 1247.0 26.67329978942871 28 14 0 10 4 1.6197131156456477 48.86517150269373 0.0 7 0.9348322429584829 4.807937218273739 1247.0 2.397916666666667 1.0 - - - - - - - 178.28571428571428 2 7 C8A complement component 8, alpha polypeptide 531 68 C20140716_OR021_03 C20140716_OR021_03 TB420194.[MT7]-GGSSGWSGGLAQNR.3y6_1.heavy 493.247 / 658.363 1630.0 26.67329978942871 28 14 0 10 4 1.6197131156456477 48.86517150269373 0.0 7 0.9348322429584829 4.807937218273739 1630.0 4.102071759519093 14.0 - - - - - - - 303.6666666666667 23 12 C8A complement component 8, alpha polypeptide 533 68 C20140716_OR021_03 C20140716_OR021_03 TB420194.[MT7]-GGSSGWSGGLAQNR.3y4_1.heavy 493.247 / 488.258 3068.0 26.67329978942871 28 14 0 10 4 1.6197131156456477 48.86517150269373 0.0 7 0.9348322429584829 4.807937218273739 3068.0 8.111602753766686 3.0 - - - - - - - 236.23076923076923 6 13 C8A complement component 8, alpha polypeptide 535 68 C20140716_OR021_03 C20140716_OR021_03 TB420194.[MT7]-GGSSGWSGGLAQNR.3y8_1.heavy 493.247 / 802.417 671.0 26.67329978942871 28 14 0 10 4 1.6197131156456477 48.86517150269373 0.0 7 0.9348322429584829 4.807937218273739 671.0 9.785416666666666 1.0 - - - - - - - 0.0 1 0 C8A complement component 8, alpha polypeptide 537 69 C20140716_OR021_03 C20140716_OR021_03 TB420290.[MT7]-VC[CAM]GFIQIWSQK[MT7].2y4_1.heavy 827.455 / 692.385 1238.0 44.635125160217285 30 9 9 6 6 0.8054066410537217 72.32858017109174 0.038898468017578125 6 0.8002252324991557 2.713823206416627 1238.0 2.705177993527508 2.0 - - - - - - - 249.08333333333334 3 12 USP29 ubiquitin specific peptidase 29 539 69 C20140716_OR021_03 C20140716_OR021_03 TB420290.[MT7]-VC[CAM]GFIQIWSQK[MT7].2b4_1.heavy 827.455 / 608.298 1753.0 44.635125160217285 30 9 9 6 6 0.8054066410537217 72.32858017109174 0.038898468017578125 6 0.8002252324991557 2.713823206416627 1753.0 7.157828331174803 3.0 - - - - - - - 271.8181818181818 5 11 USP29 ubiquitin specific peptidase 29 541 69 C20140716_OR021_03 C20140716_OR021_03 TB420290.[MT7]-VC[CAM]GFIQIWSQK[MT7].2b6_1.heavy 827.455 / 849.441 928.0 44.635125160217285 30 9 9 6 6 0.8054066410537217 72.32858017109174 0.038898468017578125 6 0.8002252324991557 2.713823206416627 928.0 3.6627003379680674 12.0 - - - - - - - 214.75 10 12 USP29 ubiquitin specific peptidase 29 543 69 C20140716_OR021_03 C20140716_OR021_03 TB420290.[MT7]-VC[CAM]GFIQIWSQK[MT7].2y3_1.heavy 827.455 / 506.306 4332.0 44.635125160217285 30 9 9 6 6 0.8054066410537217 72.32858017109174 0.038898468017578125 6 0.8002252324991557 2.713823206416627 4332.0 9.252555495721893 1.0 - - - - - - - 607.5555555555555 8 9 USP29 ubiquitin specific peptidase 29 545 70 C20140716_OR021_03 C20140716_OR021_03 TB442495.[MT7]-AQVPQFLSPQVQAQLLQFAAK[MT7].4y5_1.heavy 650.876 / 708.416 1327.0 49.63197612762451 40 17 9 6 8 3.0370702753046492 26.201789117103786 0.038501739501953125 4 0.972896298799754 7.479322204264221 1327.0 1.9978263262361249 1.0 - - - - - - - 236.9375 2 16 TNRC6C trinucleotide repeat containing 6C 547 70 C20140716_OR021_03 C20140716_OR021_03 TB442495.[MT7]-AQVPQFLSPQVQAQLLQFAAK[MT7].4y4_1.heavy 650.876 / 580.357 2780.0 49.63197612762451 40 17 9 6 8 3.0370702753046492 26.201789117103786 0.038501739501953125 4 0.972896298799754 7.479322204264221 2780.0 8.193750295336486 1.0 - - - - - - - 238.15384615384616 5 13 TNRC6C trinucleotide repeat containing 6C 549 70 C20140716_OR021_03 C20140716_OR021_03 TB442495.[MT7]-AQVPQFLSPQVQAQLLQFAAK[MT7].4b5_1.heavy 650.876 / 668.385 2274.0 49.63197612762451 40 17 9 6 8 3.0370702753046492 26.201789117103786 0.038501739501953125 4 0.972896298799754 7.479322204264221 2274.0 0.0 3.0 - - - - - - - 252.7 6 10 TNRC6C trinucleotide repeat containing 6C 551 70 C20140716_OR021_03 C20140716_OR021_03 TB442495.[MT7]-AQVPQFLSPQVQAQLLQFAAK[MT7].4b6_1.heavy 650.876 / 815.453 1769.0 49.63197612762451 40 17 9 6 8 3.0370702753046492 26.201789117103786 0.038501739501953125 4 0.972896298799754 7.479322204264221 1769.0 10.89861925383078 0.0 - - - - - - - 221.25 3 12 TNRC6C trinucleotide repeat containing 6C 553 71 C20140716_OR021_03 C20140716_OR021_03 TB435936.[MT7]-DLGIWHVPNK[MT7].2y4_1.heavy 733.922 / 601.379 4156.0 35.615501403808594 48 20 10 10 8 3.6432473690489737 27.448040132971755 0.0 4 0.9923357916376035 14.08805215226878 4156.0 12.392819622919445 0.0 - - - - - - - 309.85714285714283 8 14 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 555 71 C20140716_OR021_03 C20140716_OR021_03 TB435936.[MT7]-DLGIWHVPNK[MT7].2b4_1.heavy 733.922 / 543.326 7389.0 35.615501403808594 48 20 10 10 8 3.6432473690489737 27.448040132971755 0.0 4 0.9923357916376035 14.08805215226878 7389.0 12.025844822195062 2.0 - - - - - - - 300.25 18 12 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 557 71 C20140716_OR021_03 C20140716_OR021_03 TB435936.[MT7]-DLGIWHVPNK[MT7].2b6_1.heavy 733.922 / 866.464 5357.0 35.615501403808594 48 20 10 10 8 3.6432473690489737 27.448040132971755 0.0 4 0.9923357916376035 14.08805215226878 5357.0 16.830257864878803 0.0 - - - - - - - 205.92307692307693 10 13 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 559 71 C20140716_OR021_03 C20140716_OR021_03 TB435936.[MT7]-DLGIWHVPNK[MT7].2y3_1.heavy 733.922 / 502.311 23461.0 35.615501403808594 48 20 10 10 8 3.6432473690489737 27.448040132971755 0.0 4 0.9923357916376035 14.08805215226878 23461.0 56.746823104693135 0.0 - - - - - - - 286.2 46 10 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 561 72 C20140716_OR021_03 C20140716_OR021_03 TB435848.[MT7]-C[CAM]LVDDGTGR.2y8_1.heavy 568.778 / 832.416 3191.0 22.640000343322754 43 17 10 6 10 2.7337557181695082 28.75867730277789 0.03460121154785156 3 0.977596868245222 8.229886693605614 3191.0 15.034536399753792 0.0 - - - - - - - 172.3 6 10 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 563 72 C20140716_OR021_03 C20140716_OR021_03 TB435848.[MT7]-C[CAM]LVDDGTGR.2y5_1.heavy 568.778 / 505.237 7417.0 22.640000343322754 43 17 10 6 10 2.7337557181695082 28.75867730277789 0.03460121154785156 3 0.977596868245222 8.229886693605614 7417.0 20.56641077535963 0.0 - - - - - - - 253.125 14 16 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 565 72 C20140716_OR021_03 C20140716_OR021_03 TB435848.[MT7]-C[CAM]LVDDGTGR.2b5_1.heavy 568.778 / 747.346 3794.0 22.640000343322754 43 17 10 6 10 2.7337557181695082 28.75867730277789 0.03460121154785156 3 0.977596868245222 8.229886693605614 3794.0 26.15294783155249 0.0 - - - - - - - 193.75 7 12 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 567 72 C20140716_OR021_03 C20140716_OR021_03 TB435848.[MT7]-C[CAM]LVDDGTGR.2y7_1.heavy 568.778 / 719.332 2760.0 22.640000343322754 43 17 10 6 10 2.7337557181695082 28.75867730277789 0.03460121154785156 3 0.977596868245222 8.229886693605614 2760.0 9.442227378190255 0.0 - - - - - - - 219.45454545454547 5 11 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 569 73 C20140716_OR021_03 C20140716_OR021_03 TB419904.[MT7]-DLGSPGAR.2b4_1.heavy 458.752 / 517.274 2456.0 18.67009925842285 38 20 2 10 6 9.921866908127626 10.078748377292152 0.0 5 0.9902644668769041 12.497683702813783 2456.0 9.893386196960343 1.0 - - - - - - - 204.57142857142858 4 14 SKI v-ski sarcoma viral oncogene homolog (avian) 571 73 C20140716_OR021_03 C20140716_OR021_03 TB419904.[MT7]-DLGSPGAR.2b6_1.heavy 458.752 / 671.348 643.0 18.67009925842285 38 20 2 10 6 9.921866908127626 10.078748377292152 0.0 5 0.9902644668769041 12.497683702813783 643.0 0.5495726495726496 3.0 - - - - - - - 171.88235294117646 4 17 SKI v-ski sarcoma viral oncogene homolog (avian) 573 73 C20140716_OR021_03 C20140716_OR021_03 TB419904.[MT7]-DLGSPGAR.2y6_1.heavy 458.752 / 544.284 3625.0 18.67009925842285 38 20 2 10 6 9.921866908127626 10.078748377292152 0.0 5 0.9902644668769041 12.497683702813783 3625.0 27.802724414949353 1.0 - - - - - - - 155.73333333333332 22 15 SKI v-ski sarcoma viral oncogene homolog (avian) 575 73 C20140716_OR021_03 C20140716_OR021_03 TB419904.[MT7]-DLGSPGAR.2y7_1.heavy 458.752 / 657.368 5730.0 18.67009925842285 38 20 2 10 6 9.921866908127626 10.078748377292152 0.0 5 0.9902644668769041 12.497683702813783 5730.0 35.288373726729894 1.0 - - - - - - - 125.07142857142857 27 14 SKI v-ski sarcoma viral oncogene homolog (avian) 577 74 C20140716_OR021_03 C20140716_OR021_03 TB436003.[MT7]-ASAYC[CAM]LDQGAEDGDR.2y8_1.heavy 886.387 / 847.354 2517.0 26.104575157165527 38 13 10 5 10 2.147117303862504 37.17392052713225 0.047100067138671875 3 0.9038508690239824 3.947725235445682 2517.0 29.539955482661668 0.0 - - - - - - - 193.7 5 10 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 579 74 C20140716_OR021_03 C20140716_OR021_03 TB436003.[MT7]-ASAYC[CAM]LDQGAEDGDR.2b4_1.heavy 886.387 / 537.279 3485.0 26.104575157165527 38 13 10 5 10 2.147117303862504 37.17392052713225 0.047100067138671875 3 0.9038508690239824 3.947725235445682 3485.0 39.89325849876459 0.0 - - - - - - - 249.0 6 7 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 581 74 C20140716_OR021_03 C20140716_OR021_03 TB436003.[MT7]-ASAYC[CAM]LDQGAEDGDR.2y11_1.heavy 886.387 / 1235.5 1258.0 26.104575157165527 38 13 10 5 10 2.147117303862504 37.17392052713225 0.047100067138671875 3 0.9038508690239824 3.947725235445682 1258.0 1.1926508063797554 0.0 - - - - - - - 242.0 2 6 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 583 74 C20140716_OR021_03 C20140716_OR021_03 TB436003.[MT7]-ASAYC[CAM]LDQGAEDGDR.2y7_1.heavy 886.387 / 719.295 2420.0 26.104575157165527 38 13 10 5 10 2.147117303862504 37.17392052713225 0.047100067138671875 3 0.9038508690239824 3.947725235445682 2420.0 8.399821053881784 0.0 - - - - - - - 235.14285714285714 4 7 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 585 75 C20140716_OR021_03 C20140716_OR021_03 TB442490.[MT7]-VC[CAM]LVQGTAEALNAVHSFIAEK[MT7].4b4_1.heavy 637.098 / 616.361 18077.0 51.42130088806152 39 13 10 6 10 1.6235174994638693 39.015268000213474 0.035999298095703125 3 0.9289515689256388 4.602349872390304 18077.0 67.42624331550802 0.0 - - - - - - - 207.66666666666666 36 9 NOVA2 neuro-oncological ventral antigen 2 587 75 C20140716_OR021_03 C20140716_OR021_03 TB442490.[MT7]-VC[CAM]LVQGTAEALNAVHSFIAEK[MT7].4y7_1.heavy 637.098 / 975.538 6981.0 51.42130088806152 39 13 10 6 10 1.6235174994638693 39.015268000213474 0.035999298095703125 3 0.9289515689256388 4.602349872390304 6981.0 60.09085518716578 0.0 - - - - - - - 178.0 13 7 NOVA2 neuro-oncological ventral antigen 2 589 75 C20140716_OR021_03 C20140716_OR021_03 TB442490.[MT7]-VC[CAM]LVQGTAEALNAVHSFIAEK[MT7].4y6_1.heavy 637.098 / 838.479 5174.0 51.42130088806152 39 13 10 6 10 1.6235174994638693 39.015268000213474 0.035999298095703125 3 0.9289515689256388 4.602349872390304 5174.0 98.6002591009198 0.0 - - - - - - - 171.25 10 4 NOVA2 neuro-oncological ventral antigen 2 591 75 C20140716_OR021_03 C20140716_OR021_03 TB442490.[MT7]-VC[CAM]LVQGTAEALNAVHSFIAEK[MT7].4b3_1.heavy 637.098 / 517.292 16332.0 51.42130088806152 39 13 10 6 10 1.6235174994638693 39.015268000213474 0.035999298095703125 3 0.9289515689256388 4.602349872390304 16332.0 73.06279540684035 0.0 - - - - - - - 225.875 32 8 NOVA2 neuro-oncological ventral antigen 2 593 76 C20140716_OR021_03 C20140716_OR021_03 TB436005.[MT7]-EHVIHIIDFGLAK[MT7].2b3_1.heavy 890.522 / 510.279 8210.0 38.19942665100098 42 16 10 6 10 4.579827455075856 21.83488373326582 0.03929901123046875 3 0.9678132252311026 6.860437711642975 8210.0 54.85927654233579 0.0 - - - - - - - 183.6 16 10 CSNK1G1 casein kinase 1, gamma 1 595 76 C20140716_OR021_03 C20140716_OR021_03 TB436005.[MT7]-EHVIHIIDFGLAK[MT7].2y5_1.heavy 890.522 / 679.426 4733.0 38.19942665100098 42 16 10 6 10 4.579827455075856 21.83488373326582 0.03929901123046875 3 0.9678132252311026 6.860437711642975 4733.0 17.464489540943813 0.0 - - - - - - - 161.22222222222223 9 9 CSNK1G1 casein kinase 1, gamma 1 597 76 C20140716_OR021_03 C20140716_OR021_03 TB436005.[MT7]-EHVIHIIDFGLAK[MT7].2b4_1.heavy 890.522 / 623.363 5892.0 38.19942665100098 42 16 10 6 10 4.579827455075856 21.83488373326582 0.03929901123046875 3 0.9678132252311026 6.860437711642975 5892.0 65.64692322469104 0.0 - - - - - - - 234.71428571428572 11 7 CSNK1G1 casein kinase 1, gamma 1 599 76 C20140716_OR021_03 C20140716_OR021_03 TB436005.[MT7]-EHVIHIIDFGLAK[MT7].2y7_1.heavy 890.522 / 907.537 3767.0 38.19942665100098 42 16 10 6 10 4.579827455075856 21.83488373326582 0.03929901123046875 3 0.9678132252311026 6.860437711642975 3767.0 30.42607986421297 0.0 - - - - - - - 204.0 7 9 CSNK1G1 casein kinase 1, gamma 1 601 77 C20140716_OR021_03 C20140716_OR021_03 TB442393.[MT7]-LDDSQMEALQFALTR.2y9_1.heavy 941.478 / 1048.58 N/A N/A - - - - - - - - - 0.0 - - - - - - - ZNFX1 zinc finger, NFX1-type containing 1 603 77 C20140716_OR021_03 C20140716_OR021_03 TB442393.[MT7]-LDDSQMEALQFALTR.2b7_1.heavy 941.478 / 963.421 N/A N/A - - - - - - - - - 0.0 - - - - - - - ZNFX1 zinc finger, NFX1-type containing 1 605 77 C20140716_OR021_03 C20140716_OR021_03 TB442393.[MT7]-LDDSQMEALQFALTR.2y10_1.heavy 941.478 / 1179.62 N/A N/A - - - - - - - - - 0.0 - - - - - - - ZNFX1 zinc finger, NFX1-type containing 1 607 77 C20140716_OR021_03 C20140716_OR021_03 TB442393.[MT7]-LDDSQMEALQFALTR.2b5_1.heavy 941.478 / 703.338 N/A N/A - - - - - - - - - 0.0 - - - - - - - ZNFX1 zinc finger, NFX1-type containing 1 609 78 C20140716_OR021_03 C20140716_OR021_03 TB442291.[MT7]-QSVLHVLGILK[MT7].3b4_1.heavy 498.992 / 572.352 12426.0 42.6234016418457 46 16 10 10 10 3.486772250411649 28.679819850061612 0.0 3 0.9666796290891174 6.7420833428594005 12426.0 32.42692737430167 1.0 - - - - - - - 258.22222222222223 24 9 ZNFX1 zinc finger, NFX1-type containing 1 611 78 C20140716_OR021_03 C20140716_OR021_03 TB442291.[MT7]-QSVLHVLGILK[MT7].3b5_1.heavy 498.992 / 709.411 2324.0 42.6234016418457 46 16 10 10 10 3.486772250411649 28.679819850061612 0.0 3 0.9666796290891174 6.7420833428594005 2324.0 3.2503496503496505 0.0 - - - - - - - 156.25 4 4 ZNFX1 zinc finger, NFX1-type containing 1 613 78 C20140716_OR021_03 C20140716_OR021_03 TB442291.[MT7]-QSVLHVLGILK[MT7].3y4_1.heavy 498.992 / 574.404 9208.0 42.6234016418457 46 16 10 10 10 3.486772250411649 28.679819850061612 0.0 3 0.9666796290891174 6.7420833428594005 9208.0 41.15307262569833 0.0 - - - - - - - 268.2857142857143 18 7 ZNFX1 zinc finger, NFX1-type containing 1 615 78 C20140716_OR021_03 C20140716_OR021_03 TB442291.[MT7]-QSVLHVLGILK[MT7].3y5_1.heavy 498.992 / 687.489 6794.0 42.6234016418457 46 16 10 10 10 3.486772250411649 28.679819850061612 0.0 3 0.9666796290891174 6.7420833428594005 6794.0 44.11029850746269 0.0 - - - - - - - 193.5 13 6 ZNFX1 zinc finger, NFX1-type containing 1 617 79 C20140716_OR021_03 C20140716_OR021_03 TB442292.[MT7]-AAEVWMDDFK[MT7].3y3_1.heavy 500.586 / 553.31 23187.0 41.11370086669922 50 20 10 10 10 7.22252986149861 13.845564077633444 0.0 3 0.9940402469378595 15.978363992967742 23187.0 178.54078147468638 0.0 - - - - - - - 175.5 46 8 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 619 79 C20140716_OR021_03 C20140716_OR021_03 TB442292.[MT7]-AAEVWMDDFK[MT7].3b4_1.heavy 500.586 / 515.295 76184.0 41.11370086669922 50 20 10 10 10 7.22252986149861 13.845564077633444 0.0 3 0.9940402469378595 15.978363992967742 76184.0 157.0943237758803 0.0 - - - - - - - 229.28571428571428 152 7 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 621 79 C20140716_OR021_03 C20140716_OR021_03 TB442292.[MT7]-AAEVWMDDFK[MT7].3y4_1.heavy 500.586 / 668.337 25997.0 41.11370086669922 50 20 10 10 10 7.22252986149861 13.845564077633444 0.0 3 0.9940402469378595 15.978363992967742 25997.0 244.4494029850746 0.0 - - - - - - - 130.3 51 10 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 623 79 C20140716_OR021_03 C20140716_OR021_03 TB442292.[MT7]-AAEVWMDDFK[MT7].3y5_1.heavy 500.586 / 799.378 7327.0 41.11370086669922 50 20 10 10 10 7.22252986149861 13.845564077633444 0.0 3 0.9940402469378595 15.978363992967742 7327.0 50.71202863488046 0.0 - - - - - - - 175.5 14 8 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 625 80 C20140716_OR021_03 C20140716_OR021_03 TB442396.[MT7]-EVLQRPASIMESDK[MT7].4b8_1.heavy 473.51 / 1025.59 N/A 30.174267450968426 40 14 10 6 10 1.9153485843559273 43.397020212655306 0.031000137329101562 3 0.9401759735914328 5.020365086098684 0.0 0.0 1.0 - - - - - - - 0.0 0 0 PTH1R parathyroid hormone 1 receptor 627 80 C20140716_OR021_03 C20140716_OR021_03 TB442396.[MT7]-EVLQRPASIMESDK[MT7].4y4_1.heavy 473.51 / 622.316 2291.0 30.174267450968426 40 14 10 6 10 1.9153485843559273 43.397020212655306 0.031000137329101562 3 0.9401759735914328 5.020365086098684 2291.0 3.7295348837209303 0.0 - - - - - - - 167.08333333333334 4 12 PTH1R parathyroid hormone 1 receptor 629 80 C20140716_OR021_03 C20140716_OR021_03 TB442396.[MT7]-EVLQRPASIMESDK[MT7].4b8_2.heavy 473.51 / 513.297 8019.0 30.174267450968426 40 14 10 6 10 1.9153485843559273 43.397020212655306 0.031000137329101562 3 0.9401759735914328 5.020365086098684 8019.0 21.076079582153103 1.0 - - - - - - - 274.5833333333333 16 12 PTH1R parathyroid hormone 1 receptor 631 80 C20140716_OR021_03 C20140716_OR021_03 TB442396.[MT7]-EVLQRPASIMESDK[MT7].4y3_1.heavy 473.51 / 493.274 5012.0 30.174267450968426 40 14 10 6 10 1.9153485843559273 43.397020212655306 0.031000137329101562 3 0.9401759735914328 5.020365086098684 5012.0 20.426202634574725 0.0 - - - - - - - 626.375 10 8 PTH1R parathyroid hormone 1 receptor 633 81 C20140716_OR021_03 C20140716_OR021_03 TB435842.[MT7]-VTYEQGVR.2b3_1.heavy 548.299 / 508.289 2254.0 22.604949951171875 46 20 10 6 10 3.746220958033502 19.8296322366981 0.03549957275390625 3 0.9948795370861023 17.239404792827436 2254.0 24.829612582064787 0.0 - - - - - - - 284.6470588235294 4 17 NOVA2 neuro-oncological ventral antigen 2 635 81 C20140716_OR021_03 C20140716_OR021_03 TB435842.[MT7]-VTYEQGVR.2b4_1.heavy 548.299 / 637.331 4175.0 22.604949951171875 46 20 10 6 10 3.746220958033502 19.8296322366981 0.03549957275390625 3 0.9948795370861023 17.239404792827436 4175.0 25.364 0.0 - - - - - - - 177.8 8 15 NOVA2 neuro-oncological ventral antigen 2 637 81 C20140716_OR021_03 C20140716_OR021_03 TB435842.[MT7]-VTYEQGVR.2y6_1.heavy 548.299 / 751.373 3841.0 22.604949951171875 46 20 10 6 10 3.746220958033502 19.8296322366981 0.03549957275390625 3 0.9948795370861023 17.239404792827436 3841.0 32.53488 0.0 - - - - - - - 176.0 7 9 NOVA2 neuro-oncological ventral antigen 2 639 81 C20140716_OR021_03 C20140716_OR021_03 TB435842.[MT7]-VTYEQGVR.2y7_1.heavy 548.299 / 852.421 15197.0 22.604949951171875 46 20 10 6 10 3.746220958033502 19.8296322366981 0.03549957275390625 3 0.9948795370861023 17.239404792827436 15197.0 229.25132240963853 0.0 - - - - - - - 190.64285714285714 30 14 NOVA2 neuro-oncological ventral antigen 2 641 82 C20140716_OR021_03 C20140716_OR021_03 TB435840.[MT7]-IC[CAM]LDLQALLYK[MT7].3b6_1.heavy 546.656 / 887.478 16078.0 49.4546012878418 45 15 10 10 10 3.004440802103522 33.28406401949615 0.0 3 0.953329090348655 5.690304660680873 16078.0 180.02830985915494 0.0 - - - - - - - 147.14285714285714 32 14 PF4V1 platelet factor 4 variant 1 643 82 C20140716_OR021_03 C20140716_OR021_03 TB435840.[MT7]-IC[CAM]LDLQALLYK[MT7].3y3_1.heavy 546.656 / 567.362 77899.0 49.4546012878418 45 15 10 10 10 3.004440802103522 33.28406401949615 0.0 3 0.953329090348655 5.690304660680873 77899.0 593.4336965653571 0.0 - - - - - - - 218.06666666666666 155 15 PF4V1 platelet factor 4 variant 1 645 82 C20140716_OR021_03 C20140716_OR021_03 TB435840.[MT7]-IC[CAM]LDLQALLYK[MT7].3b4_1.heavy 546.656 / 646.335 96039.0 49.4546012878418 45 15 10 10 10 3.004440802103522 33.28406401949615 0.0 3 0.953329090348655 5.690304660680873 96039.0 774.5469262764084 0.0 - - - - - - - 266.75 192 8 PF4V1 platelet factor 4 variant 1 647 82 C20140716_OR021_03 C20140716_OR021_03 TB435840.[MT7]-IC[CAM]LDLQALLYK[MT7].3b5_1.heavy 546.656 / 759.419 24828.0 49.4546012878418 45 15 10 10 10 3.004440802103522 33.28406401949615 0.0 3 0.953329090348655 5.690304660680873 24828.0 194.82280681986657 0.0 - - - - - - - 135.63636363636363 49 11 PF4V1 platelet factor 4 variant 1 649 83 C20140716_OR021_03 C20140716_OR021_03 TB419905.[MT7]-VFNNER.2y4_1.heavy 461.747 / 532.247 4410.0 21.468950271606445 42 20 8 6 8 7.613554330310867 9.5242196286876 0.03549957275390625 4 0.9985433466751562 32.33192296761616 4410.0 69.7826124567474 0.0 - - - - - - - 203.375 8 16 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 651 83 C20140716_OR021_03 C20140716_OR021_03 TB419905.[MT7]-VFNNER.2b3_1.heavy 461.747 / 505.289 3326.0 21.468950271606445 42 20 8 6 8 7.613554330310867 9.5242196286876 0.03549957275390625 4 0.9985433466751562 32.33192296761616 3326.0 22.849709629582385 3.0 - - - - - - - 714.0 11 8 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 653 83 C20140716_OR021_03 C20140716_OR021_03 TB419905.[MT7]-VFNNER.2y5_1.heavy 461.747 / 679.316 24293.0 21.468950271606445 42 20 8 6 8 7.613554330310867 9.5242196286876 0.03549957275390625 4 0.9985433466751562 32.33192296761616 24293.0 119.86323393873678 1.0 - - - - - - - 191.35294117647058 67 17 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 655 83 C20140716_OR021_03 C20140716_OR021_03 TB419905.[MT7]-VFNNER.2b4_1.heavy 461.747 / 619.332 3470.0 21.468950271606445 42 20 8 6 8 7.613554330310867 9.5242196286876 0.03549957275390625 4 0.9985433466751562 32.33192296761616 3470.0 4.607468879668049 1.0 - - - - - - - 197.27272727272728 6 11 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 657 84 C20140716_OR021_03 C20140716_OR021_03 EFTU1_ECO24.FESEVYILSK.2y8.peptide 607.82 / 938.52 1620640.0 36.15879821777344 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1620640.0 1098.4289384574038 0.0 - - - - - - - 224.0 3241 12 659 84 C20140716_OR021_03 C20140716_OR021_03 EFTU1_ECO24.FESEVYILSK.2y6.peptide 607.82 / 722.44 285484.0 36.15879821777344 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 285484.0 479.93817000440805 0.0 - - - - - - - 296.0 570 12 661 84 C20140716_OR021_03 C20140716_OR021_03 EFTU1_ECO24.FESEVYILSK.2y5.peptide 607.82 / 623.38 501446.0 36.15879821777344 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 501446.0 559.4798321881732 0.0 - - - - - - - 219.42857142857142 1002 7 663 85 C20140716_OR021_03 C20140716_OR021_03 TB435833.[MT7]-NPDLQAIR.2y5_1.heavy 535.807 / 600.383 7047.0 27.24324941635132 40 18 9 5 8 6.646792811923832 15.044849874154004 0.04419898986816406 4 0.9848053857323354 9.999218999520298 7047.0 39.66933673469387 0.0 - - - - - - - 271.3076923076923 14 13 PTGER4 prostaglandin E receptor 4 (subtype EP4) 665 85 C20140716_OR021_03 C20140716_OR021_03 TB435833.[MT7]-NPDLQAIR.2b4_1.heavy 535.807 / 584.316 1566.0 27.24324941635132 40 18 9 5 8 6.646792811923832 15.044849874154004 0.04419898986816406 4 0.9848053857323354 9.999218999520298 1566.0 4.02332319466248 2.0 - - - - - - - 293.85714285714283 3 7 PTGER4 prostaglandin E receptor 4 (subtype EP4) 667 85 C20140716_OR021_03 C20140716_OR021_03 TB435833.[MT7]-NPDLQAIR.2y6_1.heavy 535.807 / 715.41 2055.0 27.24324941635132 40 18 9 5 8 6.646792811923832 15.044849874154004 0.04419898986816406 4 0.9848053857323354 9.999218999520298 2055.0 4.19864061467858 0.0 - - - - - - - 281.625 4 8 PTGER4 prostaglandin E receptor 4 (subtype EP4) 669 85 C20140716_OR021_03 C20140716_OR021_03 TB435833.[MT7]-NPDLQAIR.2y7_1.heavy 535.807 / 812.463 13312.0 27.24324941635132 40 18 9 5 8 6.646792811923832 15.044849874154004 0.04419898986816406 4 0.9848053857323354 9.999218999520298 13312.0 34.751575605217845 1.0 - - - - - - - 274.2 30 5 PTGER4 prostaglandin E receptor 4 (subtype EP4) 671 86 C20140716_OR021_03 C20140716_OR021_03 TB435900.[MT7]-EYLAFPTSK[MT7].2b3_1.heavy 672.376 / 550.299 11922.0 35.32080078125 47 17 10 10 10 5.12365058557086 19.517334043351504 0.0 3 0.9798231127329308 8.67365899411751 11922.0 21.094426156224586 0.0 - - - - - - - 718.4285714285714 23 7 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 673 86 C20140716_OR021_03 C20140716_OR021_03 TB435900.[MT7]-EYLAFPTSK[MT7].2y4_1.heavy 672.376 / 576.347 21144.0 35.32080078125 47 17 10 10 10 5.12365058557086 19.517334043351504 0.0 3 0.9798231127329308 8.67365899411751 21144.0 24.88377447254227 0.0 - - - - - - - 279.42857142857144 42 7 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 675 86 C20140716_OR021_03 C20140716_OR021_03 TB435900.[MT7]-EYLAFPTSK[MT7].2y5_1.heavy 672.376 / 723.416 11177.0 35.32080078125 47 17 10 10 10 5.12365058557086 19.517334043351504 0.0 3 0.9798231127329308 8.67365899411751 11177.0 32.86972563997363 0.0 - - - - - - - 253.9090909090909 22 11 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 677 86 C20140716_OR021_03 C20140716_OR021_03 TB435900.[MT7]-EYLAFPTSK[MT7].2b4_1.heavy 672.376 / 621.336 18815.0 35.32080078125 47 17 10 10 10 5.12365058557086 19.517334043351504 0.0 3 0.9798231127329308 8.67365899411751 18815.0 24.40372619709492 0.0 - - - - - - - 266.0 37 7 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 679 87 C20140716_OR021_03 C20140716_OR021_03 TB436010.[MT7]-YMFDFLDEQADQR.3y7_1.heavy 607.946 / 861.37 2326.0 46.679298400878906 39 18 9 6 6 3.276982755362368 24.85842565265322 0.037200927734375 6 0.9853257338624931 10.175403973053566 2326.0 6.629993169740285 0.0 - - - - - - - 205.4375 4 16 PLXNA3 plexin A3 681 87 C20140716_OR021_03 C20140716_OR021_03 TB436010.[MT7]-YMFDFLDEQADQR.3b4_1.heavy 607.946 / 701.308 7941.0 46.679298400878906 39 18 9 6 6 3.276982755362368 24.85842565265322 0.037200927734375 6 0.9853257338624931 10.175403973053566 7941.0 16.662998122619015 0.0 - - - - - - - 229.14285714285714 15 14 PLXNA3 plexin A3 683 87 C20140716_OR021_03 C20140716_OR021_03 TB436010.[MT7]-YMFDFLDEQADQR.3b5_1.heavy 607.946 / 848.377 2727.0 46.679298400878906 39 18 9 6 6 3.276982755362368 24.85842565265322 0.037200927734375 6 0.9853257338624931 10.175403973053566 2727.0 2.267775467775468 1.0 - - - - - - - 213.73333333333332 8 15 PLXNA3 plexin A3 685 87 C20140716_OR021_03 C20140716_OR021_03 TB436010.[MT7]-YMFDFLDEQADQR.3y5_1.heavy 607.946 / 617.3 3449.0 46.679298400878906 39 18 9 6 6 3.276982755362368 24.85842565265322 0.037200927734375 6 0.9853257338624931 10.175403973053566 3449.0 12.832652516318351 1.0 - - - - - - - 265.625 17 16 PLXNA3 plexin A3 687 88 C20140716_OR021_03 C20140716_OR021_03 TB442487.[MT7]-IVIVEEAAEVLEAHTIATLSK[MT7].4y5_1.heavy 631.867 / 663.416 N/A N/A - - - - - - - - - 0.0 - - - - - - - ZNFX1 zinc finger, NFX1-type containing 1 689 88 C20140716_OR021_03 C20140716_OR021_03 TB442487.[MT7]-IVIVEEAAEVLEAHTIATLSK[MT7].4b4_1.heavy 631.867 / 569.414 N/A N/A - - - - - - - - - 0.0 - - - - - - - ZNFX1 zinc finger, NFX1-type containing 1 691 88 C20140716_OR021_03 C20140716_OR021_03 TB442487.[MT7]-IVIVEEAAEVLEAHTIATLSK[MT7].4b5_1.heavy 631.867 / 698.457 N/A N/A - - - - - - - - - 0.0 - - - - - - - ZNFX1 zinc finger, NFX1-type containing 1 693 88 C20140716_OR021_03 C20140716_OR021_03 TB442487.[MT7]-IVIVEEAAEVLEAHTIATLSK[MT7].4b6_1.heavy 631.867 / 827.5 N/A N/A - - - - - - - - - 0.0 - - - - - - - ZNFX1 zinc finger, NFX1-type containing 1 695 89 C20140716_OR021_03 C20140716_OR021_03 TB435838.[MT7]-TTSQVRPR.2y4_1.heavy 544.818 / 527.341 N/A 14.821599642435709 33 15 2 6 10 2.0665335981173985 39.8839140450544 0.03299999237060547 3 0.9524751661365718 5.638543037049568 2899.0 5.8019000273264245 2.0 - - - - - - - 732.6428571428571 14 14 PF4;PF4V1 platelet factor 4;platelet factor 4 variant 1 697 89 C20140716_OR021_03 C20140716_OR021_03 TB435838.[MT7]-TTSQVRPR.2y5_1.heavy 544.818 / 655.4 655.0 14.821599642435709 33 15 2 6 10 2.0665335981173985 39.8839140450544 0.03299999237060547 3 0.9524751661365718 5.638543037049568 655.0 11.492880851063829 0.0 - - - - - - - 0.0 1 0 PF4;PF4V1 platelet factor 4;platelet factor 4 variant 1 699 89 C20140716_OR021_03 C20140716_OR021_03 TB435838.[MT7]-TTSQVRPR.2b4_1.heavy 544.818 / 562.295 1153.0 14.821599642435709 33 15 2 6 10 2.0665335981173985 39.8839140450544 0.03299999237060547 3 0.9524751661365718 5.638543037049568 1153.0 2.4564102564102566 1.0 - - - - - - - 98.23076923076923 2 13 PF4;PF4V1 platelet factor 4;platelet factor 4 variant 1 701 89 C20140716_OR021_03 C20140716_OR021_03 TB435838.[MT7]-TTSQVRPR.2y7_1.heavy 544.818 / 843.479 1403.0 14.821599642435709 33 15 2 6 10 2.0665335981173985 39.8839140450544 0.03299999237060547 3 0.9524751661365718 5.638543037049568 1403.0 15.924108427349132 0.0 - - - - - - - 191.125 2 8 PF4;PF4V1 platelet factor 4;platelet factor 4 variant 1 703 90 C20140716_OR021_03 C20140716_OR021_03 TB435906.[MT7]-VQVGSTPQDQR.2y8_1.heavy 679.861 / 888.417 39710.0 20.454999923706055 48 18 10 10 10 4.144191566394384 24.13015865649379 0.0 3 0.9871062132168634 10.856863532440252 39710.0 303.88403755868546 0.0 - - - - - - - 169.46153846153845 79 13 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 705 90 C20140716_OR021_03 C20140716_OR021_03 TB435906.[MT7]-VQVGSTPQDQR.2y5_1.heavy 679.861 / 643.316 17079.0 20.454999923706055 48 18 10 10 10 4.144191566394384 24.13015865649379 0.0 3 0.9871062132168634 10.856863532440252 17079.0 43.20723139044944 0.0 - - - - - - - 217.52941176470588 34 17 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 707 90 C20140716_OR021_03 C20140716_OR021_03 TB435906.[MT7]-VQVGSTPQDQR.2y9_1.heavy 679.861 / 987.485 30458.0 20.454999923706055 48 18 10 10 10 4.144191566394384 24.13015865649379 0.0 3 0.9871062132168634 10.856863532440252 30458.0 349.6235211267606 0.0 - - - - - - - 142.11111111111111 60 9 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 709 90 C20140716_OR021_03 C20140716_OR021_03 TB435906.[MT7]-VQVGSTPQDQR.2y10_1.heavy 679.861 / 1115.54 31597.0 20.454999923706055 48 18 10 10 10 4.144191566394384 24.13015865649379 0.0 3 0.9871062132168634 10.856863532440252 31597.0 277.8693427230047 0.0 - - - - - - - 154.0 63 12 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 711 91 C20140716_OR021_03 C20140716_OR021_03 TB435837.[MT7]-SLLQPNK[MT7].2y4_1.heavy 544.339 / 630.369 6739.0 26.360300064086914 48 18 10 10 10 5.023021960819862 19.90833422191089 0.0 3 0.9849833899304098 10.058458912510687 6739.0 5.428708409456244 1.0 - - - - - - - 293.0 13 5 C8A complement component 8, alpha polypeptide 713 91 C20140716_OR021_03 C20140716_OR021_03 TB435837.[MT7]-SLLQPNK[MT7].2y5_1.heavy 544.339 / 743.453 8009.0 26.360300064086914 48 18 10 10 10 5.023021960819862 19.90833422191089 0.0 3 0.9849833899304098 10.058458912510687 8009.0 18.721454721390618 1.0 - - - - - - - 293.0 16 6 C8A complement component 8, alpha polypeptide 715 91 C20140716_OR021_03 C20140716_OR021_03 TB435837.[MT7]-SLLQPNK[MT7].2b4_1.heavy 544.339 / 586.368 32916.0 26.360300064086914 48 18 10 10 10 5.023021960819862 19.90833422191089 0.0 3 0.9849833899304098 10.058458912510687 32916.0 48.69187591092831 0.0 - - - - - - - 273.4 65 5 C8A complement component 8, alpha polypeptide 717 91 C20140716_OR021_03 C20140716_OR021_03 TB435837.[MT7]-SLLQPNK[MT7].2y3_1.heavy 544.339 / 502.311 81362.0 26.360300064086914 48 18 10 10 10 5.023021960819862 19.90833422191089 0.0 3 0.9849833899304098 10.058458912510687 81362.0 118.63464687142738 1.0 - - - - - - - 390.6 165 5 C8A complement component 8, alpha polypeptide 719 92 C20140716_OR021_03 C20140716_OR021_03 TB435908.[MT7]-LGRC[CAM]LDDVK[MT7].3y3_1.heavy 455.258 / 505.31 6429.0 27.077600479125977 46 18 10 10 8 4.7816366181638426 20.913341599429234 0.0 4 0.9813307720972874 9.01822786806093 6429.0 15.85020901841138 1.0 - - - - - - - 212.45454545454547 13 11 SKI v-ski sarcoma viral oncogene homolog (avian) 721 92 C20140716_OR021_03 C20140716_OR021_03 TB435908.[MT7]-LGRC[CAM]LDDVK[MT7].3y4_1.heavy 455.258 / 620.337 3214.0 27.077600479125977 46 18 10 10 8 4.7816366181638426 20.913341599429234 0.0 4 0.9813307720972874 9.01822786806093 3214.0 14.833846153846151 0.0 - - - - - - - 230.0909090909091 6 11 SKI v-ski sarcoma viral oncogene homolog (avian) 723 92 C20140716_OR021_03 C20140716_OR021_03 TB435908.[MT7]-LGRC[CAM]LDDVK[MT7].3y8_2.heavy 455.258 / 553.791 2143.0 27.077600479125977 46 18 10 10 8 4.7816366181638426 20.913341599429234 0.0 4 0.9813307720972874 9.01822786806093 2143.0 5.317558744594961 1.0 - - - - - - - 219.25 6 4 SKI v-ski sarcoma viral oncogene homolog (avian) 725 92 C20140716_OR021_03 C20140716_OR021_03 TB435908.[MT7]-LGRC[CAM]LDDVK[MT7].3b7_2.heavy 455.258 / 487.746 9838.0 27.077600479125977 46 18 10 10 8 4.7816366181638426 20.913341599429234 0.0 4 0.9813307720972874 9.01822786806093 9838.0 30.802062697576396 0.0 - - - - - - - 274.45454545454544 19 11 SKI v-ski sarcoma viral oncogene homolog (avian) 727 93 C20140716_OR021_03 C20140716_OR021_03 TB436013.[MT7]-MLTNWFTFLLHK[MT7].3y6_1.heavy 613.679 / 902.558 1233.0 54.34619903564453 29 11 2 10 6 0.775697040236854 73.90015139959361 0.0 6 0.8503061121164615 3.1491083378332094 1233.0 13.32625514729173 0.0 - - - - - - - 198.66666666666666 2 9 PLXNA3 plexin A3 729 93 C20140716_OR021_03 C20140716_OR021_03 TB436013.[MT7]-MLTNWFTFLLHK[MT7].3y3_1.heavy 613.679 / 541.358 3144.0 54.34619903564453 29 11 2 10 6 0.775697040236854 73.90015139959361 0.0 6 0.8503061121164615 3.1491083378332094 3144.0 28.431887952730058 1.0 - - - - - - - 158.57142857142858 13 7 PLXNA3 plexin A3 731 93 C20140716_OR021_03 C20140716_OR021_03 TB436013.[MT7]-MLTNWFTFLLHK[MT7].3b4_1.heavy 613.679 / 604.325 1541.0 54.34619903564453 29 11 2 10 6 0.775697040236854 73.90015139959361 0.0 6 0.8503061121164615 3.1491083378332094 1541.0 8.526343804843805 2.0 - - - - - - - 175.53846153846155 4 13 PLXNA3 plexin A3 733 93 C20140716_OR021_03 C20140716_OR021_03 TB436013.[MT7]-MLTNWFTFLLHK[MT7].3b5_1.heavy 613.679 / 790.404 1849.0 54.34619903564453 29 11 2 10 6 0.775697040236854 73.90015139959361 0.0 6 0.8503061121164615 3.1491083378332094 1849.0 55.47 0.0 - - - - - - - 146.625 3 8 PLXNA3 plexin A3 735 94 C20140716_OR021_03 C20140716_OR021_03 TB436014.[MT7]-C[CAM]LVDDGTGRMPTLK[MT7].3b4_1.heavy 617.662 / 632.319 45925.0 31.96929931640625 41 11 10 10 10 1.246439462902998 52.585560244571894 0.0 3 0.8794827502495095 3.518652641695469 45925.0 48.2083357059009 0.0 - - - - - - - 705.1428571428571 91 7 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 737 94 C20140716_OR021_03 C20140716_OR021_03 TB436014.[MT7]-C[CAM]LVDDGTGRMPTLK[MT7].3b5_1.heavy 617.662 / 747.346 42420.0 31.96929931640625 41 11 10 10 10 1.246439462902998 52.585560244571894 0.0 3 0.8794827502495095 3.518652641695469 42420.0 60.95237914259653 0.0 - - - - - - - 622.3 84 10 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 739 94 C20140716_OR021_03 C20140716_OR021_03 TB436014.[MT7]-C[CAM]LVDDGTGRMPTLK[MT7].3y4_1.heavy 617.662 / 602.399 56584.0 31.96929931640625 41 11 10 10 10 1.246439462902998 52.585560244571894 0.0 3 0.8794827502495095 3.518652641695469 56584.0 42.11477150537634 0.0 - - - - - - - 429.0 113 2 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 741 94 C20140716_OR021_03 C20140716_OR021_03 TB436014.[MT7]-C[CAM]LVDDGTGRMPTLK[MT7].3y9_2.heavy 617.662 / 552.819 164816.0 31.96929931640625 41 11 10 10 10 1.246439462902998 52.585560244571894 0.0 3 0.8794827502495095 3.518652641695469 164816.0 268.18963184174515 0.0 - - - - - - - 1234.0 329 8 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 743 95 C20140716_OR021_03 C20140716_OR021_03 TB420497.[MT7]-AQGEHPDEFGFLLDHVQTAR.4y5_1.heavy 603.552 / 574.331 3270.0 38.21907615661621 37 13 10 6 8 2.9307400813993065 34.12107427563285 0.03929901123046875 4 0.9055160493888196 3.982933315224514 3270.0 3.967071057192374 1.0 - - - - - - - 661.125 6 8 PLXNA3 plexin A3 745 95 C20140716_OR021_03 C20140716_OR021_03 TB420497.[MT7]-AQGEHPDEFGFLLDHVQTAR.4b4_1.heavy 603.552 / 530.269 18082.0 38.21907615661621 37 13 10 6 8 2.9307400813993065 34.12107427563285 0.03929901123046875 4 0.9055160493888196 3.982933315224514 18082.0 21.650517510385182 0.0 - - - - - - - 797.0 36 7 PLXNA3 plexin A3 747 95 C20140716_OR021_03 C20140716_OR021_03 TB420497.[MT7]-AQGEHPDEFGFLLDHVQTAR.4b5_1.heavy 603.552 / 667.328 3270.0 38.21907615661621 37 13 10 6 8 2.9307400813993065 34.12107427563285 0.03929901123046875 4 0.9055160493888196 3.982933315224514 3270.0 15.32306370728083 2.0 - - - - - - - 240.33333333333334 19 12 PLXNA3 plexin A3 749 95 C20140716_OR021_03 C20140716_OR021_03 TB420497.[MT7]-AQGEHPDEFGFLLDHVQTAR.4y6_1.heavy 603.552 / 711.39 3366.0 38.21907615661621 37 13 10 6 8 2.9307400813993065 34.12107427563285 0.03929901123046875 4 0.9055160493888196 3.982933315224514 3366.0 3.4996219281663516 2.0 - - - - - - - 302.42857142857144 6 14 PLXNA3 plexin A3 751 96 C20140716_OR021_03 C20140716_OR021_03 TB420492.[MT7]-DNAIPTIFDLTSHLNNPHSR.4y9_1.heavy 602.313 / 1061.52 3260.0 43.990949630737305 36 15 10 3 8 5.176783632290899 19.31701363298946 0.07559967041015625 4 0.9547925007242424 5.782388699222753 3260.0 -1.5996074582924436 0.0 - - - - - - - 147.33333333333334 6 9 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 753 96 C20140716_OR021_03 C20140716_OR021_03 TB420492.[MT7]-DNAIPTIFDLTSHLNNPHSR.4b4_1.heavy 602.313 / 558.3 13346.0 43.990949630737305 36 15 10 3 8 5.176783632290899 19.31701363298946 0.07559967041015625 4 0.9547925007242424 5.782388699222753 13346.0 6.479979338842975 1.0 - - - - - - - 679.0 27 9 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 755 96 C20140716_OR021_03 C20140716_OR021_03 TB420492.[MT7]-DNAIPTIFDLTSHLNNPHSR.4y7_1.heavy 602.313 / 837.433 2649.0 43.990949630737305 36 15 10 3 8 5.176783632290899 19.31701363298946 0.07559967041015625 4 0.9547925007242424 5.782388699222753 2649.0 -1.238429172510519 1.0 - - - - - - - 191.25 5 8 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 757 96 C20140716_OR021_03 C20140716_OR021_03 TB420492.[MT7]-DNAIPTIFDLTSHLNNPHSR.4y6_1.heavy 602.313 / 724.349 3668.0 43.990949630737305 36 15 10 3 8 5.176783632290899 19.31701363298946 0.07559967041015625 4 0.9547925007242424 5.782388699222753 3668.0 -0.900122699386503 0.0 - - - - - - - 214.2 7 10 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 759 97 C20140716_OR021_03 C20140716_OR021_03 TB420171.[MT7]-TASYYSPYGQR.2y5_1.heavy 718.85 / 620.315 4189.0 26.606799125671387 38 17 8 5 8 2.209113018075039 36.273001080964164 0.04500007629394531 4 0.9704970354015696 7.16730638747797 4189.0 47.17025210084034 0.0 - - - - - - - 285.44444444444446 8 9 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 761 97 C20140716_OR021_03 C20140716_OR021_03 TB420171.[MT7]-TASYYSPYGQR.2y6_1.heavy 718.85 / 707.347 3522.0 26.606799125671387 38 17 8 5 8 2.209113018075039 36.273001080964164 0.04500007629394531 4 0.9704970354015696 7.16730638747797 3522.0 20.972277997972164 0.0 - - - - - - - 294.1818181818182 7 11 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 763 97 C20140716_OR021_03 C20140716_OR021_03 TB420171.[MT7]-TASYYSPYGQR.2y10_1.heavy 718.85 / 1191.54 3522.0 26.606799125671387 38 17 8 5 8 2.209113018075039 36.273001080964164 0.04500007629394531 4 0.9704970354015696 7.16730638747797 3522.0 18.731582403151673 2.0 - - - - - - - 211.55555555555554 10 9 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 765 97 C20140716_OR021_03 C20140716_OR021_03 TB420171.[MT7]-TASYYSPYGQR.2y7_1.heavy 718.85 / 870.41 3522.0 26.606799125671387 38 17 8 5 8 2.209113018075039 36.273001080964164 0.04500007629394531 4 0.9704970354015696 7.16730638747797 3522.0 54.683684210526316 0.0 - - - - - - - 238.0 7 6 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 767 98 C20140716_OR021_03 C20140716_OR021_03 TB442281.[MT7]-ANNHPAAYWQR.3y7_1.heavy 491.249 / 891.447 1534.0 24.111900329589844 36 10 10 6 10 0.9959943786881832 67.89594563631562 0.038799285888671875 3 0.833729943919743 2.983633751368557 1534.0 19.159020833333333 0.0 - - - - - - - 176.0 3 6 ZNFX1 zinc finger, NFX1-type containing 1 769 98 C20140716_OR021_03 C20140716_OR021_03 TB442281.[MT7]-ANNHPAAYWQR.3y6_1.heavy 491.249 / 794.394 4411.0 24.111900329589844 36 10 10 6 10 0.9959943786881832 67.89594563631562 0.038799285888671875 3 0.833729943919743 2.983633751368557 4411.0 18.379166666666666 0.0 - - - - - - - 228.0 8 8 ZNFX1 zinc finger, NFX1-type containing 1 771 98 C20140716_OR021_03 C20140716_OR021_03 TB442281.[MT7]-ANNHPAAYWQR.3b4_1.heavy 491.249 / 581.291 7000.0 24.111900329589844 36 10 10 6 10 0.9959943786881832 67.89594563631562 0.038799285888671875 3 0.833729943919743 2.983633751368557 7000.0 10.956521739130435 0.0 - - - - - - - 262.26666666666665 14 15 ZNFX1 zinc finger, NFX1-type containing 1 773 98 C20140716_OR021_03 C20140716_OR021_03 TB442281.[MT7]-ANNHPAAYWQR.3y5_1.heavy 491.249 / 723.357 3644.0 24.111900329589844 36 10 10 6 10 0.9959943786881832 67.89594563631562 0.038799285888671875 3 0.833729943919743 2.983633751368557 3644.0 10.764763285024156 2.0 - - - - - - - 191.88888888888889 7 9 ZNFX1 zinc finger, NFX1-type containing 1 775 99 C20140716_OR021_03 C20140716_OR021_03 TB420173.[MT7]-VVSSPPC[CAM]AAAVSR.3y7_1.heavy 482.261 / 734.361 934.0 25.04955005645752 33 8 10 5 10 0.9495867464969163 91.66737541180851 0.044200897216796875 3 0.7590983771386969 2.462131018745447 934.0 0.8343757181156644 1.0 - - - - - - - 0.0 1 0 SKI v-ski sarcoma viral oncogene homolog (avian) 777 99 C20140716_OR021_03 C20140716_OR021_03 TB420173.[MT7]-VVSSPPC[CAM]AAAVSR.3y6_1.heavy 482.261 / 574.331 19604.0 25.04955005645752 33 8 10 5 10 0.9495867464969163 91.66737541180851 0.044200897216796875 3 0.7590983771386969 2.462131018745447 19604.0 40.03080091815579 0.0 - - - - - - - 217.5 39 6 SKI v-ski sarcoma viral oncogene homolog (avian) 779 99 C20140716_OR021_03 C20140716_OR021_03 TB420173.[MT7]-VVSSPPC[CAM]AAAVSR.3b4_1.heavy 482.261 / 517.31 11856.0 25.04955005645752 33 8 10 5 10 0.9495867464969163 91.66737541180851 0.044200897216796875 3 0.7590983771386969 2.462131018745447 11856.0 90.74171839830252 0.0 - - - - - - - 317.4 23 5 SKI v-ski sarcoma viral oncogene homolog (avian) 781 99 C20140716_OR021_03 C20140716_OR021_03 TB420173.[MT7]-VVSSPPC[CAM]AAAVSR.3y8_1.heavy 482.261 / 831.414 467.0 25.04955005645752 33 8 10 5 10 0.9495867464969163 91.66737541180851 0.044200897216796875 3 0.7590983771386969 2.462131018745447 467.0 3.2129032258064516 4.0 - - - - - - - 139.9 2 10 SKI v-ski sarcoma viral oncogene homolog (avian) 783 100 C20140716_OR021_03 C20140716_OR021_03 SUCC_ECO24.LVQQFTK.2y4.peptide 432.25 / 523.29 40377.0 23.346399307250977 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 40377.0 188.73501231359927 0.0 - - - - - - - 225.42857142857142 80 14 785 100 C20140716_OR021_03 C20140716_OR021_03 SUCC_ECO24.LVQQFTK.2y6.peptide 432.25 / 750.41 50773.0 23.346399307250977 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 50773.0 709.4571344086022 0.0 - - - - - - - 185.77777777777777 101 9 787 100 C20140716_OR021_03 C20140716_OR021_03 SUCC_ECO24.LVQQFTK.2y5.peptide 432.25 / 651.35 176916.0 23.346399307250977 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 176916.0 1517.6839034578788 0.0 - - - - - - - 211.0909090909091 353 11 789 101 C20140716_OR021_03 C20140716_OR021_03 TB442287.[MT7]-HLLLVDPEGVVR.3y6_1.heavy 497.632 / 656.373 63258.0 37.57447528839111 43 20 10 3 10 31.060523991635428 3.2195207018056076 0.07590103149414062 3 0.9941763684138736 16.164208126212003 63258.0 498.6839 0.0 - - - - - - - 210.0 126 10 LOC100291393;SHC2;SHC1 SHC-transforming protein 2-like;SHC (Src homology 2 domain containing) transforming protein 2;SHC (Src homology 2 domain containing) transforming protein 1 791 101 C20140716_OR021_03 C20140716_OR021_03 TB442287.[MT7]-HLLLVDPEGVVR.3b4_1.heavy 497.632 / 621.42 20986.0 37.57447528839111 43 20 10 3 10 31.060523991635428 3.2195207018056076 0.07590103149414062 3 0.9941763684138736 16.164208126212003 20986.0 165.43963333333335 0.0 - - - - - - - 183.33333333333334 41 6 LOC100291393;SHC2;SHC1 SHC-transforming protein 2-like;SHC (Src homology 2 domain containing) transforming protein 2;SHC (Src homology 2 domain containing) transforming protein 1 793 101 C20140716_OR021_03 C20140716_OR021_03 TB442287.[MT7]-HLLLVDPEGVVR.3b3_1.heavy 497.632 / 508.336 44770.0 37.57447528839111 43 20 10 3 10 31.060523991635428 3.2195207018056076 0.07590103149414062 3 0.9941763684138736 16.164208126212003 44770.0 868.538 0.0 - - - - - - - 133.33333333333334 89 6 LOC100291393;SHC2;SHC1 SHC-transforming protein 2-like;SHC (Src homology 2 domain containing) transforming protein 2;SHC (Src homology 2 domain containing) transforming protein 1 795 101 C20140716_OR021_03 C20140716_OR021_03 TB442287.[MT7]-HLLLVDPEGVVR.3y5_1.heavy 497.632 / 559.32 19587.0 37.57447528839111 43 20 10 3 10 31.060523991635428 3.2195207018056076 0.07590103149414062 3 0.9941763684138736 16.164208126212003 19587.0 48.477825 1.0 - - - - - - - 230.0 40 10 LOC100291393;SHC2;SHC1 SHC-transforming protein 2-like;SHC (Src homology 2 domain containing) transforming protein 2;SHC (Src homology 2 domain containing) transforming protein 1 797 102 C20140716_OR021_03 C20140716_OR021_03 TB435832.[MT7]-SLGC[CAM]VHPR.2b4_1.heavy 535.288 / 562.278 767.0 20.16320037841797 28 14 4 6 4 3.108745712392021 27.196551288385997 0.038799285888671875 8 0.9304131211412169 4.651012406870924 767.0 5.373244517319123 9.0 - - - - - - - 241.30769230769232 6 13 SKI v-ski sarcoma viral oncogene homolog (avian) 799 102 C20140716_OR021_03 C20140716_OR021_03 TB435832.[MT7]-SLGC[CAM]VHPR.2y6_1.heavy 535.288 / 725.351 1743.0 20.16320037841797 28 14 4 6 4 3.108745712392021 27.196551288385997 0.038799285888671875 8 0.9304131211412169 4.651012406870924 1743.0 31.164315789473687 0.0 - - - - - - - 129.57142857142858 3 7 SKI v-ski sarcoma viral oncogene homolog (avian) 801 102 C20140716_OR021_03 C20140716_OR021_03 TB435832.[MT7]-SLGC[CAM]VHPR.2b5_1.heavy 535.288 / 661.346 279.0 20.16320037841797 28 14 4 6 4 3.108745712392021 27.196551288385997 0.038799285888671875 8 0.9304131211412169 4.651012406870924 279.0 0.8028776978417267 25.0 - - - - - - - 0.0 1 0 SKI v-ski sarcoma viral oncogene homolog (avian) 803 102 C20140716_OR021_03 C20140716_OR021_03 TB435832.[MT7]-SLGC[CAM]VHPR.2y7_1.heavy 535.288 / 838.435 1046.0 20.16320037841797 28 14 4 6 4 3.108745712392021 27.196551288385997 0.038799285888671875 8 0.9304131211412169 4.651012406870924 1046.0 11.209820788530465 0.0 - - - - - - - 116.5 2 6 SKI v-ski sarcoma viral oncogene homolog (avian) 805 103 C20140716_OR021_03 C20140716_OR021_03 TB435823.[MT7]-ETGATIK[MT7].2y5_1.heavy 504.302 / 633.405 4302.0 19.291866302490234 32 18 0 6 8 3.873417404190082 25.816995579104038 0.03710174560546875 4 0.9830170983775435 9.456705586259623 4302.0 30.690541018387552 0.0 - - - - - - - 173.58333333333334 8 12 NOVA1;NOVA2 neuro-oncological ventral antigen 1;neuro-oncological ventral antigen 2 807 103 C20140716_OR021_03 C20140716_OR021_03 TB435823.[MT7]-ETGATIK[MT7].2b4_1.heavy 504.302 / 503.258 4234.0 19.291866302490234 32 18 0 6 8 3.873417404190082 25.816995579104038 0.03710174560546875 4 0.9830170983775435 9.456705586259623 4234.0 17.61255500550055 0.0 - - - - - - - 209.05555555555554 8 18 NOVA1;NOVA2 neuro-oncological ventral antigen 1;neuro-oncological ventral antigen 2 809 103 C20140716_OR021_03 C20140716_OR021_03 TB435823.[MT7]-ETGATIK[MT7].2y6_1.heavy 504.302 / 734.453 N/A 19.291866302490234 32 18 0 6 8 3.873417404190082 25.816995579104038 0.03710174560546875 4 0.9830170983775435 9.456705586259623 9544.0 17.827667481296995 1.0 - - - - - - - 211.14285714285714 126 14 NOVA1;NOVA2 neuro-oncological ventral antigen 1;neuro-oncological ventral antigen 2 811 103 C20140716_OR021_03 C20140716_OR021_03 TB435823.[MT7]-ETGATIK[MT7].2b5_1.heavy 504.302 / 604.306 2420.0 19.291866302490234 32 18 0 6 8 3.873417404190082 25.816995579104038 0.03710174560546875 4 0.9830170983775435 9.456705586259623 2420.0 7.22026134024042 2.0 - - - - - - - 240.0 5 7 NOVA1;NOVA2 neuro-oncological ventral antigen 1;neuro-oncological ventral antigen 2 813 104 C20140716_OR021_03 C20140716_OR021_03 TB419923.[MT7]-TGYNVK[MT7].2y4_1.heavy 485.284 / 667.39 4151.0 19.89539909362793 46 16 10 10 10 1.9057384337897625 35.9487191440845 0.0 3 0.9654191236939023 6.617361158500056 4151.0 63.5621875 0.0 - - - - - - - 106.66666666666667 8 9 RAB41;RAB6B RAB41, member RAS oncogene family;RAB6B, member RAS oncogene family 815 104 C20140716_OR021_03 C20140716_OR021_03 TB419923.[MT7]-TGYNVK[MT7].2y5_1.heavy 485.284 / 724.411 14753.0 19.89539909362793 46 16 10 10 10 1.9057384337897625 35.9487191440845 0.0 3 0.9654191236939023 6.617361158500056 14753.0 322.721875 0.0 - - - - - - - 80.0 29 4 RAB41;RAB6B RAB41, member RAS oncogene family;RAB6B, member RAS oncogene family 817 104 C20140716_OR021_03 C20140716_OR021_03 TB419923.[MT7]-TGYNVK[MT7].2b4_1.heavy 485.284 / 580.285 9005.0 19.89539909362793 46 16 10 10 10 1.9057384337897625 35.9487191440845 0.0 3 0.9654191236939023 6.617361158500056 9005.0 61.02033697780679 0.0 - - - - - - - 162.72727272727272 18 11 RAB41;RAB6B RAB41, member RAS oncogene family;RAB6B, member RAS oncogene family 819 104 C20140716_OR021_03 C20140716_OR021_03 TB419923.[MT7]-TGYNVK[MT7].2y3_1.heavy 485.284 / 504.326 9516.0 19.89539909362793 46 16 10 10 10 1.9057384337897625 35.9487191440845 0.0 3 0.9654191236939023 6.617361158500056 9516.0 81.86558823529413 0.0 - - - - - - - 168.36363636363637 19 11 RAB41;RAB6B RAB41, member RAS oncogene family;RAB6B, member RAS oncogene family 821 105 C20140716_OR021_03 C20140716_OR021_03 TB435915.[MT7]-LQEDLHILK[MT7].3y3_1.heavy 466.285 / 517.383 8884.0 34.633026123046875 37 14 9 6 8 2.2031088092437785 45.39040449587472 0.0399017333984375 4 0.943905065017002 5.186199212661861 8884.0 20.985826771653542 0.0 - - - - - - - 267.8333333333333 17 6 ZNFX1 zinc finger, NFX1-type containing 1 823 105 C20140716_OR021_03 C20140716_OR021_03 TB435915.[MT7]-LQEDLHILK[MT7].3b4_1.heavy 466.285 / 630.321 10492.0 34.633026123046875 37 14 9 6 8 2.2031088092437785 45.39040449587472 0.0399017333984375 4 0.943905065017002 5.186199212661861 10492.0 50.50325218948813 0.0 - - - - - - - 243.25 20 8 ZNFX1 zinc finger, NFX1-type containing 1 825 105 C20140716_OR021_03 C20140716_OR021_03 TB435915.[MT7]-LQEDLHILK[MT7].3b5_1.heavy 466.285 / 743.406 2538.0 34.633026123046875 37 14 9 6 8 2.2031088092437785 45.39040449587472 0.0399017333984375 4 0.943905065017002 5.186199212661861 2538.0 36.26553960166744 1.0 - - - - - - - 203.0 25 5 ZNFX1 zinc finger, NFX1-type containing 1 827 105 C20140716_OR021_03 C20140716_OR021_03 TB435915.[MT7]-LQEDLHILK[MT7].3b3_1.heavy 466.285 / 515.295 592.0 34.633026123046875 37 14 9 6 8 2.2031088092437785 45.39040449587472 0.0399017333984375 4 0.943905065017002 5.186199212661861 592.0 1.0399198282032927 25.0 - - - - - - - 263.22222222222223 3 9 ZNFX1 zinc finger, NFX1-type containing 1 829 106 C20140716_OR021_03 C20140716_OR021_03 TB435828.[MT7]-C[CAM]LDDVK[MT7].2b3_1.heavy 519.281 / 533.251 6135.0 23.9166997273763 46 20 10 6 10 6.257102077497929 15.981839318176458 0.036899566650390625 3 0.9946861804909019 16.92257584076103 6135.0 28.11875 0.0 - - - - - - - 224.2941176470588 12 17 SKI v-ski sarcoma viral oncogene homolog (avian) 831 106 C20140716_OR021_03 C20140716_OR021_03 TB435828.[MT7]-C[CAM]LDDVK[MT7].2y5_1.heavy 519.281 / 733.421 3067.0 23.9166997273763 46 20 10 6 10 6.257102077497929 15.981839318176458 0.036899566650390625 3 0.9946861804909019 16.92257584076103 3067.0 13.963094623655913 0.0 - - - - - - - 248.0 6 9 SKI v-ski sarcoma viral oncogene homolog (avian) 833 106 C20140716_OR021_03 C20140716_OR021_03 TB435828.[MT7]-C[CAM]LDDVK[MT7].2b4_1.heavy 519.281 / 648.278 9667.0 23.9166997273763 46 20 10 6 10 6.257102077497929 15.981839318176458 0.036899566650390625 3 0.9946861804909019 16.92257584076103 9667.0 112.26193548387097 0.0 - - - - - - - 165.33333333333334 19 9 SKI v-ski sarcoma viral oncogene homolog (avian) 835 106 C20140716_OR021_03 C20140716_OR021_03 TB435828.[MT7]-C[CAM]LDDVK[MT7].2y3_1.heavy 519.281 / 505.31 N/A 23.9166997273763 46 20 10 6 10 6.257102077497929 15.981839318176458 0.036899566650390625 3 0.9946861804909019 16.92257584076103 4927.0 5.017999442972734 2.0 - - - - - - - 255.75 20 4 SKI v-ski sarcoma viral oncogene homolog (avian) 837 107 C20140716_OR021_03 C20140716_OR021_03 TB435917.[MT7]-TLFTDLFEK[MT7].2y4_1.heavy 701.397 / 680.41 26940.0 47.697898864746094 47 17 10 10 10 2.354524712134394 28.40624706469726 0.0 3 0.9761459958202231 7.97470485271163 26940.0 96.37201405152226 0.0 - - - - - - - 654.1428571428571 53 7 CSNK1G1 casein kinase 1, gamma 1 839 107 C20140716_OR021_03 C20140716_OR021_03 TB435917.[MT7]-TLFTDLFEK[MT7].2y3_1.heavy 701.397 / 567.326 22359.0 47.697898864746094 47 17 10 10 10 2.354524712134394 28.40624706469726 0.0 3 0.9761459958202231 7.97470485271163 22359.0 28.794299217988886 0.0 - - - - - - - 261.27272727272725 44 11 CSNK1G1 casein kinase 1, gamma 1 841 107 C20140716_OR021_03 C20140716_OR021_03 TB435917.[MT7]-TLFTDLFEK[MT7].2y6_1.heavy 701.397 / 896.485 24222.0 47.697898864746094 47 17 10 10 10 2.354524712134394 28.40624706469726 0.0 3 0.9761459958202231 7.97470485271163 24222.0 240.97251502145923 0.0 - - - - - - - 194.14285714285714 48 14 CSNK1G1 casein kinase 1, gamma 1 843 107 C20140716_OR021_03 C20140716_OR021_03 TB435917.[MT7]-TLFTDLFEK[MT7].2b5_1.heavy 701.397 / 722.384 23368.0 47.697898864746094 47 17 10 10 10 2.354524712134394 28.40624706469726 0.0 3 0.9761459958202231 7.97470485271163 23368.0 105.25043706085505 0.0 - - - - - - - 233.0 46 15 CSNK1G1 casein kinase 1, gamma 1 845 108 C20140716_OR021_03 C20140716_OR021_03 TB442476.[MT7]-IASVNPILDPWIYILLRK[MT7].3y7_1.heavy 804.826 / 1062.72 1167.0 54.57400131225586 42 12 10 10 10 2.1446895246240243 46.62679555798667 0.0 3 0.8810683678041883 3.542520307697999 1167.0 18.23643421795596 0.0 - - - - - - - 137.07692307692307 2 13 PTGER4 prostaglandin E receptor 4 (subtype EP4) 847 108 C20140716_OR021_03 C20140716_OR021_03 TB442476.[MT7]-IASVNPILDPWIYILLRK[MT7].3b4_1.heavy 804.826 / 515.331 829.0 54.57400131225586 42 12 10 10 10 2.1446895246240243 46.62679555798667 0.0 3 0.8810683678041883 3.542520307697999 829.0 8.592205678042887 0.0 - - - - - - - 0.0 1 0 PTGER4 prostaglandin E receptor 4 (subtype EP4) 849 108 C20140716_OR021_03 C20140716_OR021_03 TB442476.[MT7]-IASVNPILDPWIYILLRK[MT7].3b5_1.heavy 804.826 / 629.374 1413.0 54.57400131225586 42 12 10 10 10 2.1446895246240243 46.62679555798667 0.0 3 0.8810683678041883 3.542520307697999 1413.0 20.14184902783073 0.0 - - - - - - - 96.92307692307692 2 13 PTGER4 prostaglandin E receptor 4 (subtype EP4) 851 108 C20140716_OR021_03 C20140716_OR021_03 TB442476.[MT7]-IASVNPILDPWIYILLRK[MT7].3y5_1.heavy 804.826 / 786.568 829.0 54.57400131225586 42 12 10 10 10 2.1446895246240243 46.62679555798667 0.0 3 0.8810683678041883 3.542520307697999 829.0 14.712829650748395 0.0 - - - - - - - 0.0 1 0 PTGER4 prostaglandin E receptor 4 (subtype EP4) 853 109 C20140716_OR021_03 C20140716_OR021_03 TB442475.[MT7]-IASVNPILDPWIYILLRK[MT7].4y5_1.heavy 603.871 / 786.568 N/A N/A - - - - - - - - - 0.0 - - - - - - - PTGER4 prostaglandin E receptor 4 (subtype EP4) 855 109 C20140716_OR021_03 C20140716_OR021_03 TB442475.[MT7]-IASVNPILDPWIYILLRK[MT7].4b4_1.heavy 603.871 / 515.331 N/A N/A - - - - - - - - - 0.0 - - - - - - - PTGER4 prostaglandin E receptor 4 (subtype EP4) 857 109 C20140716_OR021_03 C20140716_OR021_03 TB442475.[MT7]-IASVNPILDPWIYILLRK[MT7].4b5_1.heavy 603.871 / 629.374 N/A N/A - - - - - - - - - 0.0 - - - - - - - PTGER4 prostaglandin E receptor 4 (subtype EP4) 859 109 C20140716_OR021_03 C20140716_OR021_03 TB442475.[MT7]-IASVNPILDPWIYILLRK[MT7].4y7_1.heavy 603.871 / 1062.72 N/A N/A - - - - - - - - - 0.0 - - - - - - - PTGER4 prostaglandin E receptor 4 (subtype EP4) 861 110 C20140716_OR021_03 C20140716_OR021_03 TB435916.[MT7]-NNVFLFIDK[MT7].2y4_1.heavy 699.405 / 666.394 11521.0 43.590301513671875 47 17 10 10 10 1.994605987232505 35.06224961987668 0.0 3 0.9720266282764357 7.361602086993131 11521.0 26.82798192038782 0.0 - - - - - - - 703.2857142857143 23 7 USP29 ubiquitin specific peptidase 29 863 110 C20140716_OR021_03 C20140716_OR021_03 TB435916.[MT7]-NNVFLFIDK[MT7].2y5_1.heavy 699.405 / 779.478 9453.0 43.590301513671875 47 17 10 10 10 1.994605987232505 35.06224961987668 0.0 3 0.9720266282764357 7.361602086993131 9453.0 33.43134146341464 0.0 - - - - - - - 270.5 18 12 USP29 ubiquitin specific peptidase 29 865 110 C20140716_OR021_03 C20140716_OR021_03 TB435916.[MT7]-NNVFLFIDK[MT7].2b4_1.heavy 699.405 / 619.332 13195.0 43.590301513671875 47 17 10 10 10 1.994605987232505 35.06224961987668 0.0 3 0.9720266282764357 7.361602086993131 13195.0 34.83750539507206 0.0 - - - - - - - 726.25 26 8 USP29 ubiquitin specific peptidase 29 867 110 C20140716_OR021_03 C20140716_OR021_03 TB435916.[MT7]-NNVFLFIDK[MT7].2y6_1.heavy 699.405 / 926.547 14573.0 43.590301513671875 47 17 10 10 10 1.994605987232505 35.06224961987668 0.0 3 0.9720266282764357 7.361602086993131 14573.0 84.97740446317403 0.0 - - - - - - - 219.46153846153845 29 13 USP29 ubiquitin specific peptidase 29 869 111 C20140716_OR021_03 C20140716_OR021_03 TB435919.[MT7]-AHVTGPVEDNAR.2y8_1.heavy 705.366 / 857.411 2030.0 19.325875759124756 41 15 10 6 10 1.7477076332351358 44.525431015147234 0.03709983825683594 3 0.9511132625324011 5.558805748252167 2030.0 13.446564885496183 1.0 - - - - - - - 183.2 4 5 PLXNA3 plexin A3 871 111 C20140716_OR021_03 C20140716_OR021_03 TB435919.[MT7]-AHVTGPVEDNAR.2y9_1.heavy 705.366 / 958.459 7727.0 19.325875759124756 41 15 10 6 10 1.7477076332351358 44.525431015147234 0.03709983825683594 3 0.9511132625324011 5.558805748252167 7727.0 67.83244274809161 0.0 - - - - - - - 130.66666666666666 15 9 PLXNA3 plexin A3 873 111 C20140716_OR021_03 C20140716_OR021_03 TB435919.[MT7]-AHVTGPVEDNAR.2y10_1.heavy 705.366 / 1057.53 4453.0 19.325875759124756 41 15 10 6 10 1.7477076332351358 44.525431015147234 0.03709983825683594 3 0.9511132625324011 5.558805748252167 4453.0 87.12360910518053 0.0 - - - - - - - 86.83333333333333 8 6 PLXNA3 plexin A3 875 111 C20140716_OR021_03 C20140716_OR021_03 TB435919.[MT7]-AHVTGPVEDNAR.2y7_1.heavy 705.366 / 800.39 982.0 19.325875759124756 41 15 10 6 10 1.7477076332351358 44.525431015147234 0.03709983825683594 3 0.9511132625324011 5.558805748252167 982.0 14.932396946564886 0.0 - - - - - - - 0.0 1 0 PLXNA3 plexin A3 877 112 C20140716_OR021_03 C20140716_OR021_03 TB436028.[MT7]-DPSEVVITLATSLGLK[MT7].3b6_1.heavy 644.382 / 771.401 184.0 54.56260108947754 24 5 10 5 4 0.4397133043624997 106.92457484314139 0.04560089111328125 9 0.6914541762954465 2.161943865893983 184.0 7.4 13.0 - - - - - - - 0.0 1 0 ZNFX1 zinc finger, NFX1-type containing 1 879 112 C20140716_OR021_03 C20140716_OR021_03 TB436028.[MT7]-DPSEVVITLATSLGLK[MT7].3b4_1.heavy 644.382 / 573.264 1198.0 54.56260108947754 24 5 10 5 4 0.4397133043624997 106.92457484314139 0.04560089111328125 9 0.6914541762954465 2.161943865893983 1198.0 18.035108695652173 0.0 - - - - - - - 99.66666666666667 2 12 ZNFX1 zinc finger, NFX1-type containing 1 881 112 C20140716_OR021_03 C20140716_OR021_03 TB436028.[MT7]-DPSEVVITLATSLGLK[MT7].3b5_1.heavy 644.382 / 672.332 277.0 54.56260108947754 24 5 10 5 4 0.4397133043624997 106.92457484314139 0.04560089111328125 9 0.6914541762954465 2.161943865893983 277.0 4.0144927536231885 7.0 - - - - - - - 0.0 1 0 ZNFX1 zinc finger, NFX1-type containing 1 883 112 C20140716_OR021_03 C20140716_OR021_03 TB436028.[MT7]-DPSEVVITLATSLGLK[MT7].3y4_1.heavy 644.382 / 574.404 737.0 54.56260108947754 24 5 10 5 4 0.4397133043624997 106.92457484314139 0.04560089111328125 9 0.6914541762954465 2.161943865893983 737.0 7.7385 5.0 - - - - - - - 0.0 1 0 ZNFX1 zinc finger, NFX1-type containing 1 885 113 C20140716_OR021_03 C20140716_OR021_03 TB420182.[MT7]-NPGYYDIQAK[MT7].2y4_1.heavy 728.887 / 603.395 10871.0 28.208975315093994 43 20 10 3 10 14.370370251636203 6.958762944094223 0.07500076293945312 3 0.99822543492701 29.292211448041297 10871.0 54.355 0.0 - - - - - - - 238.0 21 7 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 887 113 C20140716_OR021_03 C20140716_OR021_03 TB420182.[MT7]-NPGYYDIQAK[MT7].2y5_1.heavy 728.887 / 718.422 4505.0 28.208975315093994 43 20 10 3 10 14.370370251636203 6.958762944094223 0.07500076293945312 3 0.99822543492701 29.292211448041297 4505.0 6.435714285714286 1.0 - - - - - - - 245.0 9 8 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 889 113 C20140716_OR021_03 C20140716_OR021_03 TB420182.[MT7]-NPGYYDIQAK[MT7].2y9_1.heavy 728.887 / 1198.62 18118.0 28.208975315093994 43 20 10 3 10 14.370370251636203 6.958762944094223 0.07500076293945312 3 0.99822543492701 29.292211448041297 18118.0 115.24034013605441 0.0 - - - - - - - 228.66666666666666 36 9 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 891 113 C20140716_OR021_03 C20140716_OR021_03 TB420182.[MT7]-NPGYYDIQAK[MT7].2y6_1.heavy 728.887 / 881.485 5974.0 28.208975315093994 43 20 10 3 10 14.370370251636203 6.958762944094223 0.07500076293945312 3 0.99822543492701 29.292211448041297 5974.0 85.64765306122449 0.0 - - - - - - - 159.25 11 8 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 893 114 C20140716_OR021_03 C20140716_OR021_03 TNAA_ECO24.GLTFTYEPK.2y7.peptide 528.27 / 885.44 114289.0 33.377366383870445 23 -3 10 6 10 null 0.0 0.03620147705078125 3 0.0 0.0 114289.0 703.6273849455528 0.0 - - - - - - - 187.55555555555554 228 9 895 114 C20140716_OR021_03 C20140716_OR021_03 TNAA_ECO24.GLTFTYEPK.2y6.peptide 528.27 / 784.39 129329.0 33.377366383870445 23 -3 10 6 10 null 0.0 0.03620147705078125 3 0.0 0.0 129329.0 513.818682159361 0.0 - - - - - - - 187.5 258 18 897 114 C20140716_OR021_03 C20140716_OR021_03 TNAA_ECO24.GLTFTYEPK.2y5.peptide 528.27 / 637.32 288899.0 33.377366383870445 23 -3 10 6 10 null 0.0 0.03620147705078125 3 0.0 0.0 288899.0 563.9391498196513 0.0 - - - - - - - 222.2941176470588 577 17 899 115 C20140716_OR021_03 C20140716_OR021_03 TB442479.[MT7]-TLEQFHLSSMSSLGGPAAFSAR.4y5_1.heavy 610.312 / 551.294 13142.0 41.48335075378418 34 11 10 5 8 1.3273986475055004 62.0789832978622 0.042697906494140625 4 0.8692040092994902 3.3745331889710126 13142.0 13.443386462200326 0.0 - - - - - - - 369.8 26 5 SKI v-ski sarcoma viral oncogene homolog (avian) 901 115 C20140716_OR021_03 C20140716_OR021_03 TB442479.[MT7]-TLEQFHLSSMSSLGGPAAFSAR.4b4_1.heavy 610.312 / 616.342 3602.0 41.48335075378418 34 11 10 5 8 1.3273986475055004 62.0789832978622 0.042697906494140625 4 0.8692040092994902 3.3745331889710126 3602.0 7.278013698630137 1.0 - - - - - - - 255.625 11 8 SKI v-ski sarcoma viral oncogene homolog (avian) 903 115 C20140716_OR021_03 C20140716_OR021_03 TB442479.[MT7]-TLEQFHLSSMSSLGGPAAFSAR.4b5_1.heavy 610.312 / 763.411 3407.0 41.48335075378418 34 11 10 5 8 1.3273986475055004 62.0789832978622 0.042697906494140625 4 0.8692040092994902 3.3745331889710126 3407.0 4.985237199902793 2.0 - - - - - - - 340.7857142857143 10 14 SKI v-ski sarcoma viral oncogene homolog (avian) 905 115 C20140716_OR021_03 C20140716_OR021_03 TB442479.[MT7]-TLEQFHLSSMSSLGGPAAFSAR.4y6_1.heavy 610.312 / 622.331 8761.0 41.48335075378418 34 11 10 5 8 1.3273986475055004 62.0789832978622 0.042697906494140625 4 0.8692040092994902 3.3745331889710126 8761.0 20.96046030494587 0.0 - - - - - - - 778.5 17 8 SKI v-ski sarcoma viral oncogene homolog (avian) 907 116 C20140716_OR021_03 C20140716_OR021_03 TB442276.[MT7]-NPGYYDIQAK[MT7].3y3_1.heavy 486.261 / 490.311 13780.0 28.208975315093994 40 14 10 6 10 1.3420437224481307 49.67548042701216 0.03750038146972656 3 0.9357710537971449 4.843335807398386 13780.0 96.7639705882353 0.0 - - - - - - - 217.53333333333333 27 15 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 909 116 C20140716_OR021_03 C20140716_OR021_03 TB442276.[MT7]-NPGYYDIQAK[MT7].3b6_1.heavy 486.261 / 854.38 10426.0 28.208975315093994 40 14 10 6 10 1.3420437224481307 49.67548042701216 0.03750038146972656 3 0.9357710537971449 4.843335807398386 10426.0 86.18036421472382 0.0 - - - - - - - 181.66666666666666 20 3 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 911 116 C20140716_OR021_03 C20140716_OR021_03 TB442276.[MT7]-NPGYYDIQAK[MT7].3b4_1.heavy 486.261 / 576.29 13689.0 28.208975315093994 40 14 10 6 10 1.3420437224481307 49.67548042701216 0.03750038146972656 3 0.9357710537971449 4.843335807398386 13689.0 96.7332665175106 0.0 - - - - - - - 199.6 27 10 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 913 116 C20140716_OR021_03 C20140716_OR021_03 TB442276.[MT7]-NPGYYDIQAK[MT7].3b8_2.heavy 486.261 / 548.265 3989.0 28.208975315093994 40 14 10 6 10 1.3420437224481307 49.67548042701216 0.03750038146972656 3 0.9357710537971449 4.843335807398386 3989.0 9.3900826446281 1.0 - - - - - - - 272.1 7 10 ITLN2;ITLN1 intelectin 2;intelectin 1 (galactofuranose binding) 915 117 C20140716_OR021_03 C20140716_OR021_03 TB420285.[MT7]-AFSYTWFNLQAR.3y6_1.heavy 549.952 / 748.41 8848.0 46.070899963378906 48 18 10 10 10 4.187356290494778 23.88141659380602 0.0 3 0.98612984894333 10.466910615782037 8848.0 101.46167022336036 0.0 - - - - - - - 265.1111111111111 17 9 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 917 117 C20140716_OR021_03 C20140716_OR021_03 TB420285.[MT7]-AFSYTWFNLQAR.3b4_1.heavy 549.952 / 613.31 5070.0 46.070899963378906 48 18 10 10 10 4.187356290494778 23.88141659380602 0.0 3 0.98612984894333 10.466910615782037 5070.0 22.100402009371663 0.0 - - - - - - - 216.23529411764707 10 17 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 919 117 C20140716_OR021_03 C20140716_OR021_03 TB420285.[MT7]-AFSYTWFNLQAR.3b5_1.heavy 549.952 / 714.358 3181.0 46.070899963378906 48 18 10 10 10 4.187356290494778 23.88141659380602 0.0 3 0.98612984894333 10.466910615782037 3181.0 1.4216759776536314 0.0 - - - - - - - 228.6 6 10 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 921 117 C20140716_OR021_03 C20140716_OR021_03 TB420285.[MT7]-AFSYTWFNLQAR.3y5_1.heavy 549.952 / 601.342 13023.0 46.070899963378906 48 18 10 10 10 4.187356290494778 23.88141659380602 0.0 3 0.98612984894333 10.466910615782037 13023.0 57.293966674380925 0.0 - - - - - - - 265.0 26 9 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 923 118 C20140716_OR021_03 C20140716_OR021_03 TB435961.[MT7]-VYNNTLTYGEVR.2b3_1.heavy 786.911 / 521.284 17947.0 30.908599853515625 50 20 10 10 10 9.23716051468399 10.825837641451992 0.0 3 0.9967147102280984 21.525664084843303 17947.0 101.09396464992912 0.0 - - - - - - - 171.21052631578948 35 19 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 925 118 C20140716_OR021_03 C20140716_OR021_03 TB435961.[MT7]-VYNNTLTYGEVR.2y8_1.heavy 786.911 / 938.494 18981.0 30.908599853515625 50 20 10 10 10 9.23716051468399 10.825837641451992 0.0 3 0.9967147102280984 21.525664084843303 18981.0 47.53610106688505 0.0 - - - - - - - 195.7058823529412 37 17 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 927 118 C20140716_OR021_03 C20140716_OR021_03 TB435961.[MT7]-VYNNTLTYGEVR.2b4_1.heavy 786.911 / 635.327 15731.0 30.908599853515625 50 20 10 10 10 9.23716051468399 10.825837641451992 0.0 3 0.9967147102280984 21.525664084843303 15731.0 34.488411964168904 0.0 - - - - - - - 236.3 31 20 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 929 118 C20140716_OR021_03 C20140716_OR021_03 TB435961.[MT7]-VYNNTLTYGEVR.2y9_1.heavy 786.911 / 1052.54 23412.0 30.908599853515625 50 20 10 10 10 9.23716051468399 10.825837641451992 0.0 3 0.9967147102280984 21.525664084843303 23412.0 48.656197564276056 0.0 - - - - - - - 738.625 46 8 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 931 119 C20140716_OR021_03 C20140716_OR021_03 TB420283.[MT7]-WYLENVYPEMR.3b4_1.heavy 548.605 / 736.379 10424.0 42.94860076904297 44 14 10 10 10 2.336054552783863 35.791252215794415 0.0 3 0.9432681771614086 5.156726670447646 10424.0 132.6900781657113 0.0 - - - - - - - 202.25 20 8 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 933 119 C20140716_OR021_03 C20140716_OR021_03 TB420283.[MT7]-WYLENVYPEMR.3b5_1.heavy 548.605 / 850.422 14270.0 42.94860076904297 44 14 10 10 10 2.336054552783863 35.791252215794415 0.0 3 0.9432681771614086 5.156726670447646 14270.0 87.56077772521898 0.0 - - - - - - - 182.1 28 10 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 935 119 C20140716_OR021_03 C20140716_OR021_03 TB420283.[MT7]-WYLENVYPEMR.3y4_1.heavy 548.605 / 532.255 61837.0 42.94860076904297 44 14 10 10 10 2.336054552783863 35.791252215794415 0.0 3 0.9432681771614086 5.156726670447646 61837.0 120.14994374275429 0.0 - - - - - - - 270.0 123 9 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 937 119 C20140716_OR021_03 C20140716_OR021_03 TB420283.[MT7]-WYLENVYPEMR.3y5_1.heavy 548.605 / 695.318 16193.0 42.94860076904297 44 14 10 10 10 2.336054552783863 35.791252215794415 0.0 3 0.9432681771614086 5.156726670447646 16193.0 76.44695308641975 0.0 - - - - - - - 242.8 32 10 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 939 120 C20140716_OR021_03 C20140716_OR021_03 TB435964.[MT7]-YSAQIEDLQVK[MT7].2y4_1.heavy 791.44 / 631.426 4029.0 33.62049865722656 48 18 10 10 10 4.238546901829797 23.592991257647665 0.0 3 0.9858457889296894 10.361101865185708 4029.0 93.84 0.0 - - - - - - - 229.8181818181818 8 11 SKI v-ski sarcoma viral oncogene homolog (avian) 941 120 C20140716_OR021_03 C20140716_OR021_03 TB435964.[MT7]-YSAQIEDLQVK[MT7].2y6_1.heavy 791.44 / 875.495 3239.0 33.62049865722656 48 18 10 10 10 4.238546901829797 23.592991257647665 0.0 3 0.9858457889296894 10.361101865185708 3239.0 28.494999999999997 0.0 - - - - - - - 186.21428571428572 6 14 SKI v-ski sarcoma viral oncogene homolog (avian) 943 120 C20140716_OR021_03 C20140716_OR021_03 TB435964.[MT7]-YSAQIEDLQVK[MT7].2b7_1.heavy 791.44 / 951.454 2765.0 33.62049865722656 48 18 10 10 10 4.238546901829797 23.592991257647665 0.0 3 0.9858457889296894 10.361101865185708 2765.0 11.2875 0.0 - - - - - - - 142.2 5 10 SKI v-ski sarcoma viral oncogene homolog (avian) 945 120 C20140716_OR021_03 C20140716_OR021_03 TB435964.[MT7]-YSAQIEDLQVK[MT7].2b5_1.heavy 791.44 / 707.385 2291.0 33.62049865722656 48 18 10 10 10 4.238546901829797 23.592991257647665 0.0 3 0.9858457889296894 10.361101865185708 2291.0 17.11 0.0 - - - - - - - 193.9090909090909 4 11 SKI v-ski sarcoma viral oncogene homolog (avian) 947 121 C20140716_OR021_03 C20140716_OR021_03 TB420004.[MT7]-EALIETVQR.2y4_1.heavy 601.847 / 503.294 16327.0 30.255600452423096 43 17 10 6 10 2.9226286991010753 28.64930737226241 0.031198501586914062 3 0.9791771945297679 8.537608832090918 16327.0 25.93924155439214 1.0 - - - - - - - 741.6666666666666 46 9 USP29 ubiquitin specific peptidase 29 949 121 C20140716_OR021_03 C20140716_OR021_03 TB420004.[MT7]-EALIETVQR.2y8_1.heavy 601.847 / 929.542 28713.0 30.255600452423096 43 17 10 6 10 2.9226286991010753 28.64930737226241 0.031198501586914062 3 0.9791771945297679 8.537608832090918 28713.0 202.12049689440994 0.0 - - - - - - - 207.75 57 12 USP29 ubiquitin specific peptidase 29 951 121 C20140716_OR021_03 C20140716_OR021_03 TB420004.[MT7]-EALIETVQR.2y5_1.heavy 601.847 / 632.336 21474.0 30.255600452423096 43 17 10 6 10 2.9226286991010753 28.64930737226241 0.031198501586914062 3 0.9791771945297679 8.537608832090918 21474.0 40.541548138305956 0.0 - - - - - - - 635.3 42 10 USP29 ubiquitin specific peptidase 29 953 121 C20140716_OR021_03 C20140716_OR021_03 TB420004.[MT7]-EALIETVQR.2y6_1.heavy 601.847 / 745.42 19062.0 30.255600452423096 43 17 10 6 10 2.9226286991010753 28.64930737226241 0.031198501586914062 3 0.9791771945297679 8.537608832090918 19062.0 56.27886147585547 1.0 - - - - - - - 252.06666666666666 38 15 USP29 ubiquitin specific peptidase 29 955 122 C20140716_OR021_03 C20140716_OR021_03 TB420289.[MT7]-VC[CAM]GFIQIWSQK[MT7].3y3_1.heavy 551.972 / 506.306 23831.0 44.64484977722168 40 14 10 6 10 2.281442689427885 34.551226644010335 0.038898468017578125 3 0.9491267934188472 5.448277678789962 23831.0 53.331793031808196 0.0 - - - - - - - 237.92307692307693 47 13 USP29 ubiquitin specific peptidase 29 957 122 C20140716_OR021_03 C20140716_OR021_03 TB420289.[MT7]-VC[CAM]GFIQIWSQK[MT7].3b4_1.heavy 551.972 / 608.298 22386.0 44.64484977722168 40 14 10 6 10 2.281442689427885 34.551226644010335 0.038898468017578125 3 0.9491267934188472 5.448277678789962 22386.0 82.41542235973824 0.0 - - - - - - - 237.1 44 10 USP29 ubiquitin specific peptidase 29 959 122 C20140716_OR021_03 C20140716_OR021_03 TB420289.[MT7]-VC[CAM]GFIQIWSQK[MT7].3b5_1.heavy 551.972 / 721.382 6499.0 44.64484977722168 40 14 10 6 10 2.281442689427885 34.551226644010335 0.038898468017578125 3 0.9491267934188472 5.448277678789962 6499.0 60.07320388349515 2.0 - - - - - - - 206.2 24 10 USP29 ubiquitin specific peptidase 29 961 122 C20140716_OR021_03 C20140716_OR021_03 TB420289.[MT7]-VC[CAM]GFIQIWSQK[MT7].3y4_1.heavy 551.972 / 692.385 13721.0 44.64484977722168 40 14 10 6 10 2.281442689427885 34.551226644010335 0.038898468017578125 3 0.9491267934188472 5.448277678789962 13721.0 81.57475607531626 0.0 - - - - - - - 263.44444444444446 27 9 USP29 ubiquitin specific peptidase 29 963 123 C20140716_OR021_03 C20140716_OR021_03 TB442468.[MT7]-YNPVVIDFEMQPIHEVLR.3b4_1.heavy 781.748 / 618.337 65054.0 46.32889938354492 48 18 10 10 10 16.794893309236798 5.954190845916379 0.0 3 0.9899953866868455 12.328194315243682 65054.0 463.15022404371587 0.0 - - - - - - - 244.33333333333334 130 12 C8A complement component 8, alpha polypeptide 965 123 C20140716_OR021_03 C20140716_OR021_03 TB442468.[MT7]-YNPVVIDFEMQPIHEVLR.3b5_1.heavy 781.748 / 717.405 53918.0 46.32889938354492 48 18 10 10 10 16.794893309236798 5.954190845916379 0.0 3 0.9899953866868455 12.328194315243682 53918.0 214.45913775985107 0.0 - - - - - - - 263.73333333333335 107 15 C8A complement component 8, alpha polypeptide 967 123 C20140716_OR021_03 C20140716_OR021_03 TB442468.[MT7]-YNPVVIDFEMQPIHEVLR.3b3_1.heavy 781.748 / 519.268 14578.0 46.32889938354492 48 18 10 10 10 16.794893309236798 5.954190845916379 0.0 3 0.9899953866868455 12.328194315243682 14578.0 42.11844571609497 0.0 - - - - - - - 256.4166666666667 29 12 C8A complement component 8, alpha polypeptide 969 123 C20140716_OR021_03 C20140716_OR021_03 TB442468.[MT7]-YNPVVIDFEMQPIHEVLR.3b7_1.heavy 781.748 / 945.516 36703.0 46.32889938354492 48 18 10 10 10 16.794893309236798 5.954190845916379 0.0 3 0.9899953866868455 12.328194315243682 36703.0 251.7519485842027 0.0 - - - - - - - 166.2 73 15 C8A complement component 8, alpha polypeptide 971 124 C20140716_OR021_03 C20140716_OR021_03 CH10_ECO24.SAGGIVLTGSAAAK.2y7.peptide 601.84 / 605.33 364806.0 27.42530059814453 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 364806.0 312.9300953550987 0.0 - - - - - - - 2723.5 729 2 973 124 C20140716_OR021_03 C20140716_OR021_03 CH10_ECO24.SAGGIVLTGSAAAK.2y8.peptide 601.84 / 718.41 381581.0 27.42530059814453 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 381581.0 726.8962644044431 0.0 - - - - - - - 2810.0 763 2 975 124 C20140716_OR021_03 C20140716_OR021_03 CH10_ECO24.SAGGIVLTGSAAAK.2y9.peptide 601.84 / 817.48 464417.0 27.42530059814453 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 464417.0 371.01151609857925 0.0 - - - - - - - 5695.875 928 8 977 125 C20140716_OR021_03 C20140716_OR021_03 TB420387.[MT7]-QLNMFLDIIHQNK[MT7].4y4_1.heavy 476.268 / 670.375 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP29 ubiquitin specific peptidase 29 979 125 C20140716_OR021_03 C20140716_OR021_03 TB420387.[MT7]-QLNMFLDIIHQNK[MT7].4b4_1.heavy 476.268 / 631.335 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP29 ubiquitin specific peptidase 29 981 125 C20140716_OR021_03 C20140716_OR021_03 TB420387.[MT7]-QLNMFLDIIHQNK[MT7].4y3_1.heavy 476.268 / 533.316 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP29 ubiquitin specific peptidase 29 983 125 C20140716_OR021_03 C20140716_OR021_03 TB420387.[MT7]-QLNMFLDIIHQNK[MT7].4b3_1.heavy 476.268 / 500.295 N/A N/A - - - - - - - - - 0.0 - - - - - - - USP29 ubiquitin specific peptidase 29 985 126 C20140716_OR021_03 C20140716_OR021_03 TB420383.[MT7]-EVLQRPASIMESDK[MT7].3b4_1.heavy 631.011 / 614.363 7628.0 30.1613507270813 37 12 9 6 10 1.5000221630782256 52.2376083215359 0.031000137329101562 3 0.8927455374225509 3.7341722803941737 7628.0 11.021211466386887 3.0 - - - - - - - 766.1818181818181 48 11 PTH1R parathyroid hormone 1 receptor 987 126 C20140716_OR021_03 C20140716_OR021_03 TB420383.[MT7]-EVLQRPASIMESDK[MT7].3y5_1.heavy 631.011 / 753.357 14015.0 30.1613507270813 37 12 9 6 10 1.5000221630782256 52.2376083215359 0.031000137329101562 3 0.8927455374225509 3.7341722803941737 14015.0 39.120639019300995 0.0 - - - - - - - 671.7142857142857 28 7 PTH1R parathyroid hormone 1 receptor 989 126 C20140716_OR021_03 C20140716_OR021_03 TB420383.[MT7]-EVLQRPASIMESDK[MT7].3y13_2.heavy 631.011 / 809.441 21732.0 30.1613507270813 37 12 9 6 10 1.5000221630782256 52.2376083215359 0.031000137329101562 3 0.8927455374225509 3.7341722803941737 21732.0 96.21167050323119 0.0 - - - - - - - 236.6 43 15 PTH1R parathyroid hormone 1 receptor 991 126 C20140716_OR021_03 C20140716_OR021_03 TB420383.[MT7]-EVLQRPASIMESDK[MT7].3y9_1.heavy 631.011 / 1121.56 9491.0 30.1613507270813 37 12 9 6 10 1.5000221630782256 52.2376083215359 0.031000137329101562 3 0.8927455374225509 3.7341722803941737 9491.0 49.86796610169491 0.0 - - - - - - - 177.3846153846154 18 13 PTH1R parathyroid hormone 1 receptor 993 127 C20140716_OR021_03 C20140716_OR021_03 TB420382.[MT7]-LIIRAEELAQMWK[MT7].3b9_1.heavy 630.369 / 1153.71 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 995 127 C20140716_OR021_03 C20140716_OR021_03 TB420382.[MT7]-LIIRAEELAQMWK[MT7].3y3_1.heavy 630.369 / 608.335 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 997 127 C20140716_OR021_03 C20140716_OR021_03 TB420382.[MT7]-LIIRAEELAQMWK[MT7].3y12_2.heavy 630.369 / 816.457 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 999 127 C20140716_OR021_03 C20140716_OR021_03 TB420382.[MT7]-LIIRAEELAQMWK[MT7].3b7_1.heavy 630.369 / 969.585 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1001 128 C20140716_OR021_03 C20140716_OR021_03 TB420381.[MT7]-LIIRAEELAQMWK[MT7].4b8_2.heavy 473.028 / 541.838 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1003 128 C20140716_OR021_03 C20140716_OR021_03 TB420381.[MT7]-LIIRAEELAQMWK[MT7].4b7_1.heavy 473.028 / 969.585 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1005 128 C20140716_OR021_03 C20140716_OR021_03 TB420381.[MT7]-LIIRAEELAQMWK[MT7].4b7_2.heavy 473.028 / 485.296 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1007 128 C20140716_OR021_03 C20140716_OR021_03 TB420381.[MT7]-LIIRAEELAQMWK[MT7].4y3_1.heavy 473.028 / 608.335 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1009 129 C20140716_OR021_03 C20140716_OR021_03 TB442136.[MT7]-MPLFMSK[MT7].2y4_1.heavy 571.321 / 656.356 16422.0 39.359750747680664 39 13 10 6 10 2.7828256817526755 35.93469783454712 0.037097930908203125 3 0.9296305935383199 4.624770263786057 16422.0 62.35178666224287 0.0 - - - - - - - 252.0909090909091 32 11 USP29 ubiquitin specific peptidase 29 1011 129 C20140716_OR021_03 C20140716_OR021_03 TB442136.[MT7]-MPLFMSK[MT7].2y5_1.heavy 571.321 / 769.44 4619.0 39.359750747680664 39 13 10 6 10 2.7828256817526755 35.93469783454712 0.037097930908203125 3 0.9296305935383199 4.624770263786057 4619.0 56.399440171479 0.0 - - - - - - - 196.0909090909091 9 11 USP29 ubiquitin specific peptidase 29 1013 129 C20140716_OR021_03 C20140716_OR021_03 TB442136.[MT7]-MPLFMSK[MT7].2y3_1.heavy 571.321 / 509.287 15807.0 39.359750747680664 39 13 10 6 10 2.7828256817526755 35.93469783454712 0.037097930908203125 3 0.9296305935383199 4.624770263786057 15807.0 57.62005847953216 0.0 - - - - - - - 641.375 31 8 USP29 ubiquitin specific peptidase 29 1015 129 C20140716_OR021_03 C20140716_OR021_03 TB442136.[MT7]-MPLFMSK[MT7].2y6_1.heavy 571.321 / 866.493 54912.0 39.359750747680664 39 13 10 6 10 2.7828256817526755 35.93469783454712 0.037097930908203125 3 0.9296305935383199 4.624770263786057 54912.0 431.8645296167247 0.0 - - - - - - - 242.72727272727272 109 11 USP29 ubiquitin specific peptidase 29 1017 130 C20140716_OR021_03 C20140716_OR021_03 TB435813.[MT7]-AVPGSIK[MT7].2y4_1.heavy 480.31 / 548.352 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1019 130 C20140716_OR021_03 C20140716_OR021_03 TB435813.[MT7]-AVPGSIK[MT7].2y5_1.heavy 480.31 / 645.405 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1021 130 C20140716_OR021_03 C20140716_OR021_03 TB435813.[MT7]-AVPGSIK[MT7].2y3_1.heavy 480.31 / 491.331 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1023 130 C20140716_OR021_03 C20140716_OR021_03 TB435813.[MT7]-AVPGSIK[MT7].2y6_1.heavy 480.31 / 744.474 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1025 131 C20140716_OR021_03 C20140716_OR021_03 TB442460.[MT7]-ETAFLYAISSAGLTHALAK[MT7].3b4_1.heavy 751.422 / 593.305 39262.0 47.5281982421875 48 18 10 10 10 3.311897906666044 30.19416745870226 0.0 3 0.9807281692403184 8.875665672575451 39262.0 98.85490607200902 0.0 - - - - - - - 260.73333333333335 78 15 WNT9A wingless-type MMTV integration site family, member 9A 1027 131 C20140716_OR021_03 C20140716_OR021_03 TB442460.[MT7]-ETAFLYAISSAGLTHALAK[MT7].3b5_1.heavy 751.422 / 706.389 31787.0 47.5281982421875 48 18 10 10 10 3.311897906666044 30.19416745870226 0.0 3 0.9807281692403184 8.875665672575451 31787.0 114.20945015210955 0.0 - - - - - - - 221.27777777777777 63 18 WNT9A wingless-type MMTV integration site family, member 9A 1029 131 C20140716_OR021_03 C20140716_OR021_03 TB442460.[MT7]-ETAFLYAISSAGLTHALAK[MT7].3y4_1.heavy 751.422 / 546.373 29621.0 47.5281982421875 48 18 10 10 10 3.311897906666044 30.19416745870226 0.0 3 0.9807281692403184 8.875665672575451 29621.0 76.28399030183932 0.0 - - - - - - - 223.6 59 15 WNT9A wingless-type MMTV integration site family, member 9A 1031 131 C20140716_OR021_03 C20140716_OR021_03 TB442460.[MT7]-ETAFLYAISSAGLTHALAK[MT7].3b7_1.heavy 751.422 / 940.49 22425.0 47.5281982421875 48 18 10 10 10 3.311897906666044 30.19416745870226 0.0 3 0.9807281692403184 8.875665672575451 22425.0 96.38772073781561 0.0 - - - - - - - 246.3684210526316 44 19 WNT9A wingless-type MMTV integration site family, member 9A 1033 132 C20140716_OR021_03 C20140716_OR021_03 TB435975.[MT7]-WYLENVYPEMR.2y8_1.heavy 822.404 / 1037.47 24621.0 42.94860076904297 44 14 10 10 10 1.8502983539791515 43.19486014602157 0.0 3 0.9373693777205523 4.90541599989602 24621.0 58.673168578993824 0.0 - - - - - - - 643.75 49 8 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1035 132 C20140716_OR021_03 C20140716_OR021_03 TB435975.[MT7]-WYLENVYPEMR.2b4_1.heavy 822.404 / 736.379 9478.0 42.94860076904297 44 14 10 10 10 1.8502983539791515 43.19486014602157 0.0 3 0.9373693777205523 4.90541599989602 9478.0 42.32893203883496 0.0 - - - - - - - 299.6363636363636 18 11 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1037 132 C20140716_OR021_03 C20140716_OR021_03 TB435975.[MT7]-WYLENVYPEMR.2y9_1.heavy 822.404 / 1150.56 15350.0 42.94860076904297 44 14 10 10 10 1.8502983539791515 43.19486014602157 0.0 3 0.9373693777205523 4.90541599989602 15350.0 158.63322545846816 0.0 - - - - - - - 236.9 30 10 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1039 132 C20140716_OR021_03 C20140716_OR021_03 TB435975.[MT7]-WYLENVYPEMR.2y7_1.heavy 822.404 / 908.43 14526.0 42.94860076904297 44 14 10 10 10 1.8502983539791515 43.19486014602157 0.0 3 0.9373693777205523 4.90541599989602 14526.0 67.49398058252427 1.0 - - - - - - - 251.77777777777777 29 9 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1041 133 C20140716_OR021_03 C20140716_OR021_03 TB420274.[MT7]-C[CAM]TC[CAM]DEAPDLENR.2y4_1.heavy 812.347 / 531.289 2438.0 23.820924758911133 36 13 10 3 10 1.223649856709381 54.4818162655987 0.07489967346191406 3 0.9167875356572819 4.248245361509705 2438.0 14.441656050955412 0.0 - - - - - - - 170.41666666666666 4 12 WNT9A wingless-type MMTV integration site family, member 9A 1043 133 C20140716_OR021_03 C20140716_OR021_03 TB420274.[MT7]-C[CAM]TC[CAM]DEAPDLENR.2y8_1.heavy 812.347 / 943.448 3618.0 23.820924758911133 36 13 10 3 10 1.223649856709381 54.4818162655987 0.07489967346191406 3 0.9167875356572819 4.248245361509705 3618.0 52.7983552366363 0.0 - - - - - - - 157.4 7 5 WNT9A wingless-type MMTV integration site family, member 9A 1045 133 C20140716_OR021_03 C20140716_OR021_03 TB420274.[MT7]-C[CAM]TC[CAM]DEAPDLENR.2b4_1.heavy 812.347 / 681.245 2517.0 23.820924758911133 36 13 10 3 10 1.223649856709381 54.4818162655987 0.07489967346191406 3 0.9167875356572819 4.248245361509705 2517.0 11.73177966101695 0.0 - - - - - - - 202.28571428571428 5 14 WNT9A wingless-type MMTV integration site family, member 9A 1047 133 C20140716_OR021_03 C20140716_OR021_03 TB420274.[MT7]-C[CAM]TC[CAM]DEAPDLENR.2y6_1.heavy 812.347 / 743.368 1416.0 23.820924758911133 36 13 10 3 10 1.223649856709381 54.4818162655987 0.07489967346191406 3 0.9167875356572819 4.248245361509705 1416.0 16.131645569620254 1.0 - - - - - - - 275.5 4 4 WNT9A wingless-type MMTV integration site family, member 9A 1049 134 C20140716_OR021_03 C20140716_OR021_03 TB420273.[MT7]-C[CAM]TC[CAM]DEAPDLENR.3y6_1.heavy 541.9 / 743.368 4977.0 23.802199840545654 43 17 10 6 10 1.965072625891368 36.90668587326126 0.03800010681152344 3 0.971212547397046 7.256268703663897 4977.0 34.650000000000006 0.0 - - - - - - - 143.63636363636363 9 11 WNT9A wingless-type MMTV integration site family, member 9A 1051 134 C20140716_OR021_03 C20140716_OR021_03 TB420273.[MT7]-C[CAM]TC[CAM]DEAPDLENR.3b4_1.heavy 541.9 / 681.245 3950.0 23.802199840545654 43 17 10 6 10 1.965072625891368 36.90668587326126 0.03800010681152344 3 0.971212547397046 7.256268703663897 3950.0 39.25 0.0 - - - - - - - 204.08333333333334 7 12 WNT9A wingless-type MMTV integration site family, member 9A 1053 134 C20140716_OR021_03 C20140716_OR021_03 TB420273.[MT7]-C[CAM]TC[CAM]DEAPDLENR.3y4_1.heavy 541.9 / 531.289 4977.0 23.802199840545654 43 17 10 6 10 1.965072625891368 36.90668587326126 0.03800010681152344 3 0.971212547397046 7.256268703663897 4977.0 22.365 0.0 - - - - - - - 271.5625 9 16 WNT9A wingless-type MMTV integration site family, member 9A 1055 134 C20140716_OR021_03 C20140716_OR021_03 TB420273.[MT7]-C[CAM]TC[CAM]DEAPDLENR.3y5_1.heavy 541.9 / 646.315 2844.0 23.802199840545654 43 17 10 6 10 1.965072625891368 36.90668587326126 0.03800010681152344 3 0.971212547397046 7.256268703663897 2844.0 13.200000000000001 0.0 - - - - - - - 304.7142857142857 5 14 WNT9A wingless-type MMTV integration site family, member 9A 1057 135 C20140716_OR021_03 C20140716_OR021_03 TB435972.[MT7]-VQTIIEHLQEK[MT7].3y3_1.heavy 542.654 / 548.316 23118.0 37.02539825439453 45 15 10 10 10 3.0118879721154355 26.591544369322413 0.0 3 0.9507278661479666 5.536842066004769 23118.0 70.22129947103434 0.0 - - - - - - - 726.0 46 9 ZNFX1 zinc finger, NFX1-type containing 1 1059 135 C20140716_OR021_03 C20140716_OR021_03 TB435972.[MT7]-VQTIIEHLQEK[MT7].3b6_1.heavy 542.654 / 828.495 11085.0 37.02539825439453 45 15 10 10 10 3.0118879721154355 26.591544369322413 0.0 3 0.9507278661479666 5.536842066004769 11085.0 44.66740506329114 0.0 - - - - - - - 236.91666666666666 22 12 ZNFX1 zinc finger, NFX1-type containing 1 1061 135 C20140716_OR021_03 C20140716_OR021_03 TB435972.[MT7]-VQTIIEHLQEK[MT7].3b4_1.heavy 542.654 / 586.368 20086.0 37.02539825439453 45 15 10 10 10 3.0118879721154355 26.591544369322413 0.0 3 0.9507278661479666 5.536842066004769 20086.0 52.25076214695336 0.0 - - - - - - - 323.6666666666667 40 12 ZNFX1 zinc finger, NFX1-type containing 1 1063 135 C20140716_OR021_03 C20140716_OR021_03 TB435972.[MT7]-VQTIIEHLQEK[MT7].3y4_1.heavy 542.654 / 661.4 20749.0 37.02539825439453 45 15 10 10 10 3.0118879721154355 26.591544369322413 0.0 3 0.9507278661479666 5.536842066004769 20749.0 67.0221192903457 1.0 - - - - - - - 290.92857142857144 43 14 ZNFX1 zinc finger, NFX1-type containing 1 1065 136 C20140716_OR021_03 C20140716_OR021_03 TB442457.[MT7]-SFETAVAPNVALAPPAQQK[MT7].3b6_1.heavy 743.082 / 779.406 15995.0 35.45119857788086 47 17 10 10 10 3.410428449289163 29.321829056652113 0.0 3 0.9714285592511027 7.283779751503956 15995.0 31.45856694327286 1.0 - - - - - - - 248.92307692307693 45 13 SKI v-ski sarcoma viral oncogene homolog (avian) 1067 136 C20140716_OR021_03 C20140716_OR021_03 TB442457.[MT7]-SFETAVAPNVALAPPAQQK[MT7].3y6_1.heavy 743.082 / 812.475 46808.0 35.45119857788086 47 17 10 10 10 3.410428449289163 29.321829056652113 0.0 3 0.9714285592511027 7.283779751503956 46808.0 176.76570078274997 0.0 - - - - - - - 327.0 93 6 SKI v-ski sarcoma viral oncogene homolog (avian) 1069 136 C20140716_OR021_03 C20140716_OR021_03 TB442457.[MT7]-SFETAVAPNVALAPPAQQK[MT7].3b5_1.heavy 743.082 / 680.337 17074.0 35.45119857788086 47 17 10 10 10 3.410428449289163 29.321829056652113 0.0 3 0.9714285592511027 7.283779751503956 17074.0 89.01653158208293 0.0 - - - - - - - 245.25 34 12 SKI v-ski sarcoma viral oncogene homolog (avian) 1071 136 C20140716_OR021_03 C20140716_OR021_03 TB442457.[MT7]-SFETAVAPNVALAPPAQQK[MT7].3b7_1.heavy 743.082 / 850.443 25710.0 35.45119857788086 47 17 10 10 10 3.410428449289163 29.321829056652113 0.0 3 0.9714285592511027 7.283779751503956 25710.0 215.56173469387753 0.0 - - - - - - - 228.91666666666666 51 12 SKI v-ski sarcoma viral oncogene homolog (avian) 1073 137 C20140716_OR021_03 C20140716_OR021_03 TB420278.[MT7]-SNFLELIC[CAM]QVLR.3y6_1.heavy 545.972 / 788.445 N/A N/A - - - - - - - - - 0.0 - - - - - - - ZNFX1 zinc finger, NFX1-type containing 1 1075 137 C20140716_OR021_03 C20140716_OR021_03 TB420278.[MT7]-SNFLELIC[CAM]QVLR.3b4_1.heavy 545.972 / 606.337 N/A N/A - - - - - - - - - 0.0 - - - - - - - ZNFX1 zinc finger, NFX1-type containing 1 1077 137 C20140716_OR021_03 C20140716_OR021_03 TB420278.[MT7]-SNFLELIC[CAM]QVLR.3b5_1.heavy 545.972 / 735.379 N/A N/A - - - - - - - - - 0.0 - - - - - - - ZNFX1 zinc finger, NFX1-type containing 1 1079 137 C20140716_OR021_03 C20140716_OR021_03 TB420278.[MT7]-SNFLELIC[CAM]QVLR.3y5_1.heavy 545.972 / 675.361 N/A N/A - - - - - - - - - 0.0 - - - - - - - ZNFX1 zinc finger, NFX1-type containing 1 1081 138 C20140716_OR021_03 C20140716_OR021_03 TB442456.[MT7]-NLLPGVPGMGLAQEDTTSLR.3y8_1.heavy 738.395 / 949.458 7787.0 48.11384963989258 31 8 10 3 10 0.8176339445347434 75.28448992201382 0.0746002197265625 3 0.7888962965354631 2.6373038396400905 7787.0 8.034852731970414 1.0 - - - - - - - 229.28571428571428 15 14 PTGER4 prostaglandin E receptor 4 (subtype EP4) 1083 138 C20140716_OR021_03 C20140716_OR021_03 TB442456.[MT7]-NLLPGVPGMGLAQEDTTSLR.3y5_1.heavy 738.395 / 577.33 803.0 48.11384963989258 31 8 10 3 10 0.8176339445347434 75.28448992201382 0.0746002197265625 3 0.7888962965354631 2.6373038396400905 803.0 1.0006230529595015 13.0 - - - - - - - 244.66666666666666 2 21 PTGER4 prostaglandin E receptor 4 (subtype EP4) 1085 138 C20140716_OR021_03 C20140716_OR021_03 TB442456.[MT7]-NLLPGVPGMGLAQEDTTSLR.3b5_1.heavy 738.395 / 639.395 2007.0 48.11384963989258 31 8 10 3 10 0.8176339445347434 75.28448992201382 0.0746002197265625 3 0.7888962965354631 2.6373038396400905 2007.0 7.918745218803525 1.0 - - - - - - - 768.4285714285714 4 7 PTGER4 prostaglandin E receptor 4 (subtype EP4) 1087 138 C20140716_OR021_03 C20140716_OR021_03 TB442456.[MT7]-NLLPGVPGMGLAQEDTTSLR.3y9_1.heavy 738.395 / 1020.5 4175.0 48.11384963989258 31 8 10 3 10 0.8176339445347434 75.28448992201382 0.0746002197265625 3 0.7888962965354631 2.6373038396400905 4175.0 11.69679008547577 0.0 - - - - - - - 200.78571428571428 8 14 PTGER4 prostaglandin E receptor 4 (subtype EP4) 1089 139 C20140716_OR021_03 C20140716_OR021_03 TPX_ECO57.DLSDVTLGQFAGK.2y7.peptide 675.85 / 720.4 444351.0 38.386199951171875 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 444351.0 277.3189705256515 0.0 - - - - - - - 749.2857142857143 888 7 1091 139 C20140716_OR021_03 C20140716_OR021_03 TPX_ECO57.DLSDVTLGQFAGK.2y8.peptide 675.85 / 821.45 987430.0 38.386199951171875 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 987430.0 268.1215130803198 0.0 - - - - - - - 286.1666666666667 1974 6 1093 139 C20140716_OR021_03 C20140716_OR021_03 TPX_ECO57.DLSDVTLGQFAGK.2y6.peptide 675.85 / 607.32 1111750.0 38.386199951171875 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1111750.0 388.1059285651154 0.0 - - - - - - - 1196.5714285714287 2223 7 1095 140 C20140716_OR021_03 C20140716_OR021_03 TB442145.[MT7]-ASAYC[CAM]LDQGAEDGDR.3y7_1.heavy 591.261 / 719.295 9103.0 26.09280014038086 48 18 10 10 10 6.234527738570551 16.039707287103663 0.0 3 0.9878266105063359 11.174164349697909 9103.0 22.612177522349935 0.0 - - - - - - - 699.0 18 7 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1097 140 C20140716_OR021_03 C20140716_OR021_03 TB442145.[MT7]-ASAYC[CAM]LDQGAEDGDR.3b4_1.heavy 591.261 / 537.279 14290.0 26.09280014038086 48 18 10 10 10 6.234527738570551 16.039707287103663 0.0 3 0.9878266105063359 11.174164349697909 14290.0 8.498159209249344 0.0 - - - - - - - 464.75 28 4 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1099 140 C20140716_OR021_03 C20140716_OR021_03 TB442145.[MT7]-ASAYC[CAM]LDQGAEDGDR.3b5_1.heavy 591.261 / 697.31 5677.0 26.09280014038086 48 18 10 10 10 6.234527738570551 16.039707287103663 0.0 3 0.9878266105063359 11.174164349697909 5677.0 10.440333276171872 0.0 - - - - - - - 699.0 11 7 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1101 140 C20140716_OR021_03 C20140716_OR021_03 TB442145.[MT7]-ASAYC[CAM]LDQGAEDGDR.3y9_1.heavy 591.261 / 962.381 2643.0 26.09280014038086 48 18 10 10 10 6.234527738570551 16.039707287103663 0.0 3 0.9878266105063359 11.174164349697909 2643.0 8.383148741248323 1.0 - - - - - - - 188.46153846153845 5 13 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1103 141 C20140716_OR021_03 C20140716_OR021_03 TB420373.[MT7]-AGPHC[CAM]PTAQLIATLK[MT7].4y4_1.heavy 467.268 / 576.384 9516.0 36.527000427246094 43 13 10 10 10 2.524100682292864 39.61807098327043 0.0 3 0.9031029072039958 3.932205065721768 9516.0 6.687824112615353 1.0 - - - - - - - 302.625 19 8 PF4;PF4V1 platelet factor 4;platelet factor 4 variant 1 1105 141 C20140716_OR021_03 C20140716_OR021_03 TB420373.[MT7]-AGPHC[CAM]PTAQLIATLK[MT7].4b4_1.heavy 467.268 / 507.28 1613.0 36.527000427246094 43 13 10 10 10 2.524100682292864 39.61807098327043 0.0 3 0.9031029072039958 3.932205065721768 1613.0 -0.262595357963005 9.0 - - - - - - - 282.3333333333333 20 6 PF4;PF4V1 platelet factor 4;platelet factor 4 variant 1 1107 141 C20140716_OR021_03 C20140716_OR021_03 TB420373.[MT7]-AGPHC[CAM]PTAQLIATLK[MT7].4b5_1.heavy 467.268 / 667.31 2822.0 36.527000427246094 43 13 10 10 10 2.524100682292864 39.61807098327043 0.0 3 0.9031029072039958 3.932205065721768 2822.0 16.933153484569797 1.0 - - - - - - - 224.0 5 9 PF4;PF4V1 platelet factor 4;platelet factor 4 variant 1 1109 141 C20140716_OR021_03 C20140716_OR021_03 TB420373.[MT7]-AGPHC[CAM]PTAQLIATLK[MT7].4b9_2.heavy 467.268 / 532.757 10403.0 36.527000427246094 43 13 10 10 10 2.524100682292864 39.61807098327043 0.0 3 0.9031029072039958 3.932205065721768 10403.0 13.443738430203187 1.0 - - - - - - - 219.0 20 7 PF4;PF4V1 platelet factor 4;platelet factor 4 variant 1 1111 142 C20140716_OR021_03 C20140716_OR021_03 TB420400.[MT7]-GRAGPDTSASGEPGANSK[MT7].3b6_1.heavy 649.664 / 698.37 3640.0 16.802525520324707 40 14 10 6 10 1.7348922432263407 47.340063224602446 0.036899566650390625 3 0.935823398752185 4.8453322590160495 3640.0 12.532625333874918 0.0 - - - - - - - 159.6 7 15 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1113 142 C20140716_OR021_03 C20140716_OR021_03 TB420400.[MT7]-GRAGPDTSASGEPGANSK[MT7].3y6_1.heavy 649.664 / 717.401 21673.0 16.802525520324707 40 14 10 6 10 1.7348922432263407 47.340063224602446 0.036899566650390625 3 0.935823398752185 4.8453322590160495 21673.0 197.23751524390246 0.0 - - - - - - - 155.33333333333334 43 15 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1115 142 C20140716_OR021_03 C20140716_OR021_03 TB420400.[MT7]-GRAGPDTSASGEPGANSK[MT7].3y5_1.heavy 649.664 / 620.348 7640.0 16.802525520324707 40 14 10 6 10 1.7348922432263407 47.340063224602446 0.036899566650390625 3 0.935823398752185 4.8453322590160495 7640.0 33.63159821678548 0.0 - - - - - - - 252.30769230769232 15 13 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1117 142 C20140716_OR021_03 C20140716_OR021_03 TB420400.[MT7]-GRAGPDTSASGEPGANSK[MT7].3b12_1.heavy 649.664 / 1230.58 1935.0 16.802525520324707 40 14 10 6 10 1.7348922432263407 47.340063224602446 0.036899566650390625 3 0.935823398752185 4.8453322590160495 1935.0 34.41716583579997 0.0 - - - - - - - 138.84615384615384 3 13 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1119 143 C20140716_OR021_03 C20140716_OR021_03 TB420507.[MT7]-EFVQFVC[CAM]SDGSGQATGQHSQR.4b4_1.heavy 618.039 / 648.347 5747.0 32.98492622375488 36 20 4 6 6 17.67214700181264 5.658622010655692 0.03549957275390625 6 0.9976784007576245 25.608532141939946 5747.0 10.475093983661836 1.0 - - - - - - - 697.8571428571429 17 7 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 1121 143 C20140716_OR021_03 C20140716_OR021_03 TB420507.[MT7]-EFVQFVC[CAM]SDGSGQATGQHSQR.4y7_1.heavy 618.039 / 813.396 1724.0 32.98492622375488 36 20 4 6 6 17.67214700181264 5.658622010655692 0.03549957275390625 6 0.9976784007576245 25.608532141939946 1724.0 0.9704264577893822 2.0 - - - - - - - 174.57142857142858 3 14 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 1123 143 C20140716_OR021_03 C20140716_OR021_03 TB420507.[MT7]-EFVQFVC[CAM]SDGSGQATGQHSQR.4y6_1.heavy 618.039 / 712.349 1724.0 32.98492622375488 36 20 4 6 6 17.67214700181264 5.658622010655692 0.03549957275390625 6 0.9976784007576245 25.608532141939946 1724.0 3.838727634194831 3.0 - - - - - - - 589.2 3 10 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 1125 143 C20140716_OR021_03 C20140716_OR021_03 TB420507.[MT7]-EFVQFVC[CAM]SDGSGQATGQHSQR.4b3_1.heavy 618.039 / 520.289 3448.0 32.98492622375488 36 20 4 6 6 17.67214700181264 5.658622010655692 0.03549957275390625 6 0.9976784007576245 25.608532141939946 3448.0 5.301090909090909 2.0 - - - - - - - 1221.375 19 8 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 1127 144 C20140716_OR021_03 C20140716_OR021_03 TB435809.[MT7]-GALFLK[MT7].2y4_1.heavy 468.81 / 664.451 7267.0 34.3286018371582 48 18 10 10 10 5.567111775594319 17.96263556955877 0.0 3 0.9894732998039466 12.01806452096266 7267.0 79.22670594049106 0.0 - - - - - - - 246.33333333333334 14 9 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1129 144 C20140716_OR021_03 C20140716_OR021_03 TB435809.[MT7]-GALFLK[MT7].2y5_1.heavy 468.81 / 735.489 4431.0 34.3286018371582 48 18 10 10 10 5.567111775594319 17.96263556955877 0.0 3 0.9894732998039466 12.01806452096266 4431.0 16.561200972622913 1.0 - - - - - - - 288.25 26 4 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1131 144 C20140716_OR021_03 C20140716_OR021_03 TB435809.[MT7]-GALFLK[MT7].2b4_1.heavy 468.81 / 533.32 10192.0 34.3286018371582 48 18 10 10 10 5.567111775594319 17.96263556955877 0.0 3 0.9894732998039466 12.01806452096266 10192.0 41.782106315311225 0.0 - - - - - - - 236.55555555555554 20 9 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1133 144 C20140716_OR021_03 C20140716_OR021_03 TB435809.[MT7]-GALFLK[MT7].2y3_1.heavy 468.81 / 551.367 12231.0 34.3286018371582 48 18 10 10 10 5.567111775594319 17.96263556955877 0.0 3 0.9894732998039466 12.01806452096266 12231.0 4.8770252454355845 1.0 - - - - - - - 831.0 34 8 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1135 145 C20140716_OR021_03 C20140716_OR021_03 TB420406.[MT7]-RFETTAVNTLFC[CAM]SK[MT7].3y3_1.heavy 654.683 / 538.278 57951.0 36.81949996948242 43 13 10 10 10 1.1367702037947025 58.715483130503344 0.0 3 0.9258981409401641 4.50535260369117 57951.0 112.9496453315696 0.0 - - - - - - - 658.8181818181819 115 11 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1137 145 C20140716_OR021_03 C20140716_OR021_03 TB420406.[MT7]-RFETTAVNTLFC[CAM]SK[MT7].3b6_1.heavy 654.683 / 850.454 20185.0 36.81949996948242 43 13 10 10 10 1.1367702037947025 58.715483130503344 0.0 3 0.9258981409401641 4.50535260369117 20185.0 35.31132033252966 0.0 - - - - - - - 291.75 40 12 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1139 145 C20140716_OR021_03 C20140716_OR021_03 TB420406.[MT7]-RFETTAVNTLFC[CAM]SK[MT7].3y4_1.heavy 654.683 / 685.346 56730.0 36.81949996948242 43 13 10 10 10 1.1367702037947025 58.715483130503344 0.0 3 0.9258981409401641 4.50535260369117 56730.0 197.44809026395617 0.0 - - - - - - - 295.125 113 8 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1141 145 C20140716_OR021_03 C20140716_OR021_03 TB420406.[MT7]-RFETTAVNTLFC[CAM]SK[MT7].3b7_1.heavy 654.683 / 949.522 17906.0 36.81949996948242 43 13 10 10 10 1.1367702037947025 58.715483130503344 0.0 3 0.9258981409401641 4.50535260369117 17906.0 98.51132412999712 0.0 - - - - - - - 249.85714285714286 35 14 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1143 146 C20140716_OR021_03 C20140716_OR021_03 TB442453.[MT7]-SFC[CAM]FATANVC[CAM]LLPDSLAR.3y6_1.heavy 729.367 / 658.352 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1145 146 C20140716_OR021_03 C20140716_OR021_03 TB442453.[MT7]-SFC[CAM]FATANVC[CAM]LLPDSLAR.3b4_1.heavy 729.367 / 686.309 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1147 146 C20140716_OR021_03 C20140716_OR021_03 TB442453.[MT7]-SFC[CAM]FATANVC[CAM]LLPDSLAR.3b5_1.heavy 729.367 / 757.346 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1149 146 C20140716_OR021_03 C20140716_OR021_03 TB442453.[MT7]-SFC[CAM]FATANVC[CAM]LLPDSLAR.3b3_1.heavy 729.367 / 539.24 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1151 147 C20140716_OR021_03 C20140716_OR021_03 TB420409.[MT7]-LRSPGVLFLQFGEETR.3y7_1.heavy 665.038 / 866.4 12139.0 44.87120056152344 47 17 10 10 10 4.504991471622072 22.197600290682438 0.0 3 0.9771639140546929 8.15120072378383 12139.0 -2.362822384428224 0.0 - - - - - - - 308.5 24 4 SRCIN1 SRC kinase signaling inhibitor 1 1153 147 C20140716_OR021_03 C20140716_OR021_03 TB420409.[MT7]-LRSPGVLFLQFGEETR.3b6_1.heavy 665.038 / 754.469 8127.0 44.87120056152344 47 17 10 10 10 4.504991471622072 22.197600290682438 0.0 3 0.9771639140546929 8.15120072378383 8127.0 -0.5260194174757302 0.0 - - - - - - - 223.0 16 6 SRCIN1 SRC kinase signaling inhibitor 1 1155 147 C20140716_OR021_03 C20140716_OR021_03 TB420409.[MT7]-LRSPGVLFLQFGEETR.3y6_1.heavy 665.038 / 738.342 13476.0 44.87120056152344 47 17 10 10 10 4.504991471622072 22.197600290682438 0.0 3 0.9771639140546929 8.15120072378383 13476.0 -1.7444660194174801 0.0 - - - - - - - 223.16666666666666 26 6 SRCIN1 SRC kinase signaling inhibitor 1 1157 147 C20140716_OR021_03 C20140716_OR021_03 TB420409.[MT7]-LRSPGVLFLQFGEETR.3b7_1.heavy 665.038 / 867.553 10184.0 44.87120056152344 47 17 10 10 10 4.504991471622072 22.197600290682438 0.0 3 0.9771639140546929 8.15120072378383 10184.0 -0.6591585760517802 0.0 - - - - - - - 257.5 20 4 SRCIN1 SRC kinase signaling inhibitor 1 1159 148 C20140716_OR021_03 C20140716_OR021_03 TB435978.[MT7]-K[MT7]C[CAM]EDVARPTQR.2b3_1.heavy 824.446 / 706.38 N/A N/A - - - - - - - - - 0.0 - - - - - - - GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1161 148 C20140716_OR021_03 C20140716_OR021_03 TB435978.[MT7]-K[MT7]C[CAM]EDVARPTQR.2y4_1.heavy 824.446 / 501.278 N/A N/A - - - - - - - - - 0.0 - - - - - - - GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1163 148 C20140716_OR021_03 C20140716_OR021_03 TB435978.[MT7]-K[MT7]C[CAM]EDVARPTQR.2b4_1.heavy 824.446 / 821.407 N/A N/A - - - - - - - - - 0.0 - - - - - - - GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1165 148 C20140716_OR021_03 C20140716_OR021_03 TB435978.[MT7]-K[MT7]C[CAM]EDVARPTQR.2y7_1.heavy 824.446 / 827.485 N/A N/A - - - - - - - - - 0.0 - - - - - - - GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1167 149 C20140716_OR021_03 C20140716_OR021_03 TB435979.[MT7]-LWDFTQSGPIVSR.3y7_1.heavy 550.63 / 715.41 31997.0 42.66379928588867 47 17 10 10 10 2.504019170769932 31.99004613712598 0.0 3 0.9778017551443837 8.267922176145301 31997.0 133.5108423366201 0.0 - - - - - - - 216.125 63 8 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1169 149 C20140716_OR021_03 C20140716_OR021_03 TB435979.[MT7]-LWDFTQSGPIVSR.3y6_1.heavy 550.63 / 628.378 24887.0 42.66379928588867 47 17 10 10 10 2.504019170769932 31.99004613712598 0.0 3 0.9778017551443837 8.267922176145301 24887.0 112.66510840130286 0.0 - - - - - - - 652.8571428571429 49 7 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1171 149 C20140716_OR021_03 C20140716_OR021_03 TB435979.[MT7]-LWDFTQSGPIVSR.3b3_1.heavy 550.63 / 559.3 65823.0 42.66379928588867 47 17 10 10 10 2.504019170769932 31.99004613712598 0.0 3 0.9778017551443837 8.267922176145301 65823.0 134.00492179668214 0.0 - - - - - - - 243.8 131 5 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1173 149 C20140716_OR021_03 C20140716_OR021_03 TB435979.[MT7]-LWDFTQSGPIVSR.3y5_1.heavy 550.63 / 571.356 35654.0 42.66379928588867 47 17 10 10 10 2.504019170769932 31.99004613712598 0.0 3 0.9778017551443837 8.267922176145301 35654.0 145.77506948380386 0.0 - - - - - - - 225.88888888888889 71 9 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1175 150 C20140716_OR021_03 C20140716_OR021_03 TB442444.[MT7]-AVK[MT7]DELLGEK[MT7]PEIK[MT7].4y4_1.heavy 537.08 / 630.394 31927.0 30.96619987487793 47 17 10 10 10 8.115787551179332 12.321663100393586 0.0 3 0.97600169382039 7.950596266193503 31927.0 30.95966491051359 0.0 - - - - - - - 673.0 63 8 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 1177 150 C20140716_OR021_03 C20140716_OR021_03 TB442444.[MT7]-AVK[MT7]DELLGEK[MT7]PEIK[MT7].4b4_1.heavy 537.08 / 702.439 4654.0 30.96619987487793 47 17 10 10 10 8.115787551179332 12.321663100393586 0.0 3 0.97600169382039 7.950596266193503 4654.0 0.31172782388929554 0.0 - - - - - - - 198.66666666666666 9 15 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 1179 150 C20140716_OR021_03 C20140716_OR021_03 TB442444.[MT7]-AVK[MT7]DELLGEK[MT7]PEIK[MT7].4b5_1.heavy 537.08 / 831.481 4945.0 30.96619987487793 47 17 10 10 10 8.115787551179332 12.321663100393586 0.0 3 0.97600169382039 7.950596266193503 4945.0 5.052774694111521 0.0 - - - - - - - 174.4 9 10 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 1181 150 C20140716_OR021_03 C20140716_OR021_03 TB442444.[MT7]-AVK[MT7]DELLGEK[MT7]PEIK[MT7].4b6_1.heavy 537.08 / 944.565 5382.0 30.96619987487793 47 17 10 10 10 8.115787551179332 12.321663100393586 0.0 3 0.97600169382039 7.950596266193503 5382.0 24.67110564645796 0.0 - - - - - - - 195.375 10 16 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 1183 151 C20140716_OR021_03 C20140716_OR021_03 TB442447.[MT7]-ELVEIAVPENLVGAILGK[MT7].3y6_1.heavy 718.099 / 702.463 N/A N/A - - - - - - - - - 0.0 - - - - - - - NOVA2 neuro-oncological ventral antigen 2 1185 151 C20140716_OR021_03 C20140716_OR021_03 TB442447.[MT7]-ELVEIAVPENLVGAILGK[MT7].3b6_1.heavy 718.099 / 799.468 N/A N/A - - - - - - - - - 0.0 - - - - - - - NOVA2 neuro-oncological ventral antigen 2 1187 151 C20140716_OR021_03 C20140716_OR021_03 TB442447.[MT7]-ELVEIAVPENLVGAILGK[MT7].3b4_1.heavy 718.099 / 615.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - NOVA2 neuro-oncological ventral antigen 2 1189 151 C20140716_OR021_03 C20140716_OR021_03 TB442447.[MT7]-ELVEIAVPENLVGAILGK[MT7].3b5_1.heavy 718.099 / 728.431 N/A N/A - - - - - - - - - 0.0 - - - - - - - NOVA2 neuro-oncological ventral antigen 2 1191 152 C20140716_OR021_03 C20140716_OR021_03 TB442446.[MT7]-ELVEIAVPENLVGAILGK[MT7].4b4_1.heavy 538.826 / 615.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - NOVA2 neuro-oncological ventral antigen 2 1193 152 C20140716_OR021_03 C20140716_OR021_03 TB442446.[MT7]-ELVEIAVPENLVGAILGK[MT7].4b5_1.heavy 538.826 / 728.431 N/A N/A - - - - - - - - - 0.0 - - - - - - - NOVA2 neuro-oncological ventral antigen 2 1195 152 C20140716_OR021_03 C20140716_OR021_03 TB442446.[MT7]-ELVEIAVPENLVGAILGK[MT7].4y6_1.heavy 538.826 / 702.463 N/A N/A - - - - - - - - - 0.0 - - - - - - - NOVA2 neuro-oncological ventral antigen 2 1197 152 C20140716_OR021_03 C20140716_OR021_03 TB442446.[MT7]-ELVEIAVPENLVGAILGK[MT7].4b6_1.heavy 538.826 / 799.468 N/A N/A - - - - - - - - - 0.0 - - - - - - - NOVA2 neuro-oncological ventral antigen 2 1199 153 C20140716_OR021_03 C20140716_OR021_03 TB442449.[MT7]-TPELVHLDDSPSFC[CAM]LAGR.3y11_1.heavy 720.029 / 1224.53 5603.0 38.81489944458008 46 16 10 10 10 17.282173087626525 5.786309365897785 0.0 3 0.967920422761406 6.871952736312106 5603.0 30.592549019607844 0.0 - - - - - - - 240.0 11 17 WNT9A wingless-type MMTV integration site family, member 9A 1201 153 C20140716_OR021_03 C20140716_OR021_03 TB442449.[MT7]-TPELVHLDDSPSFC[CAM]LAGR.3b4_1.heavy 720.029 / 585.336 14772.0 38.81489944458008 46 16 10 10 10 17.282173087626525 5.786309365897785 0.0 3 0.967920422761406 6.871952736312106 14772.0 27.550233128834357 0.0 - - - - - - - 672.2 29 10 WNT9A wingless-type MMTV integration site family, member 9A 1203 153 C20140716_OR021_03 C20140716_OR021_03 TB442449.[MT7]-TPELVHLDDSPSFC[CAM]LAGR.3y8_1.heavy 720.029 / 907.445 13652.0 38.81489944458008 46 16 10 10 10 17.282173087626525 5.786309365897785 0.0 3 0.967920422761406 6.871952736312106 13652.0 78.65213954047877 0.0 - - - - - - - 238.0 27 12 WNT9A wingless-type MMTV integration site family, member 9A 1205 153 C20140716_OR021_03 C20140716_OR021_03 TB442449.[MT7]-TPELVHLDDSPSFC[CAM]LAGR.3y9_1.heavy 720.029 / 994.477 14161.0 38.81489944458008 46 16 10 10 10 17.282173087626525 5.786309365897785 0.0 3 0.967920422761406 6.871952736312106 14161.0 44.82142605609547 0.0 - - - - - - - 272.0 28 12 WNT9A wingless-type MMTV integration site family, member 9A 1207 154 C20140716_OR021_03 C20140716_OR021_03 TB420263.[MT7]-LQHAEADREQLR.3y10_2.heavy 537.289 / 612.808 2580.0 20.088000297546387 40 14 10 6 10 3.468894114608085 28.827631140104135 0.03579902648925781 3 0.9426819893503284 5.130034170644335 2580.0 51.53104062722737 0.0 - - - - - - - 115.0 5 8 SKI v-ski sarcoma viral oncogene homolog (avian) 1209 154 C20140716_OR021_03 C20140716_OR021_03 TB420263.[MT7]-LQHAEADREQLR.3y11_2.heavy 537.289 / 676.837 2949.0 20.088000297546387 40 14 10 6 10 3.468894114608085 28.827631140104135 0.03579902648925781 3 0.9426819893503284 5.130034170644335 2949.0 17.981707317073173 0.0 - - - - - - - 168.91666666666666 5 12 SKI v-ski sarcoma viral oncogene homolog (avian) 1211 154 C20140716_OR021_03 C20140716_OR021_03 TB420263.[MT7]-LQHAEADREQLR.3y4_1.heavy 537.289 / 545.304 1106.0 20.088000297546387 40 14 10 6 10 3.468894114608085 28.827631140104135 0.03579902648925781 3 0.9426819893503284 5.130034170644335 1106.0 9.585542446587258 0.0 - - - - - - - 177.05882352941177 2 17 SKI v-ski sarcoma viral oncogene homolog (avian) 1213 154 C20140716_OR021_03 C20140716_OR021_03 TB420263.[MT7]-LQHAEADREQLR.3y5_1.heavy 537.289 / 701.405 307.0 20.088000297546387 40 14 10 6 10 3.468894114608085 28.827631140104135 0.03579902648925781 3 0.9426819893503284 5.130034170644335 307.0 4.329969789861832 16.0 - - - - - - - 0.0 1 0 SKI v-ski sarcoma viral oncogene homolog (avian) 1215 155 C20140716_OR021_03 C20140716_OR021_03 TB420262.[MT7]-INVGGGLSGDHC[CAM]K[MT7].4y6_2.heavy 401.213 / 424.196 4120.0 26.06879997253418 38 16 9 5 8 2.8187825310885013 35.47630897279046 0.048000335693359375 4 0.9647799736814949 6.556688707841652 4120.0 32.439697794355524 1.0 - - - - - - - 212.9090909090909 9 11 C8A complement component 8, alpha polypeptide 1217 155 C20140716_OR021_03 C20140716_OR021_03 TB420262.[MT7]-INVGGGLSGDHC[CAM]K[MT7].4y3_1.heavy 401.213 / 588.304 1592.0 26.06879997253418 38 16 9 5 8 2.8187825310885013 35.47630897279046 0.048000335693359375 4 0.9647799736814949 6.556688707841652 1592.0 3.9675662166200323 0.0 - - - - - - - 260.22222222222223 3 9 C8A complement component 8, alpha polypeptide 1219 155 C20140716_OR021_03 C20140716_OR021_03 TB420262.[MT7]-INVGGGLSGDHC[CAM]K[MT7].4b6_1.heavy 401.213 / 642.369 1030.0 26.06879997253418 38 16 9 5 8 2.8187825310885013 35.47630897279046 0.048000335693359375 4 0.9647799736814949 6.556688707841652 1030.0 10.224612765957447 1.0 - - - - - - - 222.625 5 8 C8A complement component 8, alpha polypeptide 1221 155 C20140716_OR021_03 C20140716_OR021_03 TB420262.[MT7]-INVGGGLSGDHC[CAM]K[MT7].4b3_1.heavy 401.213 / 471.305 3277.0 26.06879997253418 38 16 9 5 8 2.8187825310885013 35.47630897279046 0.048000335693359375 4 0.9647799736814949 6.556688707841652 3277.0 6.193792723157773 0.0 - - - - - - - 270.44444444444446 6 9 C8A complement component 8, alpha polypeptide 1223 156 C20140716_OR021_03 C20140716_OR021_03 TB442195.[MT7]-GIPLESTDGER.2y8_1.heavy 659.342 / 906.416 2934.0 27.788400650024414 47 17 10 10 10 5.319960617303161 18.79713163190536 0.0 3 0.9777394099536181 8.25629283348103 2934.0 37.36179775280899 0.0 - - - - - - - 166.875 5 8 NFIA;NFIB;NFIC;NFIX nuclear factor I/A;nuclear factor I/B;nuclear factor I/C (CCAAT-binding transcription factor);nuclear factor I/X (CCAAT-binding transcription factor) 1225 156 C20140716_OR021_03 C20140716_OR021_03 TB442195.[MT7]-GIPLESTDGER.2y9_1.heavy 659.342 / 1003.47 58058.0 27.788400650024414 47 17 10 10 10 5.319960617303161 18.79713163190536 0.0 3 0.9777394099536181 8.25629283348103 58058.0 312.2283529734174 0.0 - - - - - - - 222.5 116 10 NFIA;NFIB;NFIC;NFIX nuclear factor I/A;nuclear factor I/B;nuclear factor I/C (CCAAT-binding transcription factor);nuclear factor I/X (CCAAT-binding transcription factor) 1227 156 C20140716_OR021_03 C20140716_OR021_03 TB442195.[MT7]-GIPLESTDGER.2y6_1.heavy 659.342 / 664.29 4179.0 27.788400650024414 47 17 10 10 10 5.319960617303161 18.79713163190536 0.0 3 0.9777394099536181 8.25629283348103 4179.0 3.9143459915611807 1.0 - - - - - - - 302.6 8 10 NFIA;NFIB;NFIC;NFIX nuclear factor I/A;nuclear factor I/B;nuclear factor I/C (CCAAT-binding transcription factor);nuclear factor I/X (CCAAT-binding transcription factor) 1229 156 C20140716_OR021_03 C20140716_OR021_03 TB442195.[MT7]-GIPLESTDGER.2y7_1.heavy 659.342 / 793.332 3734.0 27.788400650024414 47 17 10 10 10 5.319960617303161 18.79713163190536 0.0 3 0.9777394099536181 8.25629283348103 3734.0 10.069213483146068 0.0 - - - - - - - 229.91666666666666 7 12 NFIA;NFIB;NFIC;NFIX nuclear factor I/A;nuclear factor I/B;nuclear factor I/C (CCAAT-binding transcription factor);nuclear factor I/X (CCAAT-binding transcription factor) 1231 157 C20140716_OR021_03 C20140716_OR021_03 TB420128.[MT7]-LYPESEEDK[MT7].2y8_1.heavy 699.356 / 1140.52 3266.0 25.61039924621582 43 13 10 10 10 1.9128916331794794 41.83966622049705 0.0 3 0.9242678752000033 4.455973433509557 3266.0 11.469464668094218 0.0 - - - - - - - 287.15384615384613 6 13 PTH1R parathyroid hormone 1 receptor 1233 157 C20140716_OR021_03 C20140716_OR021_03 TB420128.[MT7]-LYPESEEDK[MT7].2y5_1.heavy 699.356 / 751.359 1306.0 25.61039924621582 43 13 10 10 10 1.9128916331794794 41.83966622049705 0.0 3 0.9242678752000033 4.455973433509557 1306.0 12.511481231243028 3.0 - - - - - - - 186.71428571428572 13 7 PTH1R parathyroid hormone 1 receptor 1235 157 C20140716_OR021_03 C20140716_OR021_03 TB420128.[MT7]-LYPESEEDK[MT7].2y3_1.heavy 699.356 / 535.284 1680.0 25.61039924621582 43 13 10 10 10 1.9128916331794794 41.83966622049705 0.0 3 0.9242678752000033 4.455973433509557 1680.0 3.5682012847965736 1.0 - - - - - - - 212.0909090909091 3 11 PTH1R parathyroid hormone 1 receptor 1237 157 C20140716_OR021_03 C20140716_OR021_03 TB420128.[MT7]-LYPESEEDK[MT7].2y7_1.heavy 699.356 / 977.454 12411.0 25.61039924621582 43 13 10 10 10 1.9128916331794794 41.83966622049705 0.0 3 0.9242678752000033 4.455973433509557 12411.0 70.76813704496789 0.0 - - - - - - - 203.72727272727272 24 11 PTH1R parathyroid hormone 1 receptor 1239 158 C20140716_OR021_03 C20140716_OR021_03 TB442193.[MT7]-LAPATSYDGK[MT7].2y8_1.heavy 655.863 / 982.496 110792.0 25.80459976196289 47 17 10 10 10 2.160702816305013 46.281237403581756 0.0 3 0.9742727909269209 7.677688891101427 110792.0 572.8174885364261 0.0 - - - - - - - 223.14285714285714 221 7 FAM160B2 family with sequence similarity 160, member B2 1241 158 C20140716_OR021_03 C20140716_OR021_03 TB442193.[MT7]-LAPATSYDGK[MT7].2b9_2.heavy 655.863 / 510.76 N/A 25.80459976196289 47 17 10 10 10 2.160702816305013 46.281237403581756 0.0 3 0.9742727909269209 7.677688891101427 879.0 6.937230769230769 4.0 - - - - - - - 181.42857142857142 2 7 FAM160B2 family with sequence similarity 160, member B2 1243 158 C20140716_OR021_03 C20140716_OR021_03 TB442193.[MT7]-LAPATSYDGK[MT7].2y5_1.heavy 655.863 / 713.359 10258.0 25.80459976196289 47 17 10 10 10 2.160702816305013 46.281237403581756 0.0 3 0.9742727909269209 7.677688891101427 10258.0 64.4188395904437 0.0 - - - - - - - 225.3846153846154 20 13 FAM160B2 family with sequence similarity 160, member B2 1245 158 C20140716_OR021_03 C20140716_OR021_03 TB442193.[MT7]-LAPATSYDGK[MT7].2y9_1.heavy 655.863 / 1053.53 49241.0 25.80459976196289 47 17 10 10 10 2.160702816305013 46.281237403581756 0.0 3 0.9742727909269209 7.677688891101427 49241.0 152.76628055080369 0.0 - - - - - - - 195.5 98 6 FAM160B2 family with sequence similarity 160, member B2 1247 159 C20140716_OR021_03 C20140716_OR021_03 TB442113.[MT7]-LTMGMLK[MT7].2y4_1.heavy 541.321 / 592.361 3959.0 36.67250061035156 45 20 10 5 10 16.039523822253503 6.234599050955511 0.04180145263671875 3 0.9992499161839313 45.05887268233868 3959.0 12.611460060475878 0.0 - - - - - - - 239.25 7 12 SRCIN1 SRC kinase signaling inhibitor 1 1249 159 C20140716_OR021_03 C20140716_OR021_03 TB442113.[MT7]-LTMGMLK[MT7].2y5_1.heavy 541.321 / 723.401 2375.0 36.67250061035156 45 20 10 5 10 16.039523822253503 6.234599050955511 0.04180145263671875 3 0.9992499161839313 45.05887268233868 2375.0 26.454004329004327 0.0 - - - - - - - 165.0 4 6 SRCIN1 SRC kinase signaling inhibitor 1 1251 159 C20140716_OR021_03 C20140716_OR021_03 TB442113.[MT7]-LTMGMLK[MT7].2b4_1.heavy 541.321 / 547.303 2078.0 36.67250061035156 45 20 10 5 10 16.039523822253503 6.234599050955511 0.04180145263671875 3 0.9992499161839313 45.05887268233868 2078.0 14.393073593073593 2.0 - - - - - - - 257.4 7 10 SRCIN1 SRC kinase signaling inhibitor 1 1253 159 C20140716_OR021_03 C20140716_OR021_03 TB442113.[MT7]-LTMGMLK[MT7].2y6_1.heavy 541.321 / 824.449 4058.0 36.67250061035156 45 20 10 5 10 16.039523822253503 6.234599050955511 0.04180145263671875 3 0.9992499161839313 45.05887268233868 4058.0 13.6312223773145 1.0 - - - - - - - 264.0 8 12 SRCIN1 SRC kinase signaling inhibitor 1 1255 160 C20140716_OR021_03 C20140716_OR021_03 TB420125.[MT7]-AEELAQMWK[MT7].3y3_1.heavy 465.251 / 608.335 9647.0 38.2681999206543 50 20 10 10 10 4.920670294443873 20.322434549803923 0.0 3 0.993182533603667 14.938391100796638 9647.0 35.168636298932384 0.0 - - - - - - - 152.375 19 8 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1257 160 C20140716_OR021_03 C20140716_OR021_03 TB420125.[MT7]-AEELAQMWK[MT7].3b4_1.heavy 465.251 / 587.316 14518.0 38.2681999206543 50 20 10 10 10 4.920670294443873 20.322434549803923 0.0 3 0.993182533603667 14.938391100796638 14518.0 67.08085311604896 0.0 - - - - - - - 201.69230769230768 29 13 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1259 160 C20140716_OR021_03 C20140716_OR021_03 TB420125.[MT7]-AEELAQMWK[MT7].3b5_1.heavy 465.251 / 658.353 6650.0 38.2681999206543 50 20 10 10 10 4.920670294443873 20.322434549803923 0.0 3 0.993182533603667 14.938391100796638 6650.0 5.183760683760684 1.0 - - - - - - - 234.33333333333334 13 12 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1261 160 C20140716_OR021_03 C20140716_OR021_03 TB420125.[MT7]-AEELAQMWK[MT7].3b3_1.heavy 465.251 / 474.232 22573.0 38.2681999206543 50 20 10 10 10 4.920670294443873 20.322434549803923 0.0 3 0.993182533603667 14.938391100796638 22573.0 130.9394661921708 0.0 - - - - - - - 187.5 45 8 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1263 161 C20140716_OR021_03 C20140716_OR021_03 ENO_ECO24.IQLVGDDLFVTNTK.2y8.peptide 781.92 / 937.5 252946.0 41.76100158691406 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 252946.0 681.9752941328603 0.0 - - - - - - - 286.15384615384613 505 13 1265 161 C20140716_OR021_03 C20140716_OR021_03 ENO_ECO24.IQLVGDDLFVTNTK.2y6.peptide 781.92 / 709.39 338433.0 41.76100158691406 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 338433.0 640.8513328243083 0.0 - - - - - - - 249.75 676 12 1267 161 C20140716_OR021_03 C20140716_OR021_03 ENO_ECO24.IQLVGDDLFVTNTK.2y5.peptide 781.92 / 562.32 523541.0 41.76100158691406 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 523541.0 592.43193715955 0.0 - - - - - - - 335.625 1047 8 1269 162 C20140716_OR021_03 C20140716_OR021_03 TB420518.[MT7]-TVLMIAIQLLSRMEYVHSK[MT7].4b4_1.heavy 630.863 / 589.35 N/A N/A - - - - - - - - - 0.0 - - - - - - - CSNK1G1 casein kinase 1, gamma 1 1271 162 C20140716_OR021_03 C20140716_OR021_03 TB420518.[MT7]-TVLMIAIQLLSRMEYVHSK[MT7].4b5_1.heavy 630.863 / 702.434 N/A N/A - - - - - - - - - 0.0 - - - - - - - CSNK1G1 casein kinase 1, gamma 1 1273 162 C20140716_OR021_03 C20140716_OR021_03 TB420518.[MT7]-TVLMIAIQLLSRMEYVHSK[MT7].4y3_1.heavy 630.863 / 515.306 N/A N/A - - - - - - - - - 0.0 - - - - - - - CSNK1G1 casein kinase 1, gamma 1 1275 162 C20140716_OR021_03 C20140716_OR021_03 TB420518.[MT7]-TVLMIAIQLLSRMEYVHSK[MT7].4b6_1.heavy 630.863 / 773.471 N/A N/A - - - - - - - - - 0.0 - - - - - - - CSNK1G1 casein kinase 1, gamma 1 1277 163 C20140716_OR021_03 C20140716_OR021_03 RBSB_ECOLI.LAATIAQLPDQIGAK.3y7.peptide 503.96 / 728.39 127826.0 36.527000427246094 25 -3 10 10 8 null 0.0 0.0 4 0.0 0.0 127826.0 460.17206044810825 0.0 - - - - - - - 219.7 255 10 1279 163 C20140716_OR021_03 C20140716_OR021_03 RBSB_ECOLI.LAATIAQLPDQIGAK.3y6.peptide 503.96 / 631.34 31133.0 36.527000427246094 25 -3 10 10 8 null 0.0 0.0 4 0.0 0.0 31133.0 223.7284483709273 1.0 - - - - - - - 237.125 96 16 1281 163 C20140716_OR021_03 C20140716_OR021_03 RBSB_ECOLI.LAATIAQLPDQIGAK.3y5.peptide 503.96 / 516.31 26543.0 36.527000427246094 25 -3 10 10 8 null 0.0 0.0 4 0.0 0.0 26543.0 106.84678909293265 0.0 - - - - - - - 286.1333333333333 53 15 1283 164 C20140716_OR021_03 C20140716_OR021_03 TB435945.[MT7]-IDETSEQEQK[MT7].3y3_1.heavy 498.922 / 548.316 2034.0 19.609800338745117 41 13 10 10 8 1.5089650931959246 54.44042328634536 0.0 4 0.9053268867790043 3.978887268991712 2034.0 4.12994923857868 0.0 - - - - - - - 257.3076923076923 4 13 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1285 164 C20140716_OR021_03 C20140716_OR021_03 TB435945.[MT7]-IDETSEQEQK[MT7].3b4_1.heavy 498.922 / 603.311 1443.0 19.609800338745117 41 13 10 10 8 1.5089650931959246 54.44042328634536 0.0 4 0.9053268867790043 3.978887268991712 1443.0 7.996399588600246 0.0 - - - - - - - 210.68421052631578 2 19 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1287 164 C20140716_OR021_03 C20140716_OR021_03 TB435945.[MT7]-IDETSEQEQK[MT7].3b5_1.heavy 498.922 / 690.343 525.0 19.609800338745117 41 13 10 10 8 1.5089650931959246 54.44042328634536 0.0 4 0.9053268867790043 3.978887268991712 525.0 3.8923254302339982 2.0 - - - - - - - 173.42857142857142 2 14 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1289 164 C20140716_OR021_03 C20140716_OR021_03 TB435945.[MT7]-IDETSEQEQK[MT7].3b3_1.heavy 498.922 / 502.263 1443.0 19.609800338745117 41 13 10 10 8 1.5089650931959246 54.44042328634536 0.0 4 0.9053268867790043 3.978887268991712 1443.0 11.842250939667533 1.0 - - - - - - - 201.64285714285714 3 14 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1291 165 C20140716_OR021_03 C20140716_OR021_03 TB435946.[MT7]-AAEVWMDDFK[MT7].2y5_1.heavy 750.376 / 799.378 19555.0 41.11370086669922 45 15 10 10 10 3.0705579886188263 32.56737061167869 0.0 3 0.9561212271357866 5.869946943245763 19555.0 48.54467040673212 1.0 - - - - - - - 640.1428571428571 39 7 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1293 165 C20140716_OR021_03 C20140716_OR021_03 TB435946.[MT7]-AAEVWMDDFK[MT7].2b4_1.heavy 750.376 / 515.295 67525.0 41.11370086669922 45 15 10 10 10 3.0705579886188263 32.56737061167869 0.0 3 0.9561212271357866 5.869946943245763 67525.0 124.57339722671273 0.0 - - - - - - - 698.4285714285714 135 7 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1295 165 C20140716_OR021_03 C20140716_OR021_03 TB435946.[MT7]-AAEVWMDDFK[MT7].2y3_1.heavy 750.376 / 553.31 24545.0 41.11370086669922 45 15 10 10 10 3.0705579886188263 32.56737061167869 0.0 3 0.9561212271357866 5.869946943245763 24545.0 81.31399767964652 0.0 - - - - - - - 291.2857142857143 49 7 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1297 165 C20140716_OR021_03 C20140716_OR021_03 TB435946.[MT7]-AAEVWMDDFK[MT7].2y6_1.heavy 750.376 / 985.457 56525.0 41.11370086669922 45 15 10 10 10 3.0705579886188263 32.56737061167869 0.0 3 0.9561212271357866 5.869946943245763 56525.0 147.679654801914 0.0 - - - - - - - 713.0 113 7 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1299 166 C20140716_OR021_03 C20140716_OR021_03 TB442441.[MT7]-ETLSVPTVEHIIQELK[MT7].4y4_1.heavy 531.809 / 661.4 715.0 49.575199127197266 41 17 10 6 8 4.030285916458558 24.812135434766063 0.037200927734375 4 0.9768019986018123 8.08712074330952 715.0 0.6285714285714286 1.0 - - - - - - - 247.8125 2 16 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1301 166 C20140716_OR021_03 C20140716_OR021_03 TB442441.[MT7]-ETLSVPTVEHIIQELK[MT7].4y5_1.heavy 531.809 / 774.484 2274.0 49.575199127197266 41 17 10 6 8 4.030285916458558 24.812135434766063 0.037200927734375 4 0.9768019986018123 8.08712074330952 2274.0 37.398553846153845 0.0 - - - - - - - 223.88888888888889 4 9 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1303 166 C20140716_OR021_03 C20140716_OR021_03 TB442441.[MT7]-ETLSVPTVEHIIQELK[MT7].4b4_1.heavy 531.809 / 575.316 1754.0 49.575199127197266 41 17 10 6 8 4.030285916458558 24.812135434766063 0.037200927734375 4 0.9768019986018123 8.08712074330952 1754.0 0.45003207184092364 2.0 - - - - - - - 240.5 5 10 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1305 166 C20140716_OR021_03 C20140716_OR021_03 TB442441.[MT7]-ETLSVPTVEHIIQELK[MT7].4y6_1.heavy 531.809 / 887.568 455.0 49.575199127197266 41 17 10 6 8 4.030285916458558 24.812135434766063 0.037200927734375 4 0.9768019986018123 8.08712074330952 455.0 1.6333333333333333 2.0 - - - - - - - 0.0 0 0 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1307 167 C20140716_OR021_03 C20140716_OR021_03 TB442437.[MT7]-C[CAM]GYFFLDDTDPDSMK[MT7].3y3_1.heavy 700.316 / 509.287 1471.0 42.796624183654785 35 18 6 5 6 5.491126302636193 18.211200123368453 0.040500640869140625 6 0.9886293360908567 11.562642009237347 1471.0 0.8266563944530045 9.0 - - - - - - - 259.8888888888889 6 9 ATXN7L3 ataxin 7-like 3 1309 167 C20140716_OR021_03 C20140716_OR021_03 TB442437.[MT7]-C[CAM]GYFFLDDTDPDSMK[MT7].3b4_1.heavy 700.316 / 672.293 2249.0 42.796624183654785 35 18 6 5 6 5.491126302636193 18.211200123368453 0.040500640869140625 6 0.9886293360908567 11.562642009237347 2249.0 0.4333333333333332 3.0 - - - - - - - 800.3333333333334 4 12 ATXN7L3 ataxin 7-like 3 1311 167 C20140716_OR021_03 C20140716_OR021_03 TB442437.[MT7]-C[CAM]GYFFLDDTDPDSMK[MT7].3b3_1.heavy 700.316 / 525.225 1384.0 42.796624183654785 35 18 6 5 6 5.491126302636193 18.211200123368453 0.040500640869140625 6 0.9886293360908567 11.562642009237347 1384.0 0.9945883127240167 12.0 - - - - - - - 311.6666666666667 3 15 ATXN7L3 ataxin 7-like 3 1313 167 C20140716_OR021_03 C20140716_OR021_03 TB442437.[MT7]-C[CAM]GYFFLDDTDPDSMK[MT7].3y5_1.heavy 700.316 / 721.367 1557.0 42.796624183654785 35 18 6 5 6 5.491126302636193 18.211200123368453 0.040500640869140625 6 0.9886293360908567 11.562642009237347 1557.0 0.9813025210084033 2.0 - - - - - - - 648.9166666666666 3 12 ATXN7L3 ataxin 7-like 3 1315 168 C20140716_OR021_03 C20140716_OR021_03 TB442123.[MT7]-AVSAIVQK[MT7].2y3_1.heavy 552.355 / 518.342 14297.0 26.606799125671387 41 16 10 5 10 2.1791143196810934 37.35923683602807 0.04500007629394531 3 0.9646643920124168 6.545892685923059 14297.0 28.726243257223082 0.0 - - - - - - - 357.55555555555554 28 9 NOVA2 neuro-oncological ventral antigen 2 1317 168 C20140716_OR021_03 C20140716_OR021_03 TB442123.[MT7]-AVSAIVQK[MT7].2y6_1.heavy 552.355 / 789.495 10036.0 26.606799125671387 41 16 10 5 10 2.1791143196810934 37.35923683602807 0.04500007629394531 3 0.9646643920124168 6.545892685923059 10036.0 47.54750345208506 0.0 - - - - - - - 270.2857142857143 20 7 NOVA2 neuro-oncological ventral antigen 2 1319 168 C20140716_OR021_03 C20140716_OR021_03 TB442123.[MT7]-AVSAIVQK[MT7].2b5_1.heavy 552.355 / 586.368 12309.0 26.606799125671387 41 16 10 5 10 2.1791143196810934 37.35923683602807 0.04500007629394531 3 0.9646643920124168 6.545892685923059 12309.0 32.32300326212775 0.0 - - - - - - - 223.07142857142858 24 14 NOVA2 neuro-oncological ventral antigen 2 1321 168 C20140716_OR021_03 C20140716_OR021_03 TB442123.[MT7]-AVSAIVQK[MT7].2y7_1.heavy 552.355 / 888.563 6344.0 26.606799125671387 41 16 10 5 10 2.1791143196810934 37.35923683602807 0.04500007629394531 3 0.9646643920124168 6.545892685923059 6344.0 37.90509940911963 1.0 - - - - - - - 243.71428571428572 21 7 NOVA2 neuro-oncological ventral antigen 2 1323 169 C20140716_OR021_03 C20140716_OR021_03 TB420113.[MT7]-LVAC[CAM]GSIWQGIC[CAM]QFLR.3y7_1.heavy 684.693 / 893.466 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLXNA3 plexin A3 1325 169 C20140716_OR021_03 C20140716_OR021_03 TB420113.[MT7]-LVAC[CAM]GSIWQGIC[CAM]QFLR.3b6_1.heavy 684.693 / 732.383 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLXNA3 plexin A3 1327 169 C20140716_OR021_03 C20140716_OR021_03 TB420113.[MT7]-LVAC[CAM]GSIWQGIC[CAM]QFLR.3y5_1.heavy 684.693 / 723.361 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLXNA3 plexin A3 1329 169 C20140716_OR021_03 C20140716_OR021_03 TB420113.[MT7]-LVAC[CAM]GSIWQGIC[CAM]QFLR.3y9_1.heavy 684.693 / 1207.6 N/A N/A - - - - - - - - - 0.0 - - - - - - - PLXNA3 plexin A3 1331 170 C20140716_OR021_03 C20140716_OR021_03 TB420521.[MT7]-VQPQDLIQWAADY[MT7]FEALSR.4b4_1.heavy 635.336 / 597.348 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1 ropporin, rhophilin associated protein 1 1333 170 C20140716_OR021_03 C20140716_OR021_03 TB420521.[MT7]-VQPQDLIQWAADY[MT7]FEALSR.4b14_2.heavy 635.336 / 982.511 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1 ropporin, rhophilin associated protein 1 1335 170 C20140716_OR021_03 C20140716_OR021_03 TB420521.[MT7]-VQPQDLIQWAADY[MT7]FEALSR.4b5_1.heavy 635.336 / 712.375 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1 ropporin, rhophilin associated protein 1 1337 170 C20140716_OR021_03 C20140716_OR021_03 TB420521.[MT7]-VQPQDLIQWAADY[MT7]FEALSR.4b6_1.heavy 635.336 / 825.459 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1 ropporin, rhophilin associated protein 1 1339 171 C20140716_OR021_03 C20140716_OR021_03 TB420522.[MT7]-VQPQDLIQWAADY[MT7]FEALSR.3b6_1.heavy 846.779 / 825.459 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1 ropporin, rhophilin associated protein 1 1341 171 C20140716_OR021_03 C20140716_OR021_03 TB420522.[MT7]-VQPQDLIQWAADY[MT7]FEALSR.3b5_1.heavy 846.779 / 712.375 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1 ropporin, rhophilin associated protein 1 1343 171 C20140716_OR021_03 C20140716_OR021_03 TB420522.[MT7]-VQPQDLIQWAADY[MT7]FEALSR.3b8_1.heavy 846.779 / 1066.6 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1 ropporin, rhophilin associated protein 1 1345 171 C20140716_OR021_03 C20140716_OR021_03 TB420522.[MT7]-VQPQDLIQWAADY[MT7]FEALSR.3y9_1.heavy 846.779 / 1215.61 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1 ropporin, rhophilin associated protein 1 1347 172 C20140716_OR021_03 C20140716_OR021_03 TB435954.[MT7]-TLVEYQELTGAR.2y8_1.heavy 762.413 / 937.474 19197.0 35.77830123901367 44 14 10 10 10 2.685208020082755 37.24106261120065 0.0 3 0.9443885809736186 5.208910516254278 19197.0 61.457738851802404 0.0 - - - - - - - 243.6 38 10 NOVA1;NOVA2 neuro-oncological ventral antigen 1;neuro-oncological ventral antigen 2 1349 172 C20140716_OR021_03 C20140716_OR021_03 TB435954.[MT7]-TLVEYQELTGAR.2y5_1.heavy 762.413 / 517.309 4776.0 35.77830123901367 44 14 10 10 10 2.685208020082755 37.24106261120065 0.0 3 0.9443885809736186 5.208910516254278 4776.0 9.49121165367706 0.0 - - - - - - - 340.6363636363636 9 11 NOVA1;NOVA2 neuro-oncological ventral antigen 1;neuro-oncological ventral antigen 2 1351 172 C20140716_OR021_03 C20140716_OR021_03 TB435954.[MT7]-TLVEYQELTGAR.2y9_1.heavy 762.413 / 1066.52 35772.0 35.77830123901367 44 14 10 10 10 2.685208020082755 37.24106261120065 0.0 3 0.9443885809736186 5.208910516254278 35772.0 168.03928825622776 0.0 - - - - - - - 226.33333333333334 71 12 NOVA1;NOVA2 neuro-oncological ventral antigen 1;neuro-oncological ventral antigen 2 1353 172 C20140716_OR021_03 C20140716_OR021_03 TB435954.[MT7]-TLVEYQELTGAR.2y10_1.heavy 762.413 / 1165.58 12455.0 35.77830123901367 44 14 10 10 10 2.685208020082755 37.24106261120065 0.0 3 0.9443885809736186 5.208910516254278 12455.0 47.84759804183355 0.0 - - - - - - - 257.75 24 12 NOVA1;NOVA2 neuro-oncological ventral antigen 1;neuro-oncological ventral antigen 2 1355 173 C20140716_OR021_03 C20140716_OR021_03 TB420241.[MT7]-SLFEILILMGK[MT7].2y4_1.heavy 776.475 / 592.361 725.0 51.3314266204834 25 18 2 3 2 4.785167283411998 20.897910998149342 0.0718994140625 12 0.9881742508017419 11.337547473564666 725.0 1.5425531914893618 7.0 - - - - - - - 191.94117647058823 3 17 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1357 173 C20140716_OR021_03 C20140716_OR021_03 TB420241.[MT7]-SLFEILILMGK[MT7].2b4_1.heavy 776.475 / 621.336 1088.0 51.3314266204834 25 18 2 3 2 4.785167283411998 20.897910998149342 0.0718994140625 12 0.9881742508017419 11.337547473564666 1088.0 0.9002364066193853 3.0 - - - - - - - 191.33333333333334 2 18 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1359 173 C20140716_OR021_03 C20140716_OR021_03 TB420241.[MT7]-SLFEILILMGK[MT7].2y6_1.heavy 776.475 / 818.529 544.0 51.3314266204834 25 18 2 3 2 4.785167283411998 20.897910998149342 0.0718994140625 12 0.9881742508017419 11.337547473564666 544.0 2.1130578512396694 12.0 - - - - - - - 768.5714285714286 5 7 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1361 173 C20140716_OR021_03 C20140716_OR021_03 TB420241.[MT7]-SLFEILILMGK[MT7].2b5_1.heavy 776.475 / 734.42 544.0 51.3314266204834 25 18 2 3 2 4.785167283411998 20.897910998149342 0.0718994140625 12 0.9881742508017419 11.337547473564666 544.0 1.5249236533521835 15.0 - - - - - - - 230.33333333333334 5 21 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1363 174 C20140716_OR021_03 C20140716_OR021_03 TB420048.[MT7]-C[CAM]NDDALASK[MT7].2b3_1.heavy 641.321 / 534.21 5310.0 20.817500591278076 25 13 0 6 6 1.4665890062188962 54.490448828685786 0.03560066223144531 5 0.9081572392229299 4.040718317444971 5310.0 13.693242853893395 0.0 - - - - - - - 232.6315789473684 10 19 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1365 174 C20140716_OR021_03 C20140716_OR021_03 TB420048.[MT7]-C[CAM]NDDALASK[MT7].2y5_1.heavy 641.321 / 633.405 3132.0 20.817500591278076 25 13 0 6 6 1.4665890062188962 54.490448828685786 0.03560066223144531 5 0.9081572392229299 4.040718317444971 3132.0 16.350882352941177 5.0 - - - - - - - 215.33333333333334 208 6 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1367 174 C20140716_OR021_03 C20140716_OR021_03 TB420048.[MT7]-C[CAM]NDDALASK[MT7].2b4_1.heavy 641.321 / 649.237 3404.0 20.817500591278076 25 13 0 6 6 1.4665890062188962 54.490448828685786 0.03560066223144531 5 0.9081572392229299 4.040718317444971 3404.0 15.61111172770995 0.0 - - - - - - - 188.94444444444446 6 18 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1369 174 C20140716_OR021_03 C20140716_OR021_03 TB420048.[MT7]-C[CAM]NDDALASK[MT7].2b5_1.heavy 641.321 / 720.274 1362.0 20.817500591278076 25 13 0 6 6 1.4665890062188962 54.490448828685786 0.03560066223144531 5 0.9081572392229299 4.040718317444971 1362.0 3.990765815760266 0.0 - - - - - - - 172.26666666666668 2 15 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1371 175 C20140716_OR021_03 C20140716_OR021_03 TB420049.[MT7]-WTLALDFK[MT7].3y3_1.heavy 427.92 / 553.31 2945.0 45.200674057006836 38 12 10 6 10 0.920179817059873 66.53424401665897 0.03910064697265625 3 0.889047658654732 3.6702391421832643 2945.0 43.36543079300686 0.0 - - - - - - - 254.0 5 2 PTH1R parathyroid hormone 1 receptor 1373 175 C20140716_OR021_03 C20140716_OR021_03 TB420049.[MT7]-WTLALDFK[MT7].3b4_1.heavy 427.92 / 616.357 1523.0 45.200674057006836 38 12 10 6 10 0.920179817059873 66.53424401665897 0.03910064697265625 3 0.889047658654732 3.6702391421832643 1523.0 0.0 1.0 - - - - - - - 237.0 3 3 PTH1R parathyroid hormone 1 receptor 1375 175 C20140716_OR021_03 C20140716_OR021_03 TB420049.[MT7]-WTLALDFK[MT7].3y4_1.heavy 427.92 / 666.394 203.0 45.200674057006836 38 12 10 6 10 0.920179817059873 66.53424401665897 0.03910064697265625 3 0.889047658654732 3.6702391421832643 203.0 0.7960784313725491 3.0 - - - - - - - 0.0 0 0 PTH1R parathyroid hormone 1 receptor 1377 175 C20140716_OR021_03 C20140716_OR021_03 TB420049.[MT7]-WTLALDFK[MT7].3b3_1.heavy 427.92 / 545.32 812.0 45.200674057006836 38 12 10 6 10 0.920179817059873 66.53424401665897 0.03910064697265625 3 0.889047658654732 3.6702391421832643 812.0 -0.7960784313725489 0.0 - - - - - - - 0.0 1 0 PTH1R parathyroid hormone 1 receptor 1379 176 C20140716_OR021_03 C20140716_OR021_03 TB442423.[MT7]-VVNLPTDLFNSVMNVGR.3b4_1.heavy 673.699 / 570.373 42959.0 52.588300704956055 46 20 10 6 10 6.89507487913763 14.503105731682355 0.034198760986328125 3 0.9921208601078597 13.894323161385495 42959.0 179.28386524822693 0.0 - - - - - - - 232.0 85 18 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1381 176 C20140716_OR021_03 C20140716_OR021_03 TB442423.[MT7]-VVNLPTDLFNSVMNVGR.3y8_1.heavy 673.699 / 876.436 19075.0 52.588300704956055 46 20 10 6 10 6.89507487913763 14.503105731682355 0.034198760986328125 3 0.9921208601078597 13.894323161385495 19075.0 209.47758317957263 0.0 - - - - - - - 171.875 38 16 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1383 176 C20140716_OR021_03 C20140716_OR021_03 TB442423.[MT7]-VVNLPTDLFNSVMNVGR.3b7_1.heavy 673.699 / 883.5 12999.0 52.588300704956055 46 20 10 6 10 6.89507487913763 14.503105731682355 0.034198760986328125 3 0.9921208601078597 13.894323161385495 12999.0 169.4996136993651 0.0 - - - - - - - 158.72727272727272 25 11 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1385 176 C20140716_OR021_03 C20140716_OR021_03 TB442423.[MT7]-VVNLPTDLFNSVMNVGR.3y5_1.heavy 673.699 / 576.292 22563.0 52.588300704956055 46 20 10 6 10 6.89507487913763 14.503105731682355 0.034198760986328125 3 0.9921208601078597 13.894323161385495 22563.0 122.42384858044164 0.0 - - - - - - - 220.76470588235293 45 17 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1387 177 C20140716_OR021_03 C20140716_OR021_03 TB436085.[MT7]-IAPGLALLLC[CAM]C[CAM]PVLSSAY[MT7]ALVDADDVMTK[MT7].4b8_1.heavy 877.976 / 893.594 N/A N/A - - - - - - - - - 0.0 - - - - - - - PTH1R parathyroid hormone 1 receptor 1389 177 C20140716_OR021_03 C20140716_OR021_03 TB436085.[MT7]-IAPGLALLLC[CAM]C[CAM]PVLSSAY[MT7]ALVDADDVMTK[MT7].4b7_1.heavy 877.976 / 780.51 N/A N/A - - - - - - - - - 0.0 - - - - - - - PTH1R parathyroid hormone 1 receptor 1391 177 C20140716_OR021_03 C20140716_OR021_03 TB436085.[MT7]-IAPGLALLLC[CAM]C[CAM]PVLSSAY[MT7]ALVDADDVMTK[MT7].4b5_1.heavy 877.976 / 596.389 N/A N/A - - - - - - - - - 0.0 - - - - - - - PTH1R parathyroid hormone 1 receptor 1393 177 C20140716_OR021_03 C20140716_OR021_03 TB436085.[MT7]-IAPGLALLLC[CAM]C[CAM]PVLSSAY[MT7]ALVDADDVMTK[MT7].4b6_1.heavy 877.976 / 667.426 N/A N/A - - - - - - - - - 0.0 - - - - - - - PTH1R parathyroid hormone 1 receptor 1395 178 C20140716_OR021_03 C20140716_OR021_03 TB420538.[MT7]-DFEIVDQPGLDIFGQVFNQWK[MT7].4y5_1.heavy 696.613 / 866.464 N/A N/A - - - - - - - - - 0.0 - - - - - - - ATXN7L3 ataxin 7-like 3 1397 178 C20140716_OR021_03 C20140716_OR021_03 TB420538.[MT7]-DFEIVDQPGLDIFGQVFNQWK[MT7].4b5_1.heavy 696.613 / 748.4 N/A N/A - - - - - - - - - 0.0 - - - - - - - ATXN7L3 ataxin 7-like 3 1399 178 C20140716_OR021_03 C20140716_OR021_03 TB420538.[MT7]-DFEIVDQPGLDIFGQVFNQWK[MT7].4b6_1.heavy 696.613 / 863.427 N/A N/A - - - - - - - - - 0.0 - - - - - - - ATXN7L3 ataxin 7-like 3 1401 178 C20140716_OR021_03 C20140716_OR021_03 TB420538.[MT7]-DFEIVDQPGLDIFGQVFNQWK[MT7].4b3_1.heavy 696.613 / 536.247 N/A N/A - - - - - - - - - 0.0 - - - - - - - ATXN7L3 ataxin 7-like 3 1403 179 C20140716_OR021_03 C20140716_OR021_03 TB420535.[MT7]-RNTPIEALC[CAM]ENFPEEMATYLR.4y5_1.heavy 675.333 / 623.351 1053.0 46.19039821624756 27 16 4 6 1 2.3006643725081215 34.51124385504297 0.036800384521484375 19 0.9681064508129832 6.892073003201622 1053.0 6.093580139372822 19.0 - - - - - - - 278.27272727272725 4 11 CSNK1G1 casein kinase 1, gamma 1 1405 179 C20140716_OR021_03 C20140716_OR021_03 TB420535.[MT7]-RNTPIEALC[CAM]ENFPEEMATYLR.4y9_1.heavy 675.333 / 1109.53 1436.0 46.19039821624756 27 16 4 6 1 2.3006643725081215 34.51124385504297 0.036800384521484375 19 0.9681064508129832 6.892073003201622 1436.0 12.975375218150088 1.0 - - - - - - - 206.30769230769232 2 13 CSNK1G1 casein kinase 1, gamma 1 1407 179 C20140716_OR021_03 C20140716_OR021_03 TB420535.[MT7]-RNTPIEALC[CAM]ENFPEEMATYLR.4y7_1.heavy 675.333 / 883.434 479.0 46.19039821624756 27 16 4 6 1 2.3006643725081215 34.51124385504297 0.036800384521484375 19 0.9681064508129832 6.892073003201622 479.0 1.0031413612565445 24.0 - - - - - - - 215.25 3 8 CSNK1G1 casein kinase 1, gamma 1 1409 179 C20140716_OR021_03 C20140716_OR021_03 TB420535.[MT7]-RNTPIEALC[CAM]ENFPEEMATYLR.4b6_1.heavy 675.333 / 855.481 862.0 46.19039821624756 27 16 4 6 1 2.3006643725081215 34.51124385504297 0.036800384521484375 19 0.9681064508129832 6.892073003201622 862.0 0.8106583072100314 16.0 - - - - - - - 308.44444444444446 4 9 CSNK1G1 casein kinase 1, gamma 1 1411 180 C20140716_OR021_03 C20140716_OR021_03 TB420534.[MT7]-Y[MT7]SADGLLQLGPLGSTAFLPDSK[MT7].4y4_1.heavy 671.373 / 590.327 29959.0 45.40652561187744 44 18 10 6 10 4.868603529581689 20.539770673951757 0.035900115966796875 3 0.9800771268494507 8.728964030311912 29959.0 12.03975587187147 1.0 - - - - - - - 307.0 59 1 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1413 180 C20140716_OR021_03 C20140716_OR021_03 TB420534.[MT7]-Y[MT7]SADGLLQLGPLGSTAFLPDSK[MT7].4b8_2.heavy 671.373 / 568.813 11861.0 45.40652561187744 44 18 10 6 10 4.868603529581689 20.539770673951757 0.035900115966796875 3 0.9800771268494507 8.728964030311912 11861.0 11.541107692307692 0.0 - - - - - - - 204.0 23 1 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1415 180 C20140716_OR021_03 C20140716_OR021_03 TB420534.[MT7]-Y[MT7]SADGLLQLGPLGSTAFLPDSK[MT7].4b4_1.heavy 671.373 / 725.371 3885.0 45.40652561187744 44 18 10 6 10 4.868603529581689 20.539770673951757 0.035900115966796875 3 0.9800771268494507 8.728964030311912 3885.0 10.423478363179466 1.0 - - - - - - - 178.75 16 4 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1417 180 C20140716_OR021_03 C20140716_OR021_03 TB420534.[MT7]-Y[MT7]SADGLLQLGPLGSTAFLPDSK[MT7].4b10_2.heavy 671.373 / 653.866 14724.0 45.40652561187744 44 18 10 6 10 4.868603529581689 20.539770673951757 0.035900115966796875 3 0.9800771268494507 8.728964030311912 14724.0 2.716121574660301 0.0 - - - - - - - 307.0 29 1 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1419 181 C20140716_OR021_03 C20140716_OR021_03 TB420533.[MT7]-GLLVPELYSSPSAAC[CAM]IQC[CAM]LDC[CAM]R.3y6_1.heavy 885.102 / 851.35 5373.0 44.3484992980957 50 20 10 10 10 10.60287570389714 9.43140359206932 0.0 3 0.994530505330918 16.67979165671725 5373.0 14.045601659751037 0.0 - - - - - - - 223.83333333333334 10 12 SKI v-ski sarcoma viral oncogene homolog (avian) 1421 181 C20140716_OR021_03 C20140716_OR021_03 TB420533.[MT7]-GLLVPELYSSPSAAC[CAM]IQC[CAM]LDC[CAM]R.3b6_1.heavy 885.102 / 753.463 10022.0 44.3484992980957 50 20 10 10 10 10.60287570389714 9.43140359206932 0.0 3 0.994530505330918 16.67979165671725 10022.0 89.08444444444444 0.0 - - - - - - - 244.27272727272728 20 11 SKI v-ski sarcoma viral oncogene homolog (avian) 1423 181 C20140716_OR021_03 C20140716_OR021_03 TB420533.[MT7]-GLLVPELYSSPSAAC[CAM]IQC[CAM]LDC[CAM]R.3b4_1.heavy 885.102 / 527.367 36265.0 44.3484992980957 50 20 10 10 10 10.60287570389714 9.43140359206932 0.0 3 0.994530505330918 16.67979165671725 36265.0 100.09214971525529 0.0 - - - - - - - 666.0 72 9 SKI v-ski sarcoma viral oncogene homolog (avian) 1425 181 C20140716_OR021_03 C20140716_OR021_03 TB420533.[MT7]-GLLVPELYSSPSAAC[CAM]IQC[CAM]LDC[CAM]R.3y8_1.heavy 885.102 / 1124.46 5992.0 44.3484992980957 50 20 10 10 10 10.60287570389714 9.43140359206932 0.0 3 0.994530505330918 16.67979165671725 5992.0 22.336030617823944 0.0 - - - - - - - 266.75 11 12 SKI v-ski sarcoma viral oncogene homolog (avian) 1427 182 C20140716_OR021_03 C20140716_OR021_03 TB442325.[MT7]-INVGGGLSGDHC[CAM]K[MT7].3y6_1.heavy 534.615 / 847.385 5776.0 26.09280014038086 47 17 10 10 10 2.9675472559807607 33.69786270411066 0.0 3 0.9742202527488331 7.66982757660111 5776.0 81.63020408163266 0.0 - - - - - - - 152.44444444444446 11 9 C8A complement component 8, alpha polypeptide 1429 182 C20140716_OR021_03 C20140716_OR021_03 TB442325.[MT7]-INVGGGLSGDHC[CAM]K[MT7].3y3_1.heavy 534.615 / 588.304 11749.0 26.09280014038086 47 17 10 10 10 2.9675472559807607 33.69786270411066 0.0 3 0.9742202527488331 7.66982757660111 11749.0 36.07218486756405 0.0 - - - - - - - 280.0 23 7 C8A complement component 8, alpha polypeptide 1431 182 C20140716_OR021_03 C20140716_OR021_03 TB442325.[MT7]-INVGGGLSGDHC[CAM]K[MT7].3b6_1.heavy 534.615 / 642.369 16350.0 26.09280014038086 47 17 10 10 10 2.9675472559807607 33.69786270411066 0.0 3 0.9742202527488331 7.66982757660111 16350.0 91.17244228106998 0.0 - - - - - - - 228.66666666666666 32 6 C8A complement component 8, alpha polypeptide 1433 182 C20140716_OR021_03 C20140716_OR021_03 TB442325.[MT7]-INVGGGLSGDHC[CAM]K[MT7].3y10_1.heavy 534.615 / 1131.53 N/A 26.09280014038086 47 17 10 10 10 2.9675472559807607 33.69786270411066 0.0 3 0.9742202527488331 7.66982757660111 0.0 0.0 3.0 - - - - - - - 0.0 0 0 C8A complement component 8, alpha polypeptide 1435 183 C20140716_OR021_03 C20140716_OR021_03 TB436089.[MT7]-EAGAAAVPAPVPAATEPPPVLHLPAIQPPPPVLPGPFFMPSDR.4b7_1.heavy 1115.85 / 714.39 23806.0 50.96084976196289 41 15 10 6 10 2.0264641370870087 39.209862563139424 0.0337982177734375 3 0.9573030460198149 5.9512258006064584 23806.0 40.738313213102685 0.0 - - - - - - - 396.0 47 3 SKI v-ski sarcoma viral oncogene homolog (avian) 1437 183 C20140716_OR021_03 C20140716_OR021_03 TB436089.[MT7]-EAGAAAVPAPVPAATEPPPVLHLPAIQPPPPVLPGPFFMPSDR.4y10_1.heavy 1115.85 / 1150.54 11277.0 50.96084976196289 41 15 10 6 10 2.0264641370870087 39.209862563139424 0.0337982177734375 3 0.9573030460198149 5.9512258006064584 11277.0 24.384681818181818 1.0 - - - - - - - 700.75 22 8 SKI v-ski sarcoma viral oncogene homolog (avian) 1439 183 C20140716_OR021_03 C20140716_OR021_03 TB436089.[MT7]-EAGAAAVPAPVPAATEPPPVLHLPAIQPPPPVLPGPFFMPSDR.4b5_1.heavy 1115.85 / 544.285 14838.0 50.96084976196289 41 15 10 6 10 2.0264641370870087 39.209862563139424 0.0337982177734375 3 0.9573030460198149 5.9512258006064584 14838.0 22.784548554398913 0.0 - - - - - - - 273.42857142857144 29 7 SKI v-ski sarcoma viral oncogene homolog (avian) 1441 183 C20140716_OR021_03 C20140716_OR021_03 TB436089.[MT7]-EAGAAAVPAPVPAATEPPPVLHLPAIQPPPPVLPGPFFMPSDR.4b6_1.heavy 1115.85 / 615.322 31654.0 50.96084976196289 41 15 10 6 10 2.0264641370870087 39.209862563139424 0.0337982177734375 3 0.9573030460198149 5.9512258006064584 31654.0 118.7025 1.0 - - - - - - - 374.0 63 6 SKI v-ski sarcoma viral oncogene homolog (avian) 1443 184 C20140716_OR021_03 C20140716_OR021_03 TB420345.[MT7]-FLADQQSEIDGLK[MT7].3b4_1.heavy 584.652 / 591.326 17854.0 36.367801666259766 44 14 10 10 10 2.1913304839364063 35.38244794396546 0.0 3 0.9395837850983553 4.995448054984652 17854.0 36.2743116699659 0.0 - - - - - - - 723.3333333333334 35 12 TPR translocated promoter region (to activated MET oncogene) 1445 184 C20140716_OR021_03 C20140716_OR021_03 TB420345.[MT7]-FLADQQSEIDGLK[MT7].3b5_1.heavy 584.652 / 719.385 7274.0 36.367801666259766 44 14 10 10 10 2.1913304839364063 35.38244794396546 0.0 3 0.9395837850983553 4.995448054984652 7274.0 23.590345482896403 0.0 - - - - - - - 732.2857142857143 14 7 TPR translocated promoter region (to activated MET oncogene) 1447 184 C20140716_OR021_03 C20140716_OR021_03 TB420345.[MT7]-FLADQQSEIDGLK[MT7].3y4_1.heavy 584.652 / 576.347 21077.0 36.367801666259766 44 14 10 10 10 2.1913304839364063 35.38244794396546 0.0 3 0.9395837850983553 4.995448054984652 21077.0 28.65789158558006 0.0 - - - - - - - 330.75 42 4 TPR translocated promoter region (to activated MET oncogene) 1449 184 C20140716_OR021_03 C20140716_OR021_03 TB420345.[MT7]-FLADQQSEIDGLK[MT7].3b8_1.heavy 584.652 / 1063.52 3885.0 36.367801666259766 44 14 10 10 10 2.1913304839364063 35.38244794396546 0.0 3 0.9395837850983553 4.995448054984652 3885.0 25.5235905369847 1.0 - - - - - - - 212.57142857142858 8 14 TPR translocated promoter region (to activated MET oncogene) 1451 185 C20140716_OR021_03 C20140716_OR021_03 TB420437.[MT7]-IPFSTFQFLYTYIAK[MT7].3y6_1.heavy 709.73 / 902.51 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1 ropporin, rhophilin associated protein 1 1453 185 C20140716_OR021_03 C20140716_OR021_03 TB420437.[MT7]-IPFSTFQFLYTYIAK[MT7].3y4_1.heavy 709.73 / 638.399 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1 ropporin, rhophilin associated protein 1 1455 185 C20140716_OR021_03 C20140716_OR021_03 TB420437.[MT7]-IPFSTFQFLYTYIAK[MT7].3y5_1.heavy 709.73 / 739.447 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1 ropporin, rhophilin associated protein 1 1457 185 C20140716_OR021_03 C20140716_OR021_03 TB420437.[MT7]-IPFSTFQFLYTYIAK[MT7].3b7_1.heavy 709.73 / 965.521 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1 ropporin, rhophilin associated protein 1 1459 186 C20140716_OR021_03 C20140716_OR021_03 TB420330.[MT7]-Y[MT7]SAQIEDLQVK[MT7].4b7_2.heavy 432.249 / 548.282 N/A N/A - - - - - - - - - 0.0 - - - - - - - SKI v-ski sarcoma viral oncogene homolog (avian) 1461 186 C20140716_OR021_03 C20140716_OR021_03 TB420330.[MT7]-Y[MT7]SAQIEDLQVK[MT7].4b4_1.heavy 432.249 / 738.403 N/A N/A - - - - - - - - - 0.0 - - - - - - - SKI v-ski sarcoma viral oncogene homolog (avian) 1463 186 C20140716_OR021_03 C20140716_OR021_03 TB420330.[MT7]-Y[MT7]SAQIEDLQVK[MT7].4b3_1.heavy 432.249 / 610.344 N/A N/A - - - - - - - - - 0.0 - - - - - - - SKI v-ski sarcoma viral oncogene homolog (avian) 1465 186 C20140716_OR021_03 C20140716_OR021_03 TB420330.[MT7]-Y[MT7]SAQIEDLQVK[MT7].4b6_2.heavy 432.249 / 490.768 N/A N/A - - - - - - - - - 0.0 - - - - - - - SKI v-ski sarcoma viral oncogene homolog (avian) 1467 187 C20140716_OR021_03 C20140716_OR021_03 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y7.peptide 661.38 / 836.43 311248.0 45.859700520833336 23 -3 10 6 10 null 0.0 0.039600372314453125 3 0.0 0.0 311248.0 513.0207846479184 0.0 - - - - - - - 330.3333333333333 622 12 1469 187 C20140716_OR021_03 C20140716_OR021_03 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y9.peptide 661.38 / 502.76 668272.0 45.859700520833336 23 -3 10 6 10 null 0.0 0.039600372314453125 3 0.0 0.0 668272.0 433.2932996754837 0.0 - - - - - - - 780.3333333333334 1336 9 1471 187 C20140716_OR021_03 C20140716_OR021_03 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y17.peptide 661.38 / 906.51 455015.0 45.859700520833336 23 -3 10 6 10 null 0.0 0.039600372314453125 3 0.0 0.0 455015.0 708.492633120019 0.0 - - - - - - - 254.58333333333334 910 12 1473 188 C20140716_OR021_03 C20140716_OR021_03 TB442516.[MT7]-QLTGQAPGEQLDHQTLLQGVVVLEEFC[CAM]K[MT7].3y3_1.heavy 1142.6 / 598.314 1758.0 48.33479881286621 46 20 10 6 10 14.577133763053409 6.860059160152307 0.036800384521484375 3 0.9950873601715029 17.600578907739646 1758.0 13.982004872955098 0.0 - - - - - - - 174.75 3 12 FAM160B2 family with sequence similarity 160, member B2 1475 188 C20140716_OR021_03 C20140716_OR021_03 TB442516.[MT7]-QLTGQAPGEQLDHQTLLQGVVVLEEFC[CAM]K[MT7].3b6_1.heavy 1142.6 / 743.417 2367.0 48.33479881286621 46 20 10 6 10 14.577133763053409 6.860059160152307 0.036800384521484375 3 0.9950873601715029 17.600578907739646 2367.0 43.56418574326282 0.0 - - - - - - - 155.23529411764707 4 17 FAM160B2 family with sequence similarity 160, member B2 1477 188 C20140716_OR021_03 C20140716_OR021_03 TB442516.[MT7]-QLTGQAPGEQLDHQTLLQGVVVLEEFC[CAM]K[MT7].3b5_1.heavy 1142.6 / 672.38 2096.0 48.33479881286621 46 20 10 6 10 14.577133763053409 6.860059160152307 0.036800384521484375 3 0.9950873601715029 17.600578907739646 2096.0 13.336908174446634 0.0 - - - - - - - 155.23529411764707 4 17 FAM160B2 family with sequence similarity 160, member B2 1479 188 C20140716_OR021_03 C20140716_OR021_03 TB442516.[MT7]-QLTGQAPGEQLDHQTLLQGVVVLEEFC[CAM]K[MT7].3y8_1.heavy 1142.6 / 1167.62 1691.0 48.33479881286621 46 20 10 6 10 14.577133763053409 6.860059160152307 0.036800384521484375 3 0.9950873601715029 17.600578907739646 1691.0 10.99911534089253 0.0 - - - - - - - 202.75 3 16 FAM160B2 family with sequence similarity 160, member B2 1481 189 C20140716_OR021_03 C20140716_OR021_03 TB420441.[MT7]-VGSTTNEAAGEAGAISPPRGR.4y5_1.heavy 536.281 / 582.347 1285.0 25.334774494171143 35 12 10 5 8 1.0697139537739735 65.11805384072585 0.04590034484863281 4 0.8823173779003839 3.561657344674617 1285.0 2.1632832555425905 3.0 - - - - - - - 248.4 2 10 WNT9A wingless-type MMTV integration site family, member 9A 1483 189 C20140716_OR021_03 C20140716_OR021_03 TB420441.[MT7]-VGSTTNEAAGEAGAISPPRGR.4y12_2.heavy 536.281 / 584.315 5399.0 25.334774494171143 35 12 10 5 8 1.0697139537739735 65.11805384072585 0.04590034484863281 4 0.8823173779003839 3.561657344674617 5399.0 1.135894802599113 1.0 - - - - - - - 256.8 11 5 WNT9A wingless-type MMTV integration site family, member 9A 1485 189 C20140716_OR021_03 C20140716_OR021_03 TB420441.[MT7]-VGSTTNEAAGEAGAISPPRGR.4y13_2.heavy 536.281 / 619.834 4713.0 25.334774494171143 35 12 10 5 8 1.0697139537739735 65.11805384072585 0.04590034484863281 4 0.8823173779003839 3.561657344674617 4713.0 10.143505206983104 0.0 - - - - - - - 256.8333333333333 9 6 WNT9A wingless-type MMTV integration site family, member 9A 1487 189 C20140716_OR021_03 C20140716_OR021_03 TB420441.[MT7]-VGSTTNEAAGEAGAISPPRGR.4b6_1.heavy 536.281 / 704.37 2742.0 25.334774494171143 35 12 10 5 8 1.0697139537739735 65.11805384072585 0.04590034484863281 4 0.8823173779003839 3.561657344674617 2742.0 0.7207800718132853 1.0 - - - - - - - 299.8333333333333 5 6 WNT9A wingless-type MMTV integration site family, member 9A 1489 190 C20140716_OR021_03 C20140716_OR021_03 TB442515.[MT7]-LSQC[CAM]PEVHPLPTPVLLPAVDFSLGEWK[MT7].4b8_1.heavy 830.202 / 1095.54 8301.0 51.86457538604736 40 14 10 6 10 4.226905381128439 23.657969834494715 0.035099029541015625 3 0.9359043561592991 4.848424794648957 8301.0 64.33403067971436 0.0 - - - - - - - 250.13333333333333 16 15 THPO thrombopoietin 1491 190 C20140716_OR021_03 C20140716_OR021_03 TB442515.[MT7]-LSQC[CAM]PEVHPLPTPVLLPAVDFSLGEWK[MT7].4y4_1.heavy 830.202 / 663.358 22346.0 51.86457538604736 40 14 10 6 10 4.226905381128439 23.657969834494715 0.035099029541015625 3 0.9359043561592991 4.848424794648957 22346.0 49.9974628637694 0.0 - - - - - - - 303.26666666666665 44 15 THPO thrombopoietin 1493 190 C20140716_OR021_03 C20140716_OR021_03 TB442515.[MT7]-LSQC[CAM]PEVHPLPTPVLLPAVDFSLGEWK[MT7].4b4_1.heavy 830.202 / 633.315 5174.0 51.86457538604736 40 14 10 6 10 4.226905381128439 23.657969834494715 0.035099029541015625 3 0.9359043561592991 4.848424794648957 5174.0 20.95876791613625 0.0 - - - - - - - 216.06666666666666 10 15 THPO thrombopoietin 1495 190 C20140716_OR021_03 C20140716_OR021_03 TB442515.[MT7]-LSQC[CAM]PEVHPLPTPVLLPAVDFSLGEWK[MT7].4y6_1.heavy 830.202 / 863.474 5629.0 51.86457538604736 40 14 10 6 10 4.226905381128439 23.657969834494715 0.035099029541015625 3 0.9359043561592991 4.848424794648957 5629.0 28.944010783450704 0.0 - - - - - - - 199.0625 11 16 THPO thrombopoietin 1497 191 C20140716_OR021_03 C20140716_OR021_03 TB442189.[MT7]-LFVGTAVDGK[MT7].3y3_1.heavy 432.258 / 463.263 27443.0 34.593125343322754 46 20 10 6 10 7.034745203882629 14.215155929856255 0.039897918701171875 3 0.9913667033874832 13.272755478761576 27443.0 113.47538062283736 0.0 - - - - - - - 232.75 54 12 PLXNA3 plexin A3 1499 191 C20140716_OR021_03 C20140716_OR021_03 TB442189.[MT7]-LFVGTAVDGK[MT7].3b4_1.heavy 432.258 / 561.352 5778.0 34.593125343322754 46 20 10 6 10 7.034745203882629 14.215155929856255 0.039897918701171875 3 0.9913667033874832 13.272755478761576 5778.0 42.868494809688585 0.0 - - - - - - - 214.0 11 9 PLXNA3 plexin A3 1501 191 C20140716_OR021_03 C20140716_OR021_03 TB442189.[MT7]-LFVGTAVDGK[MT7].3y4_1.heavy 432.258 / 562.332 5104.0 34.593125343322754 46 20 10 6 10 7.034745203882629 14.215155929856255 0.039897918701171875 3 0.9913667033874832 13.272755478761576 5104.0 21.557306969846763 0.0 - - - - - - - 216.625 10 8 PLXNA3 plexin A3 1503 191 C20140716_OR021_03 C20140716_OR021_03 TB442189.[MT7]-LFVGTAVDGK[MT7].3b3_1.heavy 432.258 / 504.33 7800.0 34.593125343322754 46 20 10 6 10 7.034745203882629 14.215155929856255 0.039897918701171875 3 0.9913667033874832 13.272755478761576 7800.0 39.48623376623377 0.0 - - - - - - - 234.0 15 14 PLXNA3 plexin A3 1505 192 C20140716_OR021_03 C20140716_OR021_03 TB436080.[MT7]-ALPSAVPDAAAPADAPSGLEAELEHLR.3b6_1.heavy 938.158 / 683.421 38291.0 43.110801696777344 47 17 10 10 10 5.235884673218714 19.098969179266867 0.0 3 0.9757309998275945 7.9059519168742325 38291.0 154.79759265703845 0.0 - - - - - - - 630.5714285714286 76 7 SKI v-ski sarcoma viral oncogene homolog (avian) 1507 192 C20140716_OR021_03 C20140716_OR021_03 TB436080.[MT7]-ALPSAVPDAAAPADAPSGLEAELEHLR.3b5_1.heavy 938.158 / 584.352 16425.0 43.110801696777344 47 17 10 10 10 5.235884673218714 19.098969179266867 0.0 3 0.9757309998275945 7.9059519168742325 16425.0 74.353412685873 1.0 - - - - - - - 205.5 41 12 SKI v-ski sarcoma viral oncogene homolog (avian) 1509 192 C20140716_OR021_03 C20140716_OR021_03 TB436080.[MT7]-ALPSAVPDAAAPADAPSGLEAELEHLR.3y8_1.heavy 938.158 / 996.511 6467.0 43.110801696777344 47 17 10 10 10 5.235884673218714 19.098969179266867 0.0 3 0.9757309998275945 7.9059519168742325 6467.0 43.97342809502974 0.0 - - - - - - - 182.66666666666666 12 9 SKI v-ski sarcoma viral oncogene homolog (avian) 1511 192 C20140716_OR021_03 C20140716_OR021_03 TB436080.[MT7]-ALPSAVPDAAAPADAPSGLEAELEHLR.3y5_1.heavy 938.158 / 667.389 3696.0 43.110801696777344 47 17 10 10 10 5.235884673218714 19.098969179266867 0.0 3 0.9757309998275945 7.9059519168742325 3696.0 48.88207246033625 0.0 - - - - - - - 196.1818181818182 7 11 SKI v-ski sarcoma viral oncogene homolog (avian) 1513 193 C20140716_OR021_03 C20140716_OR021_03 TB442415.[MT7]-SLLTTQC[CAM]GVISEHTK[MT7].4y4_1.heavy 491.27 / 658.364 1967.0 30.76300048828125 42 18 6 10 8 13.278285155424808 7.5310929709281975 0.0 4 0.9807865423596728 8.889181740485887 1967.0 21.556164383561647 0.0 - - - - - - - 180.11764705882354 3 17 ATXN7L3 ataxin 7-like 3 1515 193 C20140716_OR021_03 C20140716_OR021_03 TB442415.[MT7]-SLLTTQC[CAM]GVISEHTK[MT7].4y5_1.heavy 491.27 / 745.396 8304.0 30.76300048828125 42 18 6 10 8 13.278285155424808 7.5310929709281975 0.0 4 0.9807865423596728 8.889181740485887 8304.0 94.82922792388953 0.0 - - - - - - - 207.46153846153845 16 13 ATXN7L3 ataxin 7-like 3 1517 193 C20140716_OR021_03 C20140716_OR021_03 TB442415.[MT7]-SLLTTQC[CAM]GVISEHTK[MT7].4y6_1.heavy 491.27 / 858.48 1967.0 30.76300048828125 42 18 6 10 8 13.278285155424808 7.5310929709281975 0.0 4 0.9807865423596728 8.889181740485887 1967.0 17.173077625570777 0.0 - - - - - - - 178.33333333333334 3 9 ATXN7L3 ataxin 7-like 3 1519 193 C20140716_OR021_03 C20140716_OR021_03 TB442415.[MT7]-SLLTTQC[CAM]GVISEHTK[MT7].4y3_1.heavy 491.27 / 529.321 5828.0 30.76300048828125 42 18 6 10 8 13.278285155424808 7.5310929709281975 0.0 4 0.9807865423596728 8.889181740485887 5828.0 22.914222542658017 1.0 - - - - - - - 230.88888888888889 25 18 ATXN7L3 ataxin 7-like 3 1521 194 C20140716_OR021_03 C20140716_OR021_03 TB420542.[MT7]-AEVEEFSFITQLSGLTDHLPVAMR.4b5_1.heavy 709.368 / 702.343 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1523 194 C20140716_OR021_03 C20140716_OR021_03 TB420542.[MT7]-AEVEEFSFITQLSGLTDHLPVAMR.4y7_1.heavy 709.368 / 823.461 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1525 194 C20140716_OR021_03 C20140716_OR021_03 TB420542.[MT7]-AEVEEFSFITQLSGLTDHLPVAMR.4y6_1.heavy 709.368 / 686.402 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1527 194 C20140716_OR021_03 C20140716_OR021_03 TB420542.[MT7]-AEVEEFSFITQLSGLTDHLPVAMR.4b6_1.heavy 709.368 / 849.411 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1529 195 C20140716_OR021_03 C20140716_OR021_03 TB442041.[MT7]-GTGPGK[MT7].2y4_1.heavy 402.745 / 502.311 17027.0 13.666399955749512 48 18 10 10 10 3.434925017679724 29.112717012830032 0.0 3 0.9811649204844678 8.978310286552011 17027.0 55.52253677447594 0.0 - - - - - - - 167.21052631578948 34 19 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1531 195 C20140716_OR021_03 C20140716_OR021_03 TB442041.[MT7]-GTGPGK[MT7].2y5_1.heavy 402.745 / 603.358 13067.0 13.666399955749512 48 18 10 10 10 3.434925017679724 29.112717012830032 0.0 3 0.9811649204844678 8.978310286552011 13067.0 152.9095865567533 0.0 - - - - - - - 134.38095238095238 26 21 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1533 195 C20140716_OR021_03 C20140716_OR021_03 TB442041.[MT7]-GTGPGK[MT7].2y3_1.heavy 402.745 / 445.289 14608.0 13.666399955749512 48 18 10 10 10 3.434925017679724 29.112717012830032 0.0 3 0.9811649204844678 8.978310286552011 14608.0 66.63422539082076 0.0 - - - - - - - 148.15 29 20 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1535 195 C20140716_OR021_03 C20140716_OR021_03 TB442041.[MT7]-GTGPGK[MT7].2b5_1.heavy 402.745 / 514.274 2870.0 13.666399955749512 48 18 10 10 10 3.434925017679724 29.112717012830032 0.0 3 0.9811649204844678 8.978310286552011 2870.0 18.959937909466525 2.0 - - - - - - - 226.3181818181818 6 22 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1537 196 C20140716_OR021_03 C20140716_OR021_03 TB442414.[MT7]-RFETTAVNTLFC[CAM]SK[MT7].4y4_1.heavy 491.264 / 685.346 4104.0 36.84029960632324 33 8 10 5 10 0.5187445368227233 89.83248469779372 0.041599273681640625 3 0.7925363305751577 2.661214461862145 4104.0 52.24546075085324 0.0 - - - - - - - 312.8 8 5 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1539 196 C20140716_OR021_03 C20140716_OR021_03 TB442414.[MT7]-RFETTAVNTLFC[CAM]SK[MT7].4b7_1.heavy 491.264 / 949.522 195.0 36.84029960632324 33 8 10 5 10 0.5187445368227233 89.83248469779372 0.041599273681640625 3 0.7925363305751577 2.661214461862145 195.0 3.5796428571428573 1.0 - - - - - - - 0.0 0 0 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1541 196 C20140716_OR021_03 C20140716_OR021_03 TB442414.[MT7]-RFETTAVNTLFC[CAM]SK[MT7].4y3_1.heavy 491.264 / 538.278 5472.0 36.84029960632324 33 8 10 5 10 0.5187445368227233 89.83248469779372 0.041599273681640625 3 0.7925363305751577 2.661214461862145 5472.0 20.597036260649897 0.0 - - - - - - - 309.5833333333333 10 12 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1543 196 C20140716_OR021_03 C20140716_OR021_03 TB442414.[MT7]-RFETTAVNTLFC[CAM]SK[MT7].4b6_1.heavy 491.264 / 850.454 879.0 36.84029960632324 33 8 10 5 10 0.5187445368227233 89.83248469779372 0.041599273681640625 3 0.7925363305751577 2.661214461862145 879.0 9.226405298961689 1.0 - - - - - - - 0.0 1 0 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1545 197 C20140716_OR021_03 C20140716_OR021_03 TB442042.[MT7]-AGIQER.2y4_1.heavy 409.236 / 545.304 504.0 15.90952467918396 38 14 10 6 8 0.621796257786755 78.68449173357077 0.03789997100830078 4 0.9321511677775212 4.710906901304475 504.0 0.4505747126436781 32.0 - - - - - - - 655.5714285714286 13 7 C8A complement component 8, alpha polypeptide 1547 197 C20140716_OR021_03 C20140716_OR021_03 TB442042.[MT7]-AGIQER.2y5_1.heavy 409.236 / 602.326 123003.0 15.90952467918396 38 14 10 6 8 0.621796257786755 78.68449173357077 0.03789997100830078 4 0.9321511677775212 4.710906901304475 123003.0 223.82189820352866 0.0 - - - - - - - 267.0769230769231 246 13 C8A complement component 8, alpha polypeptide 1549 197 C20140716_OR021_03 C20140716_OR021_03 TB442042.[MT7]-AGIQER.2b4_1.heavy 409.236 / 514.311 2518.0 15.90952467918396 38 14 10 6 8 0.621796257786755 78.68449173357077 0.03789997100830078 4 0.9321511677775212 4.710906901304475 2518.0 17.985714285714288 3.0 - - - - - - - 228.0 20 14 C8A complement component 8, alpha polypeptide 1551 197 C20140716_OR021_03 C20140716_OR021_03 TB442042.[MT7]-AGIQER.2b5_1.heavy 409.236 / 643.353 14830.0 15.90952467918396 38 14 10 6 8 0.621796257786755 78.68449173357077 0.03789997100830078 4 0.9321511677775212 4.710906901304475 14830.0 79.18515838806786 0.0 - - - - - - - 703.4285714285714 29 7 C8A complement component 8, alpha polypeptide 1553 198 C20140716_OR021_03 C20140716_OR021_03 TB419891.[MT7]-EAPTGSR.2y4_1.heavy 431.231 / 420.22 797.0 13.838399887084961 50 20 10 10 10 34.59055688022385 2.890962419202106 0.0 3 0.997729026900087 25.892509918669223 797.0 1.2315673289183222 3.0 - - - - - - - 192.1851851851852 2 27 PTH1R parathyroid hormone 1 receptor 1555 198 C20140716_OR021_03 C20140716_OR021_03 TB419891.[MT7]-EAPTGSR.2y5_1.heavy 431.231 / 517.273 8770.0 13.838399887084961 50 20 10 10 10 34.59055688022385 2.890962419202106 0.0 3 0.997729026900087 25.892509918669223 8770.0 111.31153846153845 0.0 - - - - - - - 121.79166666666667 17 24 PTH1R parathyroid hormone 1 receptor 1557 198 C20140716_OR021_03 C20140716_OR021_03 TB419891.[MT7]-EAPTGSR.2y6_1.heavy 431.231 / 588.31 13022.0 13.838399887084961 50 20 10 10 10 34.59055688022385 2.890962419202106 0.0 3 0.997729026900087 25.892509918669223 13022.0 109.66776690794765 0.0 - - - - - - - 186.96 26 25 PTH1R parathyroid hormone 1 receptor 1559 198 C20140716_OR021_03 C20140716_OR021_03 TB419891.[MT7]-EAPTGSR.2b5_1.heavy 431.231 / 600.311 1219.0 13.838399887084961 50 20 10 10 10 34.59055688022385 2.890962419202106 0.0 3 0.997729026900087 25.892509918669223 1219.0 14.735164835164834 1.0 - - - - - - - 78.33333333333333 2 24 PTH1R parathyroid hormone 1 receptor 1561 199 C20140716_OR021_03 C20140716_OR021_03 TB442217.[MT7]-LLLIDYAARR.3y3_1.heavy 449.946 / 402.257 N/A 39.65976587931315 40 16 8 6 10 4.055523814769184 24.657727230160873 0.039798736572265625 3 0.963294943037013 6.4218770654113255 3366.0 18.645000000000003 1.0 - - - - - - - 214.2 9 10 PLXNA3 plexin A3 1563 199 C20140716_OR021_03 C20140716_OR021_03 TB442217.[MT7]-LLLIDYAARR.3b5_1.heavy 449.946 / 712.472 1326.0 39.65976587931315 40 16 8 6 10 4.055523814769184 24.657727230160873 0.039798736572265625 3 0.963294943037013 6.4218770654113255 1326.0 25.869999999999997 0.0 - - - - - - - 102.0 2 3 PLXNA3 plexin A3 1565 199 C20140716_OR021_03 C20140716_OR021_03 TB442217.[MT7]-LLLIDYAARR.3b3_1.heavy 449.946 / 484.362 3672.0 39.65976587931315 40 16 8 6 10 4.055523814769184 24.657727230160873 0.039798736572265625 3 0.963294943037013 6.4218770654113255 3672.0 41.952 0.0 - - - - - - - 229.5 7 4 PLXNA3 plexin A3 1567 199 C20140716_OR021_03 C20140716_OR021_03 TB442217.[MT7]-LLLIDYAARR.3y5_1.heavy 449.946 / 636.358 510.0 39.65976587931315 40 16 8 6 10 4.055523814769184 24.657727230160873 0.039798736572265625 3 0.963294943037013 6.4218770654113255 510.0 1.1666666666666667 2.0 - - - - - - - 0.0 1 0 PLXNA3 plexin A3 1569 200 C20140716_OR021_03 C20140716_OR021_03 TB442216.[MT7]-VLLMELEEAR.2y8_1.heavy 673.877 / 990.492 N/A N/A - - - - - - - - - 0.0 - - - - - - - TPR translocated promoter region (to activated MET oncogene) 1571 200 C20140716_OR021_03 C20140716_OR021_03 TB442216.[MT7]-VLLMELEEAR.2y9_1.heavy 673.877 / 1103.58 N/A N/A - - - - - - - - - 0.0 - - - - - - - TPR translocated promoter region (to activated MET oncogene) 1573 200 C20140716_OR021_03 C20140716_OR021_03 TB442216.[MT7]-VLLMELEEAR.2y6_1.heavy 673.877 / 746.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - TPR translocated promoter region (to activated MET oncogene) 1575 200 C20140716_OR021_03 C20140716_OR021_03 TB442216.[MT7]-VLLMELEEAR.2y7_1.heavy 673.877 / 877.408 N/A N/A - - - - - - - - - 0.0 - - - - - - - TPR translocated promoter region (to activated MET oncogene) 1577 201 C20140716_OR021_03 C20140716_OR021_03 TB436070.[MT7]-YSADGLLQLGPLGSTAFLPDSK[MT7].3b6_1.heavy 846.795 / 751.374 53185.0 49.08530044555664 43 13 10 10 10 1.7447871786139937 57.31358026108203 0.0 3 0.9046549223034414 3.9646113912918253 53185.0 89.44895402025958 0.0 - - - - - - - 633.0 106 7 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1579 201 C20140716_OR021_03 C20140716_OR021_03 TB436070.[MT7]-YSADGLLQLGPLGSTAFLPDSK[MT7].3b5_1.heavy 846.795 / 638.29 33741.0 49.08530044555664 43 13 10 10 10 1.7447871786139937 57.31358026108203 0.0 3 0.9046549223034414 3.9646113912918253 33741.0 100.41027972027973 0.0 - - - - - - - 253.36363636363637 67 11 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1581 201 C20140716_OR021_03 C20140716_OR021_03 TB436070.[MT7]-YSADGLLQLGPLGSTAFLPDSK[MT7].3y4_1.heavy 846.795 / 590.327 114590.0 49.08530044555664 43 13 10 10 10 1.7447871786139937 57.31358026108203 0.0 3 0.9046549223034414 3.9646113912918253 114590.0 319.30242145794006 0.0 - - - - - - - 633.0 229 7 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1583 201 C20140716_OR021_03 C20140716_OR021_03 TB436070.[MT7]-YSADGLLQLGPLGSTAFLPDSK[MT7].3b7_1.heavy 846.795 / 864.458 24376.0 49.08530044555664 43 13 10 10 10 1.7447871786139937 57.31358026108203 0.0 3 0.9046549223034414 3.9646113912918253 24376.0 110.88826756302521 0.0 - - - - - - - 221.4 48 10 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1585 202 C20140716_OR021_03 C20140716_OR021_03 TB419894.[MT7]-STITYR.2y4_1.heavy 442.752 / 552.314 4398.0 20.86199951171875 48 18 10 10 10 4.880094955108443 20.491404556651265 0.0 3 0.9847504834678886 9.981156939685345 4398.0 44.259572112098425 0.0 - - - - - - - 204.42857142857142 8 14 C8A complement component 8, alpha polypeptide 1587 202 C20140716_OR021_03 C20140716_OR021_03 TB419894.[MT7]-STITYR.2b3_1.heavy 442.752 / 446.273 5236.0 20.86199951171875 48 18 10 10 10 4.880094955108443 20.491404556651265 0.0 3 0.9847504834678886 9.981156939685345 5236.0 42.85316129032258 0.0 - - - - - - - 241.1818181818182 10 11 C8A complement component 8, alpha polypeptide 1589 202 C20140716_OR021_03 C20140716_OR021_03 TB419894.[MT7]-STITYR.2y5_1.heavy 442.752 / 653.362 12426.0 20.86199951171875 48 18 10 10 10 4.880094955108443 20.491404556651265 0.0 3 0.9847504834678886 9.981156939685345 12426.0 111.90178588475962 0.0 - - - - - - - 232.66666666666666 24 12 C8A complement component 8, alpha polypeptide 1591 202 C20140716_OR021_03 C20140716_OR021_03 TB419894.[MT7]-STITYR.2b4_1.heavy 442.752 / 547.321 4049.0 20.86199951171875 48 18 10 10 10 4.880094955108443 20.491404556651265 0.0 3 0.9847504834678886 9.981156939685345 4049.0 22.3389281528815 0.0 - - - - - - - 261.8125 8 16 C8A complement component 8, alpha polypeptide 1593 203 C20140716_OR021_03 C20140716_OR021_03 TB442213.[MT7]-ELQEQLWPR.2b3_1.heavy 671.865 / 515.295 3463.0 36.89229869842529 35 18 2 5 10 7.453148645701634 13.417148208585886 0.041599273681640625 3 0.9871717829214247 10.884634622034957 3463.0 2.5049938185890257 0.0 - - - - - - - 756.0 6 11 SKI v-ski sarcoma viral oncogene homolog (avian) 1595 203 C20140716_OR021_03 C20140716_OR021_03 TB442213.[MT7]-ELQEQLWPR.2y8_1.heavy 671.865 / 1069.58 6828.0 36.89229869842529 35 18 2 5 10 7.453148645701634 13.417148208585886 0.041599273681640625 3 0.9871717829214247 10.884634622034957 6828.0 2.0243237057687864 1.0 - - - - - - - 257.4 13 5 SKI v-ski sarcoma viral oncogene homolog (avian) 1597 203 C20140716_OR021_03 C20140716_OR021_03 TB442213.[MT7]-ELQEQLWPR.2b4_1.heavy 671.865 / 644.337 2771.0 36.89229869842529 35 18 2 5 10 7.453148645701634 13.417148208585886 0.041599273681640625 3 0.9871717829214247 10.884634622034957 2771.0 2.4179127252092494 14.0 - - - - - - - 1273.625 34 8 SKI v-ski sarcoma viral oncogene homolog (avian) 1599 203 C20140716_OR021_03 C20140716_OR021_03 TB442213.[MT7]-ELQEQLWPR.2y7_1.heavy 671.865 / 956.495 5442.0 36.89229869842529 35 18 2 5 10 7.453148645701634 13.417148208585886 0.041599273681640625 3 0.9871717829214247 10.884634622034957 5442.0 18.149998757860413 1.0 - - - - - - - 240.42857142857142 14 7 SKI v-ski sarcoma viral oncogene homolog (avian) 1601 204 C20140716_OR021_03 C20140716_OR021_03 TB419995.[MT7]-SAADDSEAK[MT7].2y4_1.heavy 591.298 / 578.327 1537.0 14.57699966430664 47 17 10 10 10 19.37804047491692 5.160480500050599 0.0 3 0.9785886017489299 8.419026776937379 1537.0 20.639257796257795 0.0 - - - - - - - 122.53571428571429 3 28 TPR translocated promoter region (to activated MET oncogene) 1603 204 C20140716_OR021_03 C20140716_OR021_03 TB419995.[MT7]-SAADDSEAK[MT7].2y8_1.heavy 591.298 / 950.455 1093.0 14.57699966430664 47 17 10 10 10 19.37804047491692 5.160480500050599 0.0 3 0.9785886017489299 8.419026776937379 1093.0 45.09320882852292 0.0 - - - - - - - 89.28571428571429 2 21 TPR translocated promoter region (to activated MET oncogene) 1605 204 C20140716_OR021_03 C20140716_OR021_03 TB419995.[MT7]-SAADDSEAK[MT7].2y5_1.heavy 591.298 / 693.354 1204.0 14.57699966430664 47 17 10 10 10 19.37804047491692 5.160480500050599 0.0 3 0.9785886017489299 8.419026776937379 1204.0 17.680360360360357 0.0 - - - - - - - 77.47058823529412 2 17 TPR translocated promoter region (to activated MET oncogene) 1607 204 C20140716_OR021_03 C20140716_OR021_03 TB419995.[MT7]-SAADDSEAK[MT7].2b5_1.heavy 591.298 / 604.269 1111.0 14.57699966430664 47 17 10 10 10 19.37804047491692 5.160480500050599 0.0 3 0.9785886017489299 8.419026776937379 1111.0 13.01925181894276 0.0 - - - - - - - 97.07692307692308 2 26 TPR translocated promoter region (to activated MET oncogene) 1609 205 C20140716_OR021_03 C20140716_OR021_03 TB442314.[MT7]-GLAGGAALLSEWK[MT7].2b6_1.heavy 780.953 / 571.332 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1611 205 C20140716_OR021_03 C20140716_OR021_03 TB442314.[MT7]-GLAGGAALLSEWK[MT7].2y10_1.heavy 780.953 / 1175.65 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1613 205 C20140716_OR021_03 C20140716_OR021_03 TB442314.[MT7]-GLAGGAALLSEWK[MT7].2b7_1.heavy 780.953 / 642.369 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1615 205 C20140716_OR021_03 C20140716_OR021_03 TB442314.[MT7]-GLAGGAALLSEWK[MT7].2b5_1.heavy 780.953 / 500.295 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1617 206 C20140716_OR021_03 C20140716_OR021_03 TB442312.[MT7]-SLFEILILMGK[MT7].3b6_1.heavy 517.986 / 847.505 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1619 206 C20140716_OR021_03 C20140716_OR021_03 TB442312.[MT7]-SLFEILILMGK[MT7].3b4_1.heavy 517.986 / 621.336 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1621 206 C20140716_OR021_03 C20140716_OR021_03 TB442312.[MT7]-SLFEILILMGK[MT7].3b5_1.heavy 517.986 / 734.42 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1623 206 C20140716_OR021_03 C20140716_OR021_03 TB442312.[MT7]-SLFEILILMGK[MT7].3y4_1.heavy 517.986 / 592.361 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1625 207 C20140716_OR021_03 C20140716_OR021_03 TB420334.[MT7]-VRGGSSGWSGGLAQNR.3y7_1.heavy 578.303 / 715.385 30700.0 25.61039924621582 50 20 10 10 10 46.07331989329224 2.170453534314528 0.0 3 0.9996537157949952 66.31831682991724 30700.0 52.26717104724474 0.0 - - - - - - - 245.55555555555554 61 9 C8A complement component 8, alpha polypeptide 1627 207 C20140716_OR021_03 C20140716_OR021_03 TB420334.[MT7]-VRGGSSGWSGGLAQNR.3y6_1.heavy 578.303 / 658.363 12121.0 25.61039924621582 50 20 10 10 10 46.07331989329224 2.170453534314528 0.0 3 0.9996537157949952 66.31831682991724 12121.0 60.616722214847826 0.0 - - - - - - - 300.6 24 5 C8A complement component 8, alpha polypeptide 1629 207 C20140716_OR021_03 C20140716_OR021_03 TB420334.[MT7]-VRGGSSGWSGGLAQNR.3b8_1.heavy 578.303 / 931.487 5220.0 25.61039924621582 50 20 10 10 10 46.07331989329224 2.170453534314528 0.0 3 0.9996537157949952 66.31831682991724 5220.0 23.593220338983052 0.0 - - - - - - - 212.2 10 10 C8A complement component 8, alpha polypeptide 1631 207 C20140716_OR021_03 C20140716_OR021_03 TB420334.[MT7]-VRGGSSGWSGGLAQNR.3y8_1.heavy 578.303 / 802.417 29285.0 25.61039924621582 50 20 10 10 10 46.07331989329224 2.170453534314528 0.0 3 0.9996537157949952 66.31831682991724 29285.0 315.8815890162782 0.0 - - - - - - - 212.0 58 5 C8A complement component 8, alpha polypeptide 1633 208 C20140716_OR021_03 C20140716_OR021_03 TB420337.[MT7]-TDDTSSQSPAPSEK[MT7].2b8_1.heavy 869.423 / 966.413 1191.0 17.18802499771118 43 17 10 6 10 2.5601419587896785 39.060334000883124 0.03930091857910156 3 0.9707983621861154 7.20437346970515 1191.0 29.233636363636364 0.0 - - - - - - - 89.66666666666667 2 9 SKI v-ski sarcoma viral oncogene homolog (avian) 1635 208 C20140716_OR021_03 C20140716_OR021_03 TB420337.[MT7]-TDDTSSQSPAPSEK[MT7].2y4_1.heavy 869.423 / 604.342 1422.0 17.18802499771118 43 17 10 6 10 2.5601419587896785 39.060334000883124 0.03930091857910156 3 0.9707983621861154 7.20437346970515 1422.0 13.241254779776236 0.0 - - - - - - - 115.125 2 16 SKI v-ski sarcoma viral oncogene homolog (avian) 1637 208 C20140716_OR021_03 C20140716_OR021_03 TB420337.[MT7]-TDDTSSQSPAPSEK[MT7].2y6_1.heavy 869.423 / 772.432 1653.0 17.18802499771118 43 17 10 6 10 2.5601419587896785 39.060334000883124 0.03930091857910156 3 0.9707983621861154 7.20437346970515 1653.0 21.825324675324673 0.0 - - - - - - - 108.27272727272727 3 11 SKI v-ski sarcoma viral oncogene homolog (avian) 1639 208 C20140716_OR021_03 C20140716_OR021_03 TB420337.[MT7]-TDDTSSQSPAPSEK[MT7].2y7_1.heavy 869.423 / 859.464 769.0 17.18802499771118 43 17 10 6 10 2.5601419587896785 39.060334000883124 0.03930091857910156 3 0.9707983621861154 7.20437346970515 769.0 15.979220779220778 0.0 - - - - - - - 0.0 1 0 SKI v-ski sarcoma viral oncogene homolog (avian) 1641 209 C20140716_OR021_03 C20140716_OR021_03 TB420131.[MT7]-VDGEISASHVSR.3y7_1.heavy 467.58 / 743.38 3724.0 22.342100143432617 44 20 6 10 8 3.1850914632671334 24.17879295026034 0.0 4 0.9910454892531508 13.032172829999595 3724.0 16.883414979435923 0.0 - - - - - - - 230.21428571428572 7 14 ROPN1 ropporin, rhophilin associated protein 1 1643 209 C20140716_OR021_03 C20140716_OR021_03 TB420131.[MT7]-VDGEISASHVSR.3b4_1.heavy 467.58 / 545.269 12247.0 22.342100143432617 44 20 6 10 8 3.1850914632671334 24.17879295026034 0.0 4 0.9910454892531508 13.032172829999595 12247.0 42.318865263725634 1.0 - - - - - - - 707.25 39 8 ROPN1 ropporin, rhophilin associated protein 1 1645 209 C20140716_OR021_03 C20140716_OR021_03 TB420131.[MT7]-VDGEISASHVSR.3b5_1.heavy 467.58 / 658.353 3080.0 22.342100143432617 44 20 6 10 8 3.1850914632671334 24.17879295026034 0.0 4 0.9910454892531508 13.032172829999595 3080.0 15.930038676407392 1.0 - - - - - - - 218.68421052631578 6 19 ROPN1 ropporin, rhophilin associated protein 1 1647 209 C20140716_OR021_03 C20140716_OR021_03 TB420131.[MT7]-VDGEISASHVSR.3y5_1.heavy 467.58 / 585.31 5801.0 22.342100143432617 44 20 6 10 8 3.1850914632671334 24.17879295026034 0.0 4 0.9910454892531508 13.032172829999595 5801.0 18.927853985362717 0.0 - - - - - - - 247.27272727272728 11 11 ROPN1 ropporin, rhophilin associated protein 1 1649 210 C20140716_OR021_03 C20140716_OR021_03 TB420336.[MT7]-TDDTSSQSPAPSEK[MT7].3y6_1.heavy 579.951 / 772.432 2921.0 17.18802499771118 46 20 10 6 10 9.390728124020228 10.648801528415392 0.03930091857910156 3 0.9981927052362967 29.02568279139614 2921.0 86.25235816814765 0.0 - - - - - - - 121.15384615384616 5 13 SKI v-ski sarcoma viral oncogene homolog (avian) 1651 210 C20140716_OR021_03 C20140716_OR021_03 TB420336.[MT7]-TDDTSSQSPAPSEK[MT7].3y3_1.heavy 579.951 / 507.289 3382.0 17.18802499771118 46 20 10 6 10 9.390728124020228 10.648801528415392 0.03930091857910156 3 0.9981927052362967 29.02568279139614 3382.0 16.321444155844155 0.0 - - - - - - - 194.33333333333334 6 18 SKI v-ski sarcoma viral oncogene homolog (avian) 1653 210 C20140716_OR021_03 C20140716_OR021_03 TB420336.[MT7]-TDDTSSQSPAPSEK[MT7].3y4_1.heavy 579.951 / 604.342 8378.0 17.18802499771118 46 20 10 6 10 9.390728124020228 10.648801528415392 0.03930091857910156 3 0.9981927052362967 29.02568279139614 8378.0 32.65873715862685 0.0 - - - - - - - 186.15384615384616 16 13 SKI v-ski sarcoma viral oncogene homolog (avian) 1655 210 C20140716_OR021_03 C20140716_OR021_03 TB420336.[MT7]-TDDTSSQSPAPSEK[MT7].3y5_1.heavy 579.951 / 675.379 1576.0 17.18802499771118 46 20 10 6 10 9.390728124020228 10.648801528415392 0.03930091857910156 3 0.9981927052362967 29.02568279139614 1576.0 8.108142826440698 0.0 - - - - - - - 170.21428571428572 3 14 SKI v-ski sarcoma viral oncogene homolog (avian) 1657 211 C20140716_OR021_03 C20140716_OR021_03 TB442157.[MT7]-TTK[MT7]PMAQR.3y5_1.heavy 407.572 / 602.308 34071.0 16.031200408935547 50 20 10 10 10 8.771231351399162 11.400907808006714 0.0 3 0.9983758295018292 30.618771570879982 34071.0 214.64159554730983 0.0 - - - - - - - 133.93333333333334 68 15 CSNK1G1 casein kinase 1, gamma 1 1659 211 C20140716_OR021_03 C20140716_OR021_03 TB442157.[MT7]-TTK[MT7]PMAQR.3y7_2.heavy 407.572 / 488.28 N/A 16.031200408935547 50 20 10 10 10 8.771231351399162 11.400907808006714 0.0 3 0.9983758295018292 30.618771570879982 13040.0 36.380639132695855 2.0 - - - - - - - 241.5 39 14 CSNK1G1 casein kinase 1, gamma 1 1661 211 C20140716_OR021_03 C20140716_OR021_03 TB442157.[MT7]-TTK[MT7]PMAQR.3b5_2.heavy 407.572 / 424.251 7206.0 16.031200408935547 50 20 10 10 10 8.771231351399162 11.400907808006714 0.0 3 0.9983758295018292 30.618771570879982 7206.0 64.7069387755102 0.0 - - - - - - - 224.3684210526316 14 19 CSNK1G1 casein kinase 1, gamma 1 1663 211 C20140716_OR021_03 C20140716_OR021_03 TB442157.[MT7]-TTK[MT7]PMAQR.3y4_1.heavy 407.572 / 505.255 3971.0 16.031200408935547 50 20 10 10 10 8.771231351399162 11.400907808006714 0.0 3 0.9983758295018292 30.618771570879982 3971.0 39.61140603920893 0.0 - - - - - - - 242.42105263157896 7 19 CSNK1G1 casein kinase 1, gamma 1 1665 212 C20140716_OR021_03 C20140716_OR021_03 TB442156.[MT7]-SPNMQDLK[MT7].3y3_1.heavy 407.556 / 519.326 18927.0 26.550474643707275 41 20 10 5 6 9.211505188167951 10.855989108973048 0.04509925842285156 5 0.9985472299852034 32.37511684757413 18927.0 103.96191340206185 0.0 - - - - - - - 318.7142857142857 37 7 RASL11A;RASL11B RAS-like, family 11, member A;RAS-like, family 11, member B 1667 212 C20140716_OR021_03 C20140716_OR021_03 TB442156.[MT7]-SPNMQDLK[MT7].3b4_1.heavy 407.556 / 574.278 4950.0 26.550474643707275 41 20 10 5 6 9.211505188167951 10.855989108973048 0.04509925842285156 5 0.9985472299852034 32.37511684757413 4950.0 16.04623598051433 2.0 - - - - - - - 229.27272727272728 30 11 RASL11A;RASL11B RAS-like, family 11, member A;RAS-like, family 11, member B 1669 212 C20140716_OR021_03 C20140716_OR021_03 TB442156.[MT7]-SPNMQDLK[MT7].3y4_1.heavy 407.556 / 647.385 2718.0 26.550474643707275 41 20 10 5 6 9.211505188167951 10.855989108973048 0.04509925842285156 5 0.9985472299852034 32.37511684757413 2718.0 15.996298969072164 0.0 - - - - - - - 194.0 5 10 RASL11A;RASL11B RAS-like, family 11, member A;RAS-like, family 11, member B 1671 212 C20140716_OR021_03 C20140716_OR021_03 TB442156.[MT7]-SPNMQDLK[MT7].3b3_1.heavy 407.556 / 443.237 42611.0 26.550474643707275 41 20 10 5 6 9.211505188167951 10.855989108973048 0.04509925842285156 5 0.9985472299852034 32.37511684757413 42611.0 169.56542268041235 0.0 - - - - - - - 351.625 85 8 RASL11A;RASL11B RAS-like, family 11, member A;RAS-like, family 11, member B 1673 213 C20140716_OR021_03 C20140716_OR021_03 TB442344.[MT7]-AFSYTWFNLQAR.2y8_1.heavy 824.424 / 1035.54 9786.0 46.061699867248535 40 14 10 6 10 3.1721826220452978 31.524036259780015 0.036800384521484375 3 0.9404999020666491 5.034151328193848 9786.0 0.0 1.0 - - - - - - - 243.33333333333334 19 9 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 1675 213 C20140716_OR021_03 C20140716_OR021_03 TB442344.[MT7]-AFSYTWFNLQAR.2y9_1.heavy 824.424 / 1198.6 1972.0 46.061699867248535 40 14 10 6 10 3.1721826220452978 31.524036259780015 0.036800384521484375 3 0.9404999020666491 5.034151328193848 1972.0 3.5889628180039135 0.0 - - - - - - - 243.33333333333334 3 12 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 1677 213 C20140716_OR021_03 C20140716_OR021_03 TB442344.[MT7]-AFSYTWFNLQAR.2y6_1.heavy 824.424 / 748.41 2410.0 46.061699867248535 40 14 10 6 10 3.1721826220452978 31.524036259780015 0.036800384521484375 3 0.9404999020666491 5.034151328193848 2410.0 2.701120797011208 0.0 - - - - - - - 204.4 4 10 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 1679 213 C20140716_OR021_03 C20140716_OR021_03 TB442344.[MT7]-AFSYTWFNLQAR.2y7_1.heavy 824.424 / 934.489 4455.0 46.061699867248535 40 14 10 6 10 3.1721826220452978 31.524036259780015 0.036800384521484375 3 0.9404999020666491 5.034151328193848 4455.0 12.978493150684931 0.0 - - - - - - - 202.77777777777777 8 9 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 1681 214 C20140716_OR021_03 C20140716_OR021_03 TB442151.[MT7]-GNEILELK[MT7].2y4_1.heavy 602.363 / 646.426 6800.0 34.20830154418945 37 17 2 10 8 2.585097930463636 30.829124135920768 0.0 4 0.9717608365546658 7.326711891981249 6800.0 19.790414102487233 0.0 - - - - - - - 287.3636363636364 13 11 TPR translocated promoter region (to activated MET oncogene) 1683 214 C20140716_OR021_03 C20140716_OR021_03 TB442151.[MT7]-GNEILELK[MT7].2b4_1.heavy 602.363 / 558.3 7566.0 34.20830154418945 37 17 2 10 8 2.585097930463636 30.829124135920768 0.0 4 0.9717608365546658 7.326711891981249 7566.0 5.062101432984455 1.0 - - - - - - - 1209.0 15 8 TPR translocated promoter region (to activated MET oncogene) 1685 214 C20140716_OR021_03 C20140716_OR021_03 TB442151.[MT7]-GNEILELK[MT7].2b6_1.heavy 602.363 / 800.427 3639.0 34.20830154418945 37 17 2 10 8 2.585097930463636 30.829124135920768 0.0 4 0.9717608365546658 7.326711891981249 3639.0 8.928846868748536 1.0 - - - - - - - 302.0 7 13 TPR translocated promoter region (to activated MET oncogene) 1687 214 C20140716_OR021_03 C20140716_OR021_03 TB442151.[MT7]-GNEILELK[MT7].2y3_1.heavy 602.363 / 533.341 4214.0 34.20830154418945 37 17 2 10 8 2.585097930463636 30.829124135920768 0.0 4 0.9717608365546658 7.326711891981249 4214.0 2.9498839030417976 2.0 - - - - - - - 1751.2857142857142 31 7 TPR translocated promoter region (to activated MET oncogene) 1689 215 C20140716_OR021_03 C20140716_OR021_03 TB442340.[MT7]-INVLDPGQWPSK[MT7].3y3_1.heavy 547.978 / 475.3 25213.0 40.07717418670654 41 15 10 6 10 4.401027003085011 22.721969197167493 0.038898468017578125 3 0.9583907236213386 6.029062378649783 25213.0 77.48385365853657 0.0 - - - - - - - 276.6 50 10 ZNFX1 zinc finger, NFX1-type containing 1 1691 215 C20140716_OR021_03 C20140716_OR021_03 TB442340.[MT7]-INVLDPGQWPSK[MT7].3b5_1.heavy 547.978 / 699.416 11889.0 40.07717418670654 41 15 10 6 10 4.401027003085011 22.721969197167493 0.038898468017578125 3 0.9583907236213386 6.029062378649783 11889.0 131.029175035868 0.0 - - - - - - - 256.0 23 8 ZNFX1 zinc finger, NFX1-type containing 1 1693 215 C20140716_OR021_03 C20140716_OR021_03 TB442340.[MT7]-INVLDPGQWPSK[MT7].3y4_1.heavy 547.978 / 661.379 2870.0 40.07717418670654 41 15 10 6 10 4.401027003085011 22.721969197167493 0.038898468017578125 3 0.9583907236213386 6.029062378649783 2870.0 6.768854166666666 0.0 - - - - - - - 170.66666666666666 5 9 ZNFX1 zinc finger, NFX1-type containing 1 1695 215 C20140716_OR021_03 C20140716_OR021_03 TB442340.[MT7]-INVLDPGQWPSK[MT7].3b8_1.heavy 547.978 / 981.549 1230.0 40.07717418670654 41 15 10 6 10 4.401027003085011 22.721969197167493 0.038898468017578125 3 0.9583907236213386 6.029062378649783 1230.0 7.68 0.0 - - - - - - - 193.44444444444446 2 9 ZNFX1 zinc finger, NFX1-type containing 1 1697 216 C20140716_OR021_03 C20140716_OR021_03 TB420364.[MT7]-SHLSLVGTASGLGSNK[MT7].4b4_1.heavy 454.76 / 569.316 1601.0 30.56322431564331 38 18 8 6 6 10.047502892072924 9.952721693555915 0.030500411987304688 5 0.9868185977623587 10.737504414215172 1601.0 19.05952380952381 2.0 - - - - - - - 246.15384615384616 4 13 ATXN7L3 ataxin 7-like 3 1699 216 C20140716_OR021_03 C20140716_OR021_03 TB420364.[MT7]-SHLSLVGTASGLGSNK[MT7].4b5_1.heavy 454.76 / 682.4 1095.0 30.56322431564331 38 18 8 6 6 10.047502892072924 9.952721693555915 0.030500411987304688 5 0.9868185977623587 10.737504414215172 1095.0 1.3035714285714284 1.0 - - - - - - - 142.9 2 10 ATXN7L3 ataxin 7-like 3 1701 216 C20140716_OR021_03 C20140716_OR021_03 TB420364.[MT7]-SHLSLVGTASGLGSNK[MT7].4b6_1.heavy 454.76 / 781.469 168.0 30.56322431564331 38 18 8 6 6 10.047502892072924 9.952721693555915 0.030500411987304688 5 0.9868185977623587 10.737504414215172 168.0 1.2976284584980238 18.0 - - - - - - - 0.0 1 0 ATXN7L3 ataxin 7-like 3 1703 216 C20140716_OR021_03 C20140716_OR021_03 TB420364.[MT7]-SHLSLVGTASGLGSNK[MT7].4b3_1.heavy 454.76 / 482.284 1011.0 30.56322431564331 38 18 8 6 6 10.047502892072924 9.952721693555915 0.030500411987304688 5 0.9868185977623587 10.737504414215172 1011.0 0.29920948616600773 3.0 - - - - - - - 187.05555555555554 2 18 ATXN7L3 ataxin 7-like 3 1705 217 C20140716_OR021_03 C20140716_OR021_03 TB435980.[MT7]-LWDFTQSGPIVSR.2b3_1.heavy 825.442 / 559.3 50317.0 42.66379928588867 43 13 10 10 10 1.4483285959771153 59.00718444694209 0.0 3 0.9222540868097204 4.397125689411973 50317.0 101.21140819672131 0.0 - - - - - - - 248.55555555555554 100 9 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1707 217 C20140716_OR021_03 C20140716_OR021_03 TB435980.[MT7]-LWDFTQSGPIVSR.2y10_1.heavy 825.442 / 1091.58 56517.0 42.66379928588867 43 13 10 10 10 1.4483285959771153 59.00718444694209 0.0 3 0.9222540868097204 4.397125689411973 56517.0 105.00522264604669 0.0 - - - - - - - 740.7142857142857 113 7 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1709 217 C20140716_OR021_03 C20140716_OR021_03 TB435980.[MT7]-LWDFTQSGPIVSR.2y11_1.heavy 825.442 / 1206.61 15349.0 42.66379928588867 43 13 10 10 10 1.4483285959771153 59.00718444694209 0.0 3 0.9222540868097204 4.397125689411973 15349.0 40.47959455273009 0.0 - - - - - - - 241.625 30 8 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1711 217 C20140716_OR021_03 C20140716_OR021_03 TB435980.[MT7]-LWDFTQSGPIVSR.2y7_1.heavy 825.442 / 715.41 12808.0 42.66379928588867 43 13 10 10 10 1.4483285959771153 59.00718444694209 0.0 3 0.9222540868097204 4.397125689411973 12808.0 132.43257545714914 0.0 - - - - - - - 233.9 25 10 GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) 1713 218 C20140716_OR021_03 C20140716_OR021_03 TB435788.[MT7]-AGPAPK[MT7].2y4_1.heavy 414.763 / 556.357 8455.0 15.36050033569336 48 20 10 10 8 8.40048224612273 11.904078488607643 0.0 4 0.9960330087689164 19.587908866917918 8455.0 70.18494714219331 1.0 - - - - - - - 192.06666666666666 19 15 PTGER4 prostaglandin E receptor 4 (subtype EP4) 1715 218 C20140716_OR021_03 C20140716_OR021_03 TB435788.[MT7]-AGPAPK[MT7].2y5_1.heavy 414.763 / 613.379 15680.0 15.36050033569336 48 20 10 10 8 8.40048224612273 11.904078488607643 0.0 4 0.9960330087689164 19.587908866917918 15680.0 51.535575146935344 0.0 - - - - - - - 162.0 31 14 PTGER4 prostaglandin E receptor 4 (subtype EP4) 1717 218 C20140716_OR021_03 C20140716_OR021_03 TB435788.[MT7]-AGPAPK[MT7].2b4_1.heavy 414.763 / 441.258 9070.0 15.36050033569336 48 20 10 10 8 8.40048224612273 11.904078488607643 0.0 4 0.9960330087689164 19.587908866917918 9070.0 52.984257428352976 0.0 - - - - - - - 284.0 18 18 PTGER4 prostaglandin E receptor 4 (subtype EP4) 1719 218 C20140716_OR021_03 C20140716_OR021_03 TB435788.[MT7]-AGPAPK[MT7].2b5_1.heavy 414.763 / 538.311 461.0 15.36050033569336 48 20 10 10 8 8.40048224612273 11.904078488607643 0.0 4 0.9960330087689164 19.587908866917918 461.0 1.4511400651465798 14.0 - - - - - - - 243.8695652173913 31 23 PTGER4 prostaglandin E receptor 4 (subtype EP4) 1721 219 C20140716_OR021_03 C20140716_OR021_03 TB442056.[MT7]-HFETSMIC[CAM]R.3y3_1.heavy 442.213 / 448.234 20231.0 27.25429916381836 48 18 10 10 10 4.968415049344413 20.127142963467815 0.0 3 0.9856409172859603 10.286745023122354 20231.0 252.45073402417967 0.0 - - - - - - - 282.14285714285717 40 14 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1723 219 C20140716_OR021_03 C20140716_OR021_03 TB442056.[MT7]-HFETSMIC[CAM]R.3b3_1.heavy 442.213 / 558.279 3468.0 27.25429916381836 48 18 10 10 10 4.968415049344413 20.127142963467815 0.0 3 0.9856409172859603 10.286745023122354 3468.0 3.952696978669876 1.0 - - - - - - - 234.07142857142858 8 14 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1725 219 C20140716_OR021_03 C20140716_OR021_03 TB442056.[MT7]-HFETSMIC[CAM]R.3y4_1.heavy 442.213 / 579.274 11946.0 27.25429916381836 48 18 10 10 10 4.968415049344413 20.127142963467815 0.0 3 0.9856409172859603 10.286745023122354 11946.0 172.04612694300516 0.0 - - - - - - - 163.7 23 10 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1727 219 C20140716_OR021_03 C20140716_OR021_03 TB442056.[MT7]-HFETSMIC[CAM]R.3y5_1.heavy 442.213 / 666.306 7900.0 27.25429916381836 48 18 10 10 10 4.968415049344413 20.127142963467815 0.0 3 0.9856409172859603 10.286745023122354 7900.0 61.57317532316188 0.0 - - - - - - - 180.625 15 8 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1729 220 C20140716_OR021_03 C20140716_OR021_03 TB442200.[MT7]-VNNLFNTQAR.2y8_1.heavy 660.861 / 963.501 23328.0 32.50077438354492 46 20 10 6 10 19.58932558735792 5.104820967626143 0.03070068359375 3 0.9938053803625774 15.672222959479322 23328.0 178.788641221374 0.0 - - - - - - - 203.91666666666666 46 12 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1731 220 C20140716_OR021_03 C20140716_OR021_03 TB442200.[MT7]-VNNLFNTQAR.2b4_1.heavy 660.861 / 585.348 34686.0 32.50077438354492 46 20 10 6 10 19.58932558735792 5.104820967626143 0.03070068359375 3 0.9938053803625774 15.672222959479322 34686.0 188.35216684841876 0.0 - - - - - - - 262.0 69 12 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1733 220 C20140716_OR021_03 C20140716_OR021_03 TB442200.[MT7]-VNNLFNTQAR.2y9_1.heavy 660.861 / 1077.54 120921.0 32.50077438354492 46 20 10 6 10 19.58932558735792 5.104820967626143 0.03070068359375 3 0.9938053803625774 15.672222959479322 120921.0 758.3707823992864 0.0 - - - - - - - 227.2 241 10 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1735 220 C20140716_OR021_03 C20140716_OR021_03 TB442200.[MT7]-VNNLFNTQAR.2y6_1.heavy 660.861 / 736.374 55655.0 32.50077438354492 46 20 10 6 10 19.58932558735792 5.104820967626143 0.03070068359375 3 0.9938053803625774 15.672222959479322 55655.0 363.03406506724826 0.0 - - - - - - - 197.86666666666667 111 15 SMPD3 sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) 1737 221 C20140716_OR021_03 C20140716_OR021_03 TB420027.[MT7]-IFQLSNNIR.2b3_1.heavy 624.863 / 533.32 10513.0 37.35300064086914 44 18 10 6 10 7.899340102604503 12.659285294860117 0.0391998291015625 3 0.9874591378670718 11.008895694228665 10513.0 17.483658712942876 0.0 - - - - - - - 768.5555555555555 21 9 USP29 ubiquitin specific peptidase 29 1739 221 C20140716_OR021_03 C20140716_OR021_03 TB420027.[MT7]-IFQLSNNIR.2y8_1.heavy 624.863 / 991.532 47769.0 37.35300064086914 44 18 10 6 10 7.899340102604503 12.659285294860117 0.0391998291015625 3 0.9874591378670718 11.008895694228665 47769.0 51.55650044350682 0.0 - - - - - - - 289.85714285714283 95 7 USP29 ubiquitin specific peptidase 29 1741 221 C20140716_OR021_03 C20140716_OR021_03 TB420027.[MT7]-IFQLSNNIR.2y6_1.heavy 624.863 / 716.405 9498.0 37.35300064086914 44 18 10 6 10 7.899340102604503 12.659285294860117 0.0391998291015625 3 0.9874591378670718 11.008895694228665 9498.0 17.56559249483029 0.0 - - - - - - - 250.21428571428572 18 14 USP29 ubiquitin specific peptidase 29 1743 221 C20140716_OR021_03 C20140716_OR021_03 TB420027.[MT7]-IFQLSNNIR.2y7_1.heavy 624.863 / 844.464 8853.0 37.35300064086914 44 18 10 6 10 7.899340102604503 12.659285294860117 0.0391998291015625 3 0.9874591378670718 11.008895694228665 8853.0 13.577924003707135 0.0 - - - - - - - 226.1818181818182 17 11 USP29 ubiquitin specific peptidase 29 1745 222 C20140716_OR021_03 C20140716_OR021_03 TB420025.[MT7]-IDRNPFAK[MT7].3y3_1.heavy 416.915 / 509.32 5386.0 27.91290044784546 38 12 10 6 10 0.7781013655883223 66.16438544412934 0.03800010681152344 3 0.893405556048703 3.7459296670620827 5386.0 3.1410098858277866 0.0 - - - - - - - 252.0 10 7 TBX15;TBX18 T-box 15;T-box 18 1747 222 C20140716_OR021_03 C20140716_OR021_03 TB420025.[MT7]-IDRNPFAK[MT7].3b4_1.heavy 416.915 / 643.364 2252.0 27.91290044784546 38 12 10 6 10 0.7781013655883223 66.16438544412934 0.03800010681152344 3 0.893405556048703 3.7459296670620827 2252.0 7.49134693877551 1.0 - - - - - - - 269.5 4 16 TBX15;TBX18 T-box 15;T-box 18 1749 222 C20140716_OR021_03 C20140716_OR021_03 TB420025.[MT7]-IDRNPFAK[MT7].3y7_2.heavy 416.915 / 496.276 6855.0 27.91290044784546 38 12 10 6 10 0.7781013655883223 66.16438544412934 0.03800010681152344 3 0.893405556048703 3.7459296670620827 6855.0 19.636581714899823 0.0 - - - - - - - 313.6 13 10 TBX15;TBX18 T-box 15;T-box 18 1751 222 C20140716_OR021_03 C20140716_OR021_03 TB420025.[MT7]-IDRNPFAK[MT7].3y4_1.heavy 416.915 / 606.373 5288.0 27.91290044784546 38 12 10 6 10 0.7781013655883223 66.16438544412934 0.03800010681152344 3 0.893405556048703 3.7459296670620827 5288.0 25.78772660052163 0.0 - - - - - - - 256.3076923076923 10 13 TBX15;TBX18 T-box 15;T-box 18 1753 223 C20140716_OR021_03 C20140716_OR021_03 TB420556.[MT7]-VQPQDLIQWAADYFEALSRGETPPVRER.4b7_1.heavy 854.693 / 938.543 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1 ropporin, rhophilin associated protein 1 1755 223 C20140716_OR021_03 C20140716_OR021_03 TB420556.[MT7]-VQPQDLIQWAADYFEALSRGETPPVRER.4b5_1.heavy 854.693 / 712.375 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1 ropporin, rhophilin associated protein 1 1757 223 C20140716_OR021_03 C20140716_OR021_03 TB420556.[MT7]-VQPQDLIQWAADYFEALSRGETPPVRER.4y18_2.heavy 854.693 / 1047.02 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1 ropporin, rhophilin associated protein 1 1759 223 C20140716_OR021_03 C20140716_OR021_03 TB420556.[MT7]-VQPQDLIQWAADYFEALSRGETPPVRER.4b6_1.heavy 854.693 / 825.459 N/A N/A - - - - - - - - - 0.0 - - - - - - - ROPN1 ropporin, rhophilin associated protein 1 1761 224 C20140716_OR021_03 C20140716_OR021_03 TB442205.[MT7]-HITSLEVIK[MT7].3b6_1.heavy 443.278 / 825.459 14790.0 30.40952491760254 39 13 10 6 10 4.545065677270222 22.001882283043322 0.03170013427734375 3 0.9214452831013932 4.374127037518654 14790.0 117.27562208198657 0.0 - - - - - - - 282.25 29 8 PF4;PF4V1 platelet factor 4;platelet factor 4 variant 1 1763 224 C20140716_OR021_03 C20140716_OR021_03 TB442205.[MT7]-HITSLEVIK[MT7].3y3_1.heavy 443.278 / 503.367 66808.0 30.40952491760254 39 13 10 6 10 4.545065677270222 22.001882283043322 0.03170013427734375 3 0.9214452831013932 4.374127037518654 66808.0 143.90641569459171 0.0 - - - - - - - 663.0 133 10 PF4;PF4V1 platelet factor 4;platelet factor 4 variant 1 1765 224 C20140716_OR021_03 C20140716_OR021_03 TB442205.[MT7]-HITSLEVIK[MT7].3b4_1.heavy 443.278 / 583.332 24188.0 30.40952491760254 39 13 10 6 10 4.545065677270222 22.001882283043322 0.03170013427734375 3 0.9214452831013932 4.374127037518654 24188.0 33.677066975321324 0.0 - - - - - - - 777.1111111111111 48 9 PF4;PF4V1 platelet factor 4;platelet factor 4 variant 1 1767 224 C20140716_OR021_03 C20140716_OR021_03 TB442205.[MT7]-HITSLEVIK[MT7].3y4_1.heavy 443.278 / 632.41 22221.0 30.40952491760254 39 13 10 6 10 4.545065677270222 22.001882283043322 0.03170013427734375 3 0.9214452831013932 4.374127037518654 22221.0 261.3846039309112 0.0 - - - - - - - 190.76923076923077 44 13 PF4;PF4V1 platelet factor 4;platelet factor 4 variant 1 1769 225 C20140716_OR021_03 C20140716_OR021_03 TB420023.[MT7]-DLLFSPDHR.3y3_1.heavy 415.223 / 427.205 5071.0 32.555599212646484 50 20 10 10 10 6.350047063739751 15.747914778620038 0.0 3 0.9937132546599075 15.556849414242572 5071.0 26.24352510234863 0.0 - - - - - - - 147.0625 10 16 PLXNA3 plexin A3 1771 225 C20140716_OR021_03 C20140716_OR021_03 TB420023.[MT7]-DLLFSPDHR.3y4_1.heavy 415.223 / 524.258 10214.0 32.555599212646484 50 20 10 10 10 6.350047063739751 15.747914778620038 0.0 3 0.9937132546599075 15.556849414242572 10214.0 111.76589896085224 0.0 - - - - - - - 169.5625 20 16 PLXNA3 plexin A3 1773 225 C20140716_OR021_03 C20140716_OR021_03 TB420023.[MT7]-DLLFSPDHR.3b3_1.heavy 415.223 / 486.304 15714.0 32.555599212646484 50 20 10 10 10 6.350047063739751 15.747914778620038 0.0 3 0.9937132546599075 15.556849414242572 15714.0 101.6465034965035 0.0 - - - - - - - 208.33333333333334 31 12 PLXNA3 plexin A3 1775 225 C20140716_OR021_03 C20140716_OR021_03 TB420023.[MT7]-DLLFSPDHR.3y5_1.heavy 415.223 / 611.29 3214.0 32.555599212646484 50 20 10 10 10 6.350047063739751 15.747914778620038 0.0 3 0.9937132546599075 15.556849414242572 3214.0 38.42998128631931 0.0 - - - - - - - 122.14285714285714 6 7 PLXNA3 plexin A3 1777 226 C20140716_OR021_03 C20140716_OR021_03 TB435989.[MT7]-DELLGEK[MT7]PEIK[MT7].3b4_1.heavy 568.337 / 615.347 5417.0 30.631449699401855 41 14 10 7 10 1.2426117845939846 51.5885808369729 0.029500961303710938 3 0.941209961444809 5.0647673798417925 5417.0 9.6773044397463 1.0 - - - - - - - 265.1666666666667 18 12 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 1779 226 C20140716_OR021_03 C20140716_OR021_03 TB435989.[MT7]-DELLGEK[MT7]PEIK[MT7].3b3_1.heavy 568.337 / 502.263 13758.0 30.631449699401855 41 14 10 7 10 1.2426117845939846 51.5885808369729 0.029500961303710938 3 0.941209961444809 5.0647673798417925 13758.0 36.96432346723044 1.0 - - - - - - - 723.8333333333334 27 12 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 1781 226 C20140716_OR021_03 C20140716_OR021_03 TB435989.[MT7]-DELLGEK[MT7]PEIK[MT7].3y4_1.heavy 568.337 / 630.394 23217.0 30.631449699401855 41 14 10 7 10 1.2426117845939846 51.5885808369729 0.029500961303710938 3 0.941209961444809 5.0647673798417925 23217.0 134.9825581395349 0.0 - - - - - - - 281.8888888888889 46 18 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 1783 226 C20140716_OR021_03 C20140716_OR021_03 TB435989.[MT7]-DELLGEK[MT7]PEIK[MT7].3b7_2.heavy 568.337 / 537.308 16510.0 30.631449699401855 41 14 10 7 10 1.2426117845939846 51.5885808369729 0.029500961303710938 3 0.941209961444809 5.0647673798417925 16510.0 45.660930232558144 0.0 - - - - - - - 662.2 33 10 NFIX nuclear factor I/X (CCAAT-binding transcription factor) 1785 227 C20140716_OR021_03 C20140716_OR021_03 TB420021.[MT7]-IPGLLNQTSR.2y8_1.heavy 621.868 / 888.49 18478.0 34.663400650024414 45 20 10 5 10 5.451826866560221 14.050485538201329 0.040798187255859375 3 0.9969103371063607 22.197033587382226 18478.0 197.74701754385964 0.0 - - - - - - - 239.69230769230768 36 13 THPO thrombopoietin 1787 227 C20140716_OR021_03 C20140716_OR021_03 TB420021.[MT7]-IPGLLNQTSR.2y5_1.heavy 621.868 / 605.3 18934.0 34.663400650024414 45 20 10 5 10 5.451826866560221 14.050485538201329 0.040798187255859375 3 0.9969103371063607 22.197033587382226 18934.0 34.44442978611212 0.0 - - - - - - - 725.4545454545455 37 11 THPO thrombopoietin 1789 227 C20140716_OR021_03 C20140716_OR021_03 TB420021.[MT7]-IPGLLNQTSR.2y9_1.heavy 621.868 / 985.542 563675.0 34.663400650024414 45 20 10 5 10 5.451826866560221 14.050485538201329 0.040798187255859375 3 0.9969103371063607 22.197033587382226 563675.0 1055.3300197783715 0.0 - - - - - - - 405.3333333333333 1127 3 THPO thrombopoietin 1791 227 C20140716_OR021_03 C20140716_OR021_03 TB420021.[MT7]-IPGLLNQTSR.2y6_1.heavy 621.868 / 718.384 16881.0 34.663400650024414 45 20 10 5 10 5.451826866560221 14.050485538201329 0.040798187255859375 3 0.9969103371063607 22.197033587382226 16881.0 40.36454827650111 0.0 - - - - - - - 247.0 33 12 THPO thrombopoietin 1793 228 C20140716_OR021_03 C20140716_OR021_03 TB420369.[MT7]-FLALAC[CAM]SALGVTITK[MT7].3y6_1.heavy 618.365 / 762.484 16205.0 48.980201721191406 44 14 10 10 10 2.007877699167713 39.33858923691306 0.0 3 0.9447646709118362 5.226781034727628 16205.0 30.252855202390656 0.0 - - - - - - - 783.2857142857143 32 7 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1795 228 C20140716_OR021_03 C20140716_OR021_03 TB420369.[MT7]-FLALAC[CAM]SALGVTITK[MT7].3b4_1.heavy 618.365 / 589.383 21770.0 48.980201721191406 44 14 10 10 10 2.007877699167713 39.33858923691306 0.0 3 0.9447646709118362 5.226781034727628 21770.0 25.71206140350877 0.0 - - - - - - - 280.85714285714283 43 7 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1797 228 C20140716_OR021_03 C20140716_OR021_03 TB420369.[MT7]-FLALAC[CAM]SALGVTITK[MT7].3b5_1.heavy 618.365 / 660.42 14977.0 48.980201721191406 44 14 10 10 10 2.007877699167713 39.33858923691306 0.0 3 0.9447646709118362 5.226781034727628 14977.0 37.344685835453774 0.0 - - - - - - - 678.2857142857143 29 7 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1799 228 C20140716_OR021_03 C20140716_OR021_03 TB420369.[MT7]-FLALAC[CAM]SALGVTITK[MT7].3y4_1.heavy 618.365 / 606.394 27172.0 48.980201721191406 44 14 10 10 10 2.007877699167713 39.33858923691306 0.0 3 0.9447646709118362 5.226781034727628 27172.0 61.989045107980374 0.0 - - - - - - - 724.8571428571429 54 7 ROPN1B;ROPN1 ropporin, rhophilin associated protein 1B;ropporin, rhophilin associated protein 1 1801 229 C20140716_OR021_03 C20140716_OR021_03 TB420163.[MT7]-HK[MT7]YETALK[MT7].2y4_1.heavy 711.427 / 576.384 N/A N/A - - - - - - - - - 0.0 - - - - - - - WNT9A wingless-type MMTV integration site family, member 9A 1803 229 C20140716_OR021_03 C20140716_OR021_03 TB420163.[MT7]-HK[MT7]YETALK[MT7].2y6_1.heavy 711.427 / 868.49 N/A N/A - - - - - - - - - 0.0 - - - - - - - WNT9A wingless-type MMTV integration site family, member 9A 1805 229 C20140716_OR021_03 C20140716_OR021_03 TB420163.[MT7]-HK[MT7]YETALK[MT7].2b7_1.heavy 711.427 / 1131.64 N/A N/A - - - - - - - - - 0.0 - - - - - - - WNT9A wingless-type MMTV integration site family, member 9A 1807 229 C20140716_OR021_03 C20140716_OR021_03 TB420163.[MT7]-HK[MT7]YETALK[MT7].2y7_1.heavy 711.427 / 1140.69 N/A N/A - - - - - - - - - 0.0 - - - - - - - WNT9A wingless-type MMTV integration site family, member 9A 1809 230 C20140716_OR021_03 C20140716_OR021_03 TB420415.[MT7]-VALC[CAM]NRAELTPELLK[MT7].3y3_1.heavy 672.39 / 517.383 25433.0 36.69340133666992 47 17 10 10 10 3.0430626293150222 26.200980196118856 0.0 3 0.9792226517896725 8.546975764216521 25433.0 27.09639077053032 0.0 - - - - - - - 353.25 50 8 ROPN1 ropporin, rhophilin associated protein 1 1811 230 C20140716_OR021_03 C20140716_OR021_03 TB420415.[MT7]-VALC[CAM]NRAELTPELLK[MT7].3y14_2.heavy 672.39 / 886.497 32082.0 36.69340133666992 47 17 10 10 10 3.0430626293150222 26.200980196118856 0.0 3 0.9792226517896725 8.546975764216521 32082.0 68.79790016122472 0.0 - - - - - - - 332.38461538461536 64 13 ROPN1 ropporin, rhophilin associated protein 1 1813 230 C20140716_OR021_03 C20140716_OR021_03 TB420415.[MT7]-VALC[CAM]NRAELTPELLK[MT7].3y5_1.heavy 672.39 / 743.478 36487.0 36.69340133666992 47 17 10 10 10 3.0430626293150222 26.200980196118856 0.0 3 0.9792226517896725 8.546975764216521 36487.0 58.34770189362294 0.0 - - - - - - - 287.1818181818182 72 11 ROPN1 ropporin, rhophilin associated protein 1 1815 230 C20140716_OR021_03 C20140716_OR021_03 TB420415.[MT7]-VALC[CAM]NRAELTPELLK[MT7].3b8_2.heavy 672.39 / 529.78 24020.0 36.69340133666992 47 17 10 10 10 3.0430626293150222 26.200980196118856 0.0 3 0.9792226517896725 8.546975764216521 24020.0 76.33706552706552 0.0 - - - - - - - 313.3076923076923 48 13 ROPN1 ropporin, rhophilin associated protein 1 1817 231 C20140716_OR021_03 C20140716_OR021_03 TB442158.[MT7]-ASGAGGSDPLPR.2b8_1.heavy 614.824 / 747.339 54129.0 23.06215000152588 46 20 10 6 10 8.150157380463822 12.26970171639913 0.033000946044921875 3 0.992465100495411 14.208576273938922 54129.0 172.94822212469342 0.0 - - - - - - - 314.4 108 10 WNT9A wingless-type MMTV integration site family, member 9A 1819 231 C20140716_OR021_03 C20140716_OR021_03 TB442158.[MT7]-ASGAGGSDPLPR.2y8_1.heavy 614.824 / 798.41 5051.0 23.06215000152588 46 20 10 6 10 8.150157380463822 12.26970171639913 0.033000946044921875 3 0.992465100495411 14.208576273938922 5051.0 1.1156267255659855 1.0 - - - - - - - 234.0 10 11 WNT9A wingless-type MMTV integration site family, member 9A 1821 231 C20140716_OR021_03 C20140716_OR021_03 TB442158.[MT7]-ASGAGGSDPLPR.2b6_1.heavy 614.824 / 545.28 3240.0 23.06215000152588 46 20 10 6 10 8.150157380463822 12.26970171639913 0.033000946044921875 3 0.992465100495411 14.208576273938922 3240.0 8.260420970617055 0.0 - - - - - - - 750.625 6 8 WNT9A wingless-type MMTV integration site family, member 9A 1823 231 C20140716_OR021_03 C20140716_OR021_03 TB442158.[MT7]-ASGAGGSDPLPR.2y11_1.heavy 614.824 / 1013.5 13532.0 23.06215000152588 46 20 10 6 10 8.150157380463822 12.26970171639913 0.033000946044921875 3 0.992465100495411 14.208576273938922 13532.0 40.2119607255284 0.0 - - - - - - - 306.8888888888889 27 9 WNT9A wingless-type MMTV integration site family, member 9A 1825 232 C20140716_OR021_03 C20140716_OR021_03 TB442333.[MT7]-VQTIIEHLQEK[MT7].2y4_1.heavy 813.477 / 661.4 1473.0 36.984901428222656 40 10 10 10 10 1.3550221127326527 49.197778335057606 0.0 3 0.8477850774256909 3.1222264138715325 1473.0 1.6234871180347512 1.0 - - - - - - - 283.55555555555554 3 9 ZNFX1 zinc finger, NFX1-type containing 1 1827 232 C20140716_OR021_03 C20140716_OR021_03 TB442333.[MT7]-VQTIIEHLQEK[MT7].2y5_1.heavy 813.477 / 798.459 1963.0 36.984901428222656 40 10 10 10 10 1.3550221127326527 49.197778335057606 0.0 3 0.8477850774256909 3.1222264138715325 1963.0 5.518358818508858 1.0 - - - - - - - 283.77777777777777 3 9 ZNFX1 zinc finger, NFX1-type containing 1 1829 232 C20140716_OR021_03 C20140716_OR021_03 TB442333.[MT7]-VQTIIEHLQEK[MT7].2b4_1.heavy 813.477 / 586.368 1963.0 36.984901428222656 40 10 10 10 10 1.3550221127326527 49.197778335057606 0.0 3 0.8477850774256909 3.1222264138715325 1963.0 8.319925148742882 0.0 - - - - - - - 226.53846153846155 3 13 ZNFX1 zinc finger, NFX1-type containing 1 1831 232 C20140716_OR021_03 C20140716_OR021_03 TB442333.[MT7]-VQTIIEHLQEK[MT7].2y7_1.heavy 813.477 / 1040.59 5007.0 36.984901428222656 40 10 10 10 10 1.3550221127326527 49.197778335057606 0.0 3 0.8477850774256909 3.1222264138715325 5007.0 17.2039444523646 0.0 - - - - - - - 227.1875 10 16 ZNFX1 zinc finger, NFX1-type containing 1 1833 233 C20140716_OR021_03 C20140716_OR021_03 TB420420.[MT7]-HTVIAAQSLEALSGLQK[MT7].4y4_1.heavy 514.302 / 589.379 2160.0 38.57987594604492 29 11 6 6 6 0.7514208050153116 66.75370599870087 0.0363006591796875 5 0.8580763939317609 3.2363802029832214 2160.0 9.191489361702128 2.0 - - - - - - - 238.13333333333333 5 15 SRCIN1 SRC kinase signaling inhibitor 1 1835 233 C20140716_OR021_03 C20140716_OR021_03 TB420420.[MT7]-HTVIAAQSLEALSGLQK[MT7].4y5_1.heavy 514.302 / 676.411 3569.0 38.57987594604492 29 11 6 6 6 0.7514208050153116 66.75370599870087 0.0363006591796875 5 0.8580763939317609 3.2363802029832214 3569.0 43.66329787234042 0.0 - - - - - - - 176.25 7 8 SRCIN1 SRC kinase signaling inhibitor 1 1837 233 C20140716_OR021_03 C20140716_OR021_03 TB420420.[MT7]-HTVIAAQSLEALSGLQK[MT7].4b5_1.heavy 514.302 / 666.406 1315.0 38.57987594604492 29 11 6 6 6 0.7514208050153116 66.75370599870087 0.0363006591796875 5 0.8580763939317609 3.2363802029832214 1315.0 5.106117021276596 1.0 - - - - - - - 235.0 10 14 SRCIN1 SRC kinase signaling inhibitor 1 1839 233 C20140716_OR021_03 C20140716_OR021_03 TB420420.[MT7]-HTVIAAQSLEALSGLQK[MT7].4b6_1.heavy 514.302 / 737.443 845.0 38.57987594604492 29 11 6 6 6 0.7514208050153116 66.75370599870087 0.0363006591796875 5 0.8580763939317609 3.2363802029832214 845.0 3.745567375886525 3.0 - - - - - - - 216.92307692307693 3 13 SRCIN1 SRC kinase signaling inhibitor 1 1841 234 C20140716_OR021_03 C20140716_OR021_03 TB420353.[MT7]-HTQGAQPGLADQAAK[MT7].3y6_1.heavy 594.323 / 747.412 4167.0 19.73794937133789 44 18 10 6 10 15.467146865466217 6.4653165105241115 0.036899566650390625 3 0.985157406497634 10.117397982108779 4167.0 12.15995346904861 0.0 - - - - - - - 227.91666666666666 8 12 SRCIN1 SRC kinase signaling inhibitor 1 1843 234 C20140716_OR021_03 C20140716_OR021_03 TB420353.[MT7]-HTQGAQPGLADQAAK[MT7].3b6_1.heavy 594.323 / 767.392 9267.0 19.73794937133789 44 18 10 6 10 15.467146865466217 6.4653165105241115 0.036899566650390625 3 0.985157406497634 10.117397982108779 9267.0 115.33794203898569 0.0 - - - - - - - 111.73333333333333 18 15 SRCIN1 SRC kinase signaling inhibitor 1 1845 234 C20140716_OR021_03 C20140716_OR021_03 TB420353.[MT7]-HTQGAQPGLADQAAK[MT7].3b4_1.heavy 594.323 / 568.296 3669.0 19.73794937133789 44 18 10 6 10 15.467146865466217 6.4653165105241115 0.036899566650390625 3 0.985157406497634 10.117397982108779 3669.0 4.718971061093248 0.0 - - - - - - - 224.55555555555554 7 18 SRCIN1 SRC kinase signaling inhibitor 1 1847 234 C20140716_OR021_03 C20140716_OR021_03 TB420353.[MT7]-HTQGAQPGLADQAAK[MT7].3b5_1.heavy 594.323 / 639.333 5535.0 19.73794937133789 44 18 10 6 10 15.467146865466217 6.4653165105241115 0.036899566650390625 3 0.985157406497634 10.117397982108779 5535.0 21.94804203031695 0.0 - - - - - - - 162.76923076923077 11 13 SRCIN1 SRC kinase signaling inhibitor 1 1849 235 C20140716_OR021_03 C20140716_OR021_03 TB420354.[MT7]-IC[CAM]LDLQALLY[MT7]K[MT7].4y5_2.heavy 446.269 / 448.296 2786.0 45.28754997253418 37 11 10 6 10 1.7728174572123576 56.407386780387206 0.036899566650390625 3 0.8705527913777766 3.392468709770238 2786.0 0.0 0.0 - - - - - - - 413.0 5 1 PF4V1 platelet factor 4 variant 1 1851 235 C20140716_OR021_03 C20140716_OR021_03 TB420354.[MT7]-IC[CAM]LDLQALLY[MT7]K[MT7].4b4_1.heavy 446.269 / 646.335 2993.0 45.28754997253418 37 11 10 6 10 1.7728174572123576 56.407386780387206 0.036899566650390625 3 0.8705527913777766 3.392468709770238 2993.0 -2.9058252427184463 0.0 - - - - - - - 206.25 5 4 PF4V1 platelet factor 4 variant 1 1853 235 C20140716_OR021_03 C20140716_OR021_03 TB420354.[MT7]-IC[CAM]LDLQALLY[MT7]K[MT7].4y3_1.heavy 446.269 / 711.464 516.0 45.28754997253418 37 11 10 6 10 1.7728174572123576 56.407386780387206 0.036899566650390625 3 0.8705527913777766 3.392468709770238 516.0 0.0 1.0 - - - - - - - 0.0 1 0 PF4V1 platelet factor 4 variant 1 1855 235 C20140716_OR021_03 C20140716_OR021_03 TB420354.[MT7]-IC[CAM]LDLQALLY[MT7]K[MT7].4b3_1.heavy 446.269 / 531.308 1032.0 45.28754997253418 37 11 10 6 10 1.7728174572123576 56.407386780387206 0.036899566650390625 3 0.8705527913777766 3.392468709770238 1032.0 -0.23303225806451655 0.0 - - - - - - - 258.0 2 2 PF4V1 platelet factor 4 variant 1 1857 236 C20140716_OR021_03 C20140716_OR021_03 TB435996.[MT7]-RLC[CAM]LPQILNSVLR.3b6_1.heavy 576.014 / 912.521 10371.0 48.41752529144287 40 14 10 6 10 2.2214593919232266 35.721727100342804 0.036701202392578125 3 0.9443578207307413 5.207456888762189 10371.0 136.83690380236828 0.0 - - - - - - - 406.25 20 4 SKI v-ski sarcoma viral oncogene homolog (avian) 1859 236 C20140716_OR021_03 C20140716_OR021_03 TB435996.[MT7]-RLC[CAM]LPQILNSVLR.3y6_1.heavy 576.014 / 701.43 14474.0 48.41752529144287 40 14 10 6 10 2.2214593919232266 35.721727100342804 0.036701202392578125 3 0.9443578207307413 5.207456888762189 14474.0 92.44683870967741 1.0 - - - - - - - 257.8333333333333 28 6 SKI v-ski sarcoma viral oncogene homolog (avian) 1861 236 C20140716_OR021_03 C20140716_OR021_03 TB435996.[MT7]-RLC[CAM]LPQILNSVLR.3b4_1.heavy 576.014 / 687.409 11455.0 48.41752529144287 40 14 10 6 10 2.2214593919232266 35.721727100342804 0.036701202392578125 3 0.9443578207307413 5.207456888762189 11455.0 142.81558441558442 1.0 - - - - - - - 170.2 22 5 SKI v-ski sarcoma viral oncogene homolog (avian) 1863 236 C20140716_OR021_03 C20140716_OR021_03 TB435996.[MT7]-RLC[CAM]LPQILNSVLR.3y5_1.heavy 576.014 / 588.346 23684.0 48.41752529144287 40 14 10 6 10 2.2214593919232266 35.721727100342804 0.036701202392578125 3 0.9443578207307413 5.207456888762189 23684.0 6.324233647375505 1.0 - - - - - - - 283.8333333333333 47 6 SKI v-ski sarcoma viral oncogene homolog (avian) 1865 237 C20140716_OR021_03 C20140716_OR021_03 TB435997.[MT7]-MEEMSLSGLDNSK[MT7].2b3_1.heavy 864.923 / 534.235 9977.0 35.14979934692383 43 13 10 10 10 1.3324018212451747 60.97834666991425 0.0 3 0.9094838216459384 4.070686111220947 9977.0 52.706324805365185 1.0 - - - - - - - 232.6153846153846 22 13 ATXN7L3 ataxin 7-like 3 1867 237 C20140716_OR021_03 C20140716_OR021_03 TB435997.[MT7]-MEEMSLSGLDNSK[MT7].2y9_1.heavy 864.923 / 1064.57 8238.0 35.14979934692383 43 13 10 10 10 1.3324018212451747 60.97834666991425 0.0 3 0.9094838216459384 4.070686111220947 8238.0 52.596845093475864 0.0 - - - - - - - 224.8181818181818 16 11 ATXN7L3 ataxin 7-like 3 1869 237 C20140716_OR021_03 C20140716_OR021_03 TB435997.[MT7]-MEEMSLSGLDNSK[MT7].2b4_1.heavy 864.923 / 665.276 5584.0 35.14979934692383 43 13 10 10 10 1.3324018212451747 60.97834666991425 0.0 3 0.9094838216459384 4.070686111220947 5584.0 36.87154667826057 0.0 - - - - - - - 192.5 11 10 ATXN7L3 ataxin 7-like 3 1871 237 C20140716_OR021_03 C20140716_OR021_03 TB435997.[MT7]-MEEMSLSGLDNSK[MT7].2y10_1.heavy 864.923 / 1195.61 1648.0 35.14979934692383 43 13 10 10 10 1.3324018212451747 60.97834666991425 0.0 3 0.9094838216459384 4.070686111220947 1648.0 3.4010928961748634 0.0 - - - - - - - 176.30769230769232 3 13 ATXN7L3 ataxin 7-like 3 1873 238 C20140716_OR021_03 C20140716_OR021_03 TB435995.[MT7]-C[CAM]LSLVPSVMGQLK[MT7].2b3_1.heavy 860.491 / 505.256 1521.0 41.39794921875 32 13 8 5 6 1.4498789105405767 48.73967937820099 0.04270172119140625 6 0.909832769017351 4.07867797035549 1521.0 2.241473684210526 3.0 - - - - - - - 300.8333333333333 3 12 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1875 238 C20140716_OR021_03 C20140716_OR021_03 TB435995.[MT7]-C[CAM]LSLVPSVMGQLK[MT7].2y8_1.heavy 860.491 / 1003.57 7987.0 41.39794921875 32 13 8 5 6 1.4498789105405767 48.73967937820099 0.04270172119140625 6 0.909832769017351 4.07867797035549 7987.0 48.76273684210527 2.0 - - - - - - - 285.0 20 9 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1877 238 C20140716_OR021_03 C20140716_OR021_03 TB435995.[MT7]-C[CAM]LSLVPSVMGQLK[MT7].2y5_1.heavy 860.491 / 720.419 1616.0 41.39794921875 32 13 8 5 6 1.4498789105405767 48.73967937820099 0.04270172119140625 6 0.909832769017351 4.07867797035549 1616.0 2.1521892351386143 4.0 - - - - - - - 258.6111111111111 5 18 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1879 238 C20140716_OR021_03 C20140716_OR021_03 TB435995.[MT7]-C[CAM]LSLVPSVMGQLK[MT7].2b4_1.heavy 860.491 / 618.34 666.0 41.39794921875 32 13 8 5 6 1.4498789105405767 48.73967937820099 0.04270172119140625 6 0.909832769017351 4.07867797035549 666.0 0.595222125959119 31.0 - - - - - - - 291.3333333333333 4 15 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1881 239 C20140716_OR021_03 C20140716_OR021_03 TB420013.[MT7]-SPNMQDLK[MT7].2y5_1.heavy 610.831 / 778.425 7367.0 26.539199829101562 45 15 10 10 10 2.264218553601578 33.74346325464886 0.0 3 0.9585292840837327 6.039196835736625 7367.0 6.26718252479228 0.0 - - - - - - - 248.6 14 5 RASL11A;RASL11B RAS-like, family 11, member A;RAS-like, family 11, member B 1883 239 C20140716_OR021_03 C20140716_OR021_03 TB420013.[MT7]-SPNMQDLK[MT7].2b6_1.heavy 610.831 / 817.363 20282.0 26.539199829101562 45 15 10 10 10 2.264218553601578 33.74346325464886 0.0 3 0.9585292840837327 6.039196835736625 20282.0 211.47752847274086 0.0 - - - - - - - 177.71428571428572 40 7 RASL11A;RASL11B RAS-like, family 11, member A;RAS-like, family 11, member B 1885 239 C20140716_OR021_03 C20140716_OR021_03 TB420013.[MT7]-SPNMQDLK[MT7].2y3_1.heavy 610.831 / 519.326 12246.0 26.539199829101562 45 15 10 10 10 2.264218553601578 33.74346325464886 0.0 3 0.9585292840837327 6.039196835736625 12246.0 25.036124256435393 0.0 - - - - - - - 239.33333333333334 24 6 RASL11A;RASL11B RAS-like, family 11, member A;RAS-like, family 11, member B 1887 239 C20140716_OR021_03 C20140716_OR021_03 TB420013.[MT7]-SPNMQDLK[MT7].2y7_1.heavy 610.831 / 989.521 88018.0 26.539199829101562 45 15 10 10 10 2.264218553601578 33.74346325464886 0.0 3 0.9585292840837327 6.039196835736625 88018.0 954.5950914131812 0.0 - - - - - - - 115.0 176 5 RASL11A;RASL11B RAS-like, family 11, member A;RAS-like, family 11, member B 1889 240 C20140716_OR021_03 C20140716_OR021_03 TB435998.[MT7]-MEEMSLSGLDNSK[MT7].3b4_1.heavy 576.951 / 665.276 29902.0 35.14979934692383 45 15 10 10 10 2.294441071129305 34.606868922213565 0.0 3 0.9595703065146081 6.116992923862178 29902.0 76.21754049199781 0.0 - - - - - - - 288.5833333333333 59 12 ATXN7L3 ataxin 7-like 3 1891 240 C20140716_OR021_03 C20140716_OR021_03 TB435998.[MT7]-MEEMSLSGLDNSK[MT7].3b5_1.heavy 576.951 / 752.307 36192.0 35.14979934692383 45 15 10 10 10 2.294441071129305 34.606868922213565 0.0 3 0.9595703065146081 6.116992923862178 36192.0 209.74726329188292 0.0 - - - - - - - 255.0 72 10 ATXN7L3 ataxin 7-like 3 1893 240 C20140716_OR021_03 C20140716_OR021_03 TB435998.[MT7]-MEEMSLSGLDNSK[MT7].3y4_1.heavy 576.951 / 607.317 73113.0 35.14979934692383 45 15 10 10 10 2.294441071129305 34.606868922213565 0.0 3 0.9595703065146081 6.116992923862178 73113.0 178.08711362039543 0.0 - - - - - - - 774.7 146 10 ATXN7L3 ataxin 7-like 3 1895 240 C20140716_OR021_03 C20140716_OR021_03 TB435998.[MT7]-MEEMSLSGLDNSK[MT7].3b3_1.heavy 576.951 / 534.235 62720.0 35.14979934692383 45 15 10 10 10 2.294441071129305 34.606868922213565 0.0 3 0.9595703065146081 6.116992923862178 62720.0 64.25190116964977 0.0 - - - - - - - 273.0 125 1 ATXN7L3 ataxin 7-like 3 1897 241 C20140716_OR021_03 C20140716_OR021_03 TB420213.[MT7]-IDETSEQEQK[MT7].2b3_1.heavy 747.88 / 502.263 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1899 241 C20140716_OR021_03 C20140716_OR021_03 TB420213.[MT7]-IDETSEQEQK[MT7].2y8_1.heavy 747.88 / 1122.54 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1901 241 C20140716_OR021_03 C20140716_OR021_03 TB420213.[MT7]-IDETSEQEQK[MT7].2y9_1.heavy 747.88 / 1237.57 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1903 241 C20140716_OR021_03 C20140716_OR021_03 TB420213.[MT7]-IDETSEQEQK[MT7].2y6_1.heavy 747.88 / 892.449 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1905 242 C20140716_OR021_03 C20140716_OR021_03 TB420216.[MT7]-FFPNVYALLK[MT7].2y4_1.heavy 750.447 / 588.42 1355.0 50.910250663757324 32 12 10 6 4 2.01578859983745 49.60837659666487 0.033802032470703125 7 0.8885805734356803 3.6623893451885126 1355.0 2.242080203651906 6.0 - - - - - - - 257.25 3 12 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1907 242 C20140716_OR021_03 C20140716_OR021_03 TB420216.[MT7]-FFPNVYALLK[MT7].2y8_1.heavy 750.447 / 1061.65 6172.0 50.910250663757324 32 12 10 6 4 2.01578859983745 49.60837659666487 0.033802032470703125 7 0.8885805734356803 3.6623893451885126 6172.0 -10.923893805309735 0.0 - - - - - - - 150.7 12 10 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1909 242 C20140716_OR021_03 C20140716_OR021_03 TB420216.[MT7]-FFPNVYALLK[MT7].2y9_1.heavy 750.447 / 1208.72 602.0 50.910250663757324 32 12 10 6 4 2.01578859983745 49.60837659666487 0.033802032470703125 7 0.8885805734356803 3.6623893451885126 602.0 -0.5 24.0 - - - - - - - 150.5 5 14 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1911 242 C20140716_OR021_03 C20140716_OR021_03 TB420216.[MT7]-FFPNVYALLK[MT7].2y3_1.heavy 750.447 / 517.383 1731.0 50.910250663757324 32 12 10 6 4 2.01578859983745 49.60837659666487 0.033802032470703125 7 0.8885805734356803 3.6623893451885126 1731.0 3.4479537235762794 2.0 - - - - - - - 225.78571428571428 5 14 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1913 243 C20140716_OR021_03 C20140716_OR021_03 TB420215.[MT7]-FFPNVYALLK[MT7].3y3_1.heavy 500.634 / 517.383 3544.0 50.918701171875 43 13 10 10 10 3.3039281142833516 24.178189406572315 0.0 3 0.9077821878437378 4.032362659489497 3544.0 -9.450666666666663 0.0 - - - - - - - 226.0 7 6 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1915 243 C20140716_OR021_03 C20140716_OR021_03 TB420215.[MT7]-FFPNVYALLK[MT7].3b4_1.heavy 500.634 / 650.342 3393.0 50.918701171875 43 13 10 10 10 3.3039281142833516 24.178189406572315 0.0 3 0.9077821878437378 4.032362659489497 3393.0 46.11483973509934 0.0 - - - - - - - 211.0 6 5 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1917 243 C20140716_OR021_03 C20140716_OR021_03 TB420215.[MT7]-FFPNVYALLK[MT7].3b5_1.heavy 500.634 / 749.41 3770.0 50.918701171875 43 13 10 10 10 3.3039281142833516 24.178189406572315 0.0 3 0.9077821878437378 4.032362659489497 3770.0 0.0 0.0 - - - - - - - 175.66666666666666 7 3 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1919 243 C20140716_OR021_03 C20140716_OR021_03 TB420215.[MT7]-FFPNVYALLK[MT7].3y4_1.heavy 500.634 / 588.42 3921.0 50.918701171875 43 13 10 10 10 3.3039281142833516 24.178189406572315 0.0 3 0.9077821878437378 4.032362659489497 3921.0 41.75475496688742 0.0 - - - - - - - 251.16666666666666 7 6 PRKRIR protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) 1921 244 C20140716_OR021_03 C20140716_OR021_03 TB420357.[MT7]-GWTSASTSGK[MT7]PRK[MT7].3y10_2.heavy 599.011 / 653.888 2046.0 20.202099800109863 36 10 10 6 10 1.011697868184439 66.17653084238185 0.03899955749511719 3 0.838074954510532 3.024565008275083 2046.0 21.009999999999998 0.0 - - - - - - - 171.69230769230768 4 13 PTH1R parathyroid hormone 1 receptor 1923 244 C20140716_OR021_03 C20140716_OR021_03 TB420357.[MT7]-GWTSASTSGK[MT7]PRK[MT7].3y6_1.heavy 599.011 / 960.619 558.0 20.202099800109863 36 10 10 6 10 1.011697868184439 66.17653084238185 0.03899955749511719 3 0.838074954510532 3.024565008275083 558.0 0.9 2.0 - - - - - - - 0.0 1 0 PTH1R parathyroid hormone 1 receptor 1925 244 C20140716_OR021_03 C20140716_OR021_03 TB420357.[MT7]-GWTSASTSGK[MT7]PRK[MT7].3y11_2.heavy 599.011 / 704.411 1922.0 20.202099800109863 36 10 10 6 10 1.011697868184439 66.17653084238185 0.03899955749511719 3 0.838074954510532 3.024565008275083 1922.0 4.8825 0.0 - - - - - - - 220.44444444444446 3 18 PTH1R parathyroid hormone 1 receptor 1927 244 C20140716_OR021_03 C20140716_OR021_03 TB420357.[MT7]-GWTSASTSGK[MT7]PRK[MT7].3y8_1.heavy 599.011 / 1148.7 310.0 20.202099800109863 36 10 10 6 10 1.011697868184439 66.17653084238185 0.03899955749511719 3 0.838074954510532 3.024565008275083 310.0 2.55 0.0 - - - - - - - 0.0 0 0 PTH1R parathyroid hormone 1 receptor 1929 245 C20140716_OR021_03 C20140716_OR021_03 TB420426.[MT7]-VMGILPFSAPSC[CAM]GLITK[MT7].4y5_1.heavy 520.545 / 675.452 873.0 47.17634963989258 38 16 8 6 8 2.2567421726656947 35.09637618701474 0.0334014892578125 4 0.9642008884154317 6.503124132687754 873.0 8.428044922492884 1.0 - - - - - - - 199.42857142857142 2 7 SKI v-ski sarcoma viral oncogene homolog (avian) 1931 245 C20140716_OR021_03 C20140716_OR021_03 TB420426.[MT7]-VMGILPFSAPSC[CAM]GLITK[MT7].4b4_1.heavy 520.545 / 545.324 3054.0 47.17634963989258 38 16 8 6 8 2.2567421726656947 35.09637618701474 0.0334014892578125 4 0.9642008884154317 6.503124132687754 3054.0 7.550659025787965 1.0 - - - - - - - 200.8 6 10 SKI v-ski sarcoma viral oncogene homolog (avian) 1933 245 C20140716_OR021_03 C20140716_OR021_03 TB420426.[MT7]-VMGILPFSAPSC[CAM]GLITK[MT7].4b5_1.heavy 520.545 / 658.408 2007.0 47.17634963989258 38 16 8 6 8 2.2567421726656947 35.09637618701474 0.0334014892578125 4 0.9642008884154317 6.503124132687754 2007.0 9.445342318059298 1.0 - - - - - - - 185.375 4 8 SKI v-ski sarcoma viral oncogene homolog (avian) 1935 245 C20140716_OR021_03 C20140716_OR021_03 TB420426.[MT7]-VMGILPFSAPSC[CAM]GLITK[MT7].4y3_1.heavy 520.545 / 505.347 2531.0 47.17634963989258 38 16 8 6 8 2.2567421726656947 35.09637618701474 0.0334014892578125 4 0.9642008884154317 6.503124132687754 2531.0 13.936190835579513 1.0 - - - - - - - 261.6666666666667 8 6 SKI v-ski sarcoma viral oncogene homolog (avian) 1937 246 C20140716_OR021_03 C20140716_OR021_03 TB420359.[MT7]-AIQDHLLEVEQSK[MT7].4b8_2.heavy 450.254 / 532.797 N/A N/A - - - - - - - - - 0.0 - - - - - - - TPR translocated promoter region (to activated MET oncogene) 1939 246 C20140716_OR021_03 C20140716_OR021_03 TB420359.[MT7]-AIQDHLLEVEQSK[MT7].4b4_1.heavy 450.254 / 572.316 N/A N/A - - - - - - - - - 0.0 - - - - - - - TPR translocated promoter region (to activated MET oncogene) 1941 246 C20140716_OR021_03 C20140716_OR021_03 TB420359.[MT7]-AIQDHLLEVEQSK[MT7].4b5_2.heavy 450.254 / 355.191 N/A N/A - - - - - - - - - 0.0 - - - - - - - TPR translocated promoter region (to activated MET oncogene) 1943 246 C20140716_OR021_03 C20140716_OR021_03 TB420359.[MT7]-AIQDHLLEVEQSK[MT7].4b5_1.heavy 450.254 / 709.375 N/A N/A - - - - - - - - - 0.0 - - - - - - - TPR translocated promoter region (to activated MET oncogene) 1945 247 C20140716_OR021_03 C20140716_OR021_03 TB442169.[MT7]-ELAAIAFVK[MT7].2y4_1.heavy 625.392 / 608.389 18423.0 40.52050018310547 48 18 10 10 10 5.24983600914346 19.04821404436889 0.0 3 0.9853757040996843 10.192816158259507 18423.0 13.372679536679534 0.0 - - - - - - - 498.0 36 1 FAM160B1;FAM160B2 family with sequence similarity 160, member B1;family with sequence similarity 160, member B2 1947 247 C20140716_OR021_03 C20140716_OR021_03 TB442169.[MT7]-ELAAIAFVK[MT7].2b4_1.heavy 625.392 / 529.31 21311.0 40.52050018310547 48 18 10 10 10 5.24983600914346 19.04821404436889 0.0 3 0.9853757040996843 10.192816158259507 21311.0 5.035085646780863 0.0 - - - - - - - 365.0 42 3 FAM160B1;FAM160B2 family with sequence similarity 160, member B1;family with sequence similarity 160, member B2 1949 247 C20140716_OR021_03 C20140716_OR021_03 TB442169.[MT7]-ELAAIAFVK[MT7].2b6_1.heavy 625.392 / 713.431 7668.0 40.52050018310547 48 18 10 10 10 5.24983600914346 19.04821404436889 0.0 3 0.9853757040996843 10.192816158259507 7668.0 6.0317322175732215 0.0 - - - - - - - 298.85714285714283 15 7 FAM160B1;FAM160B2 family with sequence similarity 160, member B1;family with sequence similarity 160, member B2 1951 247 C20140716_OR021_03 C20140716_OR021_03 TB442169.[MT7]-ELAAIAFVK[MT7].2b5_1.heavy 625.392 / 642.394 8266.0 40.52050018310547 48 18 10 10 10 5.24983600914346 19.04821404436889 0.0 3 0.9853757040996843 10.192816158259507 8266.0 7.635261044176707 0.0 - - - - - - - 265.3333333333333 16 3 FAM160B1;FAM160B2 family with sequence similarity 160, member B1;family with sequence similarity 160, member B2 1953 248 C20140716_OR021_03 C20140716_OR021_03 TB420156.[MT7]-SLDQIPGYLNR.3y6_1.heavy 473.929 / 719.383 15089.0 35.53340148925781 47 17 10 10 10 3.272719503743149 24.527509028309886 0.0 3 0.9778194472282589 8.271231224049057 15089.0 142.81771467144858 0.0 - - - - - - - 194.66666666666666 30 6 THPO thrombopoietin 1955 248 C20140716_OR021_03 C20140716_OR021_03 TB420156.[MT7]-SLDQIPGYLNR.3b4_1.heavy 473.929 / 588.311 16800.0 35.53340148925781 47 17 10 10 10 3.272719503743149 24.527509028309886 0.0 3 0.9778194472282589 8.271231224049057 16800.0 136.99570815450642 0.0 - - - - - - - 226.36363636363637 33 11 THPO thrombopoietin 1957 248 C20140716_OR021_03 C20140716_OR021_03 TB420156.[MT7]-SLDQIPGYLNR.3y4_1.heavy 473.929 / 565.309 1944.0 35.53340148925781 47 17 10 10 10 3.272719503743149 24.527509028309886 0.0 3 0.9778194472282589 8.271231224049057 1944.0 35.39076923076923 1.0 - - - - - - - 146.125 3 8 THPO thrombopoietin 1959 248 C20140716_OR021_03 C20140716_OR021_03 TB420156.[MT7]-SLDQIPGYLNR.3y5_1.heavy 473.929 / 622.331 7467.0 35.53340148925781 47 17 10 10 10 3.272719503743149 24.527509028309886 0.0 3 0.9778194472282589 8.271231224049057 7467.0 108.63330599547511 0.0 - - - - - - - 189.0 14 7 THPO thrombopoietin 1961 249 C20140716_OR021_03 C20140716_OR021_03 TB420424.[MT7]-DINRLLEETQAELLK[MT7].4b8_2.heavy 519.05 / 564.313 N/A N/A - - - - - - - - - 0.0 - - - - - - - SRCIN1 SRC kinase signaling inhibitor 1 1963 249 C20140716_OR021_03 C20140716_OR021_03 TB420424.[MT7]-DINRLLEETQAELLK[MT7].4b7_1.heavy 519.05 / 998.575 N/A N/A - - - - - - - - - 0.0 - - - - - - - SRCIN1 SRC kinase signaling inhibitor 1 1965 249 C20140716_OR021_03 C20140716_OR021_03 TB420424.[MT7]-DINRLLEETQAELLK[MT7].4b4_1.heavy 519.05 / 643.364 N/A N/A - - - - - - - - - 0.0 - - - - - - - SRCIN1 SRC kinase signaling inhibitor 1 1967 249 C20140716_OR021_03 C20140716_OR021_03 TB420424.[MT7]-DINRLLEETQAELLK[MT7].4y3_1.heavy 519.05 / 517.383 N/A N/A - - - - - - - - - 0.0 - - - - - - - SRCIN1 SRC kinase signaling inhibitor 1